Evaluation of GP Pharmacists’ role by key stakeholders in England & Australia by Akhtar, Noshad
U n iv er s i ty o f  H u d d e r s f i e l d  R e p o s i t ory
Akht ar, N os h a d
Evalu a tion  of GP P h a r m a cis t s’ r ole  by  key s t ak e hold e r s  in E n gla n d  & Aust r ali a
Ori g i n a l  Cita t i o n
Akht ar, N os h a d  (202 0) Evalu a tion  of GP P h a r m a cis t s’ role  by  key s t ak e hold e r s  
in  E n gla n d  & Aust r alia.  M a s t e r s  t h e sis,  U nive r si ty of H u d d e r sfield.  
This  ve r sion  is available  a t  h t t p:// ep rin t s .h u d. ac.uk/id/ ep rin t/352 9 3/
The  U nive r si ty Re posi to ry is a  digi t al  collec tion  of t h e  r e s e a r c h  ou t p u t  of t h e
U nive r si ty, available  on  Op e n  Access .  Copyrig h t  a n d  Mo r al  Righ t s  for  t h e  
it e m s
on  t hi s  si t e  a r e  r e t ain e d  by t h e  individu al a u t ho r  a n d/o r  o t h e r  copyrigh t  
ow n e r s .
U s e r s  m ay  a cc e s s  full it e m s  fr e e  of c h a r g e;  copie s  of full t ex t  it e m s  g e n e r ally
c a n  b e  r e p ro d uc e d,  dis pl aye d  o r  p e rfo r m e d  a n d  given  to  t hi rd  p a r ti e s  in a ny
for m a t  o r  m e diu m  for  p e r son al  r e s e a r c h  o r  s t u dy, e d u c a tion al  o r  no t-for-p rofi t
p u r pos es  wi tho u t  p rio r  p e r mission  o r  c h a r g e ,  p rovide d:
• The  a u t ho r s,  ti tl e  a n d  full bibliog r a p hic  d e t ails  is c r e di t e d  in a ny copy;
• A hyp e rlink  a n d/o r  URL is includ e d  for  t h e  o riginal m e t a d a t a  p a g e;  a n d
• The  con t e n t  is no t  c h a n g e d  in a ny w ay.
For  m o r e  info r m a tion,  including  ou r  policy a n d  s u b mission  p roc e d u r e ,  ple a s e
con t ac t  t h e  Re posi to ry Tea m  a t :  E. m ailbox@h u d.ac.uk.




Evaluation of GP Pharmacists’ role by 







A thesis submitted in partial fulfilment of the requirements for the 














There is a consensus on the shortage of General Practitioners (GPs) and Nurses in general 
practice framework, creating an opportunity for clinical pharmacists to step-in as General 
Practice Pharmacist (GPP). In this qualitative comparative study expectations and perceptions 
about GPPs’ role in England & Australia has been evaluated. The study is based on the 
interviews with key stakeholders, from England and Australia, including GPs, Nurses, GPPs, 
Organisational lead and Academia. The participants were involved in a semi-structured, 
audio-recorded interviews, which were later transcribed verbatim, coded and underwent a 
thematic analysis to extract the general themes. These were raised by participants, based on 
their views and experiences about GPPs’ role. From the transcribed data, main extracted 
themes were initial expectations & reservations by key stakeholders, barriers and facilitators, 
working collaboration, GPPs’ skillset, views on key performance indicators (KPIs), patients’ 
feedback, and the stakeholders’ views on the future of GPP in England & Australia. The 
participants from both England & Australia did acknowledge the growing role of GPP. Few 
concerns were raised by some participants about aspects like role description, training 
pathways, prescribing protocols and funding. Despite these concerns, all participants strongly 
believed that by taking steps to overcome main barriers like funding in Australia and training 
pathway in England, GPP could be an ideal professional to bridge the gaps in general practice 
framework. Based on the comparative data, recommendations were made on funding 
structure, role description, prescribing qualification, training pathway and key performance 
indicators for role of GPP in general practice framework. These recommendations can be used 
as guidance for both England and Australia to learn from each other’s and implement relative 
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Chapter No. 1 
INTRODUCTION 
General practices, as part of primary care, are central to the framework of health care systems 
like National Health Services (NHS) in England and Medicare in Australia. General practices 
are the first line of contact for healthcare needs like disease prevention, differential diagnosis, 
monitoring and management of medical conditions. These are provided by a multidisciplinary 
clinical team, led by GPs.  
Clinical pharmacists, working as General Practice Pharmacist (GPP), are progressively 
becoming a part of clinical teams in general practices, either employed directly by practices 
as in-house GPP or integrated as part of medicine management organisations. In England, 
GPPs were being funded under the NHS England pilot scheme (NHS England, July 2015). It has 
been replaced by new Network Contract Directed Enhanced Service from 1st July 2019 (NHS 
England, 2019).   
To evaluate the present and future impact of GPPs’ role, it is important to understand how 
this role emerged over a period of time.  
1.1 General Practice in Crisis 
Workload crisis in England’s general practices is widely acknowledged as it has been under 
immense pressure due to nature of intensity and difficulty of workload especially on General 
practitioners (GPs) which doesn’t match with proportional growth in either government 
funding or GPs workforce. An English study, conducted to analyse clinical workload in UK 
primary care between 2007-2014, showed a remarkable rise of 16% increase in GP workload 
(Avery, A.J. 2017). Factors including ageing population, increasing patient numbers with 
multiple morbidities requiring complex medical care, focus on transferring responsibility from 
secondary to primary care and rising expectations at public and political level have made GPs 
job very stressful (Baird et al., 2015), resulting in many doctors opting against to become GP 
as their career (Beech et al., 2019). This also leaves a massive imbalance between resources 
and demands for efficient general practice framework.    
1.2 Pharmacists’ Workforce Crisis 
There is a crisis in pharmacist’s workforce as well but ironically opposite to what GPs are 
facing. After the UK government refusal to cap students number in pharmacy degree 
programmes, the centre of workforce intelligence, an advisory organisation for workforce 
requirements for health and social care in England, estimated an expected excess of some 
11,000-19,000 pharmacists by 2040 (Pharmaceutical Journal, 2015). This number opened 
discussion on how to use pharmacist workforce efficiently in NHS future framework. 
Eventually, it led to the emergence of a unique opportunity for pharmacist professionals 
under NHS England pilot scheme to integrate pharmacists into general practice settings as 
GPPs. This is to work alongside GPs, nurses and other healthcare professionals from or within 
general practice to bridge the gap between workforce and demands in primary healthcare 




1.3 GPPs’ Role in England 
GPP was not a new phenomenon at the time when NHS pilot scheme was launched, as some 
practices already had clinical pharmacist working as part of their clinical team for few years. 
These were either employed directly or as part of medicine management organisations like 
PCTs (now called CCGs). National Health Service (NHS) pilot scheme for GPP was the first time 
when NHS England did consider to implement it at a policy level to utilise clinical and 
management skills of pharmacists, viewing it as an integral part of general practices 
(Pharmaceutical Journal, 2015).  
Traditionally pharmacist has been considered as “Dispensing pharmacist” supplying and 
compounding medications and delivering locally commissioned services, a setting where 
clinical expertise of pharmacist has never been utilised up to its full potential, and it has been 
hard for pharmacists to get recognition for their clinical roles by other healthcare 
professionals and patients (Ng & Harrison, 2010). This scenario has changed though with 
some key publications (Silcock, Raynor & Petty, 2004), (N et al., 2002), (Tan et al., 2012) (Tan 
et al., 2014), (Nkansah et al., 2010) encouraging a more integrated primary care vision in 
England involving a multi-disciplinary clinical team to improve working collaboration among 
healthcare professionals. 
1.4 NHS England Pilot Scheme 
In 2008, the Department of Health published a white paper “Pharmacy in England. Building 
on strengths-Delivering the future” highlighting the development and skills of the pharmacist 
as a healthcare professional (Department of Health, 2008). This paper had a significant impact 
on the professional growth of the pharmacists, leading them to take new roles in primary care 
including Independent and supplementary prescribing. A systematic review published in 2010 
highlighted the positive impact of non-dispensing roles of clinical pharmacists on patients’ 
outcomes and prescribing patterns (Nkansah et al., 2010)   
In 2014, Royal Pharmaceutical Society (RPS) and NHS Alliance made the recommendation to 
integrate pharmacist into general practices, highlighting the significant improvement in the 
performance of various surgeries that already had a pharmacist working as part of their teams 
(Bares, Ashraf and Din, 2017).   
NHS alliance in a report, published in 2015, called “Making time in general practice”. In this 
report the data was presented  to recruit clinical pharmacist into general practice in order to 
reduce the workload on GPs, describing pharmacist as a hidden army to rescue general 
practice (Making Time in General Practice, NHS England 2015). 
 
1.4.1 General Practice Forward View 
The idea to integrate GPP into general practice was re-emphasized by General practice 
forward view (General Practice Forward View, NHS England 2016) . This outlined the 




the main recommendations was to strengthen the general practice workforce by a range of 
healthcare professionals including clinical pharmacists leading from the front.  
In 2015, NHS England launched first phase of Pilot scheme, as a part of new deal for general 
practice defined by the NHS five year forward review after close collaborative work with Royal 
College of General Practice, BMA’s general practice committee, Royal Pharmaceutical Society 
and the Health Education England  (NHS England: Clinical pharmacists in general practice pilot, 
2015). The aim of the pilot scheme was to fund, recruit and employ a clinical pharmacist in a 
GP practice with objectives to support GPs by reducing their workload. This was also to 
improve patient care and by bridging the gaps present in primary care healthcare system with 
their clinical and management skills. It was highlighted that this role has the potential to be a 
win-win situation for patients, their GPs and for pharmacists. This is a working relationship in 
which GPs would be benefited by using clinical skills of pharmacists while pharmacist has a 
new role to build as their careers. (NHS England: Clinical pharmacists in general practice pilot, 
2015)  
1.4.2 Funding 
Initial total funding under NHS pilot scheme for GPP was £15 million. NHS England partly 
funded the financing cost of GPP for 36 months (60% in 1st year, 40% in 2nd year, 20% in 3rd 
year and 0% after 36 months). Each pilot site model was based on one senior pharmacist and 
5 clinical pharmacists and it was expected to recruit around 250 pharmacists in initial phase 
(NHS England, July 2015). This initial funding was increased to £31 million, aiming to continue 
part-funding of further 403 new clinical pharmacists across 73 sites in England. (NHS England, 
October 2015).   
The pilot scheme had a massive positive response from the general practice sector, especially 
GPs who acknowledged that the clinical expertise of GPPs in reducing their workload. 
Sametime, patients and carer also acknowledged the role of GPP, highlighted by a patient 
survey carried out in 2016 by patients’ association in partnership with a primary care 
pharmacist association (The Pharmacist Association, 2016).  
With such an encouraging response from both GPs and patients, NHS England reviewed its 
funding and agreed to double the initial funding to £31million. In 2016 under General Practice 
Forward View, the funding was injected with a new central investment of £112million to 
support further 1500 clinical pharmacists in general practice by 2020 (General Practice 
Forward View, 2016).  
1.4.3 GP Five-year Contract Framework 
The new GP five-year contract framework, launched in January 2019 aims to support Primary 
Care Networks (PCNs) under a new funding model by recruiting additional 20,000 healthcare 
staff in primary care including clinical pharmacists (NHS England, 2019).  
1.4.4 Proposed GPP’s Role Specifications 
The proposed job specifications for GPP varies from a medicine management role to carry out 




medication reviews, medicines reconciliation, chronic disease management, minor ailment 
clinics, repeats prescription management, prescription concordance and running audits. 
These all activities aim to improve overall practice performance (Making Time in General 
Practice, NHS England 2015) 
1.5 GPPs’ Role in Australia 
Like England, various healthcare systems around the world have been evaluating GPPs’ role 
and its overall impact from multiple dimensions. Countries with robust healthcare systems 
including Australia, Canada, New Zealand, and the USA have designed national programmes 
to integrate pharmacists in a non-dispensing clinical role into general practices (Karampatakis 
et al., 2019a). In a recent report published by Royal Australian College of General Practitioners 
(RACGP), there are close to 37,000 GPs, and 6500 accredited general practices across 
Australia, with GP to patient ratio decreasing especially in remote areas (General Practice: 
Health of the Nation, 2019). According to this report, 13% of responded GPs did say that their 
practices employ pharmacists to help with the workload, while the figure for nurses was 92%. 
These figures reflect that the GPP role is in it’s initial phase in Australia. The overall impact on 
practise still need to be evaluated in the context of general practice framework. 
Australian government in 2010-11 budget committed further $AUS370 million for 
development of general practice (GP) super clinic programme with many clinics incorporating 
pharmacist services which created the opportunity to explore new models of practice to 
further utilise clinical pharmacist in primary care settings . This paved the way for an 
established GPP role in Australian healthcare system (Freeman et al., 2012a). This working 
collaboration between GPs and the pharmacist became stronger with the introduction of a 
direct referral by GPs for Home Medication Reviews (HMR) in October 2011 (Tan et al., 2014c)  
In 2015, Australian Medical Association (AMA) after consultation with Pharmaceutical Society 
of Australia (PSA) released a proposal to make clinical pharmacists, in a non-dispensing role, 
a vital component of the future general practice healthcare team by establishing a supportive 
funding program called Pharmacist in General Practice Incentive Programme (PGIPP) 
(Australian Medical Association, 2015). This proposal was backed by independent analysis 
from Deloitte Access Economics, estimating the benefit-cost ratio of 1.56 from AMA’s 
proposal which means from every $1 invested in the programme, generated savings will be 
$1.56 (Deloitte, 2015). A proposed role for GPP, backed up by Deloitte data, received very 
positive feedback by stakeholders in the Australian healthcare system. Australian general 
practice leaders do support the concept of employing GPP in GP led team (Freeman et al., 
2012b). Emphasising the importance of GPs and pharmacist working collaboration, UGPA 
(United General Practice Australia) was very welcoming to include GPP into GP-led healthcare 
professionals’ team. This is in the view to improve prescribing patterns, efficient medication 
usage, and reducing patient’s hospital admission due to adverse drug events. (RACGP, July 
2015).   The idea of GPP has also been endorsed by recent position statement given by RACGP, 
highlighting the importance of GPP in team-based care to provide coordinated, collaborative, 




1.6 Rationale of Study 
This study aims to explore key stakeholders’ views about the GPP role since the beginning of 
the GPP pilot scheme in England and Australia. Several research articles have been published 
in the UK, which evaluates the impact of GPPs. NHS England itself did fund an evaluation 
report, aiming to provide an overview of the first phase of the pilot scheme with suggestions 
for final roll-out. This was published in 2018 and was undertaken by the University of 
Nottingham (Mann et al., 2018).  
Most of these studies evaluate overall GPP’s impact on general practices from different key 
performance indicators but lack the detailed insight about the change in views and 
perceptions of key stakeholders from initial phase to present and how this transition can be 
analysed to design a more successful framework with improved working collaboration among 
GPPs and other healthcare professionals especially GPs.  
Published reports and articles indicate that the role of GPP is evolving at a high pace and 
further research needs to be done to define parameters like views of critical stakeholders, 
future training pathway, defining job description, cost implications, barriers and facilitators 
and government policy about future funding. 
Also, up to this date, no comparative study has been undertaken to compare the dynamics of 
GPP role in England with the one in Australia. This study would provide policy insight into this 
and will provide future recommendations. The thesis also aims to explore the evolution of 
general practice pharmacist’s role in Australia and England, offering an insight into 
professional and organisational implications of this role.  
1.7 Aims & Objectives of Research 
Aim 
To explore key stakeholders' expectations and perceptions about GPPs' roles in England and 
Australia. 
Objectives 
• To evaluate possible barriers and facilitators affecting GPP role. 
• To compare the impact of GPPs' role on the healthcare system in England and 
Australia. 
• To explore the collaboration of GPP with the other healthcare professionals in their 
respective healthcare systems 
• To document recommendations for future GPPs' roles, including job description at the 
organisational level. 







Chapter No. 2 
LITERATURE REVIEW 
This chapter elaborates on the research that has already been conducted on the role of GPP 
to gather the views and perceptions of different stakeholders in various healthcare systems 
around the world.  
Fish et al. published a systematic review in 2002 and found that studies conducted on general 
practice based pharmaceutical services have primarily been of poor methodological quality, 
showing inconsistent results. Since then, there has been an increase in the number of 
published studies, exploring the role of GPPs. Most of these studies have similar themes like 
expectations of key stakeholders from this role, barriers and facilitators as well as exploring 
the future guidelines. The gaps were identified in the published literature, which provided the 
basis to design the semi-structured interview guide for this study.    
This section aims to gather and document literature about GPPs’ role at a global level. It 
explains in detail the literature search strategies that were used, explanation of the inclusion 
and exclusion criteria for the studies. This is followed up by a summarized review of selected 
studies.  
 
Table 1: Inclusion & exclusion Criteria 
 
No Category Inclusion Criteria Exclusion Criteria 




January 2000 – December 
2019 
Before January 2000 
3 Publication 
Type 
Full-text original research 
articles, policy reports, 
Systematic reviews 




Professional views, reviews, 
key performance indicator 
reports and impacts of GPPs’ 
role. 
 










































Figure 1: Study selection process 
 
Figure 1 explains the stepwise approach towards literature review, using keywords along with 
inclusion and exclusion criteria given in table 1 and 2. After screening of available literature, 




Records identified through database 
searching / total hits  







































Records after duplicates removed 
(n =  5875) 
Records screened 
(n =  5875 ) 
Records excluded 
(n = 2315) 
Abstracts, Newspaper articles, 
published before 2000. 
 
Full-text articles assessed for 
eligibility 
(n =  3560) 
Full-text articles excluded, 
with reasons 
(n = 3512 ) 
Studies conducted on 
community pharmacists, 
hospital pharmacists and 
nurses.  
Studies included in the 
synthesis 





2.1 Synthesis of Literature Review 
2.1.1 England General Practice Framework and Scope of GPPs’ Role 
General practices are the central hub in a primary care framework of various healthcare 
systems in developed countries. In the UK, National Health Services (NHS), the world’s most 
extensive healthcare system was established in 1948 on the idea of a universal health system 
in the whole country. This was based on reliable primary care services within which general 
practice has the central role. As quoted in the British medical journal “If general practice fails, 
the whole NHS fails” (Madan et al., 2017) 
Since the creation of NHS, there have been significant changes in the general practice 
framework. The General Practitioner (GP) contract in 1990 was the first challenge to the 
independent contractor status of GP. This is when not only there was a reduction in funding 
but also a fee for service pay model around the promotion of health improvement activities 
was introduced.  
Quality and Outcomes Framework (QOF): General practitioner contract 2004 changed the 
overall shape of how general practices were funded with the introduction of a pay for 
performance scheme “Quality and Outcomes Framework (QOF)” in England’s general 
practice. It moved the responsibility of patient care from single GP to the general practice 
comprised of a group of one or more GPs. In this contract, 20-25% payment for practices was 
based on available QOF points, a criterion to measure the quality of care. However, the 
effectiveness of this contract was disputed and this was highlighted in a systematic review 
(Gillam, 2012), The GP contract in 2013/14 aimed to improve general practices by overall 
tightening of  GPs’ points achievement by reducing total points and changing the indictors for 
points.  
The baseline for QOF-based GP contract is like an audit mechanism to control the funding 
available for general practices, and at the same time, it adds more responsibility on GPs to 
achieve financial incentives linked with points-based system. This opened the debate about 
the available workforce in general practices to achieve such targets and how professionals 
like clinical pharmacists can be integrated into clinical team as GPP. 
2.1.2 General Practice Workforce Crisis in England 
“The NHS could be short of 70,000 nurses and 7000 GPs within 5 
years unless urgent action is taken to address a growing staffing 
crisis” (Beech et al., 2019)  
England’s’ general practice is under immense pressure due to the nature of intensity and 
workload difficulty leading to a feeling of demoralisation, especially for the GPs. The latest 
research report indicates a worsening crisis in NHS as 4 out of 10 GPs are planning to quit, 
average face to face GPs’ consultation time has increased by 7% which means GP direct 




general perception that the work in general practice is more stressful. Also, with reduced 
funding, there is a less reward in comparison to other health care fields. The funding is also 
linked with performance-based targets, which is again extremely difficult to achieve due to 
lack of workforce.  
However, new pharmacist workforce is proportion to the demand. There are more than 
55,000 registered pharmacists in Great Britain in various settings (General Pharmaceutical 
Council, 2018), and the numbers are growing every year.  Department of health in December 
2012 requested the UK government to put a cap on student numbers in the pharmacy degree 
programmes which was refused by the government. Afterwards, the centre of workforce 
intelligence, an advisory organisation for workforce requirements for health and social care 
in England, estimated that by 2040 between 11,000-19,000 pharmacists will be in the excess 
range (Pharmaceutical Journal, 2015) 
While there is a discussion on workforce crisis in general practice, the focus is now 
pharmacists’ workforce and how this could be used to fill the gaps in primary care.  It was 
observed that eventually, it will lead to new opportunities for pharmacist professionals as 
GPPs, working alongside GPs, nurses and other healthcare professionals. 
Integrating a GPP into general practice was not a new concept as pharmacists were already 
working in many surgeries either employed directly or as part of medicine management 
teams in primary care organisations like CCG (Pharmaceutical journal, 2015). However, during 
this time it was more like a desirable effect rather than an integral part of general practice 
teams. There were also models in UK where pharmacists were involved in providing enhanced 
pharmaceutical services under local pharmaceutical contract (LPS). This requires a strong 
working collaboration among GPs and community pharmacists to integrate pharmacists 
effectively. However, despite some positive feedback a study has highlighted the concerns of 
GPs about LPS and lack of overall success to achieve the targeted goals (Bradley et al., 2008). 
 
2.1.3 NHS England Pilot Scheme 
NHS pilot scheme was the first time when GPPs’ role was accepted, recognised and integrated 
at the government policy level in England as part of building the workforce. While considering 
the actions needed to tackle GPs workforce crisis, National Health Service (NHS), Health 
Education England (HEE), Royal College of GPs (RCGP) and GP committee of British Medical 
Association (BMA) working in collaboration with Royal Pharmaceutical Society (RPS) rolled 
out a 4 years pilot to test the effectiveness of pharmacists in general practice as GPP (NHS 
England: Clinical pharmacists in general practice pilot, 2015). The main aim was to strengthen 
the multidisciplinary clinical team in primary care network, which would help to reduce the 
workload of overburdened GPs in both patients facing clinical and medicine management 
roles.  
Funding module for pilot scheme has been explained briefly in introduction chapter but to 
summarise, Initial funding for pilot scheme was £15 million which was later increased to firstly 




view, 2016, aiming to support further 1500 clinical pharmacist in general practice by 2020 
(General Practice Forward View, 2016). Partial funding for pharmacists’ salary while working 
in general practice, structured training, and support along with clinical mentorship, made the 
base of this pilot scheme.   
Most of the published literature (Tan et al., 2014), (Avery, 2017), (Bush et al., 2018) database 
has been about the impact of GPP under this pilot scheme evaluated in various dimensions. 
An evaluation report on the initial phase of pilot scheme was published in 2018, carried out 
by University of Nottingham and this was funded by NHS England. It evaluates the impact of 
the initial phase of the pilot scheme from various aspects like perceptions about GPP, role 
specifications, proposed KPIs, barriers and facilitators and training for GPP (Mann et al., 2018). 
2.1.4 Australian General Practice Framework and GPPs’ Role 
GPP role in Australia is not an established one where all stakeholders are trying to find the 
right mechanism for this integration. However, like in England, GPP is not a new concept with 
literature showing it had a limited acceptance within general practice framework though the 
idea is getting more support (Freeman et al., 2012d) as suggested by the latest position 
statement by RACGP, 2019.  
In the Australian healthcare system, major portion of pharmacist I.e. 85% work as community 
pharmacists mostly working in dispensing roles (Tan et al., 2014a) & (Freeman et al., 2014).  
GPs and pharmacists have a limited team-based working relationship in the form of home 
medication review service, where GPs refer patients to accredited pharmacists to conduct 
home medication reviews in a structured funding mode. Published literature in Australia has 
shown the views of key stakeholders on how to extend the proposed roles and government 
funding (Tan et al., 2012), (Tan et al., 2014a), (Freeman et al., 2012e) & (Freeman et al., 2014). 
When compared to research in England, though the basic concepts are almost similar as for 
barriers and facilitators, the main focus has been on the funding aspect of the proposed role 
as medical practices, been private businesses in Australia, are reluctant to recruit GPP, unless 
they have clarity on funding.  
2.2 Barriers & Facilitators 
Pharmacist integration into general practice had to face several initial barriers, some of which 
are still visible in practice. Jorgenson et al., (2014) listed seven main barriers and facilitators 
for GPP role: 
• Relationships, trust and respect. 
• Pharmacist role definition. 
• Orientation and support. 
• Pharmacist personality and professional experiences  
• Pharmacist presence and visibility. 
• Resources and funding 




The success of this role requires a detailed analysis of these barriers and facilitators with 
efforts to improve working collaboration with adequate support and planning at a personal 
and organisational level.  
 
2.2.1 Pharmacy Culture: Barrier to Pharmacy Practice Change: 
Globally, pharmacy profession has been under a lot of pressure within various healthcare 
sector as there has been a continuous discussion on how effective the pharmacists are in their 
roles. Pharmacists are mostly visualized in a dispensing role working in community pharmacy 
(Tan et al., 2014a) but there is surly a need to change this perception into a more patient-
centred role like GPP to improve patient outcomes (Freeman et al., 2014). Though, there are 
various barriers who can hinder this change however its’ worth exploring the pharmacy 
culture, or whether the pharmacists are willing to take on new roles like GPP and advance 
their careers. Factors like lack of confidence, scared of facing new responsibilities, paralysis in 
the face of ambiguity, need for approval and risk aversion were described as personality traits 
keeping pharmacists away from success (Rosenthal, Austin & Tsuyuki, 2010). Available 
literature shows pharmacists have taken the patient centred roles in primary and secondary 
care but there is always the risk that pharmacists will not be able to respond to the challenges 
of new roles likes GPPs (Mann et al., 2018)  & (Butterworth et al., 2017). This is also due to 
lack of education and because such roles push them out of their comfort zone i.e. in a 
dispensing role. Young pharmacists, who are willing to bring the change suits better to such 
roles as they continue with efforts that need to update their training and knowledge 
(Rosenthal, Austin & Tsuyuki, 2010).   
2.2.2 Mismatch between Stakeholders’ Expectations & GPPs’ Proposed Roles 
As an evolving phenomenon, it is essential to understand the concerns and aspirations of 
critical stakeholders from GPP role, especially from a GP and nurse perspective.  
Pharmacists are traditionally considered in a dispensing role working behind the counter in 
community or hospital pharmacy. Therefore, when the idea of GPP in a non-dispensing role 
was introduced in primary care there was a wide range of apprehensions and expectations 
from general practice workforce.  Most of the studies highlighted the aspect of mismatch 
between initial expectations and what pharmacist role was or the ability of GPP to perform in 
the beginning. There were some hurdles as expected at initial phase mainly around aspects 
like building trust-based relationship within the practice and with other sectors of primary 
care like community pharmacy, Clinical Commissioning Group or hospital. National evaluation 
report (Mann et al., 2018) has reported the presence of mismatch in GPs expectations from 
GPP resulting in some unrealistic assumptions about pharmacist capabilities, highlighting the 
importance of GPs guidance about this role. 
It is vital to understand the reasons behind this mismatch in expectations. As clinical 
pharmacists were considered to bridge the gap in workforce crisis at the general practice 




help them by running clinics. It also reflects a lack of initial inter-professional working 
relationship among GPs and pharmacists as healthcare professionals. (Mann et al., 2018). 
  
2.2.3 Initial Concerns of GPP 
Pharmacist perception of their roles as GPP differs across interprofessional teams which could 
be attributed to different educational background, philosophy of practice or characteristics 
of individual pharmacists (Farrell et al., 2013) 
Most of the published literature has focussed mainly on exploring views of other key 
stakeholders, primarily GPs, but it is equally vital to understand the opinions and perceptions 
of pharmacists. Pharmacists were mostly considered to be in a dispensing role at community 
pharmacy, so when the idea of GPP was brought up at policy level, there were also barrier 
among pharmacist about their clinical knowledge, patient-facing skills to run clinics, 
expectations by GPs and doubt about their acceptance in general practice as part of the 
clinical team.  
Nabhani-Gebara et al., (2020) in the latest study on GPP has presented some of the concerns 
stated by pharmacists which mainly include lack of trust with healthcare professionals and 
clerical staff, lack of role description as well as other organisational issues including lack of 
rooms or support. 
An element of mismatch in initial expectations from the pharmacist perspective is also 
present in literature. This is again, mainly attributed to lack of initial training and 
understanding of the role.  
Another concern on the pharmacists’ part was about key performance indicators (KPIs), i.e. 
how they would be able to evaluate or document their effect on general practice in numbers 
or figures. NHS England pilot scheme has a proposed set of ten KPIs to evaluate GPPs’ impact 
on general practice framework (NHS England: Clinical pharmacists in general practice pilot, 
2015). Pharmacists in a published study about KPIs expressed their concerns that the KPIs are 
mostly designed according to economic priorities, mainly how to save money for NHS and is 
not highlighting the quality of pharmacists' actual work. Also, in KPIs, there is a high possibility 
of impact by different people’s contribution, which again would indirectly impact an overall 
pharmacist performance. (Karampatakis et al., 2019a & Karampatakis et al., 2019b) 
Pharmacists have also shown concerns about the lack of understanding of their role by a 
patient. As this is not clear sometime patients do show dissatisfaction with GPP in the patient 
satisfaction surveys. This perhaps impacts on pharmacists’ job performance.  
2.2.4 Job Description / Role Specification 
Lack of role specifications can act both as a barrier as well as a facilitator for GPPs. On one 
side, it can lead to a mismatch of expectations, but on the other hand, it also allows practice 
staff and pharmacists to discuss the role and make plans to achieve these goals moving 
forward. GPs mostly hold the key to job description of a GPP and it depends on what roles 




suggested that GPs generally prefer and facilitated pharmacists’ involvement in prescribing 
related tasks but are not so supportive for direct patient care activities like GPP led in-house 
clinics. An article by Farrell et al (2013) described that there can be 2 types of pharmacists 
working as GPP, one is physician oriented which is mainly responding to physician or doctor 
requests or given tasks. Other one is working at multiple levels of interaction to provide 
patient-centered care, acting as source of education/information on medicines, and initiating 
system-level interventions to improve drug therapy. 
Bradley et al., (2018) in a cross-sectional survey of 145 pharmacists reported having the first 
evaluation from the national pilot scheme in England. This focused on integration and the role 
evolution of this role. It ranges from patient-facing to non-facing roles. Some of the 
pharmacist experiences from the study reflect lack of job description as a barrier as well as a 
facilitator at the same time. 
As stated by (Sims & Campbell, 2017), new GPP role has changed the dimensions of pharmacy 
profession. If it gets support what It needs, GPP will become a robust and trustworthy 
profession. It will also strengthen the bond between patient and pharmacists as well as help 
to enhance medication appropriateness and compliance with the patients.   
2.2.5 Training and Education 
Lack of initial training for GPP is another barrier. GPP role is a specialised role that needs 
expertise in clinical skills as well as in management. Pharmacists working in practice have 
shown concerns about the level of training they had gained during a pharmacy career, stating 
it's not enough to take on this challenge and specific postgraduate training is required. (Ryan 
et al., 2018) 
In England, GPPs are trained by Centre for Pharmacy Postgraduate Education (CPPE) under 
the GPP training pathway. In Australia, the pharmacist needs to undertake demanding 
training to get accreditation for home medication review service (HMRS). It makes the base 
for them to acquire the GPP role as this could strengthen their clinical knowledge. In a study 
by Freeman et al., (2012), participants highlighted the importance of advanced training to 
take GPP role in Australia.   
Training should be a continuous professional development process, and pharmacists should 
attain the training as per the needs of the practice. Butterworth et al., (2017), concluded that 
training should include clinical skills through exposure to general practice and should be 
delivered by primary care practitioners. This aspect has been discussed in national evaluation 
report where training for GPP by GP mentors and individuals who have experience of working 
in general practice has been highlighted. A latest study by (Matheson et al., 2020) evaluated 
the GPP response on training programmes. The study has shown the need and desire by GPP 
to attain structured training to strengthen clinical and patient-communication skills. This 
highlighted the need to integrate a structured training programme for a GPP specially in initial 





2.2.6 Key Performance Indicators (KPIs) 
Fernandes et al., (2015) recognized ideal KPIs for pharmacy services as “a measure that 
reflects quality, relates to pharmacists’ roles and is supported by adequate evidence” 
As mentioned earlier, there is an ongoing concern within GPPs about the absence of an 
appropriate mechanism of measuring KPIs of GPP role. Most feedback given by pharmacists 
and GPs in a study was that the current electronic system, which records codes for the daily 
activities is not ideal for measuring the clinical effort being put in by GPP. These concerns 
highlighted the need to have KPIs, which can better reflect GPPs’ role. This means to generate 
new activity codes which could document a range of GPP responsibilities (Karampatakis et al., 
2019b).  
2.2.7 Funding / Cost  
The cost of employing a pharmacist is one of the main barriers. Depending on healthcare 
structure, different countries have proposed different funding models for GPP. In England, a 
major portion of the funding is coming from money available via NHS pilot scheme. Though 
the concerns had been raised for future when surgeries would have to pay 80% of pharmacist 
wages, asking whether they should opt for more GP sessions, a full-time nurse or a GPP 
(Avery, 2017). However, in Australia, there is no such funding structure available specifically 
for GPP.  
Ideally, cost of employing GPP should be accounted against the savings generated by the 
pharmacists in practices. These cost savings include decreased workload on GPs, reduction in 
medications error, improvement in patient safety, improved patient service as well as 
reduction in drug budget (Ryan et al. 2018) 
Bush et al., (2018) in a study explored interventions and cost savings by GPPs over a period of 
9 months working across 49 general practices. Against a total of 23172 interventions, there 
was a cost-saving of over 1 million pounds. In 4 months, pharmacists saved 628 GP 
appointments and 647 hours that usually GPs dedicate to medication reviews or repeat 
prescription management. Although in England, funding for GP pilot scheme has been 
replaced by a combined PCN (Primary Care Networks) funding, it is strongly believed that the 
GP practices will carry on recruiting pharmacists as part of their multi-disciplinary team in 
England. 
In Australia, the signing of the Fifth community pharmacy agreement (5CPA) resulted in a 
change of business rules for home medication review service allowing GPs to directly refer to 
an accredited pharmacist of patient’s choice (Pharmacy Guild of Australia, 2010). Until now, 
this service remains the primary funding structure for pharmacists, and most GPs aim to 
utilise the same funding when integrating pharmacists into practice, resulting in role 
limitations. Freeman et al., (2012) in a study agreed that a mix of government and private 





2.3 Professional-Working Collaboration 
The success of GPPs is based on the strength of the professional working bond between 
pharmacists with other healthcare professionals, especially GPs and Nurses. As mentioned in 
previous section, there was an initial mismatch in expectations (Mann et al., 2018). 
Furthermore, there was a factor of deskilling other healthcare professionals by GPP, which 
left a negative impact on the scenario especially at the beginning. But with time and improved 
understanding of roles, the working collaboration has massively improved between GPPs with 
not only healthcare professionals but also with the clerical or management staff in the 
organisations.   
2.3.1 Relationship with GPs 
Most literature published on this topic has been focused on the perceptions, expectations 
and reservations of GPs or physicians about integrating pharmacists into general practice 
clinical teams. Both sides of coin are visible in literature where at one end GPs are reluctant 
to accept pharmacists as a solution to workforce crisis, while at the other end GPs have given 
positive feedback on roles being performed by GPPs resulting in reduced workload on GPs 
and more spare hours to spend on GPs specific tasks like increased patient-facing activities.  
As mentioned earlier, the GPPs’ role was hindered initially due to practitioners' perceptions 
and mismatch between expectations, resulting in a tense relationship in the start as both 
sides were not clear how to facilitate each other roles (Nabhani-Gebara et al., 2019). 
Prescribing is the main activity in general practice and GP prescribing is often influenced by 
experiences with individual patients. Some GPs may feel slightly offended or threatened by 
advice from GPP who normally try to promote a rational approach which highlights the 
importance of a strong working bond and a trust-based relationship. GPs will need to be 
reassured about the training, standards, clinical effectiveness, and cost-effectiveness of 
practice-based pharmacists (MARTIN, LUNEC & RINK, 1998) 
Once the understanding developed between the both, the scenario was bound to improve 
with a positive impact for both sides, a win-win situation, as stated by Simon Stevens, NHS 
England chief executive (NHS England, 2015). 
Ryan et al.'s (2018) reviewed how GPs’ workload has reduced because of pharmacists’ 
integration in general practices. This is especially dealing with medicine queries from patients 
and pharmacies, thus overall improving medicines management.  
It reflects a strong working collaboration among GPs and GPPs as expected in this scenario 
once the initial reservations were clarified. For GPs, a GPP will always be taken as a source of 
reference and help to reduce their workload, especially for the medicine management.  
2.3.2 Relationship with Nurses 
Nurses and pharmacists are considered to have complementary skills, and it is vital to have a 
close working collaboration among themselves for improved healthcare outcomes. Efforts 
have been made at organisational levels between the Royal College of Nursing and RPS 




report, “Working together across primary and community care” was published by RPS and 
RCN to summarise and inspire both pharmacists and nurses to work together with strong 
collaboration. (Royal Pharmaceutical Society & Royal College of Nursing, 2015) 
Nurses are the second primary workforce in general practice framework, which highlights the 
importance of their views on GPP roles. It was vital to engage nurses while defining the GPP 
role to build a strong bond and trust-based relationship through excellent communication.  
One of the initial reservations, raised about GPP’s role was as if it would overlap what nurses 
were already performing due to lack of clarity on a job description and shades of this is 
reflected in published literature. (Nabhani-Gebara et al., 2019). It was called as  an ongoing 
turf war between both professions mainly due to lack of job description and communication 
barrier between both professionals leading to a fear factor in the mind of nurses as if 
pharmacists were here to replace them.  
Ryan et al., (2018) reflected positive remarks about GPPs, though concerns were obvious 
about role description and medicolegal issues, emphasising the need for regular clinical 
meetings to improve understanding of each other roles. Despite acknowledging the clinical 
expertise of GPPs, participating nurses in this study showed their preference to speak with a 
GP for any medication query as they believed that GP should remain the most appropriate 
source of contact to deal with clinical queries. 
2.3.3 Working Collaboration with Non-clinical Staff 
Like the collaboration with healthcare professionals, pharmacist working relationship with 
clerical staff in practice is extremely important. Good understanding with reception and 
management staff would build the trust and confidence at both ends with appropriate task 
delegation and positive feedback from surgery as well as with patients.  
Like GPs and nurses, initially, practice staff had also confusion or reservations about how the 
idea of GPPs would work, mainly due to lack of job description causing trouble on task 
delegation. It highlights the importance of initial briefing that needs to be done by lead GP or 
organisational lead to making staff understand what the role of GPP is.  (Karampatakis et al., 
2019a) 
Available studies show the improved relationship between pharmacists and receptionist staff 
though an element of misunderstanding is still present as stated by some receptionist staff in 
a study.  (Ryan et al., 2018) 
2.3.4 Intra-Professional Working Collaboration 
GPP’s role has made an impact on working relationships within the pharmacy sector, 
especially with the community pharmacist. Volume of repeat prescriptions and mechanism 
how the repeat prescription system works at pharmacy always had concerns with surgeries 
(Mann et al., 2018). On the other hand, pharmacists were still critical of the communications 
barrier between general? practices and pharmacy (Rubio-Valera et al., 2012). GPPs seem to 
be in the ideal position to bridge this gap and to keep a close monitoring on repeat 




scenarios, it works out well, but in others, with GPPs cutting down expensive ordering or 
objecting on repeats prescription ordering does cause the relationship to get worse.  
GPP should try to have regular contact with community pharmacist which would be beneficial 
by building a direct communication line, as suggested by Karampatakis et al., (2019b) study 
gauging it as one of the KPIs for GPPs. Similarly, it was also stated that the pharmacists should 
have a strong working relationship with the hospital and organisational pharmacists to 
improve workflow.  
2.4 GPP Skillset / Job Description 
To study the shift from the non-dispensing role of community pharmacist to a clinical practice-
based pharmacist, several vital publications in recent years have been published, reflecting 
how the integration can improve the concept of the multi-disciplinary clinical team with 
specific job descriptions (Stone & Williams, 2015), (Barnes, Ashraf & Din, 2017), (Baker et al., 
2019). Results from these studies have resulted in marked changes in the proposed roles 
being taken by GPPs. 
Published literature reflects all major stakeholder’s belief that pharmacists are experts in 
medicines with strong knowledge of medications, citing many instances in which they had 
used the pharmacy team for information and advice. GPs and nurses described the 
pharmacists’ knowledge of medications as superior to their own (Ryan et al., 2018). There can 
be the differences in the assigned roles, but GPs and nurses do acknowledge clinical expertise 
pharmacists have about medications. There has been no specific description for a GPP role in 
both England and Australia; it is mainly linked with the expectations and requirements of 
surgery and population. Freeman et al., (2016) in a published paper, came up with 3 broad 
role categories for GPP, classified as patient-directed, clinician-directed and practice or 
system-directed roles. In one of the latest study a comprehensive role description and 
competency map for GPP has elaborated 7 GPP role sub-categories (medication 
management, patient examination and screening, chronic disease management, drug 
information and education, collaboration and liaison, audit and quality assurance and 
research) . It has also discussed further 48 GPP individual roles (Benson et al., 2019).  
2.4.1 Enhanced Patient-Facing Role 
It involves in-depth face-to-face or telephone medication reviews to optimise patient 
treatment plans by improving medication compliance which can include stopping, changing, 
or commencing medication as per recent guidelines for treatment (Karampatakid et al., 2019). 
It also involves clinics for patients suffering from long term medical conditions like diabetes, 
asthma, COPD and hypertension, polypharmacy as well as triage for medicine queries. (Barnes 
et al. 2017) published an article which highlights the development of advanced pharmacist 
practitioner to strengthen the role of GPP further. Another study concluded that practices 
with GPP have a lower rate of medication-related hospitalisation emphasising the role of GPP 
in managing the care of high-risk patients. (Sloeserwij et al., 2019) 
To conduct clinical medication reviews by a pharmacist is not a new phenomenon. A study 




reviews by including clinical pharmacist in the review team. This could result in reduced 
polypharmacy and increased net NHS savings. Another study by (MacRae et al., 2003) showed 
that the pharmacist-led medication review clinic in general practice leads to better 
prescribing, improved patient satisfaction, as well improvement in GPs medicine-based 
knowledge. 
World health organisation published a report (WHO, 2003, p. 7) stating that the adherence 
among patients with chronic disease averages only 50%. In the same report, the role of the 
pharmacist was highlighted and it was recommended to use clinical pharmacists to engage 
with patients and to improve compliance, a role which now has become an integral part of 
any GPPs’ job description. 
With the added qualification of Non-Medical Prescribing (NMP), GPPs are also running clinics 
for minor ailments. In the initial phase, most of the GPPs were not involved in patient-facing 
activities, but as mentioned by Bradley et al., 2018. there was a significant increase in patient-
facing activities performed by phase 1 pharmacists of NHS England pilot scheme. It involved 
activities like medication reviews, home visits or running clinics like minor ailment or 
immunisation or travel clinics.  
2.4.2 Comparing Home Medication Review Service with Medication Reviews 
Performed in the GP Practice 
HMRS is the main structures medication service been performed in Australia now. As 
discussed earlier, the focus is to extend this role with medication reviews to be completed by 
GPP inside clinics. A study conducted by Tan et al., (2014a) showed the positive impact of 
performing such reviews in clinics rather doing it at home or in community pharmacy with 
much-improved satisfaction rate among patients. Similar findings were published in a study 
by Freeman et al., (2012) suggesting an increase in timeliness and completion rate of 
medication reviews by GPPs conducting medication reviews inside the clinic.  
Mackie et al., 2019 conducted a study in Australia on medication reviews for patients living 
with HIV. The study concluded that the GPP working within general practice has better clinical 
knowledge and access to medical records to provide a timely and clinically useful medication 
review.  
2.4.3 Medicines Management / Optimization Pharmacists’ Role 
Reducing the medicine management workload on GPs has been the primary expectation from 
GPs, especially in the initial phase. This role involves dealing with GPs, nurses, community 
pharmacy and patient’s medication query. This also involved conducting audits to improve 
prescribing and medication usage, reducing medicine wastage, management of repeat 
prescriptions, dealing with the hospital discharge summaries, QOF monitoring as well as 






2.4.4 GPP in Prescriber Role 
At present pharmacists are legally able to prescribe prescription medications in New Zealand, 
in certain provinces of Canada as well as in some parts of United States (Raghunandan, 
Tordoff & Smith, 2017) 
The prescribing role for pharmacists is gaining more importance as healthcare systems both 
in England and Australia are aiming for a multi-disciplinary team with diverse qualifications. 
Though concerns are present about protocols needed to supervise prescribing qualification, 
it is widely accepted by healthcare professionals that GPPs can take over the responsibility of 
dealing with repeat prescriptions authorisations and managing medication changes while 
running clinics for chronic conditions, medication reviews or minor ailment clinics. Gerard et 
al., (2012), demonstrated that patients do value pharmacist prescribing service as an 
alternative to doctor prescribing  
In Australia, prescribing annotation for a pharmacist has not been approved by the 
government as GPs at this stage are not willing to award it to pharmacists. Although, like 
England, role acknowledgement is visible in the literature (Hale et al., 2016) but need to set 
up strict protocols structure is the way going forward (Hoti et al., 2011). Association Medical 
Association (AMA, 2008) in a report indicated that they do not support prescribing roles for 
pharmacist in response to a proposed limited extension of prescribing role by Pharmacy Guild 
of Australia, as they believe it is the sole right of doctors raising concerns on pharmacist 
training and conflict of interest with pharmacist engaged in both dispensing and prescribing.  
 
2.5 Patients’ Feedback on GPPs’ Role 
Patients feedback and satisfaction plays a significant impact on the dimensions of care plans. 
Strong understanding of patient’s expectations by GPP role is imperative for the success of 
this role. The literature reflects initial hindrance by patients to interact with GPP as they had 
concerns about their clinical knowledge and expertise in comparison to their GPs and nurses, 
which shows lack of role understanding (Ng, Harrison, 2010). For patients, to interact with 
GPP at the surgery has been a new experience as they are used to see the pharmacist in the 
community (Bajorek et al., 2015). Literature shows an improvement in the trust of patients 
for GPP though concerns about their clinical knowledge and expertise in comparison to GPs 
and nurses are also apparent.   
The research was done by Petty et al. (2003) on-medication reviews conducted by 
pharmacists in GP settings. It did not show any significant benefit of this exercise as many 
patients were not satisfied with the expectations of improving medication compliance or 
quantity of medicines they are taking, also they showed a preference for GPs to conduct the 
review. 
The feedback is also reflected in one of the pharmacist statements given during a study 
conducted by Karamapatais et al., (2019). The study narrated that there is no clarity regarding 




positive impact on patient care is getting more visible which is also reflected in the feedback 
of patients given in the study by Ryan et al., (2018) 
In a published report (Pharmaceutical Journal, 2016) on patient feedback about GPPs in 
England, 76.9% of 316 patients and carers said having a clinical pharmacist in practice was an 
advantage while 77.5% said they would welcome the chance to have their medicines 
reviewed by a clinical pharmacist. In another survey conducted in Australia (Freeman et al., 
2012c) patients were welcoming the idea of integrating pharmacists into general practice. 
2.6 GPP Role in Private Clinics: 
Literature has also been published on proposed role of GPP in private clinics (Saw et al., 2015) 
& (Saw et al., 2017). With private clinics working independently, the studies have aimed to 
analyse how beneficial it could be to integrate a pharmacist in clinic to help with medication 
related issues while keeping an eye on costs. A study conducted in Malaysia (Saw et al., 2017) 
exploring pharmacists’ views reflects the views presented by GPs, patients and pharmacists 
on the proposed role. The similar patterns as those of public healthcare sector can be seen 
with the private GPs and consumers perceived GPP to be helpful in roles including prescribing 
audits, medication reviews, drug information, disease management, patient counselling and 
medication stock management with improved communication among GPs and pharmacists. 
At the same time, GPs showed concerns about pharmacists affecting private clinic business 
as taking over some of the of GPs’ functions and in turn increasing the cost. As for the 
pharmacists, the study showed young pharmacists are more willing to take this challenge in 
comparison to pharmacists who had been working in dispensing environment for a long time. 
The feedback from patients or consumers in private practice depends on the cost of 
treatment. Positive feedback is obvious for using pharmacist as source of medication expert, 
but concerns were raised about possibility of increase in overall cost due to pharmacist 















Chapter No. 3 
RESEARCH METHODS 
This chapter provides a comprehensive insight into methodology adopted to conduct this 
study. Choosing the right methodology is a crucial component of a successful research 
project. Some researchers believe quantitative research has more impact on figures for key 
indicators, but qualitative research has its importance that goes beyond numbers 
(Greenhalgh & Taylor, 1997). Research solely based on “numbers” in quantitative research 
will not be enough to understand the feelings of individuals involved in specific phenomenon.  
3.1 Qualitative Research 
Qualitative research is an important tool to improve understanding of medicines (Malterud, 
2001). It helps in finding the answer for questions about “why” something is the way it is and 
“how” different individuals think and respond to circumstances by sharing their views and 
thoughts to analyse present and guidance for future (Austin and Sutton, 2014).Qualitative 
research is widely used in NHS England and other healthcare organisations with growing  
acceptance and recognition of the benefits in clinical and biomedical fields by gathering views 
and perceptions of key stakeholders and to probe deeper into findings of quantitative 
research (Pope, Pope & Mays, 2019) & (NHS England, 2017). Qualitative research can provide 
valuable insight into the health-related phenomena by gaining an understanding of 
underlying reasons, opinions and motivations of stakeholders about study objectives, 
providing rich details about study objectives as well as stakeholders’ perspectives, 
expectations and experiences (Neal et al., 2015). It explores various types of existing 
practices, policies and beliefs with analysis leading to recommendations of how to improve it 
and guidance for further research by adopting person-centred and holistic perspective based 
on understanding of human experiences (Holloway, Wheeler, 2010, p. 12 and Babar, 2015, p. 
27). 
National websites such as NHS Choices enable people to give qualitative feedback about the 
services they receive, as do many national surveys on healthcare. At a local level, patients can 
give qualitative feedback in a variety of ways including through patient participation groups, 
complaints, or comments on online platforms. NHS England commissions qualitative research 
and uses qualitative data in a variety of ways, including in the design and development of new 
policies, in the delivery of national programmes, in the evaluation of policies and initiatives 
and communications and campaign activities. 
Qualitative research consists of different phases, aiming for the systematic gathering of data 
on the required topic, which can be divided up into conceptual, design and planning stage, 
empirical data-generation phase, analytical phase and dissemination (Babar, 2015, p. 51). 
There are 3 main methodologies that are used in qualitative research to gather and analyse 
data. These are ethnography, grounded theory and phenomenology (Zubin & Sutton, 2015, p 
172). The researcher should make sure that the selected design is appropriate for research 
main aim and objectives as the validity of drawn conclusion in qualitative research is 




the appropriateness of the chosen design (Chapman, Hadfield & Chapman, 2015). One-to-one 
interviews, focus groups and observational research techniques are the ones which are most 
commonly used in qualitative research but additional useful methods include participant-
observer research, action research, grounded theory, case studies and the Delphi method 
(Zubin & Sutton, 2015, p 194-202) 
This is a general inductive study in which the principal researcher has used semi-structured 
one-to-one interviews. The GPP roles in England are still new with ongoing research to analyse 
its impact on the healthcare system under NHS England pilot scheme. As the main aim of this 
study is to explore views and perceptions of key stakeholders by understanding their 
individual experiences about GPPs’ role, hence it was decided to undertake an Interviews 
technique which can unearth rich contextual data. 
3.2 Ethics Approval 
Ethical approval to conduct any research project is a must and a vital step. For this study, an 
ethical application was submitted to the Ethical board for approval with the details of aims 
and objectives of study, participant group detail and semi-structured interview guide. The 
study is approved by the University of Huddersfield Human Research Ethics Committee 
(Reference number: SAS-SREIC 14.5.19-3). 
Following are the main ethical issues which were considered during this project: 
Anonymity: To protect the identity of participants, it is vital to ensure anonymity wherever 
possible with techniques like allocating pseudonyms or participant numbers instead of using 
real names. In this study, a unique participant number/letter was assigned to each participant 
from both England and Australia. 
Confidentiality: personal details of participants are mostly necessary to be shared with the 
researcher directly or indirectly. The researcher must ensure confidentiality of such data like 
email ID, phone numbers, job perspectives and personal views and to access only that 
information which is needed only for the research project. During this course of study, the 
principal researcher must maintain a high level of confidentiality in all these aspects.  
Ask/Observe only what is necessary: It is essential to ensure that interviews and focus groups 
should remain within the targeted framework related to the topic of the subject. Researchers 
should respect the time availability of participants as discussing irrelevant information would 
not only distract participants from the original purpose but also would lose their interest. To 
ensure this, an email was sent to all participants with relevant topic information and specific 
questionnaire for them to have a first-hand knowledge before the actual interview. It also 
gave them an opportunity to gather their views according to the interview structure, which 
did help to keep actual interviews within the targeted time framework. 
Participant respect and honour: To schedule interviews and focus groups considering the 
time availability of participants is essential to highlight their respect and to acknowledge the 
support they are providing for the research project. It should be the researcher’s 
responsibility to provide all the necessary facilities for participants ranging from commuting 




flexible in accordance with the time slots for interviews and adjusted his working diary in 
accordance with time available by participants, especially for participants from Australia, 
considering time difference between England and Australia. It is important to highlight that 
there was no financial compensation requested from any participant neither it was offered at 
first point to lure them into participating in the study. 
Option to review or withdraw: It is the researcher’s responsibility to provide all participant 
with an opportunity to review the interview’s transcripts. Participants were informed that 
they can withdraw from the project anytime whenever they like. The principal researcher sent 
an email to all participants with a participant information sheet, consent letter and with an 
interview guide.  
Secure storage of raw data: All collected data, as part of this study is subject to secure data 
protocol approved by the University of Huddersfield. 
Informed consent: To gain consent from all participants is essential in any research project. 
As highlighted before, all participants for this project were given the required information 
which did include rationale, objectives, methods, confidentiality, storage/disposal provisions.  
Their rights to withdraw or review data and informed consent were obtained from the 
participants before the actual interviews were conducted.  
Safety netting: Finally, all participants should have details whom to contact if they have any 
concerns before, during or after about the research project as part of safety netting. The 
principal researcher provided details of relevant departments at the University of 
Huddersfield.  
3.3 Sampling / Participant Selection 
For successful research, it is vital to have relevant and well-reasoned participants who can 
share their experiences and views towards qualitative data. Unlike quantitative analysis, 
qualitative research normally has a small sample size. Sampling can be either conceptually 
driven approach (purposive & theoretical) or non-conceptual driven approach (convenience 
& opportunistic) depending on study requirements (Farrugia, 2019). 
As this research is about key stakeholders’ perceptions of GPP, the principal researcher opted 
for purposive sampling technique. After a detailed discussion with the supervising research 
team, five stakeholders’ professionals’ groups were identified. These were GPs, Nurses, GPPs, 
Organizational lead and Academics from England and Australia.  
3.4 Semi-Structured Interview Guide  
A comprehensive literature review was performed. The themes identified from the literature 
feed into design the semi-structured interview guide. 






3.4.1 General Practitioners (GPs) (Appendix 1) 
GPs are at the centre of every general practice framework. Any clinical or organisational 
policymaking at the government level is profoundly affected by the views of GPs on relevant 
issues. As mentioned in the introduction section, the emergence of GPP role was mainly 
aimed to facilitate GPs in their workload and to bridge gaps due to GP workforce crisis. Hence 
it was essential to have detailed information about GPs initial perceptions and as well as what 
changed since the beginning. Considering the central role of GPs, their views will have the 
main say in deciding the future of GPP role, so interview guide was designed to find if they 
believe GPP has reduced their workload as per their initial expectations and how they want 
this role to evolve in the future. (Appendix No: 2) 
3.4.2 Nurses (Appendix 2) 
Nurses are a central part of any multidisciplinary clinical team performing a range of clinical 
roles. As the role of GPP lack specific job description, there is a school of thought about GPP 
role being overlapping with what nurses are already performing in general practice. 
Therefore, it is important to get views from nurses about GPP and how they feel working 
along with GPP have changed their training, so interview guide was designed to explore 
Nurses’ views on GPP as a member of a multidisciplinary team and their perspectives on 
barriers and facilitators especially role overlapping and the future co-ordination. 
3.4.3 Clinical Practice based Pharmacists (GPP) (Appendix 3) 
It is important to understand how a pharmacist has professionally grown while working as 
GPP. Many of the studies conducted so far have focused on views of mainly GPs and the 
impact of GPP on healthcare system but little focus has been on what were the perceptions 
of pharmacist when they took on this role and how they have changed since considering the 
barriers and support they have received during this time. Interview guide for a pharmacist 
was designed to give them an opportunity to discuss aspects like working collaboration with 
other healthcare professionals, job descriptions, organizational support, training 
requirements and any suggestions they might want to share keeping in view their experience 
to support future of GPP role. 
 
3.4.4 Organizational Lead (Appendix 4) 
The interview guide was designed to get the views of a stakeholder in practice or organization 
that has a role to play in the recruitment of clinical staff. It will give an idea of what are 
concerns or importance of including a GPP in the multi-disciplinary team. 
3.4.5 Academic staff (Appendix 5) 
A professional who has experience of research in the healthcare sector, especially the general 
practice framework. It will highlight how the general practice framework has been evolving, 
any gaps that they had found in their research, government past or ongoing policies and what 




Attempts were made to keep the whole process within a defined structure, with some 
adjustments to make it more specific to each stakeholder. The initial interview guide was 
reviewed by research supervising team a few times and after a few adjustments, it was 
approved to be submitted for Ethics approval. The interview guide was designed on the 
following main themes: 
3.4.6 Perceptions & Challenges 
Open-end questions asking stakeholders to give their views on the initial perceptions and 
reservations they had about GPP’s role, operational challenges that they came across in 
beginning and how these parameters have changed since the integration of this role in 
general practice.  
3.4.7 GPPs’ Working Collaboration 
To review working collaboration of all stakeholders with GPP, how this collaboration can be 
improved and the impact a GPP had on the scope of practice of different healthcare 
professionals. 
3.4.8 Pharmacists’ Skillset 
To review professional competency of pharmacists working as GPP to perform either patient-
facing roles in clinics and medication reviews or non-patient facing roles like medication 
management and running clinical audits etc. It also allows discussing prescribing accreditation 
of GPP and how the other main stakeholders value this annotation.  
3.4.9 Government Policies 
Most of the available literature on GPP role is about the evaluation of government funding 
policies for GPP role, therefore it was important to get views of stakeholders on such policies. 
3.4.10 Future of GPP Role 
To review stakeholders’ perception on the future of GPP including aspects like government 
policies for funding, pharmacist training pathways, defining job description for GPP and 
defining key performance indicators (KPIs) to evaluate the success of GPP role in general 
practice framework.  
3.5 Interviews 
For this study, principal researcher has opted to select individual Interviews to design and to 
collect the data. It gives an ideal opportunity to engage in a conversation with participants in 
a comfortable environment to share their personal views and perceptions about GPPs’ role in 
their own words. 
3.5.1 Participant Recruitment 
As mentioned earlier, it is very important to design the interview in a correct manner, where 
the participants should be respected and valued by keeping the structure of interview (format 




Same time, it is equally important to select those participants who are willing to engage in 
the research process with an open mind and to share their views honestly.  
The purposive sampling was implemented to recruit main participants, based on their 
respective expertise and experiences were the ideal professionals with a deep understanding 
of the GPP role. It was decided to recruit total of 10 participants for this study, 5 each from 
England and Australia, though this figure was changed later due to participant’s response and 
availability. As it was a comparative study between England and Australia, so it was made sure 
that participants are working in the same set of environments in both countries. It was 
followed by preparing a semi-structured interview guide to perform interviews.  
A participant information letter (Appendix 6) was sent to the proposed participants via email. 
In England, a total of 15 individuals were contacted out of which 7 did agree to participate in 
the main study. They were 2 GPs, 2 nurses, 1 GPP, 1 organisational lead and 1 academia.  
There were difficulties in recruiting participants from Australia. The principal researcher did 
contact in a total of 62 individuals via email, Facebook and twitter. The primary researcher 
also did visit Australia during November 2019 and contacted few healthcare professionals 
regarding the study. Finally, the principal researcher was able to recruit in a total of 8 
participants from Australia. They were 1 GP, 1 nurse, 3 GPPs, 1 organisation lead and 2 
Academia. Out of these, 3 participants of Blackburn Medical clinic in Australia (GP, Nurse and 
pharmacist) agreed to provide a written response to the designed interview guide. Ideally, an 
interview would have been a preferred choice, but as the principal researcher was unable to 
recruit any GP or nurse from Australia despite all attempts, after consultation with the 
supervisor, it was agreed to proceed with a written response. The pharmacist from same 
surgery was also asked to provide a written response. So, for this study, in total 12 interviews 
were conducted including 2 pilot interviews. The details are provided in table 2 and 4. 
3.5.2 Pilot Interviews 
After approval of ethics application and the initial draft of the interview guide the main 
researcher contacted participants, both in England and Australia, to conduct pilot interviews. 
The main researcher is working as a GPP since 2016, an informal discussion with the GPs 
helped to develop a semi-structured interview guide as well. 
The pilot interviews were also conducted with a GP in England (Appendix 7) and a clinical 
pharmacist in Australia (Appendix 8) who gave valuable views about the scenario of GPP role 
in England and Australia respectively.  
3.5.3 Conducting Interviews 
To get the best, out of participants during interview, it is particularly important to create a 
professional interview environment where participants have got beforehand information 
about the topic. The participants were also provided with interview guide, study description 
and a participant information sheet.  
The ethics approval form and the guide were sent to the participants. Time for interviews was 




participants to proceed with interviews as well as to record the interviews either via skype or 
on phone. Each interview was scheduled for about 30-45 minutes. The interviews transcripts 
are provided in the appendix. 
Appendix 9: Interview with GP2/England 
Appendix 10: Interview with GPP/England 
Appendix 11: Interview with Organizational Lead/England 
Appendix 12: Interview with Academia/England 
Appendix 13: Interview with Nurse 1/England 
Appendix 14: Interview with Nurse 2/England 
Appendix 15: Interview with GPP1/Australia 
Appendix 16: Written Statement by GPP2/Australia 
Appendix 17: Interview with Organizational Lead/Australia 
Appendix 18: Interview with Academia 1/Australia 
Appendix 19: Interview with Academia 2/Australia 
Appendix 20: Written statement by Nurse/Australia 
Appendix 21: Written statement by GP/Australia 
3.6 Data Analysis 
All interviews were transcribed verbatim and the detailed data analysis was 
performed. During the coding stage, the principal researcher after reading the transcribed 
document, identified possible themes that emerged from the available data. For the analysis 
of qualitative data, thematic analysis was used because it is a method with a flexible approach 
that can be used to identify, analyse, organize, describe and report themes found within the 
available data and can produce trustworthy and insightful findings (Braun & Clarke, 2006).  
. There are two ways to identify the themes in thematic analysis namely, deductive, and 
inductive thematic analysis. The inductive thematic analysis was employed to identify and 
analyse themes in this study. The inductive analysis is preferred over deductive thematic 
analysis because no pre-determined theory or framework is used to analyse data and 
researcher use the logic to understand concepts, results and then summarize them unlike 
deductive analysis in which researcher has already a picture or idea in mind (Wardani, 
Kusuma, 2020). Another reason was that little is known about the topic under study, 
therefore inductive analysis is a better option as it is a process of coding the data without 
trying to fit it into a pre-existing coding frame or the researcher’s analytic preconceptions 
(Nowell et al., 2017). For this study inductive thematic analysis was performed 






Chapter No.  4 
RESULTS 
4.1 Demographics 
The main idea of the research was to compare GPPs’ role between England and Australia in 
similar settings for which a similar number of key stakeholders from both countries were 
targeted for interviews. In total 21 participants from England and 41 from Australia were 
contacted but only 7 from each country agreed to participate. It is important to highlight that 
the number of participants within each group varies between both countries. Table 2 and 
table 4 describe the breakdown of participants in detail. 
Table No.2: Participants’ profiles from England (E) 
 Contacted Responded Discussion 
GPs 5 2 GP1/E & GP2/E 
Nurses 6 2 Ns1/E & Ns2/E 
GPPs 4 1 GPP/E 
Organizational Lead 3 1 OL/E 
Academics 3 1 Ac/E 
Total 21 7  
 
Table No.4: Participants’ profiles from Australia (A) 
 Contacted Responded Discussion 
GPs 6 1 GP/A 
Nurses 8 1 Ns/A 
GPP 7 2 GPP1/A, GPP2/A 
Organisational Lead 8 1 OL/A 
Academics 12 2 Ac1/A, Ac2/A 
Total 41 7  
 
Overall, in total 62 professionals were contacted to participate in this study, out of which 14 
agreed to participate. In total, 12 interviews were conducted. This low rate of response might 
have an impact on the strength of the results as well as on conclusion. This aspect has been 
acknowledged while gathering the results and drawing conclusions. Same time it is important 
to understand that, at government policy level, GPP is a new role and it is hard to recruit large 




pharmacists and GPs were also approached in Australia and England. Though numbers may 
be small, but they do significantly add to the thesis. This has also been described in the section 
6.1 under limitations of the study 
 
4.2 Themes 
Major themes that emerged during the interviews were: 
1. Initial Expectations & Reservations by Key Stakeholders 
2. Barriers and Facilitators 
3. Working collaboration 
a. GP and Pharmacist 
b. Nurse and Pharmacist 
4. Pharmacist Skillset 
a. Patient facing role 
b. Prescribing role 
c. Medicine management role 
5. Key performance indicators 
6. Evolving GPP role 
7. Future of GPP role 
a. Government funding 
b. Future Research 
c. Training and job description 
8. Patients feedback 
Table No. 4: Thematic analysis of data 
Main themes Sub-themes 
1. Gaps in general practice framework  How GPP can fill the gaps highlighted in 
general practice framework. 
2. Initial expectations & reservations 
by key stakeholders 
1. Lack of training 
2. Medicolegal issues 
3. Role overlapping with nurses 
4. Patient facing role 
5. Patients’ acceptance 
3. Working collaboration 1. GPs & Pharmacists 
2. Nurses & Pharmacists 
3. Inter-professional collaboration 
4. GPP as link in between organizations 
4. Pharmacist Skillset 1. Patient facing role 
2. Prescribing role 




5. Future of GPP role 1. Government funding 
2. Training and job description 
3. Future research 
6. Patients’ feedback  
7. Key Performance Indicators Discussion about what measures can be 
used to evaluate GPP impact on healthcare. 
8. Evolving GPP role Discussion about how GPP role has evolved 




4.3 Gaps in the General Practice Framework 
All participants from England and Australia recognised that there are gaps present in the 
healthcare system, whether it is primary or secondary, having a significant impact on the 
general practice framework. Reasons behind this widening gap, range from staff levels, i.e. 
shortage of healthcare professionals, especially GPs and nurses to an ageing population with 
complex medical conditions that need a multi-disciplinary clinical team to address issues from 
various angles.  
GPs said that there is a big gap which is getting bigger and with present steps taken, it could 
be another 5-10 years before the situation can be improved. This also highlights to focus on 
a multi-disciplinary clinical team approach. This can facilitate other healthcare professionals 
including pharmacists into the team. 
England’s academia also highlighted the significant impact of Brexit on workforce especially 
nursing sector which would have a dominos effect on primary healthcare workforce adding 
more pressure on GPs and a negative effect on the quality of patient care.  
Academic from Australia highlighted the impact of gaps in general practice onto the 
secondary care, where she believes many patients come in an emergency or for hospital 
admission, which could have been treated in the general practice.  
“I think in terms of gaps, one of the main gaps or one of the main 
challenges is the fact that it can be quite difficult to get into a good 
GP. And yeah, that then flows on to the public hospitals being 
flooded” (Ac/E) 
GPP as a source to bridge the gaps in general practice framework 
A consensus has emerged from the collected data that clinical pharmacist can bridge the gaps 
present in general practice framework. Though some reservations have been raised, in 
general, participants agreed that the expertise of the pharmacist regarding medicines can be 
used to facilitate the workflow of general practice and support for all clinician. There are 




the NHS pilot scheme under which pharmacist integration into medical practices is being 
facilitated financially. Australia seems to be in very much initial phase, where Home 
Medication Review Service (HMRS) is being considered as the leading team-based service 
which involves pharmacists. 
Nurses from both England and Australia acknowledged the importance of integrating 
pharmacist in general practice to fill the gaps and perform roles in medication reviews, minor 
ailment clinics, optimise medications and to be the professional to contact by patients who 
get anxious when medications are changed in accordance with local guidelines.  
“I think there’s always a gap in healthcare system to be honest, but 
with the clinical pharmacists, I think every GP practice needs to have 
them because they do cover a broad range of topics in the practice 
itself, and they’re more of a support for every clinician, any GP 
practices they don’t have pharmacist, they’re kind losing out.” 
(Ns2/E) 
Academic from England (A/E) believes that there is strong potential for pharmacists to lead 
from the front and fill this gap especially if they can support GPs in managing long term 
medical conditions. This could be linked to possible shortage of nurses in coming years due 
to Brexit. Similar observations were described by academia from Australia that as a medicine 
expert, the GPP can look into medication-related issues and can be a valuable addition to the 
general practice workforce in providing a holistic approach to treat long term conditions by 
performing medication reviews.  
“I think putting pharmacists into GP practice has a lot of benefits 
because then patients experience holistic care, especially if you got 
pharmacists, nurse and GPs”. (Ac2/A) 
Organisational lead from England (OL/E) highlighted the clinical pharmacists as the 
professionals best placed to deal with the clinical issues such as polypharmacy.  
 
The views from OL/Australia were also important, and she said that writing a prescription is 
the most common intervention done in general practice where pharmacists’ clinical expertise 
can be vital in providing quality use of medicines framework.  
“within that episodic care that the GPs provide probations, there’s a 
gap in more overarching expertise into decisions about medications 
and monitoring that would be- could fulfil by having a resource of a 







4.4 Expectations by Key Stakeholders Regarding GPPs’ Role 
This study shows a variance of expectations by key stakeholders from GPP role in initial 
phases. The initial expectations vary and are based-on surgery’s requirements.  
One of the GPs said that the initial phase was very unstructured with time limitations linked 
with available funding. The main aim was to utilise pharmacists in their best expertise but 
same time making sure pharmacist is enjoying and developing the role. 
“I didn’t have any great massive expectations. It was more like, see 
how the things work out in the end. Initially it was very unstructured, 
in retrospect, unfortunate, may be and I wish we’d been able to 
structure it a bit better” (GP1/E).  
The Organisational lead (OL/E) from England was expecting pharmacist as a professional who 
could join the organisation in a management role performing optimisation and audits, but 
with time it was realised that in addition to management, the pharmacist could be a beneficial 
addition to the clinical multi-disciplinary team as well.  
“Yeah. So, I think they were used as sort of a bit of a lower level at 
work forms. Whereas actually what we’re realising now is that 
they…they have all of those skills that actually probably placed it at 
more of an advanced level”. (OL/E) 
Her counterpart in Australia has mentioned the aspect of variance in expectations mainly 
keeping GPs as the focal point but emphasised that it is a new role and needs time to allow 
pharmacist to develop a professional relationship. In her views, some GPs are proactive to 
create this trust, and some are slow to build this bond leading to miscommunication and 
mismatch between expectations and performances.  
One of the nurses mentioned mismatch of expectations which has improved over time. She 
was expecting broad job specification role for GPP at beginning which they would get on with 
straight away as already trained professionals.  
With some reservations about patients’ consultation, pharmacists had also performed some 
duties which she was not expecting them to perform. She thinks now she has an idea of what 
to expect from any new GPP who joins the clinical team.   
Views of pharmacists from both countries slightly differ regarding the expectations of their 
roles. The pharmacist from England reflects an element of mismatch of expectations while 
pharmacist from Australia said that her expectations were fairly matched with no initial 
reservations at both ends, mainly because she knew what surgery was looking for and 




“Some GPs had over expectations with the impression that as 
pharmacist we should be able to do anything or everything, but 
some GPs were very cautious” (GPP/E) 
 No, the expectations were fairly well matched. They wanted 
someone who could champion the prescribing and that was the area 
of my PhD. So, it was fairly well matched and the principal GP and I 
had fairly similar interests and skills, so we were able to work at 




4.5 Reservations by Key Stakeholders 
Following are the main sub-themes that have emerged from the interviews. 
• Lack of training  
• Medicolegal issues 
• Role overlapping with Nurses 
• Patient facing role 
• Patients’ acceptance 
Pharmacist, in general, has been seen in England and Australia mostly in a dispensing role so 
there were initial concerns if they have been well trained to integrate into general practice, 
raising some interesting reservations from the participants. 
For England’s’ pharmacist, the main one was clinical knowledge with an element of anxiety 
while talking to doctors to make sure he sounds professional whatever he says, while giving 
his clinical opinions. Australian pharmacist did not mention any reservations as she was very 
confident with her role specifications and the clinical knowledge, she had to fulfil her role. 
Nurses also did not mention any specific reservation from the role and were very positive. 
“No, not at all, I always think the more people you’ve got with a 
difference of experiences, the better it is” (Ns1/E) 
GPs did not mention of any significant reservation regarding the pharmacist’s role, though 
due to the lack of job specification and training, above mentioned concerns were reflected in 
the interviews. They attributed it towards the strong supervision system that has always been 




“No reservation, because we have quite a robust system supervision. 
So confident that, that is effective” (GP2/E) 
 
 
4.6 Pharmacists’ Skillset 
One of the main themes that have emerged in this study is regarding “what should be the role 
of GPP”. As mentioned earlier, there is no specific job description set by any regulatory 
organisation for GPP. Every organisation has a job description based on its population and 
practice demands.  
Following are 3 main sub-themes that emerged from this study: 
4.6.1 Patient-Facing Clinical Role 
One of the expectations from GPP is to perform a patient-facing role by running clinics or in 
the form of performing medication reviews either in surgery or during home visits. 
Community or hospital pharmacists both are in practice to face patients but with different 
skills set. Any pharmacist while working as GPP must make sure to be equipped with strong 
communication and clinical skills. GPs and nurses both are confident that pharmacists can be 
successful in a patient-facing role but needs to have professional training and development 
with continuous support and supervision.  
“I think yeah, they are getting there. It’s all about training and 
development” (GP2/E) 
Nurses believe pharmacist have got good patient-facing skills when doing medicine reviews, 
as reflected in patient feedbacks and comprehensive consultation notes, but to run clinics 
they are not well trained as it is not a part of their professional study. Hence to have 
competent pharmacists, they should shadow nurses and GPs to improve the skill.  
“I think medication reviews and all the other reviews, home visits 
where it’s a few minutes; they’re really good at that right at the 
beginning. But face to face it needed time to build up. So I think 
what they will benefit from like other pharmacists is maybe to sit in 
with the nurse a little bit” (Ns2/E) 
“Well, what I see, the patients' feedback or the consultations and it's 
just another way to make sure patients are having the right 
medication, another way for patients to understand and therefore 




really quite comprehensive and the patients' feedback has been 
good as well” (Ns1/E) 
Pharmacist participants have highlighted the need for supervision for patient-facing role 
especially in the initial phase. Sametime, the pharmacists, should make sure they are involved 
in continuous professional development by attending courses or regular training session. The 
same aspect was highlighted by organisational lead that mentorship and consultation audits 
are essential to train and supervise pharmacists in the patient-facing role.  
“Yeah, so I think there needs to be a level of doing that under the 
clinical supervision first. So having clinical supervision within the 
practice is very, very important and having the GP on board for 
that”. (GPP/E) 
One pharmacist mentioned the need for making strong rapport with patients along with 
consultation skills and documentation to ensure competency in this patient-facing role. 
Yeah, it's not just the clinical knowledge, though, it's also that ability 
to build that rapport and get that information and how do you 
synthesise that information. (GPP1/A). 
Organisational leads from both England and Australia believe that patient-facing role is 
something that will be eventually be an integral part of GPP job description. It is at an evolving 
stage, and with the skills and expertise, pharmacists have, sooner or later specific clinics which 
are at present been run by sole nurses would be delegated to pharmacists as part of multi-
disciplinary settings.  
4.6.2 Prescribing Role of GPP 
Prescribing annotation is one of the competencies where not all the participants are on the 
same page. It is also most probably the main difference in job description between GPP in 
England and Australia.  
In England, Non-Medical Prescribers (NMP) qualification as an independent or supplementary 
prescriber has been awarded to pharmacists for past few years after completing the specific 
non-medical prescribing course. Afterwards, they must make sure that they would prescribe 
within their competency based on their prescribing p-list. On the other hand in Australia, this 
aspect has not been approved, though it has been discussed by keeping NHS England as a 
model, it is evident from participants’ views that it is not something that will happen in near 
future as GPs are not very keen to allow pharmacists to starts prescribing.  





“I think it would fit quite well but it’s- we’re not mature enough in 
that area yet to actually have sensible discussions with practices 
about that yet, that’s not possible yet”. (OL/A) 
Organisation Lead (Australia) believes that the way the UK initiated model of supplementary 
prescribing in primary care, similar type of settings will be initiated at first stage, though it is 
something at very initial stages and being discussed between various governing bodies but at 
this moment GPs are not willing to let pharmacist prescribes and this might take a long time. 
“That will be exactly how it happened, so limitations, yeah, the 
doctor has to be involved in the beginning and it has to be like you 
say, no changes, no red flags, it’s really just a repeat and things 
going well, and I think that we’re all moving to that, but it would 
probably take 50 years.” (OL/A) 
The same aspect has been mentioned by an English GP. In her practice, the pharmacist is not 
allowed to prescribe as she believes unless someone has specialist qualification like in 
diabetes or asthma, the pharmacist should not prescribe. Though she thinks pharmacist has 
got skills and knowledge to be a competent prescriber, it is they need close monitoring and 
supervision protocols to ensure safe prescribing practice.  
“it’s ironic isn’t it because as doctors we don’t receive much training 
I’m prescribing yet we’re…we’re, you know, giving free reign to a 
prescriber when a pharmacist will know a lot more about 
premedical terms you know how stuff works. So, I think it will be 
gradual under supervision and then expand their role”. (GP2/E) 
On the other hand, GP1/E said he would be happy for pharmacists to take the prescribing role 
but does believe protocols should be developed by organisations to facilitate prescribing role 
by pharmacists and nurses. English nurses and OL believe pharmacist as an expert in 
medicines can perform well as prescriber as they are in an ideal position to ensure safe and 
cost-effective prescribing.  
“’because they got pharmacological background. Naturally, 
they…the actual…the prescribing, the medication. They understand 
the medication better. So, definitely prescribing sits well with 
pharmacists” (OL/E) 
“Because they’re the ones who pick up all the mistakes the doctors 





Pharmacists from both countries emphasised the importance of strict protocols for 
prescribing to avoid scenarios of any medico-legal issues and setting where patients can get 
prescriptions without being supervised by doctors. 
“I think as long as pharmacists are prescribing within their 
competence and there’s no pressure on them to prescribe outside of 
their competence is fine” (GPP/E). 
“My reservations would include patients wanting to bypass the GP 
and ‘just get a script’. There would need to be strict protocols in 
place.” (GPP2/A) 
GP and Nurses from Australia did not mention anything specifically related to the prescribing 
role of the pharmacist. 
 
4.6.3 Medicine Management Role 
Medicine management skill is the one which all stakeholders believe is the biggest strength 
of GPP role. GPs and other healthcare professionals had given very positive remarks about 
medicine management skillset of GPP. As mentioned by organisational lead in her interview 
that GPs are not very confident in dealing with medicine management queries, so it was one 
of the expectations by GPs from pharmacists to come and help them with. GPs did highlight 
the increasing medicine management workload especially from hospitals where he feels the 
presence of GPP would be helpful. They also emphasized to have more pharmacist’s time in 
general practice.  
 
“I feel that we need more pharmacist time. I've felt that...felt that 
for a long time because I'm a busy GP. My idea would be that I 
wouldn't have to deal with as many medicine managements queries 
each day, maybe do more ones which need to be discussed between 
GP and pharmacist, that’s how I would view it, hopefully” (GP1/E) 
The nurses mentioned it as the main advantage of GPP role, a quick source of medicine 
information helping them to ensure safe practice.   
“Well, I think that's probably one of the biggest advantages of the 
role which is this safer medications and that's the area of the 
pharmacist”. (Ns1/E) 
“Yeah, they are quite…and especially when they’ve done clinical 




Australian pharmacist said it’s not just the knowledge about medicines, on a bigger scale it 
also involves analysing the requirements of patients and to help them in improving 
medication compliance. 
“I think that's essential and I don't think it's just the clinical 
knowledge, I think it's also being able to see what patients are doing 
and support patients to manage their medications”. (GPP1/A) 
OL/A in her interview also mentioned medicine management skills as a strong point for 
pharmacists’ recruitment in the organization. She highlighted pharmacist maturity, 
experiences, patient approach and documentation aspects like writing reports for their 
consultations as main recruitment points when undergoing an interview for GPP jobs. 
4.6.4 GPP as a Link between Organisations 
With GPP integration in general practice, we have a pharmacist in all healthcare sectors like 
hospital, community, GP practice and at organisational levels like CCG or similar ones in 
Australia. It puts them in an ideal position to act as someone who can bridge gaps in all these 
sectors. When participants were asked their views on this, all agreed that pharmacist should 
be the one who can liaise with not only their counterparts in other sectors but also with GPs, 
nurses or medicine management department to improve medication compliance and cost-
effective safe prescribing, especially when dealing with hospital discharge notes. GPs gave 
positive remarks about pharmacists’ ability to link with community pharmacy to sort out 
issues like medication availability, suitable alternatives, medication usage reviews or issues 
with electronic prescribing. They can also guide them with queries regarding hospital only 
medications, unlicensed usage of any medicine or can communicate with hospitals if there 
has been an issue with the hospitals document or reports.  
“Yeah. I think because pharmacists are now in each of those areas. 
And they can become the bridge”. (GGP/E) 
 “I think that coordinating role where decision is being made about 
medicines is just- it’s underestimated how much improvement could 
be made if that role is done and done well” (OL/A) 
 
4.6.5 In-house GPP & Organizational Contracted GPP 
Another aspect discussed during interviews was a comparison of GPP with on contract 
pharmacist sent to practices by organisations. Participants in England did agree that it is more 
beneficial to have in house GPP recruited directly by practice compared to CCG pharmacists 
who they believe have specific agenda of cost-saving, trying to implement changes. 
Sometimes these changes don’t agree with the requirements of that specific surgery, 




“So I think the thing is the in-house pharmacist focussed on the 
expectations of the practice rather than the expectations of the CCG. 
So CCG pharmacist may just be, you know, just focussing on cost-
saving, but sometimes that can create problems within the 
practice.” (GPP/E).  
“As I said, CCG had their remits with their pharmacists. I mean, 
that's the main thing. I...I don't know them very well, so I haven't got 
an obvious working relationship with them”. (GP1/E) 
  
 
4.7 Working Collaboration  
Strong Working collaboration between GPP and other team members is essential for the 
success of this role. Participants did reflect strong working relations with the need to improve 
it further with support from not only clinical staff in practices but also management staff like 
practice managers. 
4.7.1 GPs & GPPs 
Future of GPP role mainly depends on a strong working relationship between GPs and 
pharmacists as the main goal of pharmacist integration into general practice is to reduce GPs 
workloads. GPs form both England and Australia have shown improved collaboration in their 
views with both sides having a trust-building attitude. 
“I think it’s very positive. We’re very open. We have a quite a flat 
hierarchy here so if anyone’s got queries, you know, they’re 
welcome to come and discuss it and vice versa”. (GP2/E) 
“My experience as one of the practice principals and directly 
involved in the GP pharmacist role has been overwhelmingly 
positive”. (GP/A) 
4.7.2 Nurses & GPPs 
Nurses are the second most vital element of GP practice framework. Patients are in touch 
with nurses more than GPs, and their say on any new role within GP practice has great 
importance. It is, therefore, the main discussion point in this theme i.e. working collaboration 
between pharmacists and nurses. 
Role overlapping between Pharmacist and nurses was a significant concern in the initial 
phases of GPP integration into the system. It was mainly due to the non-clarity of job 




as part of the multi-disciplinary team. They feel it has improved their scope of practice as they 
have an additional source of reference in the form of pharmacist whom they can look forward 
to as expertise in medicines. Although concerns were raised about non-clarity on role 
specifications especially in initial phases, however with time, it has grown on a positive note.  
“As nurses, we don’t deal a lot with medications but as we grow in 
our career and become prescribers, I feel that we need clinical 
pharmacists more than even doctors, to be honest” (Ns2/E) 
Organisational leads’ views were that with demands, roles of nurses and pharmacists are 
changing rapidly like advance practitioners and most probably the roles will shape up similar 
but due to individuals’ skills and preferences, one can perform better than the other due to 
professional expertise.   
Organisational lead from Australia also mentioned this aspect and advised pharmacists to 
take a cautious approach at this initial stage and do not step over nurses’ practice boundary. 
She believes, this might be in future once active working collaboration would be developed, 
the pharmacist can take some of the roles which nurses are performing at the moment, 
perhaps giving nurses more time to perform roles based on their sole expertise. 
“I think the pharmacist is very aware of that, that that’s going to be 
a problem solving, they’re just very careful and offer- they offered to 
help separately but don’t try to take over”. (OL/A) 
 
4.7.3 Pharmacists’ Views 
Pharmacist participants have shown more like a cautious approach when answering questions 
about working collaboration. This collaboration as mentioned by all pharmacists has 
massively improved with much broader support been provided by GPs, nurses and other 
members of organisations and this support should be continued on the same note for 
prosperous future of this role.  
“GP acceptance, trust and understanding of the capabilities of the 
pharmacist in GP role plays a big part in how this collaboration 
works. (GPP2/A) 
England pharmacist stressed on regular clinical meetings and dialogues between healthcare 
professionals, like a regular daily meeting where all clinicians can gather and discuss various 
work-related issues.  
I think more dialogue between the different divisions rather than 




Australian pharmacist expressed her strong working relationship due to her professional 
expertise in clinical and academic background. In her views practice will not have the same 
level of working relationship with anyone else and although is willing to increase her working 
hours but is not to recruit another pharmacist or her to mentor another pharmacist to join in.  
Ah, it's stronger as they’re used to having me there, I think that's 
because they trust me. I don't think that's necessarily because it's a 
pharmacist role that they’re used to, I don't know if another 
pharmacist could walk into this. In fact, I've suggested another 
pharmacist comes and works at the same clinic and they’re like, 
“No.” (GPP1/A) 
Pharmacists’ views on collaboration with nurses have been the central aspect of this theme, 
acknowledging the risk of role overlapping, pharmacists highlighted importance of expertise 
in medicine-related issues as their strong points to show their value and support they can 
provide to nurses.  
So yeah, there’s definitely an overlapping. I think…I think it’s always 
when it comes to medications side I think when it’s polypharmacy, 
when there’s comorbidities, there’s, you know, those kind of areas I 
think is where it really differentiates and even management of 
medication side as well is our strong point. (GPP/E) 
While Australian pharmacist, on the other hand, was very affirmative that this is not an issue 
she has faced as she had clarity on her job specification, i.e. someone who has purely 
medication-focused roles. 
“I am very specific that I don't want to do any roles that are already 
being filled by the practice nurse. So, we've got that differentiation, 
that's not been an issue because I'm very aware of it” (GPP1/A) 
 
4.8 Key Performance Indicators 
Discussion about KPIs was another central theme that emerged during interviews. Key 
Performance Indicators (KPIs) were found to be linked with participants’ expectations and 
perceptions and is mainly evaluated against pharmacists own personal and professional 
development along with the professional performance. 
England’s pharmacist said it should be the time and money, not only cost-saving i.e. how 
much money a GPP is saving for surgery but also money-making as well while nurses stressed 
more on the quality of pharmacist’s work i.e. the level of professional skills shown by the 
pharmacist. GPs views were also similar indicating safe practice and factors including audits 




also includes absence of GPP for the specific number of days which can include the number 
of daily queries or tasks. Organisational leads were not very sure to pinpoint any specific ones 
but did mention patients’ satisfaction and medicine management as the main ones linked 
with the pharmacist’s skillset.  
“I think one of the key ones would be timing, medication reviews. 
Safety so safety auctioning alerts and things that you get. Ensure 
we’re on top of any medication compliance orders” (GP2/E) 
Don’t know. So, I suppose the indicators are a bit difficult to 
measure one…because a lot of it is about patient satisfaction, about 
whether the…the right skill mix has been used for the right 
consultation. (OL/E) 
In Australia, the main KPI suggested by participants have been the numbers and compliance 
of home medication review service. OL also did point out things like patient encounters with 
the pharmacist, clinical meetings and presentations done by the pharmacist and overall 
satisfaction guidance given as feedback from GPs and patients and other team members. 
Pharmacists’ views were bit different as she believes it is tough to have specific KPI as the role 
of GPP varies surgery to surgery and it will not make sense to pinpoint definite KPIs due to 
differences in demands of GPs and population of that area.  
“Yes, because the needs of the patient population and the needs of 
the GPs change so much”. (P1/A) 
“The key performance indicators to analyse GP pharmacist role 
should include patient outcomes, clarity of medications, GP-
pharmacist care plans, healthy at home- keeping patients at home 
and minimising risks for patients”. (Ns/A) 
 
4.9 Evolving GPPs’ Role 
In this study, we have discussed various aspects linked with GPP role. This section explains 
the participants’ views about how this role has evolved since the beginning and what they 
think about the present or future scope of practice for GPP.  
All participants believed that this role has greatly evolved. Overall GPPs with their broad skill 
set have performed to high standards and have become an integral part of the multi-
disciplinary team, especially in England.  All participants have a common understanding that 
it is not possible to design a generic model as different surgeries have different expectations 
linked with the demands of the population. Prescribing annotation gives an extra dimension 




OL/E in her interview mentioned about the change in the role and acceptance that is visible 
because now the surgeries are recruiting pharmacists directly as in GPPs rather than CCG ones 
which are more helpful from training and objective perspectives. She also mentioned medical 
practices taking on GPPs at pre-registration level, which reflects its importance and shaping 
up the future with pharmacists getting training before registration and taking it as an optional 
career. 
Yeah. So, I think maybe in the two or three years there’s been a 
change in how they avenue pap. But that’s mainly because they’ve 
stopped coming out of that CCG role or coming out of pharmacists 
and into GP practices. (OL/E) 
Same views were given by an English pharmacist who is also working as a mentor for pre-
registration pharmacists, so he believes GPP would take a supervisor role in the future. He 
also mentioned face to face clinics as significant evolving change which he said would not 
have imagined about five years ago when he first started working as GPP 
I think pharmacists will start taking more of a supervisory role as 
well. I think it’s evolved certainly in the face to face…there’s a lot 
more face to face clinics and things like that now compared to 
before. And…and I think taken…pharmacists taken more leadership 
roles now as well within general practice because I think slowly, 
slowly pharmacists can start to establish themselves more within, 
you know, general practice. (GGP/E) 
Nurses from England said roles of all healthcare professionals had evolved to meet the 
patients’ requirements. She was very positive that pharmacists with all their clinical and non-
clinical skills can perform various roles and with future training pathway, they can become 
advanced practitioners.  
“it is definitely evolving because so much is going into practice now, 
that there is just not the capacity to deal with it so everybody that's 
involved in general practice within their role is evolving hugely. I just 
I think it is a positive thing having a pharmacist within the practice 
and I do see the role will probably evolve quite a lot over the next 
few years.” (Ns1/E) 
GPs supported the idea of widening GPPs’ role in the form of clinics like Disease-modifying 
anti-rheumatic drugs (DMARDs) monitoring, though mainly focussing on medicine 




“My personal views are, because I have so much medicine 
management already, that's almost a full-time job on its own”. 
(GPP1/E) 
I think my reservation and that’s shared by a couple of our partners 
is that, you know, that the core fixation of medication safety isn’t 
overlooked. So make sure medication reviews are done in a timely 
way and that, that loop is closed. I think it’s just going back to basics 
in a way and making sure that actually that, that is covered. (GP2/E) 
As mentioned earlier, in Australia, this role is in its early stage. All participants stated that it 
was evolving continuously with new roles to be integrated into job description however it is 
also linked to the availability of funding.  
“It’s changed a lot. It's continuing to evolve as we look for new 
programmes to initiate and develop over time”. (GGP1/A) 
I feel we are still in the early stages of seeing how the role can 
evolve and an important part of this is improving the understanding 
about what services the pharmacist can provide. (Ns/A) 
4.10 Patient Feedback 
Patient feedback is an important aspect to determine the present scope of GPP role as health 
and medicines policies are designed to achieve high-quality patient care, based on continuous 
patient feedback.  
This study has shown some initial concerns by patients as they were not used to see the 
pharmacist in the general practice. It also shows a great positive change that has come up 
with time with patients started to realise the beneficial impact of having a pharmacist in the 
general practice. Different patients have different needs which cannot be achieved by 
implementing the same set of guidelines. The participants mentioned the importance to 
understand individual patients’ needs and they view pharmacists in the ideal position as they 
have more time to contact with patients in comparison to only 10 minutes appointment with 
the GPs. However, this also depends on a strong working relationship between patients and 
pharmacists and this is based on trust and understanding.   
“listen to patient stories and develop a plan with all their needs. I 
think pharmacist with more consultation time may be able to do 
that, but again it depends how well is their working relationship with 
the patients” (Ac/E) 




One of the GP and OL/E mentioned that as long as patients are being seen by a competent 
healthcare professional, they won’t have any concerns. 
“I think it’s generally positive. I think our patients are happy to see anyone who they feel is 
competent and who’s well supervised. So yeah”. (GP2/E) 
“Yeah, so I don’t think patients really care who they see. I think that 
they just care that they…that they feel like they’ve got their 
expectations met. So, I don’t know that describing somebody in one 
role and then another role really matters to the patients”. (OL/E) 
One pharmacist mentioned that the initial hurdles he had seen when patients were asking to 
see GP instead of pharmacist. However, with the passage of time the trust has developed, 
and now he is running an acute clinic where patients are happy to come and see him. It was 
endorsed by a nurse working in the same practice who has observed that patients do come 
now, and they asked to see the pharmacist.  
“they were not happy because they wanted to see a GP. But then 
slowly, slowly because they’ve started to see what I’ve been able to 
do. In the beginning I used to get a lot, oh, I wanted to see a GP, but 
now because a lot of them know me, they’re okay” (GPP/E) 
“Yeah, do have a lot of patient feedback now. We actually have 
patients who will say, can I please see this person? Can I please see 
this person? Because they know they’ve been able to manage their 
symptoms a lot better”. (Ns2/E) 
The participants from Australia also gave the same views. The pharmacist’s views also show 
her strong relationship with the patients, while OL/A told a high score of 4.9 / 5 in a patient 
satisfaction survey conducted in one of her pilot practices. 
“Most of the feedback from the patients is via the GPs or via 
patients contacting me again and it's been overwhelmingly 
positive”. (GPP1/A) 
Australian academic echoed pharmacist’s views that once the initial hurdle of explaining 
patient about their role and performing on a satisfactory level, patients start understanding 
the role and later prefers to be seen by pharmacists first that will then help the GP to make 
better-informed decisions. 
“So yeah, once I think they got past that initial questioning about 





4.11 Future of GPP Role 
The main question at present is how safe the future of GPP role and it is interesting to review 
participants views on it. These are divided in following sub-themes: 
4.11.1 Government Policy on Funding 
The financial support for this role was one of the main challenges mentioned by the 
participants. It is a more significant challenge in Australia in comparison to England due to 
financial support being provided by NHS England under GPP pilot scheme.    
Governments both in England and Australia do acknowledge the pressure on the primary 
health care system, especially on GP practices due to lack of health workforce. It is in their 
plans to support injecting more funding to increase the resources. In England, GPP pilot 
scheme was in the same context while in Australia, there are similar pilot schemes, however 
it is being run on a smaller scale.  The academic from England raised interesting points 
explaining the present workforce shortages and government proposed plans. Highlighting the 
workforce crisis, he said government policy would be to invest more in this sector, but it is 
vital to implement strategies ensuring pharmacists’ recruitment with appropriate skills. He 
also said the grand model of care could be changed in future depending on how the 
government decides to delegate services to other sectors in primary care especially 
community pharmacy and the results of the national evaluation. He thinks, if community 
pharmacists get more roles, it can affect the need for GPPs. It reflects something that is 
happening in the Australian healthcare system in the form of Home medicine review service. 
“NHS has not been able to recruit the number of GPs, the target 
number of GPs that they wanted to recruit by 2020, so there is the 
potential that more money will come to GP practises to recruit 
pharmacists. But again, whether they're able to find the right 
pharmacists with the right skill set who can deliver the patient care 
and achieve patient outcomes; that may vary” (Ac/E) 
One nurse supported the idea of injecting more funding into the GPP role because of it’s 
overall benefits. She said if pharmacists get improved funding, it can broaden the roles they 
are performing. Also organisation or practice would have more confidence and trust on 
pharmacist’s skills while the lack of funding not acting as a barrier.  
“So sometimes what stops them against…can be the funding to do 
stuff and the GP practices as well because they’re thinking oh, will 
the funding be coming out of our pocket. That makes them a little 
bit apprehensive as well. I think on that level if that could’ve been 




Australian healthcare financial structure, as mentioned by the pharmacist, is based on 
rewarding doctors for the offered services, instead of other healthcare professionals. It results 
in role limitation or willingness of job delegation. As explained by a participant, home 
medication review model is being used by GP practices for their funding to employ a 
pharmacist in practice. She also mentioned the issues raised by the Pharmacy Guild of 
Australia as a conflict of interest, as they do not support the idea of GPP performing HMRS. It 
believes that community pharmacists should do it as it will have an impact on the overall 
funding for the community pharmacists. 
Australian participants do not see any significant change in near future, but they do stress on 
the funding structure to claim for the services pharmacist provide. This is like Medicare 
benefits scheme for doctors to reflect on their contribution at government level. 
“I don't think it's going to change substantially in the next couple of 
years, but where I'd like to see it is if there was a funding stream 
pharmacists could access the same sort of funding that doctors do, 
which is called our MBS, our Medicare Benefits Scheme, so that we 
could actually bill for the services that we provide. (GPP1/A) 
The main hurdle is really to sort of try and get some sort of funding 
mechanism because we really need to make sure these dedicated 
funding for pharmacists to provide that service. (Ac1/A) 
“so that’s how the government seems to get involved because 
there's only a certain amount of money and the government has to 
use that as best, for the best of the country.” (Ac2/A) 
OL/A believes strong efforts are being made at government or organisational levels with 
about 20 pilot schemes being run for this role giving support to surgeries by creating a 
workforce model. This also includes reviewing barriers and facilitators for this role. 
Pharmaceutical Society of Australia (PSA) has also created a training path so she believes 
things will improve in next five years. However, the main hurdle or deciding factor would be 
the support from the government in the form of funding.  
The figures have also been quoted in few studies giving an estimate of cost-savings o, but it is 
must at government level to recognise positive impact of GPP role and provide additional 
funding incentive. This is in addition to home medication review service.  
“I think a critical thing would be how is it going to be remunerated if 
the government can see that this would save them money, they may 
provide some incentive funding to practices to have practice 
sessions there has been a sort of a cost benefit analysis done for to 




dollar invested in the role of the GP pharmacist would transfer to a 
saving of a $1.56 costs to the health system.” 
GP from Australia has also raised the same concerns i.e. funding for GPP role once the pilot 
scheme is finished.  
“My only reservation for this role and future is how it will be funded 
beyond its current pilot programme” GP/A 
Despite funding issues, GPs in England have stated that they would continue with GPP role 
once the funding is no more available from government, though it will need a review on the 
roles to make sure that task delegation is appropriate with all healthcare professionals fitting 
in nicely in general practice healthcare framework and there is no role overlapping.    
“So it may be prudent to, you know, look at roles and make sure that 
the most appropriate people are doing the most appropriate talks. 
So yeah, we’d continue with it yeah, because it’s embedded, it’s part 
of our team” (GP2/E) 
On the other hand, OL/A showed serious concerns about the sustainability of the role if health 
organisations paying the money to practices for pharmacist stop funding,  as it was still not 
very clear if pharmacists have done enough to convince GPs to continue with them as part of 
their clinical team and pay from surgery’s budget with no funding to support them. 
“so organisations like us getting often paid, give the practice the 
money to pay the pharmacist, but when we step away if they can’t 
see that there’s enough value to continue that themselves with 
perhaps what they can generate from home medicine reviews, it’s 
likely to diminish, it’s likely to be an eight hour a week role” OL/A 
 
4.11.2 Training & Job Description 
Future of GPP role depends on how well the pharmacists are trained whether it is the training 
before taking on this role or continuous professional development during their career. All 
participants do agree on the importance of training requirements that need to be 
implemented by healthcare organisations as well as by professional bodies.  
As mentioned earlier, one of the main barriers is how well the pharmacists had been trained 
both emotionally and clinically to face this challenge. Academia said NHS should work more 
closely with universities and develop relevant training programmes and modules. He also 
mentioned that there couldn’t be a one generic training module as it would vary depending 




in practice primarily in the start and developing short courses to help pharmacists to get 
trained as per practice expectations.  
“And there is a potential role that the universities should work more 
together with the NHS to develop appropriate training programmes 
for pharmacists. So they're up-skilled to a level that they can deliver 
better patient care, and pharmacists themselves should be prepared 
to take up those additional roles, develop confidence, build clinical 
skills” (Ac/E) 
Australian participants gave similar views. In their opinions, training module can vary 
depending on the requirements, but only highly skilled professionals should join this role with 
well-developed clinical, patient-facing and inter-professional skills. Both pharmacists from 
Australia have said that current level of training does not prepare pharmacists to take this 
role and it is their strong clinical background training that had helped them to take on this 
role with success. 
“Current pharmacist training in Australia does not fully prepare you 
for this role, though there are programs being implemented now 
through the Pharmaceutical Society of Australia (PSA) to address 
this. Being an experienced pharmacist working in both hospital, 
retail, manufacturing and Home Medicines Reviews gave me a good 
foundation for the role of GP pharmacist” (P2/A) 
“Not specific training, because it depends on what sort of practise 
specific needs there are and patient specific needs at that particular 
practise, But I do think it needs to be a highly skilled pharmacists 
going into the role. I don't think it's an entry-level position”. (P1/A) 
“I don’t think any new graduate might have, they might have the 
clinical skills, but they may not have the communication and the 
system skills to moving to that role. So, I do think it needs additional 
credentialing”. (Ac1/A) 
OL/A was more focussed on the importance of practical experience that pharmacists gain 
once they join the practice. In her views, training modules have an influence, but due to 
variance in role specifications or practice expectations, the actual role can be different to 
what the pharmacist was trained for. This could be due to differences in the requirements at 
surgeries. It reflects the importance of mentorship during the initial phase of the role who 




“I think you can do that sort of training but nothing will substitute 
actually working in a GP practice, so you might have done a whole 
lot of training about general practice, and then, in reality, they’re all 
different, they all go about things slightly differently, and they are 
private businesses here and there so they’ve got a bottom line, 
they’ve had expectations, I think the opportunity to experience 
working in a general practice alongside the theory training will be a 
very important.” (OL/A) 
In England, pharmacists’ views were endorsed by GPs that the training should be focused on 
clinical skills.  He said training or courses like prescribing course are more focusing on skills 
like communication or leadership but not that much on clinical skills which do leave a gap 
once pharmacists join this role. He also mentioned that the pharmacists could be trained at 
the pre-registration level that’s where they could be more helpful from the training 
perspectives.  
“Yeah, but I think mainly the focus should be on the clinical 
knowledge as well for a lot of pharmacists because, you know, either 
rusty or it’s not their strong point. And a lot of the courses like 
prescribing I feel there’s a lot of emphasis on like the non-clinical 
aspects” (P/E) 
“So lots of things like clinical reasoning, decision making, how to 
improve the competence and confidence of venerable ones by doing 
that”.   (GP2/E) 
 
4.11.3 Future Research 
All participants endorsed the importance and the need for future research. 
Ac/E emphasis was to conduct both qualitative and quantitative research studies to evaluate 
the scope and implementation of subset of services. His primary focus was the importance of 
national evaluation or to assess the impact on a bigger scale. In his views, there can be so 
much variance in quality or nature of services being provided. These services are mainly 
dependent on competence of pharmacist along with the requirements of organisation. In his 
views, a careful selection of pharmacists should be made on a larger scale for national 
evaluation and then further decisions can be made regarding future funding.  
“So, there is a need. Whether pharmacists can fulfil the need or not, 
that's the question that needs to be answered. And that's why I 




very critical in determining the future of GP pharmacist workforce” 
(Ac/E) 
Other participants from England echoed similar views highlighting the importance of research 
which would reflect the overall impact of pharmacist role in an evidence-based manner.  
“Yeah, hard factual evidence on the impact that’s been made by 
pharmacists because I think that will allow more documentation. 
(P/E) 
I suppose if you want to show your effect as a pharmacist, you 
probably need to have some research probably done about the...the 
workload you do and the reduction in workload for GPs (GP1/E) 
One nurse said that pharmacists don’t get much recognition for the role they play in practice 
especially as advocates for patients and more research is needed to document their practices.  
“We never thought of them as advocates, but that is what they are. I 
think research into that and actually giving them at recognition 
would be really good for them.” (N2/E) 
Not much research has been done in Australia about the overall impact of GPP. This is because 
the role is new and not many surgeries having a GPP working for them as highlighted by a 
pharmacist. In her views, there is a need for research in this area and ideally this should be 
done on a larger scale.  
“I think it would be really valuable to have a lot more research over 
multiple practices on the GP practise role. I mean, there's hardly any 
to date and it would be useful to see how it changes the 
appropriateness of medication therapy. The only reason we haven't 
done that is because we're limited to one practice and choosing 
outcomes is challenging.” (P/A) 
Australian academic mentioned the requirement of research on barriers and facilitators for 
this role along with role specification and inter-professional working collaboration. They 
believe that this can help to structure the required training and future funding for this role. 
While working together GPs and pharmacists can have mutual benefits. 
“So there’s more research needed because that can help inform 
whether there are special training required for a pharmacist working 
in GP practices and also they could have been informed potential 





“I would like to see how positive results or the sharing of positive 
results and experiences can actually impact and encourage people 
to explore more interprofessional work because there is much good 
that could be done for the benefit of patients when GP’s and 
pharmacists work together” (Ac2/A) 
 
Giving her views about future research, OL/A raised the concern of funding as she believes 
the present funding is not enough to keep pharmacist working in practice for a period where 
the actual impact of interventions on patient care or aspects like polypharmacy could be 
evaluated. Hence any research that can demonstrate patient benefits or how much money 
























Chapter No. 5 
DISCUSSION 
This section explores and evaluates views of key stakeholders on GPP role in England and 
Australia in view of results of this study. All themes that have emerged have been discussed 
in detail. 
5.1 Gaps in General Practice Framework & Role of GPP 
All stakeholders have agreed that there are gaps present in general practice framework which 
are getting bigger due to staff shortage, polypharmacy, due to complex medical conditions, 
doctors not opting to choose general practice as future career and present GPs opting to 
move overseas (Beech et al., 2019). This scenario has created a big gap, risking the quality of 
patients’ health care leading to discussion of having additional clinical staff, including GPPs, 
which can help to reduce GPs workload. 
The participants of this study have reinforced the idea of GPP, as stated by one of GPs, “it is 
a no-brainer to have a pharmacist in practice” shows the GPs’ confidence on GPPs. It reflects 
statement of study (Williams, Hayes & Brad, 2018) in which the authors suggested GPP as 
medical expert and GPs and patients would not choose to work without them. At the same 
time, the participants have shown concerns mainly regarding job specifications which should 
be addressed to make the role successful.  
Australia: In comparison to England, GP workforce crisis is not as severe as in Australia as 
shown by figures published in a report by RACGP (General practice: Health of Nation 2019). 
Most GPs work in urban areas with GP: patient ratio decreases in remote areas. It means 
there are fewer GPs per person in regional and remote settings. Our study participants believe 
that like England, pharmacists can take on the role of GPP in Australia to facilitate GPs in their 
workload but unfortunately, however this is moving on a slow phase. As can be seen that only 
13% of GPs told their practices that they have GPP working for them (General practice: Health 
of Nation 2019), This is because of limited funding from the government (Freeman et al., 
2016). As mentioned by an Australian pharmacist in our study, currently there are not many 
GPPs, mainly due to lack of specific funding for this role. It makes GPs very reluctant to recruit 
a GPP, and this is also being discussed in the literature (Baker et al., 2019). On the positive 
side, the feedback that has come from all Australian’s participants is very promising, 
acknowledging the positive impact of GPPs on the overall healthcare system. 
5.2 GPP Skillset / Job Description 
One of the objectives of this study was to explore pharmacist skillset and training 
requirements accordingly. The views of participants on this are one of the central themes that 
have emerged in results.  It is accepted nationally, both in England and Australia, that there is 
need to strengthen workforce to fill the gaps present by the shortage of GPs and nurses, but 
the question, i.e. has the pharmacist got the skills to fill in this gap remains open for 




al., 2020) and NHS England valuation report (Mann et al., 2018). Initially GPs were not very 
clear about the role description of the pharmacist and the same is reflected in views given by 
participants in our study. However, at the same time GPs believed that it has created an 
opportunity for the pharmacist to develop themselves in a role with diverse dimensions 
enabling them to mould themselves in a job description as per organisation expectations and 
requirements. 
The results of our study emphasise that no two practices can be alike so the role of GPP should 
be flexible to meet the needs and expectations of that specific practice and in accordance 
with the demands of the local community as explained in a study by (Freeman et al. 2018) .  
5.2.1 Medicine Management Role 
England: One of the main concerns presented by GPs was the time they had to spend on 
medicine queries from patients, pharmacies and tasks like hospital discharge notes. So, GPP 
coming in and taking this work away from GPs was the main objective which would enable 
GPs to spend more time on patient-facing roles. This was mentioned by one of GPs during his 
interview in this study.  
The GPs participants in our study believed that aspects like updated medication records, 
medication reconciliation with hospital discharge notes, close monitoring of repeat 
prescription protocol and the source of contact for patients to discuss issues about 
medications to improve medication adherence, are some of the roles which GPPs have taken 
on. This has reduced workload on GPs. These views reinstate the findings of (Benson, Lucas & 
Kmet, 2018) that pharmacists are experts in medicines and their knowledge about medicine 
indications, side effects, contraindications and dosage make them an ideal source of 
reference to be contacted by GPs and other healthcare professionals regarding medication 
queries.  It also reflects the role presented by the WHO in 2003 report about low medication 
adherence by patients and how it can be improved by involving pharmacists (WHO, 2003). 
The participants in our study also mentioned the positive impact GPP could have on medicines 
wastage/ This could be done by reducing medicine wastage directly or indirectly by improving 
medication compliance and by managing the repeat prescriptions. It also reflects the role 
description of GPP in a study done by Truemaan et al. (2010) which shows that GPP can play 
an active role in reducing medicine wastage. This is an important a factor in lowering primary 
care medicine wastage cost which is estimated to be in the range of £250-300 million in 
England (Trueman et al., 2010) 
Our study also reflects the value of GPP in a central position to link and bridge gaps between 
the hospital, community pharmacy, healthcare organisations like CCG in England and general 
practices. All participants in our study believed that with evolving role and pharmacists 
working in all these organisations; it is an ideal network where GPPs can coordinate with their 
colleagues for a fast and reliable exchange of information. So, dealing with queries about 
hospital discharge notes, unlicensed medication usage, medicine shortage and alternatives or 
to implement prescribing protocols set by local medicine management department, are some 




Australia: The participants from Australia also gave similar views. Although at the moment 
due to lack of funding, GPPs are mostly involved in-home medication reviews, but the 
capabilities of GPP in a medicine management role is acknowledged and is the part of evolving 
job description, mainly depending on available funding as highlighted in the studies (Freeman 
et al., 2012e) & (Freeman et al., 2014).  
5.2.2 Patient-Facing role 
The patient-facing role has also become the central part of the evolving job description of 
GPPs as said by GPs and organisational lead in this study. Their views show that initially, GPP 
role was dealing with medicine management with GPs and nurses running clinics, but this 
scenario has changed in the past few years (Deeks et al. 2018). As there is a shortage of GPs 
and nurses, the demand for other healthcare professionals is increasing. This is very pertinent 
in the roles as advanced practitioners, where pharmacists and nurses could do so in patient-
facing roles (Barnes et al., 2017). In our participants’ views, this has also led practices to get 
pharmacists to involve in patient-facing roles like running specific clinics, medication reviews 
and home visits etc.  
This study shows the importance of professional development required for pharmacists to 
enhance their clinical knowledge and patient-facing skills to perform well in such roles. The 
participants of our study do believe that GPP has clinical skills to run clinics like managing 
chronic conditions or minor ailments but to polish them in a patient-facing role while working 
in surgery needs training and development. It also highlights the need for mentorship where 
GPP should work in shadow with either GP's or nurses, especially in the initial phase, to learn 
and adapt skills, required to run such clinics. This has been also mentioned in the NHS 
evaluation report (Mann et al., 2018).  
Australia: The participants of our study think that Home Medication Review Service (HMRS) 
provides the platform as the primary patient-facing role for GPP and with better resources 
and available support, medication reviews performed inside the clinic would improve the 
timeliness and completion rate. This viewpoint has also been supported by studies (Freeman 
et al. 2012) and (Tan et al., 2013). All participants in our research from Australia do firmly 
believe that pharmacists who do join GP practice as GPP have the skills to take on such roles 
due to their training. This is required for HMRS accreditation and with more funding options 
available in future, GPPs would take on more patient-facing roles in clinics as a part of multi-
disciplinary settings (Deeks et al., 2018).  
5.2.3 Pharmacist as a Prescriber 
Like patient-facing role for pharmacists, additional qualification of prescribing annotation for 
GPP is gaining more importance and demand by organisations. The views of our participants 
who support GPPs’ prescribing role are also in line with the study by Gerard et al., 2012, which 





Our study reflects the difference of opinions among participants. Although all stakeholders 
do agree on the benefits of this role, there are obvious concerns about required protocols. 
Governing bodies in England have set up guidelines for Non-Medical Prescribers (NMP) with 
a structured course and then to ensure all NMPs would prescribe within their competency 
level (Royal Pharmaceutical Society, July 2016) & (GPhC accreditation criteria, 2019). The 
central theme that has emerged from the views of participants especially GPs in our study is 
the need for strict protocols for pharmacists to prescribe under supervision. They believe that 
it could be beneficial for pharmacists to help GPs in their workload of managing repeat 
prescriptions, as a GPP can review repeat requests and address any safety issue before signing 
it off but it needs to be done under protocols and pharmacists should know the limitations. 
Similarly, participants think that if the pharmacist is running clinics like minor ailment or 
medication reviews, prescribing qualifications can be helpful as pharmacists can prescribe to 
treat any minor condition or if they want to titrate dosage (Ryan et al., 2018 and Stewart et 
al., 2009).  
In Australia, at present, only GPs can prescribe. Although, participants of this study do believe 
it is something that can be a part of the future role but at present GPs are not willing to accord 
this to pharmacists (Australian Medical Association, 2008). According to views of 
organisational lead from Australia in this study, healthcare organisations are looking at 
prescribing model of NHS England for independent and supplementary prescribing 
perspectives. She believes a similar model can be implemented in Australia wherein initial 
phase, once the diagnosis has been confirmed and the treatment plan is finalised, the 
pharmacist can then join the team and take over repeat prescribing (Baker et al., 2019). 
However, it is still in very early stage and it will take a lot of effort and consultation to develop 
the trust among GPs and governing bodies to commence this exercise. 
5.2.4 Comparison between In-house GPP and Contracted Organisational GPP 
Due to the funding aspect involve in this role, there are different models regarding how the 
pharmacist could be integrated into general practice. In England, there are models like Clinical 
Commissioning Group (CCG) pharmacist or pharmacist employed by a private organisation 
(Organisational Pharmacist) who later integrates into practice on a contract basis with specific 
tasks or agenda. Also, there are a GPP, who are directly employed by the practice as an in-
house practice pharmacist. Our study compared the benefits of such models. All participants 
from England agreed having an in-house pharmacist is much more beneficial than having an 
organisational pharmacist which is sent over on to do a specific task or agenda in most cases 
to save money by stopping or changing medications.  
Our participants believed that In-house pharmacist develops personal rapport not only the 
clinical team but also with the patients. It is also helpful to establish strong rapport among 
team member, and this is also a view supported in a study by Blondal et al., 2017. This also 
helps GPP to adapt under the requirements of surgery which is not the case with 
organisational pharmacists. Although, members of this study do believe that organisational 
pharmacists are an excellent resource, but an in-house pharmacist is a better option to form 




In Australia, although practices have recruited GPP directly as an in-house pharmacist, 
however it is not a common practice. Healthcare organisations are running pilot schemes 
where they are helping practices to recruit pharmacist but again like England, they are short 
of funding. One difference which came up during this study was the recruitment procedure. 
In England, organisational pharmacists were appointed in practices without much 
consultation with general practices, but in Australia, general practices do the interviews for 
pharmacists and have a say on the final decision. 
5.3 Working Collaboration 
Our study shows that GPP role is in its evolving stage, and it needs support, based on a strong 
working relationship from all key stakeholders as suggested in the study by Mercer et al., 
2020. In primary care settings, the relationship between pharmacist and GPs has never been 
on ideal terms due to lack of communications and funding issues for services (Bradley, Ahcroft 
et al., 2018). 
Nevertheless, the GPP role opened a new dimension in this scenario as it provided an 
opportunity for pharmacists to bridge this gap and to involve in direct patient care. But at the 
same time, according to the participants of our study, there are  concerns or  barriers which 
pharmacist needs to cross and build a robust, trustworthy and respectful relationship. This 
study endorses the facts found by (Ryan et al. 2018), which reported that though there were 
barriers for GPPs in initial phases, mainly due to hierarchy and jurisdictional tensions, the 
working collaboration has increasingly improved.   
The views given by participants in our study are very positive and it shows positive 
relationship, which has not only improved between pharmacists and GPs but also with the 
other healthcare professionals like nurses, health care assistants and clerical staff of 
organisations. This shows the acceptability of GPP as an integral part of daily working routine, 
which is essential to facilitate transition from non-clinical role to patient-facing role as 
elaborated in a study conducted at Sheffield primary care (Marques et al., 2018). It is essential 
to understand that this relationship is not something that can develop overnight; it is a slow 
process and it is aided by the willingness of all sides to interact, communicate and to develop 
a strong understanding. 
Also, it is not only limited to clinicians, a strong working bond with clerical staff of 
organisations at a micro or macro level is also vital helping to delegate the tasks to right 
clinician with most appropriate clinical skills. This is also suggested by (Hampson, 2018) which 
has suggested tips for both GPP and practice to build strong working relationship. 
Looking at views of organizational leads in this study, it is evident that organisations have 
started to develop more trust in GPP acknowledging their professional expertise, especially 
in England. The scenario in Australia seems to be different where this is in the initial phase 
and pharmacists are trying to create an initial strong impression. As mentioned by Australian 
organisational lead in this study, she has experienced a few pilot projects where due to lack 




highlights the importance of consultation work, that needs to be done before a GPP joins a 
surgery. It includes discussing the support that is required by GPs as well as by GPPs in the 
form of robust working collaboration among healthcare professionals (Polasek et al., 2015). 
Also, the pharmacists must understand the expectations of a specific organisation where they 
are working. It is also important to note that there are no one rules for success in this role, 
every GP organisation and population has its own demands. The best way is to take a 
collaborative approach. 
5.3.1 GPs & GPPs 
This study shows that GPP working along with GPs in medical practices has made the base for 
strong future working collaboration especially once the initial phase of expectations started 
to match with actual roles. This could lead to better understanding, training to improve 
professional skills (Nabhani-Gebara et al., 2019) and to reduce GPs workload (Ryan et al., 
2018). In England, looking at GPP pilot scheme, GPs and GPPs’ relationship was not a major 
concern as it was a win-win situation for both sectors with GPs knowing they were being 
supported by pharmacist integration to reduce their workload and being funded by the 
government, while for pharmacists it was a new career option (NHS England, 2015).  
In Australia, though GP has shown support for the GPP role, due to funding issues and non-
clarity on the role, the views of some participants of this study reflect the struggle a GPP had 
to build a relationship with the clinical team.  
The pharmacists’ views from Australia in this study indicate a strong working collaboration.  
This was built on strong professional relations with clinical lead due to strong clinical 
background and this perhaps facilitated to fulfil practice expectations, as highlighted in 
another study (Mercer et al., 2020). However, our study shows that this is not the case with 
every GPP as few GPPs struggled to build a strong professional relationship. 
5.3.2 Nurses & GPPs 
The views in our study by nurses and pharmacist have shown a great improvement in this 
working collaboration with both sides getting a better understanding of each other roles. 
Especially this is evident from the comment from the nurses. This has also been supported in 
an NHS pilot review report (Mann et al., 2018). However, there are concerns from nurses that 
pharmacists are stepping on their shoes and taking on the roles that have already been 
offered by them (Nabhani-Gebara et al., 2019) but nurses in our study have mentioned that 
they feel more comfortable and confident with their scope of practice especially prescribing 
role as they can always go and check with the pharmacist to clarify any doubts about 
prescribing a medicine.  
Overall view of participants in this study showed that pharmacists and nurses are a part of a 
clinical team, been led by GP, and sometimes the roles can be very similar, as stated by one 
of the GPs that they are developing the working of a clinical team rather than an individual 




represent and answer the query. It is also supported by feedback and input from other 
professionals, if required. Hence, it is all about to acknowledge and complement each other 
roles as stated in a joint report published by RPS and RCN (Royal Pharmaceutical Society & 
Royal College of Nursing, 2015). The results of our study reflect that nurses can always help 
the pharmacist in learning clinical skills while pharmacist can be a source of reference for all 
medication-related queries like drug interactions, dosage, contraindications and side effects. 
If it works out correctly, both professions can have a very positive impact on each other’s 
scope of practice (Mann et al., 2018). 
Australia: The comments by Australian participants show that there is an element present 
in GPP mind that they can or should perform duties which are at present being done by 
nurses, more like a “taking over” factor as mentioned by an organisational lead. Any such 
actions can directly or indirectly damage the working relationship and ideally should be 
avoided, especially at an initial phase. This was highlighted in the views of Australian 
pharmacist during this study that pharmacist should perform well within their expertise. So, 
any possibility to expand their roles should be done together with a mutual understanding 
with GPs and nurses, as highlighted in the study by Dennis et al., 2009. 
5.4 Medicolegal Issues 
The pharmacist’s expertise is another focal point while discussing the job specifications. 
Ideally, as mentioned by one GP in this study, it should neither be crossing the line nor to be 
scared of taking actions within your scope of practice due to factors like role overlapping or 
indemnity insurance. In our study, although no other participant has mentioned any specific 
comments related to the medicolegal issue, the concerns have been raised mainly by 
organisational leads. 
The results of this study showed that in England, GPPs are performing a comprehensive role 
in comparison to Australia, which is in the process of broadening up the scope of practice. 
The main concerns raised by participants in this research were prescribing annotation of GPP 
and if it could lead to any medicolegal matters. This study reflects a robust proposed level of 
confidence on prescribing skills but at the same time, it also emphasized that GPP should only 
prescribe from their own approved P-formulary under strict protocols. It should not be taken 
as granted with the understanding that as NMPs, they are responsible and accountable to 
their prescribing as highlighted by the study (Gerard et al., 2012).  
The supervision by GPs or other senior healthcare professionals is vital with regular appraisals 
as mentioned by one of the GPs during the interview. An important message given by one of 
the GP during is not to pressurise pharmacists to perform duties which they don’t feel 
comfortable to, as there is a possibility that sometime pharmacists when given a task which 
is out of their scope of practice feel scared to report it back without any action, thinking it 
might impact their relationship. To avoid such scenarios, there should be a direct line of 
communication between GPP and clinical lead with set job specifications. If there are set 
boundaries which both pharmacist and other members of clinical team know there is a 




In Australia, as mentioned earlier, GPPs’ role is in the initial phase and mostly linked with 
medication reviews either at home or in the clinic. All respondent pharmacists in this study 
have mentioned an active working collaboration within the team with a good understanding 
of their roles as well as limitations. Understandingly, in some cases, the pharmacist, with a 
strong clinical background and work experience, had developed a strong rapport with clinical 
staff and patients which is evident from the confidence and trust of lead GP. 
5.5 Key Performance Indicators 
This study reflects the difficulty to list down specific and a generic model of KPIs for GPP roles, 
mainly because it varies from surgery to surgery as well as with the population demands. It 
demonstrates the statement given by (Karampatakis et al., 2019a & Karampatakis et al., 
2019b) about the difficulty faced by GPP to measure and record their impact in general 
practice.  
Following are the main KPIs worth discussing from this study: 
5.5.1 Cost-Effectiveness 
This study emphasises the importance of the cost-effectiveness aspect of GPP as this has been 
suggested by the various participants in this study. This is also reflected in NHS pilot scheme 
review report (Mann et al., 2018). Although, organisations or practices are seeing pharmacist 
as the role to fill in the gaps left by GP shortages, at the same time issues like funding has 
been raised by participants especially from Australia, whereas practices get reluctant to 
recruit pharmacist (Avery, 2017).  
The results from this study show that GPs would like to review how much time a GPP has 
saved on daily or weekly basis. This is to show a marker for the overall cost-effectiveness 
(Deeks, Kosari & Naunton, 2018). Only the use of GP hours saved by GPP would 
underestimate the overall impact pharmacists have hence it is vital to document various 
clinical and patient health outcomes to measure the value of GPP. 
5.5.2 Medication Reviews  
Medication review have been mentioned by all participants in their interviews. This study 
indicates that shortage of GPs and nurses along with pharmacist expertise in medicines put 
GPPs in a good position to conduct medication reviews. Hence the numbers of medication 
reviews performed by a GPP on a weekly or monthly basis can be a good key performance 
indicator and this is also being highlighted by GPs in this study.   
5.5.3 Home Medication Reviews Service (HMRS) in Australia 
As evident from views by Australian participants in this study, due to the funding issue, the 
focus has been on number and quality of HMRS, and it can be used as a KPI in Australia. The 
organisational lead mentioned that it’s a complicated process where GPs need to refer 
patients to pharmacists for review, so by improving the workflow the quality and numbers of 




having a GPP to perform in-clinic medication reviews, as suggested in the literature (Tan et 
al., 2014a). The literature also shows that reviews or consultations done by pharmacists 
located in health clinics were more effective in resolving medicine-related problems, receiving 
better feedback from the patients as well as  improving the timeliness and completion to 
conduct medication reviews (Freeman et al., 2012c). 
Same time as per views of Australian participants in this study, it should not be the sole KPI. 
Every GP surgery has different requirements or expectations which are mostly based on 
population demands, so it is crucial to review GPP’s role in Australia at a larger bigger scale. 
Also, according to participants, HMRS is already been performed by accredited community 
pharmacists so organisations should also focus on additional roles, which a pharmacist can 
offer. It is a funding issue as GPs want to use HMRS funding for GPP roles but looking in bigger 
picture GPPs can save money by decreased workload, decreased medications error, improved 
patient safety, improved patient service and reduction in practice drug budget (Baker et al., 
2019). 
5.5.4 Medicine Management 
Improvement in medicines management is another main KPI mentioned by our participants. 
It is a difficult one to measure as many aspects of medicine management hasn’t got the 
numerical figures (Karampatakis et al., 2019a) but as suggested by a GP participant in our 
study, comparison between the time taken by GPs or other healthcare professionals to 
complete daily medicine management, in presence and absence of GPP, can be a good 
indicative measure. Overall, the data reflects that organizations expect GPP to play a major 
role in reducing the time that GPs spend on medicine management. This includes hospital 
discharge notes, action on safety alerts, dealing with the patients and pharmacy medicine 
queries and be a central figure to communicate in between different sectors of healthcare 
system. This is also discussed in more detail in pharmacist skillset section. 
5.5.5 Evidence-Based Practice 
Another essential aspect in KPIs is the quality of work being done by pharmacists which is 
more important than just the numbers or figures. As mentioned by nurses in interviews, there 
should be measures to make sure whether the recommendation being made by the 
pharmacist for patients is backed up by evidence-based practice. It also reflects the need to 
have continued professional development by the pharmacist. This could help pharmacists to 
keep them equipped with the latest professional skills (Mann et al., 2018). Some activities 
that have been mentioned by respondents of this study are attending regular clinical 
meetings in surgery and on other forums with the active participation in the forms of 
presentations and written reports.  
5.5.6 Patients’ Satisfaction 
Patient satisfaction can be another vital key performance indicator. This might be the one 
having the most effect on the overall role. As said by one of the nurses in the interview, it is 
all about GP’s and patient’s satisfaction. So, results from this study shows that to evaluate 




to give feedback about their interaction with the GPP (Pharmaceutical Journal, 2016), . This is 
also being mentioned by Karampatakis et al., (2019a) that there are limitations of any such 
surveys, and they should be reviewed before reaching to any results. The limitations of these 
surveys are as sometimes feedback given by patients does not reflect the actual insight of 
pharmacist contribution.  
5.6 How GPPs’ Role has Evolved in the Last 5-10 Years 
The GPP role is evolving at a high pace with more input from different sectors in the form of 
reviews and research. This study reflects the views of key stakeholders reflecting on how this 
role has developed in the last 5-10 years. This is with the support provided by government in 
the form of pilot schemes. As reflected by view of this study participants, GPP role is evolving 
on a positive note, creating an opportunity for GPP pharmacist to develop, grow and train. 
This is also being observed by Anderson et al. (2019) that GPP to be successful, they need to 
be visible, communicate well, be flexible and they must be innovative.  
England: This study shows that GPP’s role has become a crucial part of general practice 
framework in England. In the initial phase, the position has been funded by the government 
under a specific GPP pilot scheme (NHS England, July 2015) and due to the positive impact 
during pilot scheme, organisations are willing to recruit GPP without a significant part of their 
salary been funded from the government. While discussing the role description, views of 
participants indicate that initially most of the pharmacists were performing non-clinical role 
including medication management, but recently the role has evolved in more towards a 
patient-facing one with pharmacist getting more involved in running clinics and home visits. 
These views are also supported from the literature (Ryan et al., 2016). All participants from 
England in our research do believe that pharmacist have got the clinical capabilities and skills 
to take on this challenge and with prescribing annotation, pharmacists are in an ideal position 
to show their value (Stewart et al., 2009). Same time, it also highlights the importance of 
continuous professional development for GPP to keep themselves updated with the training 
requirements. This was also mentioned in the pilot scheme review report (Mann et al., 2018).  
This research also shows the growing role of GPP to work as a supervisor as mentioned by 
some participants in this study. In England, practices are recruiting pharmacists at the pre-
registration stage to train them as GPP for the future. It is a very positive step as it shapes the 
future of this role and it allows GPP to act in a supervisor role not only for pre-registration 
pharmacist but also for the other staff members (Girvin & Wilson, 2018).  
Looking at the present scenario and data collected during this study, it reflects GPP role to 
evolve on a positive note in the future. The GPs are looking forward to work with GPPs who 
can take on patient-facing clinical tasks like running specific clinics along with their medicine 
management role. The nurses also have a very positive attitude towards GPP, acknowledging 
their clinical and management skills to improve overall working efficacy from clinical and time 




Australia: Australia, in comparison to England, as described by our participants, is at the 
initial phase of integrating pharmacists into general practices with the support from 
healthcare organisations (Sake et al., 2018). It is difficult to analyse at this stage how the role 
is evolving although participants in our research have mentioned that it is growing with new 
roles and programmes are being developed and positions becoming more clinical (Deeks et 
al. 2018). The central theme seems to be the amount of funding required to continue with 
this development, as suggested by Freeman et al., (2016).  A flexible model is needed on the 
basis of individual skills of GPs and pharmacists which could allow structuring as per specific 
population needs.  
During this study, participants from Australia mentioned taking England pilot scheme as a 
model and to follow it up further. At this stage, it seems like the focus is mainly on HMRS, 
because of available funding. Hopefully, with time and improved financing, pharmacists 
would be able to perform roles outside of this service including medication management, 
running clinics and liaising with the patients to deal with any medication queries, as 
highlighted by Freeman et al., (2016).  
5.7 Patients’ Views on GPP 
The patient feedback is an essential tool to analyse the performance of any healthcare 
professional. With healthcare organisations targeting high-quality patient care, all healthcare 
professionals need to understand the needs of patients by developing a strong working 
relationship with them.  This aspect becomes even more critical when a new role like GPP is 
being developed. 
Pharmacists in this study highlighted the impact. Traditionally patients were used to seeing 
the pharmacist in community sector so seeing by pharmacist in clinical roles for their 
medications at surgery was a new experience for the patients (Bajorek et al., 2015). As 
reported by some pharmacists in our study, it was the main hurdle in the start as patients 
were not willing to be seen by the pharmacist and were asking to see a GP. The similar concern 
was also observed in other studies (Karamapatais et al., 2019a).  
The views given by participants in our study reflect the change in that behaviour. It shows 
that patients have realised that pharmacists are not only someone standing behind the 
dispensary in a white coat, but they are also an expert in medicines with clinical knowledge. 
They can be a part of the multidisciplinary team who are responsible for their care.  
Our study also shows the change in the way patients are accepting GPPs on a positive note. 
This reflects findings in patients’ feedback survey (Pharmaceutical Journal, 2016). The 
participants believed, in the past patients used to adamant to be seen only by the GPs for 
their medical issues. However, with the shortage of workforce, with some GPs appointment 
diary booked for almost month in advance, this trend is changing and now patients are fine 
to be seen by other healthcare professionals including nurses, and pharmacists. The patients 
are fine as long as their concerns have been addressed and the treatment is of high quality. 




Our study also reflects the approach a GPP should take to improve the relationship with the 
patients. As shown from the results in this study, the patients have their individual needs, and 
no one formula can fit all patients.  To understand patients’ needs is a difficult job which 
requires time. This scenario puts GPP in an ideal position to fill the communication and care 
gap between patients, GPs or nurses. GPs only have 10-15mintes per appointments and they 
don’t have time to talk with the patients on factors which can have an indirect impact on 
patients’ health. However, GPPs can fill this gap. As having more time while doing medication 
reviews, home visits or medicine management, they can develop a relationship of trusts with 
the patients, especially with those ones suffering from chronic medical conditions. This is also 
evident from the results of this study where GPs, nurses and GPPs from both England and 
Australia have mentioned positive and overwhelming response from patients. These resulted 
are also supported by Tan et al., (2014b) stating that a better satisfaction was noted when 
medication reviews were performed by the pharmacists. 
According to the results from our study, in Australia, HMRS does help to build this bond. One 
of the participants who is managing a pilot scheme noted a very high patient satisfaction score 
for pharmacists. This reflects that although this service is in it’s initial phase or at pilot scheme 
level, the positive impact of GPP is already visible.  
Another critical aspect highlighted by participants was the efforts of pharmacist to improve 
their clinical knowledge. It is very clear that patients’ needs, or demands can be different, but 
they expect to be seen by a skilled healthcare professionals. The patients would only trust 
GPP as an alternative to GPs or nurses if pharmacists have an excellent level of 
communications as well as clinical skills. 
5.8 Training / Education 
The results of this showed that the future of GPP mainly lies in pharmacist’s own hands, i.e. 
how well they perform as GPP to bridge the present gaps in general practice framework and 
develop the necessary skills and understanding of the role. This has also been mentioned by 
Hampson, 2018. Our study also reflects the importance of training requirements that need to 
be reviewed to strengthen professional expertise of GPP. 
Though pharmacist is a medical expert but the clinical knowledge what pharmacist acquire 
during their professional studies raises questions whether it makes them competent to take 
on this role. This is a question or concern that has emerged from pharmacists’ views in our 
study and reflects on views given by (Barnes et al., 2017) in which a minimum of 2 years post 
qualification and clinical therapeutic diploma has been suggested. Our participants do agree 
that surely there is a need for training modules to be designed and implemented as part of 
this role, but at the same time it is tough to have a generic training model for this role as 
mentioned by Ryan et al., (2018).  
The results in our study show that factors like professional background and length of 
experience would have a significant effect on required training and education. The central 
theme that has emerged from participants’ views is the need to have continuous professional 




The results show that most modules are focusing on non-clinical skills like leadership, 
communication skills but training on clinical skills has more importance. This is in the context, 
if the future of GPP role lies in more of a patient-facing role like running various clinics or 
performing medication reviews.  
Hence, specific training on managing chronic conditions including diabetes, asthma, blood 
pressure and COPD etc. can be beneficial. As highlighted by one of the study participants, it 
would be a good idea if the government can involve universities in this initiative. The 
Universities can offer Non-Medical Prescribing courses and can re-structure the training by 
adding clinical perspectives into the modules. It endorses the suggestion of a recent study 
(Girvin & Wilson, 2018) & (Donovan et al., 2019) that clinical skills sections should be 
improved in MPharm course. Also, to enhance GPP clinical skills, there is a need to have an 
integration of pre-registration training in general practice.  
In Australia, HMRS seems to provide the base for the training. The participants believed it is 
a good training programme which strengthens the clinical knowledge of accredited 
pharmacists and can be taken as an initial competency threshold for the GPP role. Also, the 
Pharmaceutical Society of Australia (PSA) has started training programmes for this role.  
Although participants of this study believed that certain elements in pharmacy courses such 
as pathology, patient counselling and medicine optimisation are there however to perform 
this role an upskilling is needed. The real challenge starts when the pharmacist joins the 
medical practice, where the actual reflection of their knowledge and expertise is tested. The 
pharmacists would only be successful if they can develop the skills per the needs of the 
practice site. This is also supported from the literature that there is a need to upskill the newly 
graduated pharmacists to perform the GPP role. (Benson, Lucas & Williams, 2020) 
This also highlights the importance of mentorship by GP. This has been mentioned in our 
study and this has also been endorsed in the literature by (Mann et al, 2018). Training 
modules provided by professional bodies have their value but the real knowledge and skills 
that a pharmacist gains while working in the clinic under the supervision of a mentor has no 
alternatives and nothing can substitute it. This is also supported from the literature that any 
organisation or practice who recruits a pharmacist must provide mentorship to review and 
improve their scope of practice (Butterworth et al., 2017).  
5.9 Government Funding 
The government funding is one of the main factors, which is going to decide the future of GPP 
service. This study shows that though; all participants do agree on the positive output by GPP 
at organisational and patient-level, medical practices depend on government funding for this 
role. 
NHS England has changed its structure of funding and the Primary Care Networks (PCN) been 
guaranteed funding for approximately 20,000 additional staff including GPPs, so the funding 
is still available though not directly in the form for specific GPP role (NHS England, 2019). It is 
yet to be cleared how this would look like in the future once the funding for GPP role would 




2019). GPs and organisational leads in our research have given positive remarks about future 
though understandably there would be a review of role specifications to make sure that there 
is no role overlapping especially between pharmacists and nurses. It is like a puzzle where you 
must find the right piece for the right place. It will take time but as discussed in the results of 
this study, if pharmacists continue to improve their clinical and patient-facing skills, there is 
no doubt that they have a huge role to play in future general practice framework. 
Australia: In Australia, it’s the initial phase of GPP role. The views by Australian participants 
reflect a stage where England was about 5 years back when the government started the 
national pilot scheme for the GPP. This study shows that the primary funding for pharmacist 
sector is via HMRS where the government is giving money to doctors as well as pharmacists 
to perform medication reviews referred by GPs. This has also been mentioned in a study done 
by Baker et al., 2019. The participants from Australia have shown their concerns about 
dependence on this funding model as it does restrict their job description. Ideally as 
mentioned by one of the participants, a pharmacist should be able to bill for the services they 
are providing like doctors (Medicare Benefits Scheme). Some other options are flexible 
funding model as mentioned in study by Freeman et al., 2016, or a funding model by Polasek 
et al., 2015, which recommend a Pharmacists in General Practice Incentive Programme 
(PGPIP) funding model. It will give pharmacists a chance to come forward and play a broad 
role which is not much tied up with the HMRS money. Results of this study suggest that 
although Australian pharmaceutical society and other healthcare organisations are in talks 
with the government about future funding models, however it is believed that not much will 


















Chapter No. 6 
CONCLUSION 
This study shows the gaps as well as differences in England and Australia about expectations 
and perceptions of GPPs’ role. Although, the study has some limitations, which have been 
explained in detail later in this chapter, however the points gathered are vital to provide 
future discussion points. 
Pharmacy culture needs to change: First and most importantly, it is vital for pharmacists as a 
professional to bring a change in their culture. Globally, there is a change in trend of how the 
primary care services have been designed to counter the workforce crisis of GP. There are 
ever increasing opportunities for pharmacists to make their mark in healthcare sector by 
presenting themselves as the missing link which can bind the workforce together. But for this, 
pharmacists need to come out of their comfort zone of dispensing culture and equip 
themselves with required clinical knowledge and consultation skills to leave a positive mark 
and earn the confidence of the GPs.   
Comparing training pathways for GPP: England lacks a training structure to prepare clinical 
pharmacists before they take on the GPP role. England can take a lead from Australia who 
requires pharmacists to complete highly skilled clinical course to get accreditation for HMRS. 
Similar design for such training or accreditation course in England would be helpful to improve 
clinical pharmacist skills and to perform at a high level, especially with improvement in clinical 
knowledge and patient facing roles. This is also an important aspect of GPPs’ job description.   
Prescribing annotation: Both countries need to review their policy on prescribing annotation. 
Though in England, most GPPs are acting as NMP, however taking on prescribing roles in 
surgery is a challenging task and a lack of protocol creates unclarity about the boundaries. On 
the other hand, Australia should take a proactive approach towards awarding prescribing 
qualification to pharmacists, as with defined protocols and closed supervision. Prescribing 
skill can play a big part in reducing GPs’ workload, who spend a bulk of their daily time in 
dealing with repeat prescriptions. Also, GPPs who are running minor ailment clinics and 
monitoring patients with long term medical conditions can use their prescribing qualifications 
to enhance their credibility.  
Funding for GPP: It seems like Australia now stands where England was about 5 years back 
when NHS pilot scheme was launched at the national level. It has been a success in England, 
though the workforce shortage still exists, GPP has been a valuable addition to the multi-
disciplinary clinical team, endorsed by all participants in this study. Australia needs to perform 
further research on a similar designed pilot scheme at the national level which can facilitate 
GPP role in primary care, backed up with improved funding from the government. With 
practices using HMRS funding, it limits a GPP role and also creates friction within organisations 
that might prefer this role to be performed by accredited community pharmacists.  
Job description & KPIs: As for England, further research should be done to design generic role 




pharmacist expertise. Also, the government should facilitate further development for 
pharmacists in the role of advanced practitioners. At the same time, GPPs should realise that 
this is a highly skilled role which needs excellent communication and clinical skills. A fresh 
university graduate cannot take this role so they should continue to develop themselves 
professionally by taking on training courses to improve their clinical skills. Availability of pre-
registration in surgeries is a positive step to provide initial training for pharmacists during 
qualification, something Australian healthcare can take the lead from for future education 
and training.  
6.1 Limitations of Study 
Overall, this study has few limitations, which are described below: 
• Small sample size due to low response especially from Australia. As mentioned earlier, 
GPP role in Australia is in initial phase and number of available professionals who have 
experience of working as GPP or with GPP is small. Attempts were made to contact 
large pool of those professionals from Australia; however, it was challenging to recruit 
participants. Factors like time difference between England & Australia made it difficult 
to arrange a suitable time for interviews. 
• Lack of similarity among the number of the same stakeholders' group. 
• No direct involvement of the patient and the patients’ feedback was based on the 
views of other stakeholders.  
• Inconsistency in data collection as some of the participants from Australia has 
provided a written response which can have an impact on overall comparative data.  
Due to these limitations there is a possibility of bias or lack of enough data to back up the 
results or conclusions. It is vital to acknowledge these limitations while synthesizing the 
results or conclusions, however the study offer valid points to improve the role of GPP in both 
countries. It also provides guidance to perform future policy and practice research in this area. 
Same time, it is important to understand that GPP role is fastly evolving and any qualitative 
input, especially when there is lack of comparative data between countries for this role, would 
be highly beneficial to highlight the present differences in views and expectations from GPP 
role and also how both countries can take steps forward to make this role successful.  
 
6.2 Future Research 
This study reflects on the importance of present research that has been done on GPP role and 
the need for any future research that can be beneficial to improve the future of GPP role. The 
participants have mentioned points on which further research can be conducted.  
Qualitative research has its importance, highlighting the views of different stakeholders, but 
this study shows the need of more quantitative analysis which can reflect the figures of 
various measurable KPIs that can be used to show the overall impact of GPPs’ role on the 
healthcare sector. Few suggestions given by participants are factors like reduction in GP visits, 




management), the overall impact on the cost of prescribing budget, reduction in hospital 
admission, and reduction in risk of falls in elderly patients. It is essential to document these 
measures to highlight the changes that have come with the role of both performance and cost 
perspective. If work is not documented, then as stated by one of the participants the excellent 
work been done by a pharmacist can go unnoticed and won’t get the actual recognition which 
it deserves. This study also reflects the importance of national evaluation and to review the 
overall impact of the GPP role at a bigger scale. 
In Australia, research has been conducted on GPP role, but there is not much of quantitative 
work. Due to small pool of GPPs working in Australia at this moment, it is difficult to get a 
decent size of data or relevant results and outcomes on a reliable scale. However, there is 
need for future research to be planned, agreed by all participants in this study, to highlight 
the services been provided by GPPs. It should also include views about barriers and facilitators 
for this role. Ideally, research should be planned over multiple practices on a large scale to 
show the positive impact of GPPs with a larger sample size as highlighted in the study 
(Freeman et al., 2014) suggesting multicentre cluster-randomised controlled practice-based 
research. 
This study reflects the importance of future research that can be used to structure the future 
training pathway and job description for GPPs in the light of collated data and views. With 
funding been a significant barrier, active future research would be helpful to present a strong 
case to the government and other healthcare organisations for future funding and to expand 
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Chapter No. 8 
Appendix 
Appendix 1 
Sem-structure interview guide for GPs 
Perceptions & Challenges    
 
What are your views about general practice framework; do you believe there are any gaps 
present in it? 
What was your initial perception about integrating pharmacist into GPP’s role to fill present 
gaps (if any) in general practice framework? (role specifications) 
Do you believe there was a mismatch in the professional expectations you had from GPP’s 
role in the early stages?  
What were your initial reservations about integrating pharmacist into the clinical team? 
(factors like clinical knowledge, communication skills, management skill, and cost factor)   
How well you believe pharmacist was professionally prepared to perform as GPP?  
What were the operational challenges or hurdles you faced while working with the 
pharmacist (factors like lack of role specifications, room availability, working collaboration 
with other staff members etc.)?  
In your views what should be the key performance indicators, you believe to analyse GPP 
role?  
  
Pharmacist-GP working collaboration  
 
How do you evaluate your existing working relationship with the pharmacist and how it has 
changed since the beginning? 
Have you got any concerns related to medico-legal implications and scope of GPP’s practice, 
(situations where you think pharmacist has gone beyond the area of expertise)? 
How easy you find a pharmacist to approach and communicate? 
What factors do you believe influence this working collaboration?  
What steps can be taken to improve this working collaboration?  





Pharmacist’s Skills set 
How you evaluate the competency of the pharmacist in the patient-facing role , e.g. to 
run clinics, perform medication reviews and home visits etc.   
What are your thoughts about prescribing role of pharmacist highlighting any reservations 
you have about pharmacist working as a non-medical prescriber?   
In your views, what protocols should be set up at the organizational level for prescribing 
pharmacist?  
What are your thoughts about medicine management skills of pharmacist performing at GP 
surgeries?   
How you differentiate GPP’s role with practice nurse as occasionally it is confused to be 
overlapping with each other?   
How do you evaluate GPP’s role to link surgery with a community pharmacy, hospital and 
other health-related organisations like CCG?  
What are your thoughts on comparing in house GPP employed directly by surgery with one 
employed by local health organisations like CCG?    
 
Future of GPP   
 
What future do you see for GPP’s role in future general practice framework, briefly 
summarising what activities they should be involved at the patient level, clinician level and at 
practice level? 
How do you evaluate the patient’s feedback and perceptions about GP pharmacist? 
How do you evaluate the cost of employing a GPP and aspects linked with it like indemnity 
insurance?  
Based on your experiences and need of workload, do you see GPP as a part time or full-time 
role?    
What are your thoughts on available funding options for GPP?  Will you recruit GPP once GP 
pilot scheme funding is finished? (England only)  
Based on your overall experience, what training would you like to see for the pharmacist to 
improve competency as GPP? 
How well you believe GPP has evolved/performed as GPP impacting on overall healthcare 
provision and patient care at GP surgeries, highlighting practice-level benefits?   
Has GPP’s role changed your overall perceptions about Pharmacist?  
Considering the possible barriers and facilitators for the current GPP role, what steps should 
be taken at the organizational level to improve GPP’s role?  
Briefly describe any further research you would like to see on GP GPP?  




















Semi-structured interview guide for Nurses 
Perceptions & Challenges    
 
What are your views about general practice framework and do you believe there are any gaps 
present in it?  
What was your initial perception about GPP’s role integrated to fill present gaps (if any) in 
general practice framework?  
Do you believe there was a mismatch in the professional expectations you had from GPP role 
in early stages?  
What were your initial reservations about integrating pharmacist into the clinical team? 
(Factors like clinical knowledge, communication skills, management skill, and cost factor)   
How well you believe pharmacist was professionally prepared to perform as GPP?  
What were the operational challenges or hurdles you faced while working with GPP?  
What should be the key performance indicators you believe in analysing GPP role? 
  
Pharmacist-Nurse working collaboration  
 
How do you evaluate your present working relationship with the pharmacist and how it has 
changed since the beginning? 
How you differentiate GPP’s role with your role as a Nurse practitioner as occasionally it is 
confused to be overlapping with each other?   
Have you got any concerns related to medico-legal implications and scope of GPP’s practice, 
(situations where you think pharmacist has gone beyond the area of expertise)?  
How easy you find a pharmacist to approach and communicate? 
What factors do you believe influence this working collaboration?  
What steps can be taken to improve this working collaboration?  
Briefly explaining, what impact a GPP has made on your scope of practice?  
 
Pharmacist’s Skills set  
 
How you evaluate the competency of the pharmacist in patient-facing role e.g. to run clinics, 




What are your thoughts about prescribing role of pharmacist highlighting any reservations 
you have about pharmacist working as non-medical prescriber?   
In your views, what protocols should be set up at the organizational level for prescribing 
pharmacist?  
What are your thoughts about medicine management skills of pharmacist performing at GP 
surgeries?   
How do you evaluate GPP’s role to link surgery with a community pharmacy, hospital and 
other health-related organisations like CCG?  
What are your thoughts on comparing in house GPP employed directly by surgery with one 




Future of GPP   
 
What future do you see for GPP’s role in future general practice framework, briefly 
summarising what activities they should be involved at the patient level, clinician level and 
at practice level?    
How do you evaluate the patient’s feedback and perceptions about GP pharmacist? 
Based on your experiences and need for workload, do you see GPP as a part-time or full-time 
role? 
Based on your overall experience, what training would you like to see for the pharmacist to 
improve competency as GPP? 
How well you believe GPP has evolved/performed as GPP impacting on overall healthcare 
provision and patient care at GP surgeries, highlighting practice-level benefits?   
Has GPP’s role changed your overall perceptions about Pharmacist?   
Considering the possible barriers and facilitators for the current GPP role, what steps should 
be taken at the organizational level to improve GPP’s role?  
Briefly describe any further research you would like to see on GP GPP?  




Sem-structured interview guide for GPP 
Perceptions & Challenges    
  
What are your views about current general practice framework and do you believe there are 
any gaps present in it?  
What was your initial perception about GPP’s role integrated to fill present gaps (if any) in 
general practice framework? (job specifications) 
What are your thoughts about initial expectations other healthcare professionals had from 
GPP, do you think there was a mismatch in their professional expectations? 
What were your initial reservations about your role as GPP? (Factors like clinical knowledge, 
communication skills, management skill, and cost factor)  




What are your views on an emotional challenge especially in the initial phase to such as 
perceived professional inadequacy and developing a clinical aptitude for patient-facing 
clinical skills? 
What support did you receive at the organizational level to overcome all these challenges? 
How well you believe you were professionally prepared to perform as GPP?  
What should be the key performance indicators you believe to analyse your role as GPP? 
  
GPP’s working collaboration:  
 
How do you evaluate your present working relationship with other staff members in an 
organization especially GPs & Nurses and how it has changed since the beginning? 
How you differentiate your role as GPP with practice nurse as occasionally, it is confused to 
be overlapping with each other? 
Have you got any concerns related to medico-legal implications and scope of your role as GPP 
(situations where concerns raised about pharmacist been gone beyond area of expertise)?  
How easy you find GP and Nurses to approach and communicate? 
What factors you believe influence this working collaboration?  
What steps can be taken to improve this working collaboration?  
 
Pharmacist’s Skills set:  
 
How you evaluate the competency of the pharmacist in patient-facing role e.g. to run clinics, 
perform medication reviews and home visits etc.   
What are your thoughts about prescribing role of pharmacist highlighting any reservations 
you have about pharmacist working as non-medical prescriber?   
In your views what protocols should be set up at the organizational level for prescribing 
pharmacist?  
What are your thoughts about medicine management skills of pharmacist performing at GP 
surgeries?   
How do you evaluate GPP’s role to link surgery with a community pharmacy, hospital and 
other health-related organizations like CCG?  
What are your thoughts on comparing in house GPP employed directly by surgery with one 
employed by local health organizations like CCG?    
 
Future of GPP   
 
What future do you see for GPP’s role in future general practice framework, briefly 
summarizing what activities you should be involved at the patient level, clinician level and at 
practice level?    
Based on your overall experience what training would you like to see to improve your 
competency as GPP? 
How do you evaluate the patient’s feedback and perceptions about GP pharmacist?    
Based on your experiences and need for workload, do you see GPP as a part-time or full-time 
role? 
How well you believe GPP has evolved/performed as GPP impacting on overall healthcare 




Considering the possible barriers and facilitators for the current GPP role, what steps should 
be taken at the organizational level to improve GPP’s role?  
Has GPP’s role changed your overall perceptions about Pharmacist? 
Briefly describe any further research you would like to see on GP GPP?  
Do you have any other comments to add on this topic?    
  
Appendix 4 
Sem-structure interview guide for Organizational lead 
 
Perceptions and Challenges 
 
What are your views about the current general practice framework and do you believe there 
are any gaps present in it?  
 
What was your initial perception about GPP’s role integrated to fill present gaps (if any) in 
general practice framework as a part of your organization’s MDT? 
Do you believe there was a mismatch in the professional expectations you had from GPP role 
in early stages?  
What were your initial reservations about the role of GPP? 
How well you believe pharmacist was professionally prepared to perform as GPP?  
What were the initial operational challenges or hurdles you faced while working with GPP, 
considering expectations and reservations you had, please give views on aspects like lack of 
job description, management skills, communication skills, initial training, cost factor and 
availability of rooms etc? 
What support you as the organizational lead did provide to GPP to overcome these challenges 
and hurdles? 
What are your views on GPP’s scope of practice, has there ever been any medicolegal issues 
where concerns were raised by yourself or other healthcare professionals about GPP’s area 
of expertise? 
What should be the key performance indicators you believe to analyse GPP role? 
 
Working Collaboration 
How do you evaluate the present working relationship of GPP with other team members of 
your organization and how it has changed since the beginning? 
How you differentiate GPP’s role with practice nurse as occasionally it is confused to be 
overlapping with each other? 
How easy you find GPP to approach and communicate? 
What factors do you believe influence this working collaboration?  
What steps can be taken to improve this working collaboration?  
 
Pharmacist’s Skills set:  
 
How you evaluate the competency of the pharmacist in patient-facing role e.g. to run clinics, 
perform medication reviews and home visits etc.   
What are your thoughts about prescribing role of pharmacist highlighting any reservations 




In your views what protocols should be set up at the organizational level for prescribing 
pharmacist?  
What are your thoughts about medicine management skills of pharmacist performing at GP 
surgeries?   
How do you evaluate GPP’s role to link surgery with a community pharmacy, hospital and 
other health-related organizations like CCG?  
What are your thoughts on comparing in house GPP employed directly by surgery with one 
employed by local health organizations like CCG?    
 
Future of GPP 
 
What future do you see for GPP’s role in future general practice framework, briefly 
summarizing what activities they should be involved at the patient level, clinician level and at 
practice level?    
How you evaluate NHS response to GPP role, and do you think the government will continue 
this role (how you see in 5-10 years)? 
How do you evaluate the patient’s feedback and perceptions about GP pharmacist?   
How would you comment on the success and failure of this role by highlighting possible 
barriers and facilitators? 
What are your views on the cost of employing a GPP, how cost-effective is the role of GPP? 
Will you recommend recruiting GPP once GP pilot scheme funding is finished? 
How well you believe GPP has evolved impacting on overall healthcare provisions  
Based on your experiences and need for workload, do you see GPP as a part-time or full-time 
role?    
Based on your overall experience, what training would you like to see for pharmacist to 
improve competency as GPP? 
Has GPP’s role changed your overall perceptions about Pharmacist?   
Briefly describe any further research you would like to see on GP GPP?  
Do you have any other comments to add on this topic?    
 
Appendix 5 
Semi-structured interview guide for Academia 
Perceptions and Challenges 
Based on your research in the healthcare sector: 
What are your views about the current general practice framework and do you believe there 
are any gaps present in it?  
What is your perception about GPP’s role and how important you feel GPP role can be in 
bridging gaps present in the primary healthcare system? 
What barriers, facilitators and opportunities do you see in pharmacists adopting this role? 
How do you compare healthcare systems of other countries (e.g. Australia/Canada, New 
Zealand) where the role of GPPs is already established? How do you view the role in these 
countries and if there are any opportunities and differences? 




Future of GPP 
What future do you see for GPP’s role in general practice framework?    
How you evaluate NHS response to GPP role, and do you think the government will continue 
this role (how you see in 5-10 years)? 
How do you evaluate the patient’s feedback and perceptions about GP pharmacist? 
How would you comment on the success and failure of GPP’s role? 
Based on your overall experience what training would you like to see for the pharmacist to 
improve competency as GPP? 
Has GPP’s role changed your overall perceptions about Pharmacist?  
Briefly describe any further research you would like to see on GP GPP and how it will impact 
to improve the quality of the healthcare system in relation to GPP’s role? 
Do you have any other comments to add on this topic? 
 
Appendix 6 
Participant information letter 
Department of Pharmacy,  
University of Huddersfield, 
 Queensgate, HD1 3DH 
United Kingdom 
Invitation Letter for participation in Research study 
Research topic: A qualitative evaluation of key stakeholders’ expectations and perceptions 
regarding GPPs’ role in England and Australia 
Dear Sir / Madam, 
My name is Noshad Akhtar, presently working as a clinical GPP with gtd healthcare. I in 
collaboration with the centre of pharmaceutical policy and practice research, University of 
Huddersfield, UK, have planned a qualitative comparative study on the above mentioned 
research topic. 
For that purpose, our team identified you, as an essential and influential stakeholder with 
interests and experienced relevant to the aim of this study and would like to humbly 
request you for an interview session either personally or by telephone. Below please find 
some information about the project.  
Project Description: 
The aim of this qualitative study is to evaluate the expectations and perceptions of key 
stakeholders in England and Australia about the role of GPP. 
The objectives of this research project are to: 
• compare the impact of GPPs’ role on the healthcare system in England and Australia. 
• determine and formulate questions regarding key stakeholders’ views on barriers 




• determine questions regarding the future of GPP role 
• formulate questions regarding the training of GPP 
Project Procedures: 
A semi-structured interview guide has been developed and a total of 10 key stakeholders 
will be individually interviewed. Each Stakeholder will be asked their opinion regarding their 
views and perceptions on the impact of GPP on the general healthcare system in relation to 
the above-mentioned themes, the sorts of policy-related questions that need to be 
answered and to explore any new themes that will emerge from collected data. 
The participants are selected from a wide range of experts who has direct interests in the 
primary healthcare system. They can be broadly divided into the following groups: 
• Healthcare professionals including GPs, Nurses and Clinical Pharmacist. 
• Organizational lead  
• Academics who have written on various aspects of healthcare system 
The interview will be recorded, transcribed and then analysed. 
 
Anonymity and Confidentiality 
Participation in this project is voluntary; however, after taking part in the interview, it will 
not be possible to withdraw from this research. All audio files and electronic data will be 
stored in a password-protected computer at the University of Huddersfield. All paper files 
will be stored in a locked cabinet at the University of Huddersfield. Digital files of recordings 
will be destroyed upon completion of transcript approximately 7-10 days after the call, and 
names and other identifying information will be deleted from all electronic and paper copies 
of the transcript. The data will be used for writing a report and a paper and results of this 
project will be available through an academic publication, yet to be determined. Any 
information you provide may be quoted in publications or presentations; however, 
confidentiality will be maintained, and any references will be quoted anonymously. 
The Interview: 
The interview is planned to last about 25-30 minutes; either via phone or face-to-face 
interview. 
An independent transcriber will transcribe the tapes after signing a confidentiality 
agreement form with the Principal investigator of this study. The transcription of your 
interview will be sent to you; you will be able to go through and edit it, prior to analysis and 
publication. 
The information provided by participants will be quoted anonymously in the final report. It 





The project has been financially supported by the University of Huddersfield, United 
Kingdom. 
What if you decide to take part? 
If you decide to take part in this study, please let us know by replying to this email as soon 
as possible and an interview guide will be sent to you by email, prior to the mutually agreed 
date for interview. If you do have any queries, please do not hesitate to contact the 
Principal Investigator: 
Professor Zaheer-Ud-Din Babar PhD 
Research Supervisor 
Professor in Medicines and Healthcare 
Department of Pharmacy, University of Huddersfield, Queensgate, HD1 3DH 
Huddersfield, United Kingdom 
z.babar@hud.ac.uk 
Tel (office): +44 1484471471 
 
Dr. Syed Shahzad Hasan 
Research Supervisor 
Department of Pharmacy, University of Huddersfield, Queensgate, HD1 3DH 




Postgraduate Research Student 
Department of Pharmacy, University of Huddersfield, Queensgate, HD1 3DH 






























Interview with GP1/England (Pilot Interview)  
 
S1 Noshad Akhtar 
S2 Dr. Simon Rushton 
 
Timecode Speaker Transcript 
00:00:06 S1 Oh, hi.  My name is Noshad and I'm a clinical pharmacist working at 
Smithy Surgery and this interview is basically...is a part of my 
research study which is...the topic is to evaluate the expectations 
and perceptions of the stakeholders about the GP pharmacists' role 
in England and Australia.  And today I am doing the interview with 
one of the GPs, Dr. Rushton.  And we will just do on...on the basis of 
the semi-structured guide.  I have provided a semi-structured guide 
and information about to study to Dr. Richton before.  He will just 
briefly introduce himself and then we carry on for...with the 
interview.  Hi, Dr. Richton. 
00:00:47 S2 Hi, Nos had.  I'm Simon Rushton, G.P.  I used to be a partner here.  
I've been here for over 20 years and been involved in...with the 
pharmacists' development, hopefully a little bit here at the Smithy. 
00:01:00 S1 Oh.  And you have got the information about the study? 




00:01:04 S1 And you have...you're...you're giving me the consent to do the 
interview? 
00:01:07 S2 Absolutely.  Yeah, that's fine. 
00:01:08 S1 Thank you.  All right.  Dr. Rushton, do you know the...the structure of 
the study which I have provided?  It has a couple of sections, so we 
will start with the first section.  Most of those questions might be 
overlapping, so I will skip a questions which you already have 
answered and then we will just carry on with the same flow.  The 
first one is about the perception and challenges.  So based your own 
experience on the present situation on the...of the general practice 
framework in England, how you feel...what are your views about 
the...the present situation?  Is there any gaps present in the general 
practice framework?   
00:01:47 S2 I think, if this question relates to how we get other professionals 
involved in general practice, in particular, pharmacists, then my 
opinion is that, particularly in general practice, with a lot more work 
coming through from the hospital with more complex drugs, a lot 
more discharging of complex patients, that any help we can get by 
our pharmacists in-house to help us with mainly...many of the 
medicines management issues is...is gonna be very good.  I 
personally feel that we need more pharmacist time.  I've felt 
that...felt that for a long time because I'm a busy GP.  My idea would 
be that I wouldn't have to deal with as many medicine management 
queries each day and maybe do more ones which may need to be 
discussed between the GP and the pharmacist.  That's how I would 
view it, hopefully. 
00:02:53 S2 All right.  That...that's fine.  Yeah, just...just to...I'm having...making it 
a bit more specific.  You know that there was a study where they say 
that...that most of the GPs, they are the...there is a big gap of the 
GPs in the present situation and not many doctors?  They are looking 
to have the root of GP as a...that's...that's where the gap is coming 
between the workforce and the general practitioner.   
00:03:18 S2 Yup. 
00:03:18 S1 So just...just to...how do you think the pharmacists can play a bit of 
role to cover that gap? 
00:03:25 S2 Absolutely.  I think it'd be a bit of a no-brainer, really, with the...with 




could be another five to ten years, at least, before we can turn that 
around, if we can at all.   
00:03:40 S1 Right. 
00:03:41 S2 I think of general...in general practice, it's gonna have to be much 
more of a...a more to a disciplinary approach, whereas in the past I 
think GPs have really been a little bit too...felt more overly precious 
over what they've let go.  I think, realistic...  realistically now, you 
have to...and quite frankly, it's better for...for patient care as well, so 
yeah, there's a big gap and it's getting bigger.   
00:04:06 S1 All right.  That's good.  So are you...you have been working with the 
practice pharmacists for the past two, three years... 
00:04:12 S2 Mm-hm.   
00:04:12 S1 ...so I mean, when we started...when you started with the 
pharmacists, do you believe there was a bit of mismatch with the 
expectation that you had from the pharmacists in the initial phase 
and what you had in the initial phase of when the pharmacists were 
working with you? 
00:04:31 S2 This may take me a while to answer.   
00:04:35 S1 This must be a... 
00:04:35 S2 I...I...we...I worked with the lead clinician that initially had some 
monies through...through commissioning savings.  So...and we knew 
there was an issue with the medicine management workload in 
general.  So it was me that, in the practice, initiated having 
Noshad...yourself, Noshad. And then it was me doing a bit of 
research about what we could use you for.  It was very unstructured, 
in retrospect, I think, unfortunately for you, maybe and I wish we'd 
been able to structure it a bit better. 
00:05:12 S1 Mm-hm.  Mm-hm.   
00:05:13 S2 And I think as GPs, we should have discussed it a bit more about 
what belonged with you initially, what you were happy to do, 
because I think maybe the different GPs gave you different bits of 
work due to how...how structured it was and how consistent it was.  
So that's...that's my point of view.  I wanted to make sure that you 
were doing things that you were happy with, that you felt 
comfortable with, and we didn't overload you... 




00:05:37 S2 ...initially.  So I think there was...my expectations, I...I just hoped that 
you would help...help with the workload.   
00:05:46 S1 Yeah, yeah. 
00:05:47 S2 But also, of course, enjoy the role and...and develop in the role.  That 
was, sort of, my expectations and I think, in terms of your 
professional time here, in retrospect, we probably could have done a 
little bit better, but things moved on after that.  But yeah, I didn't 
have any great, massive expectations.  I just wanted to see how it 
went, really. 
00:06:03 S1 It was more like, see how the things work out in the end. 
00:06:05 S2 Yeah, yeah.  I don't know if that's the same from the other clinicians 
here  and how they send you work, but that's how I looked at it, 
anyway. 
00:06:11 S1 That's fine.  That's fine.  Yeah.  And did you have any initial 
reservations while working with the pharmacists from any 
perspective?   
00:06:20 S2 No, very few... 
00:06:20 S1 That's fine. 
00:06:20 S2 ...to be honest, I hoped we'd have no great issues or problems, but... 
00:06:23 S1 All right.  Yeah, that's fine.  That's fine.  That's pretty good.  Okay.  
And having...I think you have answered the next one as well, so 
what...are there any operational challenges in, like, integrating that 
pharmacists into the team within the practice?  Any...any challenges, 
you feel? 
00:06:40 S2 I...I think the main issue probably was maybe a lack of a structured 
development programme for you and how we...we met up.  We used 
to try making occasional on Friday mornings, didn't we?  But from my 
point of view, we had...suddenly had this money, it seemed like a 
really good idea and it was, but it wasn't really that structured. 
00:07:04 S1 Structure, yeah. 
00:07:05 S2 I think...and I...whether nowadays there are more structured ways of 
doing it, with more protected time with the lead clinician, I hope 
otherwise, going into the surgery is really...wasn't...wasn't...wasn't 




was a bit of a...a work in progress as we weren't used to the system 
as well, wasn't it? 
00:07:25 S1 This one, yeah.  It was more like the harder things were working in... 
00:07:29 S2 I think we should have had a...a pre-developed...a practice-specific 
pack for new pharmacists and then so you [inaudible 00:07:38] for 
the next three months.  That probably would make sense.  I wasn't 
for the... 
00:07:42 S1 Yeah, yeah.  It's all about the...how the things were working... 
00:07:46 S2 Yeah. 
00:07:46 S1 ...and how the conditions can become in the future, yeah.  Yeah, 
yeah.  All right.  We can do the next section here.  We are finished 
with the first section.  Are you okay? 
00:07:54 S2 Yeah. 
00:07:54 S1 Or do you want me to pause...no.  Now, this is about the working 
collaboration.  I think this...this is a bit more main part of the study, 
yeah. 
00:08:00 S2 Yeah. 
00:08:01 S1 So...and how are you related to your present working relationship?  
Because I think there...there are a couple of pharmacists working 
within the practice on this and myself in-house... 
00:08:11 S2 Yeah. 
00:08:11 S1 ...and then I think one is coming from CCG... 
00:08:13 S2 That's right, yeah. 
00:08:14 S1 ...so yeah.  So you feel the working relationship? 
00:08:17 S2 Well, I hope...and I think our working relationship is really good.  And 
I'm sure the same with the other commissioners here with...with 
their share.  I think with a bit of back story...when I was 
involved...I...I...I am no longer a...a management partner here.  
We've merged about 12 months ago with the folks that do the 
management decisions now.  I...so with myself, I don't have 
any...that role anymore.  Prior to that, I think...and I did make the 
point at least to attend our local allocating...that the CCG managed 
to get some money which was supposed be at practice level, actually, 
for pharmacist time.  And I tried to add into our pre-existing hours.  




pharmacists in than we have already.  Unfortunately, that...I couldn't 
swing that one.  And the CCG pharmacists, who's relationship is okay, 
but I think they have a very different remit to your remit here. 
00:09:23 S1 Our scope, yeah. 
00:09:25 S2 I think the CCG pharmacist is basically looking at trying to be quality, 
but also trying to reduce costs a lot.  While certainly your role here, I 
think, is...is really quite different.  I mean, you...and you do have both 
those roles, but there's of other things that you do as well.  So I 
think...I think...hopefully, I've explained it a bit.  And so we do have 
at least two pharmacist's notes and...and maybe another one at 
some times turns up.  Who...I'm afraid I don't know much about the 
other two, really. 
00:09:54 S1 All right.  Okay.  So you think the working relationship has gotten 
stronger since the beginning? 
00:09:59 S2 Oh, gods, yeah.  I'm all for...all the evidence is that if you've got 
health professionals discussing care, it's much better they discuss it 
either with face-to-face as we obviously do, or at least at a level 
where they can discuss the case quite quickly and within...e-mail's 
not too bad, I suppose, but face-to-face is much better care for the 
patient, as well.  That's where all the care evidence is, I believe.   
00:10:24 S1 That's fine. 
00:10:24 S2 I think practice-based pharmacists should be pharmacists should be 
practice-based. 
00:10:28 S1 Yeah, yeah.  And I'm just stretching to the next one, medical-legal 
implication.  Have you ever followed either the in-house or CCG 
pharmacists crossing the boundary of...I mean, did you find that they 
had gone beyond their expertise, at least in CCG area? 
00:10:44 S2 Difficult for me to comment much on the CCG.  I think they have 
quite fairly strict remits.  Yourself...I hope I made it clear all the way 
through that you must only be helping with what you are happy 
doing within what you are qualified to do... 
00:10:59 S1 Yeah, yeah, yeah. 
00:11:00 S2 ...which we covered, as well.  And we discussed that a few times in 
terms of when you were prescribing.  And the last thing I'd ever do to 




having to do.  You mustn't do that and I hope that's not what 
happened with... 
00:11:14 S1 Yes, yes.  Yeah, that's...so then, do you find the pharmacists easy to 
approach and communicate any prospective message you have got? 
00:11:23 S2 Absolutely.  No problems at all. 
00:11:23 S1 Yeah?  Yeah.  That's good. Yeah, yeah.  Any factors that you think 
that might affect this working collaboration? 
00:11:34 S2 I think the best thing is that you're here three days a week already.  
And I do e-mail you at times, when you're not around, for advice.  So 
I think...I think our communication channels work pretty decently, I 
would like to think.  I just mentioned before, I think having it in-
house is really important here. 
00:11:50 S1 Yeah, yeah.  And...and yeah, I think it's quite reasonable to have that,  
but if any...any steps you think might be taken or you think might be 
bit more time or something or any factor, anything? 
00:12:03 S2 Well, I...all I would say is, I mean, more time for you to have more 
time here and more protected time to develop a relationship with 
whoever should be, maybe a mentor here now and then at the 
practice.   
00:12:03 S1 Yeah, yeah. 
00:12:18 S2 Which I suppose, there's still been a little bit, I suppose, but it's just 
with a unofficial role, really.  I thought that another… 
00:12:23 S1 And that's all pretty good.  And just...just this last part of it.  How you 
feel that working with the GP pharmacist has changed your scope of 
practice in past...before you were working and now?  Any...any 
specific change in your scope of practice? 
00:12:37 S2 Yeah.  A lot of...my bane of my life is medicine management and also 
scripts coming out of hospitals which are either dangerous or 
in...in...not clear.  And nowadays, thankfully, most of the time, I can 
forward these queries onto yourself where we discuss them, rather 
than me having to plough through the BNF or send... I write letters 
back to consultants at the hospital. 
00:13:06 S1 Okay.  That's fine.  Okay.  So it has... 
00:13:08 S2 Frankly... 




00:13:09 S2 Absolutely yeah.  
00:13:10 S1 That's fine.  So it...that was the second section.  I'll move to the next 
section, right, the...about the skill-set of the pharmacists.  We'll be 
covering both CCG and...because at the end we will just have a small 
question about the in-house and the CCG one, yeah.  So with skill-
set, now, how are you about the...the patient-facing role of the GP 
pharmacists?  So, I mean, there is medicine management and then 
the patient-facing roles. 
00:13:33 S2 Yup.  They do some clinics and they used to do visits with me, as well.  
I have...unfortunately, I would say that we haven't been able to 
anything formal with audits or peer-review, which probably should 
now be more in the remit of Ghostdoc, who are now our employers.  
But all the work I've seen you do, I've never had an issue with what 
you've done, not in two years or so, actually.  I think...I think...well, 
just about every decision you've made, I don't think about finding out 
if that's right or ill do that.  So that face objective that I think if I had 
issues with what you were doing clinically, I would assume I'd have 
spoken to you already.   
00:14:13 S1 That's fine.   
00:14:14 S2 But we haven't ever formally done that. 
00:14:16 S1 Yeah, yeah. 
00:14:17 S2 Which is probably the...but I think that's Ghostdoc's issue now, really.   
00:14:21 S1 But you're running...because the CCG pharmacists...they are working 
more like patient-facing roles, so you are content with their 
competency, as well?   
00:14:30 S2 Well, again, we don't control...there's no, sort of, monitoring over a 
practice level...because there's no point in that, really.  They must 
have their own competencies.  They must have their own indicators 
and stuff 
00:14:47 S1 Yeah, yeah, yeah. 
00:14:48 S2 ...that they have to meet.  And that would be part of the commission, 
so it's from the CCG.  If they started doing bizarre things from our 
point of view of GP, than we either go the pharmacist directly or deal 
the with the CCG and say, look, this pharmacist has come in and 
done this.  It's really bizarre.  Hopefully, they have to have 




00:15:07 S1 Yeah, yeah, yeah. 
00:15:07 S2 ...but I know...I...the kind of the stuff they've done [inaudible 
00:15:10] basically the... 
00:15:12 S1 That's a [inaudible 00:15:11].  And I mean, the same perspective 
from the prescribing annotation, prescribing...how you feel...I mean, 
how do you feel?  Confident to have the prescribing role of the 
pharmacist? 
00:15:23 S2 Oh, absolutely.  I think all they...that's why I jumped onto the front 
part pharmacists at the GP, to be honest with you.  And again, I've 
had no issues.  Oh, where's the... 
00:15:32 S1 Yeah, yeah, yeah.  This one.  So you think they're prescribing...the 
role of the pharmacist is helpful within the practice? 
00:15:38 S2 Absolutely, yeah.  And I think GPs who don't think that are...they're 
being a little bit precious about their...their workload. 
00:15:45 S1 Right.  But any...do you have any suggestion you feel...I think we 
have discussed this before, as well, where there should be some 
protocols with the prescribing... 
00:15:54 S2 Yeah, I think for everybody's benefit. 
00:15:54 S1 Yeah, yeah, yeah, yeah, yeah. 
00:15:57 S2 And you know, I'm still a bit... 
00:15:58 S1 Yeah, this...this should be a working progress… 
00:16:00 S2 Yeah, it's still a work in progress. 
00:16:02 S1 Yeah. 
00:16:02 S2 And they have got some, but, you know, it's a...anyway. 
00:16:05 S1 Yeah, I think you did have this discussion with gtd as well, and they... 
00:16:08 S2 Yeah. 
00:16:08 S1 ...but there is no specific role description, so that's where I think the 
problem comes up.  Yeah. 
00:16:13 S2 Yeah, that's what it is.  Most of the comment to these is that we 
should have protocol already.   
00:16:16 S1 I think you have also the next one about medicine management, 




one.  Yeah.  All right.  The next one I think might be probably just in 
how you see it.  The...the difference of the practice pharmacists and 
the nurse practitioners, because I mean, there is a school of thought 
that the role is overlapping, it's repetitive, so what's your thoughts 
on that? 
00:16:42 S2 It...I think it's overlapping in terms of, from the clinics you can do for 
Cortisones. 
00:16:46 S1 Yeah, yes.  Yeah, yeah, yeah. 
00:16:49 S2 Yeah, I mean, again, but...again, nurses are a limited resource, as 
well.   
00:16:54 S1 Mm-hm.  Mm-hm.   
00:16:54 S2 I think all the pharmasists limited resources that if not already.  And 
we know practice nurses are good at following protocol if we have 
them and I'm sure pharmacists are, as well.   
00:17:04 S1 Yeah, yeah. 
00:17:04 S2 So I think...I don't, again, think it much of an issue, really.  If you're 
working, roughly, to do the same thing using the same protocol if we 
have them or ideas, then, I...I...I suppose it's all down to an 
economic...economic factors in the range.  Unless you're saying, do 
practice nurses have more contact with patients, so does that affect 
the consultation than the pharmacists?  I don't see an issue though 
[inaudible 00:17:30].  I just think the train of thought's just gone 
overhead and won't come back. 
00:17:34 S1 And that is the different scope of practice for both sectors in the end, 
yeah. 
00:17:36 S2 Yeah, yeah.   
00:17:37 S1 That's fine.  That's fine.  I mean, if you're just highlighting or just 
giving... 
00:17:37 S2 Yeah. 
00:17:41 S1 ...info, it's about the...the link road.  Because, as with myself, in 
working with the letters from hospital communities, so you feel that 
GP pharmacists can bridge the gap, like a bridge between hospital 
and... 
00:17:54 S2 Oh, yeah.  I think, particularly with you, all the communications you 




invaluable for the...for the sets than we can do.  So...so I'm post-
dating things that aren't working, so making sure that we've got 
things like, at the dispensing end. 
00:18:12 S1 Mm-hm.  Mm-hm.   
00:18:13 S2 Because you have that dispensing experience, as well.  I think that's 
been really important, to be honest with you.   
00:18:18 S1 That's fine.  Really.  Yeah.  I think you have covered the next one, but 
again, I will just ask the question.  If you have something comparing 
the in-house practice pharmacists with the CCG pharmacists, 
anything you want to add? 
00:18:30 S2 As I said, CCG had their own remits with their pharmacists.  I mean, 
that's really the main thing.  I...I don't know them very well, so I 
haven't got an obvious working relationship with them. 
00:18:39 S1 Yeah, yeah, yeah.  So if...if... 
00:18:41 S2 Yeah. 
00:18:42 S1 ...if given an option, you will go with the in-house pharmacists... 
00:18:46 S2 Yeah. 
00:18:46 S1 ...or the CCG?  Yeah, yeah. 
00:18:48 S2 As I mentioned it before, I...I would...well, they won't offend you 
further, but I won't go into...I don't know why.  They may not with 
anyone.   
00:18:57 S1 Yeah, yeah.  That's fine.  All right.  At the last part, about the future 
rules and how you see the future for the GP pharmacists, from your 
own experience.  So...and what future do you see, as a GP, for the GP 
pharmacists and the...and the future general practice framework and 
any specific activity you want to see GP pharmacists doing in the 
future or... 
00:19:22 S2 I suppose as a clinician in your own right, in a way, anything 
that's...well, there's quite a lot of open doors, I suppose, aren't 
there?  Things could go about doing that or the DMAL monitoring, 
which is where we overlap with the practice nurse again, I 
suppose...of Cortisone monitoring and all of the stuff that you do 
already, it's quite a big area already, to be honest with you.  So 
having your own specific clinics to see patients who are drug 




have so much medicine management already, that's almost a full-
time job on its own.   
00:20:03 S1 Oh, no. 
00:20:04 S2 And it may not particularly be practice, so as a...from my point of 
view, that's one of the really good things, that I don't have to do as 
much medicine management.  But if I understand, it's your personal 
preference, isn't it, as well, and what the practice plan would say 
for... 
00:20:19 S1 Yeah, that's fine.  And have you received any patient feedback, in 
which work has been done by in-house or CCG pharmacists?  Any 
patient feedback you have received? 
00:20:30 S2 Only positive stuff. 
00:20:31 S1 Oh, yeah. 
00:20:31 S2 Only...only positive.  We did have one complaint between the two of 
us, but it was initiated by me and was completely appropriate on the 
clinical grounds.  I had a bit of fun with that, but that was me.  It 
should have been aimed at me.   
00:20:43 S1 All right.  Just while you're listening.  It was something...some 
medication prescribed... 
00:20:48 S2 Something...some stupid man.  So... 
00:20:53 S1 That's fine. 
00:20:53 S2 Sorry. 
00:20:54 S1 It's fine.  Just don't keep this thing in the recording.  All right.  And I 
mean, how are you with the cost of employing GP pharmacists and 
the expense, I mean, like, with everything, insurance, if...because 
now we are working at the gtd employer, but suppose you're facing 
independent practice and if you employ a GP pharmacist, you think 
that it is a cost-viable option to go with and complete  insurance, as 
well? 
00:21:27 S2 Absolutely, and I am arguing this.  Did you...you were going to say, at 
first, you...you did say you were going to stop… 
00:21:33 S1 No. 
00:21:35 S2 No, not gonna stop.   




00:21:36 S2 Do it for your own...again, I...I think it's in the [inaudible 00:21:39] of 
the public indemnity for most of us, now, anyway, so it's not a huge 
amount.  I don't...compared to it used to be, if you max one out for 
the GP, it's come down significantly.  It's still a lot, but, it seems to 
come down for pharmacists, as well.  But thankfully, most of the 
nationwide one do you want to pause it? Come in. 
 
 (Irrelevant speech) 
 
So yes, I think that's a no-brainer again.  Absolutely. 
00:22:12 S1 That's fine.  And now, in the...based on the workload, do you feel 
that the future of the pharmacists can be, like,  a full-time load within 
the GP? 
00:22:20 S2 As I mentioned, we've already got 4,000 patients, well, mostly the 
short of GP that, well...I, yeah, absolutely. 
00:22:28 S1 I think, yeah.  I think you have answered the next one, with 
the...once the funding option does go out, run out from the NHS, you 
will feel that you can employ or you will employ the GP pharmacists? 
00:22:39 S2 Yeah. 
00:22:39 S1 Yeah. 
00:22:40 S2 I don't see how we can manage our workload without the 
pharmacists working here in your role. 
00:22:44 S1 Yeah, yeah, yeah.  All right.  And any specific option...and specific 
competence that you feel you would like GP pharmacists to improve 
on? 
00:22:56 S2 I...I just think that depends on what you...how you want to develop 
really. 
00:22:59 S1 Mm-hm.   
00:22:59 S2 I mean, and your...your personal development along the practice on 
some track.  I've already answered that, I think.  What you're doing 
at the moment is fine.  Very good. 
00:23:06 S1 It's a...just to the point, if I say, what I'm giving...the question is more 





00:23:17 S2 Yes, absolutely. 
00:23:16 S1 Yeah, yeah, yeah, yeah, yeah. 
00:23:18 S2 I think, and I hoped that you might come up with that at some point, 
because it's been more bits of...see, you've had the stuff already 
since we employed you, to be honest.  But...and I hope we've done 
alright, but it's...it's...it'd be better if it was structured, I think, for 
you. 
00:23:31 S1 All right.  That's good.  All right.  Yeah.  I think we have done the next 
one.  Yeah, so...and have GP pharmacists changed your overall 
perception about the role of the pharmacist... 
00:23:42 S2 Oh, yeah, absolutely. 
00:23:43 S1 ...overall?  Yeah, yeah, yeah, yeah. 
00:23:44 S2 Yeah, yeah.  This... 
00:23:44 S1 I think before it was just, like, a community pharmacy.  It's...now, it's 
the GP pharmacy, so I think that... 
00:23:48 S2 Yeah, absolutely.  It feels...you've fended well with...you're really 
doing a lot of the work we used to do as GP, which is great, really.  
And certainly don't think everything.  A pharmacist used to be an 
extensive [inaudible 00:24:02]. 
00:24:03 S1 Yeah, yeah, yeah.  That's fine.  On the organisational level, do you 
feel any steps can be taken to improve or to facilitate this role, like 
the...I mean, how well have you cleared the rooms within the facility 
as a part of clinics. 
00:24:19 S2 Yeah, I mean...I think you probably would like to know you've got 
your...your...this is where you are normally.  And if I had enough 
room, you'd have your own room and then go in there if you were 
going to do your own clinics.  Unfortunately, we are short rooms.  
But I think that and along with, maybe, support of the group of 
pharmacists within the...within the area, like a sort of a meeting 
room.  Come in. 
 
 (Irrelevant speech) 
00:24:48 S1 That's fine.  We're just finishing up. 




00:24:48 S1 Yeah, yeah.  And that's fine.  So we have done this one.  And...and as 
a part of your research for the...because coming on this one and I 
think there was a report for the project initiatives at the moment 
with the team, as well.  So any...any specific or more research or any 
section of the research that you want to be worked on more for the 
future? 
00:25:11 S2 I suppose if you want to show your effect as a pharmacist, you 
probably need to have some research probably done about the...the 
workload you do and the reduction in workload for GPs. 
00:25:22 S1 Mm-hm.   
00:25:23 S2 For my point, I've already mentioned it.  I can't...couldn't imagine 
going back to before you were here.  Literally, we are one...still one 
GP down.  Even then, I couldn't imagine...you'd have to cope with 
everything and all of the invested time for drug inquiries.  I know 
how many you get through every day through reception, as well.  My 
passes anyway, as well, sort of [inaudible 00:25:42].  And all 
the...the...the discharges and all other queries, yeah, I'm...I'm...I'm 
[inaudible 00:25:50] you.   
00:25:51 S1 That's fine.  And just the last one.  I would say that what you think 
should be the key performance indicators for...for the...to 
evaluate...to analyse the role of the GP pharmacists, any specific key 
performance indicators?   
00:26:07 S2 I missed KPIs.  I'd have to think about that, because I think...I know, 
subjectively, my workload is much more manageable... 
00:26:19 S1 You had mentioned, yeah. 
00:26:20 S2 ...and high daily workload might've...I suppose along with, I mean, 
you have to make sure your pharmacists do safe...are doing safe 
things clinically, is being productive in the practice and...which I 
know you are, definitely, so how to make a...a KPI out of that without 
it being just chasing for figures... 
00:26:41 S1 Yeah, yeah.  You said the figured weren't... 
00:26:44 S2 I'd say, maybe, they all...discharges are reconciled by you now.  
Having to do up the discharge.  You could do a...how many times the 
discharges to GP do I have to reconcile?  That...you could do that, I 




00:26:57 S1 Some way we can...like the...you think might be just giving a take 
over, the time you think...just make a rough guess, how much time 
GP pharmacists has saved in your daily or weekly... 
00:27:12 S2 I can audit.  We can audit how much time we spend doing medicine 
management...which we had more to do before you started, but 
maybe when you're not over there, you could go back in there and 
see what it looked like and then that would be...could be a 
nightmare.  You could spend your time at how much of each...each 
area of the general practice work, as well.  The amount of queries 
you get every day, look at the tasks and the answers are listed there.  
There's a few [inaudible 00:27:37]. 
00:27:37 S1 That's fine, really.  I think we have got all the sections.  Any additional 
comment?  Anything you want to add on? 
00:27:43 S2 I don't think so, no. 
00:27:44 S1 No, no.  Yeah. 
00:27:45 S2 It's been...it's been great having you here.   
00:27:47 S1 Yeah.  Brilliant, that’s fine.  Well, Dr. Rushton, I think we have 
covered most of the sections, but if anything comes up and you mind 
later, anything, you can always add your comments later, as well.  
And once we have got this ready, we definitely...I will pass all of the 
transcripts to you.  If you want to add or remove any part of it, it's 
always...   
00:28:08 S2 Sure, sure. 




(End of Audio) 
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Timecode Speaker Transcript 
00:00:01 S1 Hi, my name is Noshad and this is the interview regarding my 
research project which is based on to explore the views and 
perceptions of the main stakeholders about the role of GP 
pharmacist in comparison to, a comparative study between England 
and Australia.  And this is the interview being done with Mr Adnan 
Gohol, GP pharmacist in Australia.  Hi, Adnan. 




00:00:32 S1 I'm good.  Thank you.  So, Adnan, you have got the interview guide 
which I have sent you email so what I will do, I will go through the 
guidance, the main questionnaire and I will record this interview as 
well.  Is it okay? 
00:00:51 S2 Yeah, it's fine.  Thank you. 
00:00:52 S1 Thank you.  So, Adnan, you know this, the main title of the study is 
“The relation of expectation and perception of GP pharmacist role in 
England and Australia by key stakeholders”.  So, it is a comparative 
study about the role of the GP pharmacist and as you're working as a 
GP pharmacist in Australia so I will try to get as much as the 
knowledge or your views about this role. And you have seen the 
questionnaire.  It has been divided in a few sections and the first 
section is “Perceptions and challenges of the GP pharmacist role”.  
So, starting from there, what are your views about the general 
practice framework and do you believe there are any gaps present in 
the general practice framework in Australia? 
00:01:57 S2 In terms of framework, yes.  There is a gap in terms of the availability 
of, especially related to medication management and also in terms of 
long-term chronic disease management.  So there is a crisis in terms 
of number of GPs in certain areas, especially in the rural or remote 
areas where we don’t have access to GPs at a lot of times, especially 
in areas like Queensland where I live and other areas like in Western 
Australia, Adelaide.  So, if you just exclude the big cities and even the 
big regional areas there is definitely a lack of GPs available.  But 
there are 5,000 pharmacies and more than around 10,000 
pharmacists are available which may be available in those areas and 
can be incorporated into a practice.  And I will call it more of a health 
practice that may have include nurse practitioners, pharmacists, GPs 
of course and other allied health professionals.  So this is what the 
current situation is but I mean in most cities we have availability of 
pharmacists and GPs very close to each other or within the same 
vicinity.  The model which I usually, which I have had over the past 
11 years along with some other colleagues in the similar situation 
and model where we have actually a big medical clinic which has 
pharmacy or we call it, I’ll call it a dispensary because it's not as big 
as a normal pharmacy which you can see usually and, but it is inside 
the medical centre where we have between 10 and 15 GPs and 
sometimes specialist nurses and all other allied health professionals, 
dentist, physiotherapist, dieticians, some have diabetes educators 
and of course other nurses in terms of the practice nurse so there's 




vicinity which work as a collaboration among each other and GP 
pharmacist if you call that person who liaison with the GPs and work 
together is what we, what’s the model we are using at the moment.  
00:05:02 S1 Right, right.  So, this is the model where you are working at the 
moment, yeah? 
00:05:07 S2 That’s correct. 
00:05:09 S1 This one, it's good.  So, as you said there is a gap like there is a lack of 
GP availability at the moment.  There's a bit of, the present situation 
which is also the same situation in England as well.  So, based on 
those, this is based on this situation, what do you think, before you 
started working as a GP pharmacist, what were your initial 
perception about the GP pharmacist role?  Is it something you felt 
that can be integrated into GP or in this framework to fill the present 
gaps? 
00:05:52 S2 It's definitely because I work as clinical pharmacist and that’s why we 
have a very good hospitals and we have a really good terms of 
relationship in terms of the gaps and in terms of scope of practice.  
But in tertiary care settings, it’s slightly different because you have, 
everyone has their own role and scope of practice.  But when it 
comes to primary care, those roles can be challenging or integrated 
and sometimes there is no real clarity about who will or can do what, 
so that is what the perception was and what type of role would a 
pharmacist, I do have ideas before I started working at what type of 
role I would be doing but it was actually, in terms of clarity, it was 
not clear until we start working and then we start working out what 
will be the specific role within the scope of practice we will be doing.  
And also because of, as you can see both in UK and in Australia there 
is a medical benefit scheme and the pharmaceutical benefit scheme 
and there are lots of barrier in terms of, for example at the moment 
still there is no medical benefit scheme for pharmacists.  There are 
things available which is for other allied health professionals but 
there is no medical benefit schedule which allow pharmacists to have 
some kind of payment options to get into a practice.  So, it's the 
same with this type of arrangement that’s why within that 
framework it is the model which we are working currently at the 
moment is ideal because it does not rely on the medical benefit 
schedule for pharmacists.  
00:08:03 S1 That’s good.  That’s good.  Yeah, when you started the role, was it 
always the, because it's a new role same thing in England as well so 




job description which mainly depends upon the expectations from 
the GPs or the clinical team where you're working.  Just based on 
those things, do you feel that when you started and where you are 
now, the initial expectations from the health professionals within the 
team where you're working, do you feel there was a mismatch in the 
professional expectations from the GP pharmacists? 
00:08:48 S2 I wouldn’t say mismatch.  I would say more of not really clear about 
what we can do as a pharmacist for them so I would say that GPs 
may not have clarity or neither do us have a clarity that what we can 
do to help them in this integrated big centre environment.  But then 
as we move along and I bring all my clinical expertise in what we had 
in working as a clinical pharmacist previously we started working in 
terms of what I can do for them and then they realise, okay yeah, I 
need help.  I will just help have to [inaudible 00:09:32], you know, to 
ask him what needs to be done.  So this is how it evolved slowly from 
then onwards.  So I think it was more of what our pharmacists can do 
for them that was more of them and so for us too in the primary care 
what would be my areas to help them and integrate as a one team.  
So that was areas which we worked on initially and then, which we 
use a lot of other things so that’s probably might be few other 
questions which are coming through, I might mention that was we 
did.   
00:10:16 S1 Yeah, yeah, so it's more like the initial expectations from them what 
we can do and then just bringing them in line with those 
expectations? 
00:10:25 S2 Yeah. 
00:10:26 S1 That’s fine.  That’s good.  Were there any initial reservations when 
you started as a GP pharmacist, like, I mean, the expectation or the 
transition from a community pharmacist to a GP pharmacist because 
there is a big change, the role, the specifications, the expectations.  
So, I mean were there any initial resolutions on your end like clinical 
knowledge? 
00:10:53 S2 Yeah, on my end or other GPs in general? 
00:10:58 S1 I think it's on your end when you were changing this role from 
community to GP pharmacist, any reservations? 
00:11:07 S2 Yeah, I mean I didn’t have any reservation but I was not sure how it's 
going to work in terms of what is our role in this situation, in this 
scenario or in this environment. But then it starts slowly clearing up 




usually did is to start having, talking to the general practice both the 
practice managers and the doctor said, I am here, this is what my 
qualifications are, that’s what I had done in the past, how can I help? 
So I started doing a few things for them like in terms of having 
newsletter, having, coming into their meetings and presenting things 
about different topics so this is how yeah, it was reservation in terms 
of if it's not clear, I will be actually offering them in this type of 
system. 
00:12:10 S1 Alright, great.  That’s good.  I mean were there any initial 
organisational hurdles or barriers?  Because at my end if I just share 
my experience, because it’s a new role and when I started there was 
some, not from the GP level but something on the, like availability of 
the room or presenting yourself as a team member within the team 
so on those levels, did you face any organisational hurdles? 
00:12:44 S2 We did, yes.  So we did in terms of because the organisation 
structure for both the medical centre and pharmacy and other are 
different like it's like independent roles.  It's not integrated as per say 
but it was, I will say it was, we have to talk to their or more like 
medical centre like legal practice manager has limited 
responsibilities.  It was more controlled through head office which is 
in Sydney and they have like forty different centres and every centre 
have different types of structure.  So we have to go and talk to their 
GP liaison officers or development managers and things like that or 
regional or state managers of those organisations.   
00:13:44 S1 Hello? 
00:13:45 S2 Hello. 
00:13:46 S1 Hi, you can hear me so, can you hear me? 
00:13:51 S2 Yeah, yeah, I can hear you. 
00:13:51 S1 Yeah, sorry.  I just think there was a little beep.  That’s fine.  You 
want to carry on or should I already move on? 
00:13:59 S2 I'm fine.  I think I did finish. (Overlapping Conversation).  
00:14:02 S1 I think you have already answered the next question which I was 
going to ask about the emotional challenge.  I think you have already 
answered a bit.  It was a part of the initial setup and all those.  Do 





00:14:18 S2 No, I think it's always when you start those types of things, you try to 
develop confidence and deal with different personalities so of course 
not everyone has a similar attitude or personality towards promises 
or availability or things like that.  So that was a challenge to 
individually actually talk with different doctors and nurses and other 
allied health professional to see what their individual needs are and 
how can I look after every other, every one person’s needs to keep 
them in the same loop. 
00:14:58 S1 Yeah so just to bring yourself as a part of the clinical team.  Because I 
have gone through the same process so yeah, I can see where you're 
coming from so that’s good, that’s good.  And I mean you have 
mentioned about the, a bit of hurdles or a bit of difficulties in the 
start time at organisational level.  I mean just going through that, 
what type of support did you get to that level to help you out in the 
initial phase?  What type of…? 
00:15:30 S2 So, we did as a I said we did, I've individually spoken to the regional 
managers and the state managers and the GP liaison officers who 
actually are responsible to talk to the whole GPs.  So we talked to 
them and then we individually talked to the GPs so that we can be on 
the same level so the organisation have a clarity about whatever 
roles are and also the individual GPs also.  So that was, and that’s the 
support we got, it's usually the support from our perspective, from 
our end, we got the support from overall like our organisation.  We 
used to have a bigger group and we have liaison person who used to 
go and talk to the state managers and things so we feed them our 
feedbacks on them and they spoke to their manager and their 
managers spoke to them and then this is how it's usually worked out.   
00:16:30 S1 I mean when you are passing the message on to the managers, were 
you getting the support, what you were expecting at their end? 
00:16:39 S2 I think so, most of the time, we did, yeah.  We did get understanding 
and level of support in terms of they can understand what actually 
they want to achieve and what we can offer them so it did become 
clear after we have a lot of communication back and forth.   
00:16:57 S1 Alright, then that’s good.  And I mean just analysing the whole 
picture so if you just analyse it and if I ask you that looking at those 
hurdles at the initial phase of how well you were prepared to take 
that role on.  And just analyse, if you want to analyse. 
00:17:18 S2 I think I have skills because I have experience in working in different 




hospitals so then I deal with a lot of different situation in terms of 
being a part of pharmacy and therapeutic committee, part of the 
other pharmaco vigilance committee so I did have skills in terms of 
how to deal with different type of organisational challenges so if it 
was like a person who didn’t have much experience in those type of 
setting, I would’ve said that they would find  it really hard and that’s 
what happened with other pharmacists who subsequently come in 
and have interactions with the GPs.  They have some kind of conflicts 
and things like that with them instead of having more of, you know, 
so that’s because they didn’t have much experience of working in 
those type of environment and situations and settings so it did help 
me being a bit more experienced pharmacist.   
00:18:34 S1 Yeah, so just to summarise this, but I think you have answered my 
next question [inaudible 00:18:36].  For you, based on your 
experience, it was easy for you to get yourself in the loop but if it 
would have been someone like not newly qualified but which hasn’t 
got that background or the previous experience, it would have been 
difficult for him or her to understand or integrate themselves into 
the system. 
00:19:00 S2 Absolutely, yeah.  They may not have enough confidence also and 
skills to really see how can they assess the situation and then 
integrate themselves so it's really important that if you are going into 
those types of roles, you do have good experience behind you 
because otherwise, it will not be feasible and it will be hard to stay 
around in that situation for a longer period of time or have 
sustainable type of models so it is imperative.  I mean I know 
pharmaceuticals are recommending but they need to really upskill 
pharmacists to get into, I mean they're recommending in general.  
Pharmacists should be available but there is a lot of training and 
experience required before you go in those type of situations.   
00:19:55 S1 Yeah, I think…. 
00:19:55 S2 But otherwise, it may be a failure or they may not be able to cope or 
integrate themselves very well. 
00:20:02 S1 I mean there will be another question later but because this topic 
has started, I mean, if I just get the question from there.  What do 
you think will be the basic training aspects?  What your 
recommendation will be if anyone wants to apply for this role and 




training aspects for that person before or in the initial phase to start 
this role?   
00:20:32 S2 I definitely think a bit of clinical knowledge about different disease 
types and also how the system work is very important like in terms 
of you know the nitty-gritty of the system, how like in terms of GP 
softwares, in terms of all these types of training because all those 
trainings when we are doing the pharmacy courses or even 
afterwards so it's important to know the programs, important to 
know the medical benefit schedule.  It's important to know how does 
it work and of course clinical knowledge is imperative.  So definitely 
if you have come across and have you work in settings so for 
example people who have in pharmacies in terms of, let’s say, 
community that it needs to be pharmacies were offering a lot of 
professional services and have been under the mentorship of good 
experienced pharmacists, especially for, you know, so it definitely 
needs to be upskilled in terms of those before you joined those type 
of practices. 
00:21:43 S1 So basically we just summarise, you think the basic thing will be the 
clinical skills, yeah. 
00:21:47 S2 Yeah. 
00:21:47 S1 And understanding of how this [inaudible 00:21:52] working, a bit of 
pre-type of preparation before you start to get a bit more knowledge 
about how the thing is working along with clinical skills.  That’s good. 
00:22:00 S2 And of course, the basic, good communication skills and interactive 
and how to deal with different situation is imperative for 
pharmacists who are planning to work in GP practices.   
00:22:16 S1 That’s fine.  So, moving on, I mean just based on your experience, 
what do you think should be or will be the key performance 
indicators to analyse how the GP pharmacist role is moving ahead.  
Any specific key performance indicators?   
00:22:35 S2 In terms of KPI’s? 
00:22:36 S1 Yeah, yeah. 
00:22:36 S2 The key performance so yeah definitely.  I mean it will be a 
combination of things in terms of both the financial aspect which you 
can, pharmacists can bring in, in terms of providing, for example, in 
terms of very specific Australian environment when you have a lot of 




management plan which you get paid for.  So it will bring a lot of 
financial incentive if the pharmacists knows what areas they need to 
focus on especially chronic disease management.  And of course, 
medication reviews will be a major part of that.  So definitely those 
type of indicators in terms of the revenue generated or the cost 
saving in terms of preventing medications’ adverse effects and 
misadventures so that is definitely will be two or three major 
indicator for pharmacists working in GP practices. 
00:23:49 S1 That’s fine.  That’s good.  Alright, that’s fine.  We will move to the 
next section which I think is basic or the main section of how the 
working collaboration based on my own experience I can see that 
the stronger the working collaboration is within the team, the better 
your role is analysed or highly valued so we will move to that section.  
So based on your experience we will go through, yeah.  So, you know 
the clinical team within the GP practice is basically based on mainly 
GPs, nurses, healthcare assistants and a few other members that 
chip in for different roles.  So how do you value your present working 
relationship with those healthcare professionals and has it changed 
since the beginning?    
00:24:38 S2 Yeah.  So in our environment, in our settings, we have GP definitely 
are the main thing and then we have other where we call them 
admin staff plus of course the nursing staff and other allied health 
professionals so in terms of, so the GPs definitely in Australian 
environment, GPs definitely the focus and they are the one who 
initiate and authorise things which is important.  And this is where 
the pharmacist can give them a really good feedback or response to 
how to initiate different things you know which a lot of time they're 
not aware of or don’t know how to go ahead.  So we have been in for 
example the nurses on our centres are only responsible for example 
administering vaccines and other type of work like wound dressing 
and all those types of things.  So they are strict to that, restricted to 
that.  They are not involved in any other type of, and most of them 
are enrolled nurse.  There is one RN, one or two RN’s.  And that’s 
mostly they run their treatment room which is do different variety of 
things and help the doctors in arranging or assisting.  So we don’t 
have physician assistant in Australia as yet.  Well, we do have them 
but we don’t have as many.  We have nurse practitioners but they 
are mostly based, most of them are based in treasury case settings, 
very few in primary care.  At least in our centre, we don’t have any 
nurse practitioner.  We do have other allied health, like dentist and 




them different type of plans and treatment plans and other things.  
So, it is easy.  I mean we haven't had any issues.  It was quite good 
integration between who was actually doing what so it's clear now.  
And it wasn’t initially clear also but, because of the fact that the GP is 
definitely the main person who… we worked it out.  And of course, 
then we got administrator like as we discussed before that, practice 
managers and they're also like more of a liaison type of jobs.  They 
do between different aspects of their running the business as the 
practice. 
00:27:37 S1 So, you think that the working relationship, I mean it is in a good 
condition or should I say in a good working collaboration system with 
your role and the GPs, yeah?   
00:27:52 S2 That’s correct, yes.  At the moment it seems to be running well with 
all different members of these healthcare settings.   
00:28:00 S1 And would you feel that it has got stronger since you have started 
with the time, much stronger? 
00:28:05 S2 Yes.  So, as the year goes by it's become more and more stronger as 
we move.  And of course, there’s always the turnovers in terms of 
people left and then you have new people so there is a very high 
turnover in this practice.  And in general, I think a lot of practices 
have these type of issues in terms of staffing going in, and staffing 
because every time there is new staff start, you have to go and 
elaborate your role and who you are, introduce yourself so it's just 
an ongoing process every time there is a change in the management.  
00:28:49 S1 I think you have answered the next question basically.  As you said 
that the nurses… Because in England, the nurses have got a broad 
role in the primary care with running the clinics and doing the 
reviews.  But you're saying that in your centre the nurses they are 
just merely dealing with the wound management or those type of 
treatment clinics, yeah? 
00:29:11 S2 That’s correct, yes.  In our situation, in our setting, we have enrolled 
nurse and then we have registered nurse.  So they're mostly are just 
focused on running the treatment room and maybe doing the care 
plans also and then we, the practice manager is not a nurse and they 
have more of administrative job to coordinate between the GPs in 





00:29:52 S1 Is it the general design of your practice or is it something which is 
overall like a situation for the nurse role in the tertiary care? 
00:30:04 S2 In community primary care setting that is usually most of the nurses’ 
roles are.   
00:30:10 S1 That’s fine.  But then if we go to the tertiary role then yeah, the role 
broadens up, yeah? 
00:30:15 S2 That is right.  In most primary practices around Australia, the nurses 
have very similar role of just helping the GPs in designing those 
things.   Like we have nurse practice managers and things like that 
but in terms of most of their duties are restricted to those types of 
work. 
00:30:40 S1 It seems to give you like the, I mean quite a good opportunity for the 
pharmacists to bring in the clinical skills they have.  I'm just citing a 
few comments from my side, sorry, just because over here the role 
like medication reviews, the clinical, running clinical, small clinics, 
they are being done by the nurses but if there's not the role or what 
being done in Australia that gives you a big opportunity to chip in 
and give, provide that role, isn’t it, in Australia, isn't it?   
00:31:16 S2 That’s correct.  Yeah, it does in those type of setting and that’s what 
we have done over the years that we have involved ourselves in a bit 
more broader roles which we can offer in help because of the fact 
that the nurses they employ and have a bit more of restricted role.  
00:31:37 S1 Because over here it's always a bit of concern that we are 
overlapping our role with the nurses by offering the same thing what 
already being offered by the nurses.  But yeah, that’s good.  In 
Australia it's not the case but yeah, [inaudible 00:31:51]. 
00:31:51 S2 But that’s, yeah, that is where some kind of [inaudible 00:31:53] type 
of things happen.  But in general, most of the surgeries around the 
country are very much similar.  I mean I know there are surgeries 
who have, where nurse training and reviews and things like that but 
it's not as common and of course those reviews are not as reliable in 
terms of what they can offer really.  That’s very simple basic things 
so. 
00:32:20 S1 That’s good.  That’s good.   
00:32:20 S2 Because that’s not their expertise and skills to do those type of 




00:32:27 S1 That’s good.  Alright, just a small topic, you know the medical legal 
implication sometimes you know the boundary or the red line will 
be, other healthcare professional they draw what the expertise of 
the GP pharmacist.  Have you ever experienced any scenario where 
there has been concerns raised by any healthcare professionals 
especially GPs where they see the GP pharmacists has crossed or has 
gone beyond their expertise in any scenario?   
00:33:04 S2 Yes.  So I've done things because we both know what our scope of 
practice are like the practice within the medical legal framework of 
what is our role is which is basically more of collaborative approach.  
We have no autonomous type of prescribing or dispensing roles 
which we, so in our centre environment, we have never crossed any 
line in terms of what actually our roles are.  And there never has 
been any question raised about the validity of what pharmacists can 
or can’t do or they, I think, on both side that is very clear what is our 
roles are, and then we remain in that scope of practice.   
00:33:59 S1 That’s good.  But I mean just generally I mean based on your 
experience with your other colleagues who have been working in 
another practices, do you, I mean have you come across from any 
other colleague, any issue…? 
00:34:13 S2 I don’t think so.  Because I mean I think it maybe and there are 
certain avenues available which is for example continued prescribing 
which is [inaudible 00:34:24] pharmacist in certain areas which we 
do like if a person you know have been on some or a contraceptive 
pill or starting and they are unable to see GP they needed so we can 
initiate those type of continuous prescribing or continuous 
dispensing which is what most pharmacists are aware of and GPs are 
also.  Some who don’t may have questioned that why this person 
was given this but I think most of the GPs are aware that there is a 
continuing of supply arrangement or prescribing arrangement which 
pharmacies can do within their scope of practice.   
00:35:11 S1 That’s good.  That’s good.  I will just summarise the next three 
questions in one and yeah, so I mean within your practice you find 
yourself easy to communicate or other healthcare professionals it’s 
easy to communicate with yourself and I mean any suggestions to 
improve this overall situation or collaboration based on your 
experience? 
00:35:32 S2 Yeah, it's definitely a regular constant talking and presence of 
pharmacists is necessary to have realisation that we are there, 




do.  Other pharmacists and myself that we always have some kind of 
conversation with the GPs, all the time.  So that is imperative 
because I can see people who have done it in the past and they're 
not communicating or they're having some kind of communication 
issues with the GPs or with more of like a conflicting type of 
situations where they were unable to resolve issues or they have, 
refer them to the AFRA which is the body so those type of things.  So 
I know they have situations or maybe not going along well with the 
practice managers so it is imperative that we not indulge ourselves in 
type of conflicting situations or a lack of communication where  
you're not communicating with the other health professionals which 
I have seen and experienced with other pharmacists or my 
colleagues in the past or recently.   
00:37:06 S1 This was, I mean this is like a continuous discussion with those 
people around and within the team, the continuous discussion or the 
communication you think is the main thing to improve yourself as a 
part of... 
00:37:24 S2 Yes. 
00:37:24 S1 Just to discuss overall situation, yeah. 
00:37:28 S2 Yes, definitely.  If there is a conflict arises, it's always good to resolve 
it within… as soon as possible instead of letting it go or building it up 
and then the communication have stopped or you're not talking to 
the person.  I mean that doesn’t really help.   
00:37:50 S1 That’s good.  So, you think - just moving away from the question - 
overall, you think that the admin team or the non-clinical team in 
your practice, they have accepted pharmacists as a part of the 
practice, overall practice team, yeah? 
00:38:08 S2 Definitely, yes, so our non-clinical people who are either involved in 
the administration or, for example, the secretaries or the reception 
staff, they definitely know that we have a pharmacist here who we 
can refer to and that they do, a lot of the time they just refer to us 
especially in this situation where they don’t have any answer.  They 
kind of communicate with the GPs or the GP doesn’t know so we 
always get those type of queries coming to us.  And the staff knows 
who they need to contact when those type of situation arise.  So, 
they always are good and the reason why is that, we’re always there 
communicating with them and telling them if you have any issues 




00:39:00 S1 Yeah, that’s good, that’s good.  I think that’s the situation basically 
over here as well.   The time that communication improves they 
know that they can always come to the pharmacist and it's easy to 
approach and [inaudible 00:39:15]. 
00:39:18 S2 Yeah, there shouldn’t be any barriers there for the non-clinical staff 
to approach the pharmacist.  This is what I will be emphasising.   
00:39:26 S1  Yeah, that’s good, that’s good.  Alright, that’s fine.  I'm moving to the 
next section.  It’s more like the pharmacy skill set and how well they 
are prepared to take this role.  So different sections of it.  Do you 
know the different section like patient facing role and non-patient 
facing role?  I mean if you just compare them if you are having a 
patient facing role based on your own experience, how you valued 
your competency in both roles whether they are patient facing?  I 
think you are quite experienced so it will be quite interesting to 
know and how confident you feel in the start, from the beginning 
and now in the patient facing role working as a GP pharmacist? 
00:40:17 S2 Yeah so definitely because as I said I did have good experience 
previously so it was not really hard for me to directly interact with 
patients or you know having some kind of check-up whether it’s 
blood pressure or any other type of light clinical type of interactions.   
So because we have done that in the past possibly with a lot of new 
pharmacists which we employed they were reluctant to have that 
type of interaction. They were not sure whether they can do it or if 
they're not, they're not sure how to do it so we have to really train 
them to have a bit of confidence develop in them.  For example, we 
do applied replacement programs so we have to train them to see, 
assess a patient if they're intoxicated or not you know how to talk, 
what to ask them, how to respond to those type of, if there are some 
kind of behaviour happening in terms of patient turning up to have 
the replacement doses and they are not, they're intoxicated or not 
feeling well.  So it is imperative that we need to prepare the staff and 
pharmacist to deal with those situations and this is why we have 
things in place for people who go and do trainings where they do it 
locally, whether you train them on how to do the different things, in 
house training which we call them or send them to external training 
opportunities which we also had with different organisations.                                                                 
00:42:06 S1 Alright, fine. That’s good.  Based on, seeing your experience, it was 
easy for you or easier now to have the patient facing role but do you 




their part it will be a bit difficult for them to have that patient facing 
role.  They will be more [inaudible 00:42:24] on patient facing role. 
00:42:22 S2 That’s correct. 
00:42:25 S1 But you have got the framework for the training to provide them 
that confidence, yeah, if I'm getting it right.  
00:42:30 S2 Yes, that’s right.   
00:42:33 S1 Alright, that’s fine.  And I mean you know the prescribing role for the 
pharmacist, I'm not sure how it works up in Australia so can you just 
highlight or give a bit more explanation about the prescribing role of 
the pharmacist.  I mean do you still need reservation of that 
prescribing role within that sector? 
00:42:54 S2 Look, I mean we don’t have a very clear, first of all we don’t have 
pharmacist describing autonomous as yet in Australia.  So, it is still in 
the work in progress so we are still having discussion and 
collaboration in terms of what will be the role of like, how it's going 
to go about.  I know in UK you have a lot of pharmacy prescribing, 
autonomous pharmacy prescribing available.  But in Australia, we’re 
still working on it.  The work I was referring to before was more of 
we call as continuation of medication in terms of certain classes of 
drug which we can continue with the patient was on it previously 
and they can’t see the general practitioner in the timeframe when 
they are actually going to miss out on medications.  So, it's more of a 
continuous supply and prescribed.  We can call it prescribing because 
you have to initiate for people who have done it, who were on it 
before.  You can’t initiate it for a new person.  So, it is already for 
people who are, for example, if people were on contraceptive pill 
and they run out of prescription which is what we have.  We have 
prescription only or a contraceptive pill.  And they can come to a 
pharmacist or pharmacy to have a supply given to them for three 
months, between one to three months, or whatever the previous 
quantities are and then they can go and see the GP.  So these 
provisions are available under the law so they are, which is a 
frameworks of the medical legal situation.  Pharmacies can do that 
for certain classes of drugs.  So, at the moment, it's only two which is 
the statins and oral contraceptive.  But autonomous pharmacist 
prescribing for certain variety of medication, unlike UK, we’re still 
working on it.  Like, for example, in UK, you can prescribe a statin 
after, initiate a statin as, and then some other medications you can.  




00:45:24 S1 So, is it something working it's been considered within those the 
main organisations, they are considering this role like…? 
00:45:34 S2 Yes, so we are having a discussion paper was just released a couple 
of months ago and it’s still, it's just waiting for the feedback from 
different organisation by the pharmacy board of Australia.  And so 
they were asking for what type of model we should adopt or 
recommend to the government to be a part of the medical legal 
situation where what pharmacies can do so it's in the discussion.  It 
doesn’t have any outcome as yet but I will say, there will be some 
kind of outcome coming out probably at the end of the year or 
maybe next year.    
00:46:16 S1 So just getting, I mean, from your experience if somebody ask you 
your views on this role, what are you going to tell what your views 
are and how, is it something that should be coming up like in England 
and…? 
00:46:35 S2 I think so.  I think I'm quite pro about pharmacist prescribing and 
various model.  I don’t really want to stick to one model.  There are 
organisation for example Pharmacy Guild of Australia want to go 
with the autonomous model whereby pharmacists can initiate any 
pharmacists who have a certain qualification, minimum qualification 
or upskilling has been done, they can initiate whatever for example 
initiating a urinary tract infection antibiotics.  So they want those 
type of autonomous prescribing compared with the pharmaceutical 
society who are more work on collaborative prescribing or 
supervised prescribing which may work in a tertiary care setting but 
it will be a bit more harder to have it in a primary care unless of 
course we have more GP pharmacist type of positions available 
which we don’t because there is no funding for it.  There has been 
trial going on.  So it needs to be sorted out what will be that 
reimbursement and how they want to incorporate those things 
within a GP practice. 
00:47:59 S1 Right.  That’s fine.  You have mentioned the trial or the funding so at 
the moment, there is a trial.  Because in England at the moment, GP 
pharmacist role is being funded like in a pilot scheme where 60 or 
about 60% of the role, the cost of it is being funded under NHS.  So, 
is it something, the same trial been going on in Australia as well? 
00:48:27 S2 Yes, so it is a very similar trial. I'm not exactly sure how much it's 
been funded through the government trial like how many.  I know 
there are operational medical centres so a medical person who have 




is all funded.  I don’t think it's part funded.  It is all funded through 
the trial program and they are mostly doing it in the outer regional or 
remote or rural areas whereby there is definitely a shortage of GPs.  
So, and I think it is fully funded within that budget of that program.   
00:49:14 S1 And is it like a trial or is it something?   
00:49:16 S2 Yes, it is definitely a trial which is going on since last year.  And I think 
it's going to go on for another 12 months and then we’ll get the 
results and see what impact it had and then whether it's going to be 
then rolled out to other areas or other primary care practices 
whether that funding will be available at some stage but we are not 
sure.   
00:49:40 S1 And that funding is basically for GP pharmacist role, yeah? 
00:49:44 S2 Yes, that is correct.  That funding is just to employ our pharmacist in 
a GP setting.  That’s right. 
00:49:51 S1 GP setting.  So just to summarise if I have got it right, the trial is 
going on for a GP pharmacist role in remote areas, yeah?  And it's 
being funded by NHS, oh, by the government. 
00:50:06 S2 The Medicare, yeah.   
00:50:07 S1 And for the prescribing role, it's still under the review and how they 
can bring one or different models to give the prescribing annotation 
to the pharmacist. 
00:50:21 S2 That’s correct.   
00:50:23 S1 That’s fine.  Brilliant.  That’s good.  So just a final, the last questions, I 
mean, you know the GP pharmacist role linking the GP with the 
community pharmacy and other healthcare organisation, how you 
see that role and I mean you know with sometime the pharmacist is 
being provided by different organisations who can get the funding 
through different sources and then they provide that pharmacist, in 
England it's happening.  It might be not in Australia but just to have a 
bit of, and there is one pharmacist who is in-house GP pharmacist 
and some pharmacists who are being provided by different 
healthcare organisations.  Is it something happening in Australia as 
well?   
00:51:12 S2 Not at the moment.  So, it's basically very independently being, it's 
very independent, like GP practices have rent out and have 
pharmacists employed, have some kind of arrangement with them 




setup available to employ and just like they employ other allied 
health professionals.  So, there is more, it's no cohesive type of 
arrangement.  It is more independently organised between the 
practices and pharmacists itself. 
00:51:52 S1 And if you just want to highlight a few things about the medicine 
management of the GP pharmacist and then we will move on.   
00:51:59 S2 So definitely it is one of those roles which will be the key in terms of 
being a GP pharmacist which is what we are trying to achieve by 
having, reviewing all patients which are do require, I mean anyone 
who prescribe a medication should be reviewed anyway.  But of 
course there are certain criteria which we follow in terms of whether 
it's adherence issues, whether it is in terms of how many 
medications there are, whether they have other complex 
comorbidities, there is definitely, either the patient which need to be 
identified and worked through by the GP pharmacist through 
medication reviews or home medication reviews whereby you can go 
to people’s houses and see how they are dealing with their 
medications in general.  And then brought those type of feedback, 
give feedback through the GPs what needs to be done in order to 
improve those if they are not doing it well.  So those type of 
medication management is definitely the main areas which we will 
be focused on in terms of a presence of pharmacist in a GP practice. 
00:53:26 S1 That’s good, that’s good. Yeah, I think we have quite good, [inaudible 
00:53:29] quite a lot of information from that perspective, so thanks, 
Adnan.  Right, moving on just the last part, future of the GP 
pharmacist role, I  think you have brought a few questions from this 
section but I will just quickly go through one by one and if you want 
to just, I mean if any additional, [inaudible 00:53:55] with those 
sections anyway.  So looking at the future of the GP pharmacist role 
in the present general practice framework, I mean briefly 
summarising what activity should be involved for the GP pharmacist 
role.  Hello?   
00:54:22 S2 Sorry, sorry.  I think you got…okay.  Now it's good.  What I will want 
to see, can you hear me? 
00:54:28 S1 Yeah, I can hear you. 
00:54:30 S2 So what I will like to see is the role of a pharmacist in a GP practice is 
definitely include medication management and medication 
misadventures to prevent medication management and 




which has a massive cost and being in a surgery, in a GP practice, a 
pharmacist can easily prevent and save a lot of cost by reviewing the 
patient medications and following them up at their home in terms of 
adherence issues.  That is definitely will be the major areas where 
pharmacy should be focused on in terms of being in a GP practice.  
The other areas which we can work on is definitely areas like in 
terms of chronic care models, having feedback or following up 
people in terms of their overall management of chronic diseases, not 
only just from the medication perspective, but overall management 
like how they are coping and all those type of things with their 
chronic diseases and then refer over to, and then GP can refer to 
them if the pharmacist can identify areas where there are issues, 
they can request GPs to refer them to the other health professionals 
like gynaecologist or psychiatrist or physios and any other so I mean I 
can say that some nurses will be able to do that.  But there is a 
limited scope of nurse practice then GP pharmacists can actually do 
that very well because of their scope of practice and their experience 
of dealing with different variety of patients.  So that is definitely a 
role which we need to expand.  There is also, especially in the rural 
and remote areas where you have issues in terms of GPs not readily 
available or they, even we have situation in Australia where we have 
in, fly-in and fly-out GPs who comes only for a day or two a week and 
then they get out and then some new person comes in.  So in that 
situation, pharmacists can be readily available to do autonomous 
prescribing of mild to minor illnesses so that will be a role of GP 
pharmacists to initiate those type of treatment maybe along with the 
nursing personnel to help and then of course they can also do 
immunisation if there is a lack of availability of even nurses there so 
they can with the practice, they can administer vaccinations to the 
people being in a GP practice.  So those definitely type of role which 
need to be evolved and accepted by the various health settings in a 
primary care. 
00:58:00 S1 That’s good, that’s good. Brilliant, brilliant. All right. And you have 
already answered this question, as I said, we have discussed it next 
time but again, coming back to the training, anything additional 
came up in your mind about the training that can be given to the 
pharmacist, especially I mean considering that prescribing is being 
considered as a part of the future role?    
00:58:19 S2 Yes, so definitely will be extended, I’ll say, I mean that the current 
course and structure of pharmacy which is in Australia still four years 




extension.  And those type of prescribing, once it's approved, must 
be included as a part of the normal pharmacy course.  Those skills, 
and for those who have already graduated and working, there needs 
to be for example for medication reviews, you have to be an 
accredited pharmacist and that required, in Australia you have to 
have minimum a certain year of experience before you apply.  I mean 
it used to be a bit more harder but they have relaxed it a bit like for 
example when I applied to become accredited pharmacist there was 
a minimum of two years of post-study  experience that does not 
include the internship but now you can actually apply to become 
accredited pharmacist while you're doing your internship.  So that 
has been watered down I will say a little bit.  And that’s why we 
have, we definitely need extra clinical skills especially for primary 
care pharmacist who have not experienced in community pharmacy 
setup those clinical skills which the pharmacist or clinical pharmacist 
in hospital have, all have gone through.  So definitely those type of 
clinical skills needs to be done whether it's a six-month to a year 
course of post-graduate course which needs to be done as in clinical 
pharmacy or prescribing or whatever.  Without that, I don’t think it 
would be possible to have some kind of acceptance from, especially 
from GPs lobbyists, and GPs themselves if you don’t have those skills.   
01:00:32 S1 Yes, all right, that’s good. Just to clarify you know the accreditation 
you’ve mentioned, is it the medication review accreditation you 
said? 
01:00:38 S2 That is correct, yes.  So home medication review is a separate type of 
accreditation which every, it is not part of normal registered 
pharmacists jobs so you have to accredit with Australian Association 
of Consultant Pharmacists which is a course you can do after, after 
you graduate, while you're doing internship.  You can do a course 
which is only a day or two course really and then you can apply to sit 
in the exam and do case studies so you have to do 50 NCQ’s plus 4 
case studies before you can get accreditation to conduct medication 
reviews and get reimbursed through the medication system.   
01:01:32 S1 So just this, just getting off from the subject but is it the GPs who 
recommend you for the medication reviews or is it…? 
01:01:41 S2 That is correct.  The GPs are the initiators so our pharmacists cannot 
initiate a review on its own.  They can request a review and then that 
can be initiated by a GP because this is how it works in the Australian 




go and do the review and then report it back to the GP about what 
changes or situation needs to be done.  
01:02:13 S1 That’s good. So I mean just making like a model where you can do 
the reviews and if you have got a prescribing annotation, prescribing, 
I mean you can prescribe as well, so it looks like an ideal situation 
where you can go, do the reviews and if there is anything you want 
to change…? 
01:02:31 S2 That’s correct, yes.  So, in terms of a real model our pharmacist in a 
GP practice, if they are accredited, they can then initiate the review 
on their own.  That will be the ideal situation.  They don’t have to 
wait or rely on GP to get their permission.  In a GP practice and 
accredited pharmacist but prescribing rights would be able to initiate 
the review, do the review and if there is anything missing, they will 
be able to initiate that treatment within their scope of practice. 
01:03:08 S1 Yeah, definitely.  It looks like a big gap which can be definitely be 
filled by all these additional accreditations by the pharmacists.  
That’s good.  That’s good. 
01:03:18 S2 That’s right. 
01:03:19 S1 It's a really good knowledge which I'm getting just comparing the 
system which is working here and in Australia.  It's good.  So, moving 
on, yeah, sorry. We have covered quite a few aspects from the 
organisational and the clinical team.  How you find the patient’s 
feedback about this role, I mean the patient which you come across? 
(overlapping conversation) normally get. 
01:03:49 S2 Yeah, I think the patient really appreciate it because they can see the 
value of the expertise and knowledge of the pharmacist.  And they 
really appreciate that they are getting not only a good feedback from 
pharmacist but when they go and see their GP, their GP also tell 
them, oh yeah, yeah, we discussed this.  So, the collaborative effect 
it has on the patient is really good, not only in terms of improving 
their situation, but they really enjoy that interaction which they had 
both with GPs and pharmacists.  So, it has been really positive from 
every angle that they don’t see that this is not our scope.  They don’t 
question that that why pharmacists are doing this.  They think most 
patient and of course there are certain patient who will query then 
why you're asking that many question with them because they are 
not used to those type of situation where most commercial based 
pharmacies where they go which are not in a practice where they are 




take a script and the pharmacists just dispense it and give them the 
information on how to use them instead of inquiring more about 
their health and in general but then they come to us in our GP 
practice.  So some of them who never had that experience found 
them quite amazing that the pharmacists are more interacting with 
them instead of just covering to a pharmacists system giving them 
this script and then taking it back and take that into the house.   
01:05:35 S1 That’s good, that’s good. So, it's always positive feedback from the 
patient once they [inaudible 01:05:39] the roles and once they know 
that it's a part of the overall healthcare, then it’s always a good 
thing. 
01:05:49 S2 Yes. That is correct, yes.   
01:05:51 S1 Brilliant.  Alright.  I will summarise all the last few questions in one 
statement because most probably you have answered these 
questions before so I mean the GP pharmacist role has evolved since 
you have begun, right? So, believing or considering what you have 
experienced in the back or your years, I mean, any possible barriers 
or facilitators you think were in the start and now still present and 
how you feel those barriers can overcome for the future role?  
01:06:30 S2 Yeah, so barriers are definitely more of the way the settings are, so I 
don’t think so there are many settings like what we are in.  It's still in 
the very early phases.  So that’s why it always, when the new GPs 
comes in, they are not really aware of that that’s happening in these 
settings.  You understand what I'm saying? Because they haven’t 
experienced them in the past of their practice so that’s always a 
barrier in the past and in the future and in going forward also then 
you have new patient, new GPs that allied health professionals 
started the practice then you have to explain it to them what your 
roles are and how they can be benefited in them and in general and 
the patient in general.  So that’s always a barrier because of the fact 
that these practices are not common.  So once in the future, they will 
start getting more common then we will not have those type of 
barriers of not knowing what actually the roles are. 
01:07:41 S1 Yeah, yeah. That’s good, that’s good. And getting in the system and 
getting the points where you're coming from definitely, that’s good.  
And I mean based on all this structure you can see that in the future 





01:07:58 S2 Well, that would be ideal and that will be the situation if, depending 
upon like, for example, if you have two GPs, I can see there will be 
any [inaudible 01:08:09] pharmacist in those type of practices.  So 
you're looking at a minimum of between eight GPs to have a practice 
pharmacist available. So I think anything under that would be 
probably may not be financially sustainable for any of, or I don’t 
know whether it will help in general but I say between six to eight 
GPs minimum, minimum six, I will say, if they are fulltime and the 
practice is open five days a weeks at least from eight o’clock until 
five o’clock doing their normal business hours which is what probably 
will be more slightly the scenarios available for most GP pharmacist 
and practices.  There's not many after-hour practices available even 
in Australia, you know, it's very few like, one hours it’s after hours, 
because we’re open until 10 o’clock and open at 7.  And we’re open 
every day but that’s not the situation for most practices, GP practices 
in Australia where they’re only open between Monday to Friday and 
maybe some Saturdays or very small hours on Saturdays and most of 
them are closed on Sundays.    
01:09:26 S1 Okay, okay. So just to clarify this point you have said only two or 
three or less GPs you feel that there won’t be much role of the GP 
pharmacist in that practice if I'm right? 
01:09:41 S2 I said so because it may not, the GPs may not be seeing that number 
of patients to have a viable pharmacist available for between, let’s 
say, Monday to Friday.  But that is my understanding based on the 
numbers of patients a GP see in every day in those type of settings.   
01:10:11 S1 But there might be some role, like a part-time role, for medicine 
management? 
01:10:15 S2 Yes, definitely in a smaller practice there will be definitely a role of 
two or three days a week for GP pharmacist to be available to do 
those reviews, medication reviews and other plans need to be done 
if they don’t have a fulltime practice manager or a practice nurse.  
And that can be, it can then be taken by the pharmacist.   
01:10:42 S1 But for the fulltime role, you feel that they should be at least a 
practice with six to eight weeks? 
01:10:45 S2 Six, yes, that’s correct.  That’s based on the current number of 
patients seen by GPs.  So definitely a role for part-timers but ideally 




01:11:05 S1 Five days a week, which can do both the reviews and medicine 
management role at the same time, right? 
01:11:09 S2 Yes. 
01:11:17 S1 That’s good, that’s fine. Brilliant. Okay. And you feel the GP you 
know the perception for the overall perception about the pharmacist 
is changing with the studies coming up, with the new roles being 
started within the healthcare professional, you feel the perception 
has improved about this role?  
01:11:34 S2 I’d say so, over the years it has gotten a bit more acceptance from 
the primary care practitioners, primary care GP practitioners.  And of 
course, in Australia it's still in very early stage.  I mean we have been 
doing it for the last 10, 11 years but it is still evolving and it's still not 
as common as it would have been ideally in those type of settings.  
But it is definitely evolving. 
01:12:07 S1 It is evolving.  I mean from all these discussions, to be honest, I can 
see that there is a big scope of GP pharmacists and I think most 
probably this would be studied within the healthcare system and not 
much about the whole things that are working but I can see that 
there will be studies.  There will be research team going on about 
this role.  From your side, do you feel that more research needs to be 
done?  Any specific part of this overall role? 
01:12:40 S2 I think definitely more research and it needs to be collected of the 
effectivity of our pharmacists in the practice and how much saving 
they can do to overall health system and being available there. 
01:13:00 S1 Right, right, that’s good. And I mean you know the topic of this study, 
how important you feel this study might be for this whole scenario?  
01:13:09 S2 Yeah, it will be good to have that what is happening currently in both 
Australia and England in terms of comparative studies so what’s 
happening in GP pharmacist area in UK and what’s happening here, 
what lessons we can take from UK or what lesson you can take from 
situations here.  I would say it would be more lessons for us from UK 
because I can say that it might be more, I'm not sure.  I mean you're 
probably the best person to know that whether it is more commonly 
happening there compared to here in Australia. 
01:13:55 S1 I mean from my own experience I can see that prescribing might be a 
more like a game changer to be honest because that’s what has 
happened in UK with the role taking a bit of workload off from the 




not sure how the repeat prescribing works in Australia but yeah, 
prescribing and patient accreditation might be a big game changer 
for the GP pharmacist role in Australia so I will definitely have a bit 
more read through on this how the things in Australia and yeah it will 
be a major part of my writing discussion at the end of this study so 
that will be good. [inaudible 01:14:42].  Just a final step, any 
additional that you want to add based on our discussion what we 
have done before? 
01:14:53 S2 No, I think we covered most of the thing which your study is 
covering.  And then of course my opinion about what I will see in my 
experience so far.  So, I think it's definitely what is, I can add more, 
not more than anything else. 
01:15:12 S1 Yeah, you have brought loads of [inaudible 01:15:15] and quite a 
new information to me as well so brilliant.  If anything comes up in 
your mind later which you find or you feel that might be useful for 
this study, you can always let me know, yeah? 
01:15:30 S2 Yeah, definitely.  I will send you an email regarding and I will 
probably also will see whether my other colleagues which are in the 
similar setting they would like to have a session with you.  I will 
forward you, if you can the email you forward me previously, I 
believe that is the same still about the scope of the studies and all 
those thing because I did receive an email from you about what 
you're doing so I can forward that to them and then they can contact 
you.  
01:16:03 S1 Anyone who wants to have additional from (overlapping 
conversation) 
01:16:06 S2 I will CC it to you so you can know who they are so in case, you know, 
if they're not sure, you know, how to contact you, you can contact 
them then. 
01:16:18 S1 Yeah, yeah. I mean, it will be interesting to find the views from the 
GPs and nurses or, you know, the practice manager how they are 
taking this role and definitely once I have done the interviews with 
them it will be interesting to know their end as well and it will be 
really interesting to compare the views from both ends, both sides, 
yeah.  Alright, brilliant. (Overlapping conversation). 
01:16:44 S2 No worries. 
01:16:45 S1 Thanks a lot, and it was helpful.  And I will look forward to have the 




will be interesting to find how the comparison is coming between 
England and Australia.  Thanks a lot. 
01:17:04 S2 No worries.  Thank you. 
01:17:06 S1 It was really helpful.  Thank you.   
01:17:09 S2 Okay.  Thank you. 
01:17:11 S1 Thank you. 
01:17:10 S2 Okay.  Bye.   





[End of Audio] 







Interview with GP2/England 
S1 Interviewer 
S2 Respondent 
Timecode Speaker Transcript 
00:00:02 S1 Hi, my name is Nosha Abenda , and I’m a GP pharmacist as well as 
I’m working on a master research project to evaluate GP pharmacist 
role in England and Australia.  Today I’m doing the interview with a 
GP working in one of the practices in Manchester area just to get her 
views about the GP pharmacist role.  I would like to…please 
introduce yourself and then we’ll carry on with the interview. 
00:00:28 S2 Sure.  So I’m doctor Haria Amed.  I’m a GP partner here.  I’ve been 




00:00:41 S1 All right.  Dr. Amed, You have got basic information about this study? 
00:00:45 S2 Yup. 
00:00:45 S1 Yeah.  And you’re giving me the consent to do this research 
interview? 
00:00:49 S2 Yeah. 
00:00:51 S1 Oh thank you.  Basically this research is to evaluate the GP 
pharmacist role and this interview guide…this interview guide is 
divided in four sections.  Hopefully it’s gonna take about 20, 25 
minutes. If you want to skip any question or don’t want to answer 
any question, please let me know.  And at the end of the interview 
this interview will be transcribed.  If you want a copy of it I can 
provide you a copy and if you want to add something you can always 
let me know.  All right. You’re okay for me start?  
00:01:21 S2 Yeah. 
00:01:20 S1 All right.  As I said it has got four sections, the first one is about 
perception and challenges about the GP pharmacist.  So what are 
your views about general practice framework at the moment?  Do 
you believe there is any gap present in the general practice 
framework?   
00:01:39 S2 I’m not familiar with the GP framework, I’m more familiar with the 
long term plan now.  The five year forward view.  So…so I know more 
about how they are looking to expand and diversify the GP workforce 
even more.  So it was more the workforce even more.  So not just 
pharmacist, but physician associates, paramedics, practitioners, et 
cetera, so.  
00:02:04 S1 All right.  What was your initial perception about integrating 
pharmacists into GP pharmacists’ role?  If there was any gap in 
general framework, but your initial perception when you started 
working with the GP pharmacist?  
00:02:16 S2 So I’ve been fortunate, I think throughout my training even we’ve 
always had a pharmacist in the practice.  So I’ve been open to them 
they’ve been really helpful.  So instead of having to, you know, call 
up a pharmacy for advice from your pharmacist colleagues so that 




00:02:38 S1 All right.  Right.  And did you believe there was any mismatch in the 
professional expectations you had from the GP pharmacist role in the 
early stages?  
00:02:47 S2 No. 
00:02:51 S1 Okay. And any initial reservations you had about the GP pharmacists 
as a part of your clinical team like clinical knowledge, communication 
skills, management skills, qualifications? 
00:03:01 S2 No because we have quite a robust system supervision.  So confident 
that, that’s effective.  
00:03:11 S1 That’s fine.  Okay.  And how well you believe pharmacists was 
professionally prepared to perform as a GP pharmacist.  [Inaudible 
00:03:12]?   
00:03:17 S2 So they have a good understanding of the, you know, the role of 
primary care and where they sit within that role.  So I think they’ve 
been mostly been well prepared.  
00:03:30 S1 Okay.  Any operational challenges or hurdle you faced while working 
with the pharmacist?  
00:03:35 S2 No.  I don’t think so.  I think particularly our practice were quite 
innovative and we’re expanding and reviewing roles quite often.  So 
for example, you know, we had our pharmacist review blood results.  
We’ve had them actually seeing acute patients, the ones who are, 
you know, who are trained at advanced practitioner level.  So it’s just 
a case of trying and seeing how…seeing how it goes. 
00:04:07 S1 Okay.  Okay.  And in your views, what should be the key performance 
indicators you believe to analyze GP pharmacist role?  
00:04:13 S2 I think one of the key ones would be timing, medication reviews.  
Safety so safety auctioning alerts and things that you get.  Ensure 
we’re on top of any medication compliance orders and things like 
that. 
00:04:37 S1 Okay.  Okay.  That’s fine.  That was the first section.  The second one 
is about the working collaboration between the GP pharmacist and 
yourself as a GP.  So how you value your present working 
relationship with a GP and has it changed since the beginning?  
00:04:53 S2 No, I think it’s very positive.  We’re very open.  We have a quite a flat 




to come and discuss it and vice versa.  If I’ve got medication queries 
I’m more than happy to ask them. 
00:05:04 S1 All right. 
00:05:06 S2 And here the benefit is that our pharmacists are trainees as well.  So 
we have…yeah, we’re really open to development and training here. 
00:05:16 S1 But has it been proved since the beginning, you think so?  
00:05:18 S2 The perception yeah, probably I think.  Particularly with having 
trainees on board too, seeing their development over the course of 
their placement as well.  It’s definitely positive.  So they’re willing to 
learn.   
00:05:32 S1 Have you got any concerns related to medical, legal implications in 
the scope of GP pharmacists, situations like where the pharmacist 
has gone beyond their expertise?  
00:05:43 S2 No, I think it is about just emphasizing, you know, make sure you 
work within your limitations because ultimately they are working on 
the supervision and it’s just a case of reminding and make sure they 
undergo regular appraisal.  
00:05:59 S1 All right.  But do you have any experience in any situation where you 
think that oh that pharmacist should not have done this?   
00:06:05 S2 No.  It’s probably in the reverse where I think maybe they could’ve 
done a bit more like amending someone’s blood pressure medication 
for example.  
00:06:16 S1 All right.  Okay.  Okay.  That’s fine.  How is you find pharmacists to 
approach or communicate?  
00:06:20 S2 Fine yeah. 
00:06:22 S1 Fine, yeah, yeah.  Any factor you believe can influence this working 
collaboration?  
00:06:32 S2 No, I think maybe as we have dug the work force further as how to 
clarify the pharmacist role alongside the role of say a physicians’ 
associates.  For example, they’re new to our team, how can we make 
sure that all the roles and functions are covered among the whole 
team. 
00:06:55 S1 Okay.  Okay.  And they’re just the same thread of questions, what 





00:07:00 S2 I think it’s just clarification of roles.  So to make sure the most 
appropriate people are doing the most appropriate things.  So for me 
a priority is that medication reviews are done in a time  because it’d 
be a shame if GP pharmacists aren’t meeting their duty in that 
respect, but are then expanding their skills, you know, say in terms of 
seeing clinical patients, acute patients.  So that’s…that’s one issue 
that we do have here.  I don’t think were on typical medication 
reviews.  That’s more of a function of, oh this is partnership, looking, 
reviewing roles again and making sure that, you know… 
00:07:39 S1 Because this thing about the medication reviews, how we collect the 
data for the patients who are due for their medication reviews, is it 
something that a receptionist or other teams do?     
00:07:52 S2 Yeah, so it is.  So admin.  They will, they’ll send a reminder saying, so 
you know nudging the patients’ medication review, but it’s those 
that don’t.  It’s how they then, you know, second or third attempt 
and they still fail.  And looking at you know, patients’ medication list 
or have loads that are, you know have four-six of three issues for 
example.  And we’ve done a lot of work recently with one of our 
trainee practice pharmacists who’s put quite a few patients onto the 
pre-dispensing.  So hopefully that will improve things as well.  But it 
is just a bit more improving the system there.   I think it still needs 
review, yeah.     
00:08:30 S1 All right.  That’s fine.  Okay.  And briefly explain what impact a GP 
pharmacist has made on your scope of practice.  On where you were 
working before you started with GP pharmacists and now when you 
are working with GP pharmacists. 
00:08:44 S2 So it’s great in terms of you know, we have pharmacists that see 
acute patients.  So it’s reduced our workload there.  They are 
pharmacists, so they did used to review our blood results and record 
them and they still do cover if a physician services can’t do that.  So 
obviously there’s that workload that has been moved, shifted to 
them as well.  So they definitely help with the workload and they 
help in terms of just being on site to ask for clinical clinician queries. 
00:09:17 S1 Just…just again, I mean has pharmacists worked on his own when 
there is no GP in the practice or if there’s… 
00:09:23 S2 No, there’s always.  
00:09:25 S1 That’s fine.  Okay.   Thanks, this was our second section.  We are just 
moving to the third one which is about the pharmacist skillset.  How 




view.  So first one is about the patient facing role.  How you see the 
competency of GP pharmacists in doing the patient facing role like 
around clinics, meds reviews, or doing the home visits?  
00:09:49 S2 So I think yeah, they get in there.  It’s all about training and 
development.  So they do…so they do all of that, off clinics, do home 
visits and stuff.  I think probably some do need a bit of support in 
time management, but they’re always willing to ask if they’re unsure, 
we’re always willing to help them.  
00:10:11 S1 But you feel that they are…with the time they are getting more 
competent or they are competent to do the patient visits? 
00:10:20 S2 Yeah, definitely.  
00:10:20 S1 Okay.  About the pharmacist as a prescriber, what are your thoughts, 
any reservation you have about prescribing them, what are your 
thoughts on describing them? 
00:10:31 S2 Yeah, so it was…as a policy we’ve decided not to allow them to be 
independent prescribers at the moment.  Unless they have…so say 
there some who are specialist qualifications in diabetes so they can 
do diabetes drugs especially some are specialist in asthma, so they 
can do asthma prescribing, but beyond their scope we’re not…we’re 
not keen to allow them.  
00:10:53 S1 Okay.  So they are not doing like a repeat prescribing…singing of the 
repeat prescribing.  It’s more like a…if they have the expertise, they 
will do it.    
00:11:04 S2 Yeah, exactly.  I mean we will probably move towards that.  
00:11:06 S1 Okay.  That’s fine.  All right.  I mean it goes with the next section, but 
yeah, in your views what protocols should be set up at an 
organizational level or practice level for them to work as a 
prescriber? 
00:11:19 S2 Yeah, I think…I think it’s reviewing their competence.  They will need 
close supervision to start off with because you know obviously it’s 
ironic isn’t it because as doctors we don’t receive much training I’m 
prescribing yet we’re…we’re, you know, giving free reign to a 
prescriber when actually a pharmacist will know a lot more about 
premedical terms you know how stuff works.  So I think it will be 




00:11:49 S1 All right.  Yeah, yeah.  All right.  The second part about the medicine 
management skills, how you see them working on that kind of the 
workload as a medicine management.   
00:12:00 S2 What do you mean, sir? 
00:12:01 S1 Medicine management, when dealing with the [inaudible 00:12:01] 
from the pharmacies, from the patients.  
00:12:06 S2 Yeah, so they’re very good at that.  Yeah, they do that anyway and 
actually because we’ve got trainees, the trainee pharmacists do that 
very well.  Yeah, so it’s… 
00:12:13 S1 This is something which you are confident they can do.  
00:12:13 S2 Yeah.  
00:12:17 S1 Yeah, yeah.  All right.  Brilliant.  Okay.  Most of…what I have learned 
from my own experience as well, there’s always a bit of confusion 
about the practice performances and the nurse practice role.  So 
how…it’s obvious that there might be the overlapping of the roles 
between, you know, professionals.  How…in your views how…where 
we stand in this practice in your own views?   
00:12:41 S2 I think they work very well, it helps that they’re, you know, very 
friendly together.  You know, they respect each other.  So they…you 
know, nurses and pharmacy clinics and they divvy up, you know, 
things like home visits.  So I think it works well. 
00:12:56 S1 But you don’t think there is any overlapping coming up in the 
environment. 
00:12:58 S2 No, no.   
00:13:04 S1 That’s fine, that’s fine.  Okay. And how you evaluate your GP 
pharmacist role to link surgery with community pharmacy, hospital 
and like organizations like CCG? 
00:13:12 S2 I think that there’s probably more that could be done there in terms 
of including cross organizational cooperation.  Yeah. 
00:13:21 S1 All right.  Yeah.  But do you think they…are there any letters that’s 
coming up, are they…the person who is giving most of the care. 
00:13:30 S2 It is, yeah.  So any…anything related to medications just go to 





00:13:39 S1 It is yeah, so any…anything related to medications does go to 
pharmacists or the nurse and they action it.  So they’re already doing 
that, yeah.  
00:13:39 S1 What are your thoughts about on comparing the in-house 
pharmacist like the ones you have and the one which come from CCG 
or the like organizations?   
00:13:49 S2 I think it varies.  So I’m relatively new here, but I know from my 
colleagues the experiences that it is quite variable.  They tend to be 
quite skill achieved.  This is due to pharmacists.  
00:14:01 S1 All right.  Yeah.  
00:14:03 S2 But it’s figuring out who…who’s the good ones and who…who’d want 
to support us further.   
00:14:07 S1 All right, yeah, yeah.   
00:14:09 S2 Yeah, as with a lot of things, it just depends.    
00:14:12 S1 It depends.  
00:14:13 S2 Yeah. 
00:14:13 S2 Yeah, vary.    
00:14:15 S1 Okay.  Yeah, this is the last part.  It’s about the future of GP 
pharmacist role which you can just how you see them.  So what 
future do you see for GP pharmacist role in future general practice 
framework.  Any activities there you think that should be warded 
patient of clinical level? 
00:14:33 S2 I think we’re…you know, we’re quite an intense practice.  So they’re 
already doing a lot of in terms of, you know, some have done the 
advanced practitioner course and is seeing acute patients.  Some are, 
you know, they’re dealing with blood results, home visits, queries.  I 
think my reservation and that’s shared by a couple of our partners is 
that, you know, that the core fixation of medication safety isn’t 
overlooked.  So make sure medication reviews are done in a timely 
way and that, that loop is closed.  I think it’s just going back to basics 
in a way and making sure that actually that, that is covered.  
00:15:14 S1 But generally you see that in the future like in five years or 
something, do you see pharmacists working in the general practice? 
Fulltime?    




00:15:27 S1 Okay. How you evaluate patients’ feedback.  Have you received any 
patient feedback about the GP pharmacist role?  
00:15:26 S2 I think it’s generally positive.  I think our patients are happy to see 
anyone who they feel is competent and who’s well supervised.  So 
yeah.  
00:15:40 S1 Have you ever received any negatives from anyone? 
00:15:47 S2 No, no.  
00:15:44 S1 Okay.  That’s fine. Okay.  And how do you evaluate the cost of 
employing a GP pharmacist and [inaudible 00:15:52] like indemnity 
insurance?   
00:15:56 S2 It’s reasonable, yeah.  I think.  Because at the moment.  I think as I’ve 
mentioned before, as our workforce diversifies further, you probably 
will…we probably will have to look at value for money.  So for 
example a physician is associated coming through, they are by nature 
they’ve trained in clinical reasoning and how to see patients and 
things.  So it may be prudent to, you know, look at roles and make 
sure that the most appropriate people are doing the most 
appropriate talks.  So yeah.  
00:16:34 S1 Okay. Based on your experience and need of workload, do you see 
GP pharmacists as part time or fulltime role? 
00:16:38 S2 So we have two-part time pharmacists, yeah.  
00:16:45 S1 And… 
00:16:43 S2 It works well. 
00:16:43 S1 It works well.   
00:16:46 S2 Yeah.  
00:16:47 S1 [Inaudible 00:16:50] one fulltime.  Is it better for you to have two 
fulltime pharmacists? 
00:17:01 S2 I think it’s nice to have a bit of diversity. 
00:17:06 S1 What are your thoughts about available funding options for GP 
pharmacists?  Will you recruit a GP pharmacist once all the funding is 
not available anymore?  
00:17:17 S2 I think yeah, we’d continue with it yeah, because it’s embedded, it’s 




00:17:22 S1 All right.  And based on your overall experience, what training would 
you like to see the pharmacists to improve their competency of the 
GP pharmacist? 
00:17:30 S2 It would be interesting for whoever’s in charge of the training to look 
at programs like the physicians’ associates training and you know, 
consider how we can kind of work together to integrate elements.  
So lots of things like clinical reasoning, decision making, how to 
improve the competence and confidence of venerable ones by doing 
that.   
00:17:54 S1 How do you believe practice pharmacists has evolved the 
performance of GP pharmacists impacting overall healthcare 
provision in highlighting any practice level planning bits.  Have they 
evolved since you have seen them from where they started and 
where they stand now? 
00:18:14 S2 I think quaff work is when we’ve probably seen most benefits, you 
know, quaff clinics, stuff that can be easily protocolised. So it can 
follow [inaudible 00:18:29]. 
00:18:32 S1 As a healthcare professional…have they evolved positively.  I mean… 
00:18:33 S2 Yeah, definitely. So they always, they’re opened to, you know, 
expanding the role and always open to developing themselves.  
00:18:41 S1 Brilliant.  All right.  And have GP pharmacist roles changed your 
overall perception about pharmacists?  Because most of the GP’s 
they might be…they have the perception or they had link with the 
community pharmacist before, but since this role has started you are 
more close with the pharmacists as a healthcare professional.   So 
has it changed your role of perception about the pharmacists? 
00:19:01 S2 Yeah, I think so.  And like I say I’ve been fortunate, I’ve worked and 
trained and practiced the hazards in house pharmacists anyway.  So 
they’re a core part of our team so we’ve…we’re lucky in that respect.  
00:19:14 S1 All right.  That’s fine.  And considering the possible barriers and 
facilitators [inaudible 00:19:18] GP pharmacist role, what steps 
should be taken or can be taken at an organizational level to improve 
GP pharmacist role? 
00:19:26 S2 I think just be open.  I think we know that there’s a shortage of GP’s 
so it’s just being open that actually there are all the health 




open and being honest about the challenges that we face as a 
primary care workforce.          
00:19:50 S1 Okay.  All right.  Yeah.  Just last two questions, summarizing them up.  
Any future or further research you would like to see on GP 
pharmacist role in England? 
00:20:01 S2 I think I forwarded Zeeshans…a study that showed, you know, make 
sure that pharmacists are embedded with a routine well enough for 
their recommendations to be implemented, you know, otherwise, 
you know, they’ll do all this excellent work and then it’s just ignored, 
it just sits at the bottom of a pile.  So it’s to make sure that you know 
the work they do is truly integrated into the work they practice.  
00:20:25 S1 All right.  Is it research that has been done in UK? 
00:20:31 S2 It is yeah.  I’ll try and forward it.  I did email Zeeshan, I’ll ask him to 
forward it to you, yeah. 
00:20:37 S1 All right.  Yeah, I think that covers up all our sections, but just a final 
question, any other comments you want to add up or say about this 
whole process about GP pharmacists for this interview.  Anything you 
want to add? 
00:20:50 S2 No, that’s fine. Thank you. 
00:20:52 S1 That’s fine.  Thanks Dr. Amed, that was really helpful for the views 
and hopefully it will lead up to good data about our study.  Thank 
you.     
 
 (00:21:04) 
(End of Audio) 





Interview with GPP/England 
S1 Interviewer 






Timecode Speaker Transcript 
00:00:01 S1 Oh hi my name is Nosh Akhtar and I’m a master research student in 
Huddersfield University and today I’m doing the interview with 
Zeeshan and Zeeshan is a GP pharmacist and he is giving me the 
interview about my study which is to value the expectation and 
perceptions of GP pharmacists all in England and Australia.  So thank 
you Zeeshan.  Zeeshan, do you have…just introduce yourself.   
00:00:29 S2 Okay.  So my name is Zeeshan Raghmani.  I’ve been working in 
general practice for about five years now.  I’ve done the prescribing 
course and I’ve also done one year of the advanced practitioner 
course as well.  So I do many face to face role within general practice.   
00:00:52 S1 Zeeshan, do you have got the basic information sheet about this 
study and you are giving me the consent to do this interview? 
00:00:57 S2 Yeah. 
00:00:57 S1 Thank you, Zeeshan.  So Zeeshan you know this study is basically 
about the relation of the GP Pharmacist and its competitive study 
about this role in England and Australia?  So the interview is gonna 
take about 20, 25 minutes and it is divided in four sections.  
Perceptions and challenges, GP pharmacists working in collaboration 
with health care professionals, pharmacist skillset and future of GP 
pharmacist role.  So any views you want to share you can give in your 
interview.  This interview is being recorded and then at the end of 
the interview this will be transcripted and if you need I will pass you 
a copy about the interview.  So starting with perception of 
challenges, you’re okay for me start?  
00:01:40 S2 Yeah. 
00:01:40 S1 Yeah, yeah.  So starting with perception and challenges you are…you 
started working as a GP pharmacist.  So what are your views 
about…around general practice frame work.  How the general 
practice framework is working and do you believe there is any gaps 
present in the general practice framework?  
00:01:59 S2 So what exactly is it that you’re referring in the general practice 
framework? 
00:02:01 S1 Just general…yeah, general practice GP you know the primary care.  
The general practice is the main step stone of the primary care.  So 
how the things are working in the general practice framework, is 




health care professionals and that can be build up by any health care 
professional? 
00:02:28 S2 Yeah, I think in terms of the…the gaps, obviously there’s more 
pressure.  I think there’s the…the expectations of pharmacists, you 
know, compared to what pharmacists can actually do.  l think there’s 
a bit of a gap there.  And I think there is a need for kind of more 
training to make sure that pharmacists are fully competent in filling 
those roles.    
00:03:02 S1 It feels more like, you know, this role has just started about four, five 
years ago.  So if it goes *back about four, five years ago, there is 
always the perception or there is always in the news or in the media 
or  that the general practice framework is under the pressure of the 
workload of…and we need to include…the *homes of GP’s, nurses 
and other healthcare professionals so that it leaves a bit of [inaudible 
00:03:33]. 
00:03:36 S2 So I think…I think that’s happened.  There’s been…there’s been 
definitely a massive influx of pharmacists of nurses and others.  But I 
think the other thing is as well that we’ve always had is we’ve had a 
lot of GP’s leaving as well.  And the issue is…is that you have one GP 
and you have lots of other healthcare professionals.  It’s making sure 
that those healthcare professionals are being able to operate safely 
with sufficient like supervision as well.  And I think sometimes 
general practice they…they misunderstand the role of a pharmacist 
and what pharmacists can do and what they can’t do.  So that’s why I 
think to make sure that pharmacists are, you know, fully competent 
in that role.      
00:04:23 S1 Yeah, yeah.  I think you did at least do my next question then.  I 
mean would you been working yourself as a GP pharmacist role.  So 
what were your initial perception about the GP pharmacist role when 
you started this role?  What was your perception…that what roles 
you’re gonna play within the GP practice?   
00:04:42 S2 So initially mine was just…it was a desk role. 
00:04:43 S1 All right.  Okay.  Is that your perception, what you got? 
00:04:48 S2 I think that was…I thought my role would be very limited.  
00:04:55 S1 All right.  Okay.  
00:04:56 S2 Based on what I could do before.  So I think my perception was, you 




00:05:06 S1 More like a management type of role? 
00:05:09 S2 Yeah, medicines management type things, audits and doing hospital 
discharges, things like that.  I thought maybe basic face to face, but 
to think…five years ago to think I’d be doing like the normal walk in 
clinic… 
00:05:25 S1 Yeah. 
00:05:27 S2 Yeah, I didn’t think that would happen.  
00:05:28 S1 Yeah, yeah.  And what are your thoughts about the initial 
perceptions of other health care professionals especially GP’s when 
you started this role?  What was your *expectations if you 
remember, what they were expecting from you and do you believe 
there was any mismatch of expectations in the initial phase?   
00:05:53 S2 So going back like five years ago I think the perception varied 
between from GP to GP.  Some GP’s I think would have over 
expectations.  They think that you can do everything.  And some GP’s 
were very wary.  I think they were very wary almost as if you, you 
know, when it feels like someone’s stepping on your toes.   
00:06:10 S1 Yeah, yeah, yeah. 
00:06:15 S2 So I think there was a bit of… 
00:06:18 S1 What was more in this practice, what did you find more? 
00:06:23 S2 I think even within this practice I think some GP’s were quite, you 
know, you’ll be able to do XY and Z.  And some were… 
00:06:33 S1 Yeah. 
00:06:32 S2 Yeah, but generally speaking I think I was always given lots of support 
to develop in this practice.   
00:06:40 S1 So just to summarise I mean you do believe that initially you do 
believe initially there was a bit of expectations between the 
expectations.    
00:06:44 S2 Yeah, yeah, yeah.  
00:06:49 S1 That’s fine.  Yeah, yeah.  And what were your initial resolutions about 
this role.  I mean when you started this role, your personal 




00:07:00 S2 I didn’t feel so confident with my clinical knowledge because I was 
working in community for like either years before I came here.  So I 
didn’t feel that confident giving clinical advice.  
00:07:11 S1 What about communication skills?  
00:07:12 S2 Communication skills I think generally speaking community 
pharmacists are…communication skills were always quite good.  So I 
wasn’t too fussed about the communication skills.  I think it 
was…there was a bit of anxiety about, you know, dealing with 
doctors.    
00:07:34 S1 Yeah, yeah, yeah. 
00:07:35 S2 You know, not wanting to appear like stupid or… 
00:07:37 S1 Yeah, *makes sense, makes sense.  Yeah.  I think it’s…the general 
idea which I’m getting is more they were confident about the 
communication and management skills, but yeah, the clinical 
knowledge because they were not very much aware of what they are 
gonna face in the GP practice.    
00:07:55 S2 Yeah.  
00:07:58 S1 That’s what the reason was here.  Yeah, yeah.  And was your initial 
operational challenges when you came here? 
00:08:04 S2 Operational challenges?   
00:08:06 S1 Just give an example like  how comfortable it was for you to deal 
with the practice scene apart from the GP’s and availability of the 
rooms or the task allocation.  How are the… 
00:08:23 S2 I think practically yeah, practically speaking I think it wasn’t so much 
of an issue… 
00:08:30 S1 All right, all right.  
00:08:31 S2 …really.  I think there was some issues where certain things I wanted 
to do.  So it was basically what…it was a balance of what I wanted to 
and what the practice wanted me to do.  The practice needs and my 
needs were more admin type tasks which I didn’t really want to do.  I 
wanted to do more of the clinical work.   
00:08:52 S1 [Inaudible 00:08:53] like the rooms? 




00:08:56 S1 Okay.  And what about the views on the emotional challenges in the 
initial phase like…I mean so just perceived professionally in 
[inaudible 00:09:06] and development and clinical [inaudible 
00:09:08] for patient facing clinical skills? 
00:09:10 S2 Yeah.  
00:09:10 S1 It’s more like from the clinical side.  
00:09:14 S2 Yeah, I think there’s obviously that anxiety about… 
00:09:17 S1 Maybe emotional. 
00:09:16 S2 …being out of your comfort zone. 
00:09:24 S1 Yeah, yeah, yeah.  All right.  And what school did you receive an 
organisational level.  
00:09:31 S2 Sorry, what was that? 
00:09:34 S1 What support did you get from the organisation level? 
00:09:37 S2 So I think the best thing was that I was assigned a clinical supervisor.  
One of the GPs was my clinical supervisor.  He was my go-to person 
for clinical queries.   
00:09:44 S1 Okay.  Okay.  
00:09:46 S2 And I think every day whenever I had a clinic patient facing, I always 
had one GP that I knew would be available for me to answer clinical 
questions as well.  That made it very, very easy, yeah.   
00:10:00 S1 Brilliant.  And I mean I think you have answered everything, but if 
you want to add something…how well you believe you were 
professionally prepared to perform as GP pharmacist?   
00:10:08 S2 To be honest, I was just thrown in the deep end.   
00:10:11 S1 Yeah, yeah.  
00:10:13 S2 I just had to find my way.   
00:10:17 S1 Okay.  From your experience now, what do you think should be the 
key performance indicators to value the role of the GP pharmacist? 
00:10:28 S2 So I think it should be time, how they’re saving time to the practice.  
Money, I think so cost savings in terms things like the management.  
But also cost making as well.  So for example [inaudible 00:10:42] 
and standards.  We have Manchester standards which shows you can 




money that perhaps someone brought into the practice.  And then I 
think it’s yeah, really, the time and the...and money and pressure.  
How much… 
00:11:07 S1 How much time you’re saving for the GP ? 
00:11:07 S2 Yeah. 
00:11:10 S1 Listen using emails?   
00:11:14 S2 Yeah.           
00:11:12 S1 Okay. That was the first section, yeah.  Yeah, that was the first 
section.  So we’re gonna move now to working collaboration within 
the GP practice now.  So how are you valued at your present working 
relationships with the staff members? 
00:11:28 S2 Very good.  
00:11:29 S1 And do you believe that it has changed since the beginning? 
00:11:36 S2 Yeah, I think they value my employment a lot more now.   
00:11:38 S1 Yeah, yeah.  So they know how the things are going now. 
00:11:41 S2 Yeah, they know. 
00:11:43 S1 Yeah, yeah. So how do you differentiate your role as a GP pharmacist 
with [inaudible 00:11:46]?  That’s a very common theme.  That’s 
something [inaudible 00:11:50].  So how do you differentiate your 
role and latest things?   
00:12:02 S2 So yeah, there’s definitely an overlapping.  I think…I think it’s always 
when it comes to medications side I think when it’s polypharmacy, 
when there’s comorbidities, there’s, you know, those kind of areas I 
think is where it really differentiates and even management of 
medication side as well is our strong point.  And then there’s other 
roles as well which...so I mean even now I know there’s a lot of 
advanced practitioner, nurses that do the same things that I do, but 
you know, I also have the added thing of hospital discharges acute 
prescription queries and things like that.  
00:12:45 S1 So you think in the start there was a bit of the concern, yeah, like you 
said they’re stepping on their toes or something. 
00:12:52 S2 Yeah, yeah because I mean in the beginning I was doing a lot of the 
nurses’ job because the nurse went off…the nurse was on maternity 




everything the nurse was doing right from baby clinical to everything, 
you know.  So there was a lot overlap at that time. 
00:13:08 S1 But now you think that there are some specific roles that [inaudible 
00:13:14]? 
00:13:13 S2 Yeah, yeah, yeah.  
00:13:15 S1 That’s good, that’s good.  So have you got any concerns related to 
medical legal implications and scope of your… as a GP pharmacist in 
situations where it concerns about pharmacists going beyond their 
area of expertise?   
00:13:29 S2 Yeah, definitely.  That’s always a worry.  About the…the worry of risk 
of litigation is always a…is always a worry.   
00:13:38 S1 Is it mostly coming from the nurse or is it coming from the GP or is it 
coming from the GP or which like any medical legal implication? 
00:13:44 S2 So I think it’s from patients more.  
00:13:46 S1 Patients.  
00:13:46 S2 More like yeah, like making a mistake when it comes to the 
management of patients I suppose.  Most likely. 
00:13:54 S1 And how is it you find post communicate?   
00:13:57 S2 Oh yeah, very good.  Very good. 
00:13:59 S1 It has improved? 
00:14:01 S2 Yeah. 
00:14:01 S1 Yeah.  
00:14:02 S2 That’s fine.   
00:14:02 S1 And any factors, specific factor you believe that influence this 
working collaboration?  
00:14:08 S2 That was…sorry? 
00:14:10 S1 Any specific factors you think that can influence this working 
collaboration?  
00:14:14 S2 Infuse, what do you mean?  
00:14:17 S1 Any specific factors that can influence this… 




00:14:18 S1 Yeah, yeah.  So any… 
00:14:24 S2 Yeah, I think multidisciplinary meetings which we do is a really good 
way to do that.  Because we have…so even now they have a huddle 
every day.   
00:14:35 S1 Okay.  
00:14:34 S2 Where we…the nurse GP’s, pharmacists, we all get in one room and 
we discuss patients and what’s happening and things like that.   
00:14:40 S1 Any steps that can be taken to improve within this general 
practice…are they willing to improve this collaboration apart from… 
00:14:50 S2 I think more dialog between the different divisions rather than 
having people working independently, they speak regularly.   
00:14:55 S1 More like a meeting. 
00:14:58 S2 Yeah. [Inaudible 00:14:59].  
00:15:02 S1 Right.  That’s fine.  It covers over second part.  So moving up to third 
one, pharmacist skillset, yeah?  Mostly it might be that you’ve have 
given the answers a bit in the back, but it’s just more specific on 
skillset now.  So how do you value your competency of pharmacists 
in patient facing role for example clinics, medication reviews or 
home visits? 
00:15:24 S2 Yeah, so I think there needs to be a level of doing that under the 
clinical supervision first.  So having clinical supervision within the 
practice is very, very important and having the GP on board for that.  
And this is the thing, problem where sometimes GPs assume that you 
can just do everything because you’re a pharmacy, you’re 
competent, but that doesn’t work like that.  Over here I’ve had a GP 
supervise me for a long period of time before they…before working 
independently.   
00:15:51 S1 Yeah, yeah.  
00:15:55 S2 And then the other thing as well is actually gaining some credible, 
professional qualifications as well like prescribing courses like 
advanced practitioner qualifications, other weekend courses, things 
like that.   
00:16:07 S1 Improve the patient facing. 




00:16:07 S1 That’s fine.  And what are your thoughts about prescribing role of 
pharmacists?  Highlighting any relations you might have? 
00:16:15 S2 I think as long as pharmacists are prescribing within their 
competence and there’s no pressure on them to prescribe outside of 
their competence is fine.   
00:16:21 S1 Yeah.  It’s more about the outcome yes.  Yeah.  And have you ever 
felt that pressure from anyone in the organisation that you have to 
do the prescribing or to be prescribing? 
00:16:32 S2 No, never. 
00:16:34 S1 That’s great.  Yeah.  So in your views, what protocols should be set 
about organisational level for prescribing [inaudible 00:16:39] like 
they knowing what you can prescribe.   
00:16:45 S2 Yeah, the GPs knowing info. 
00:16:46 S1 Yeah.  Have you ever worked on your own like an on-call clinician? 
00:16:53 S2 Not on my own, no.  Always with a team leader.     
00:16:57 S1 Okay.  And what are your thoughts about medicine management 
skills of the pharmacist? 
00:17:03 S2 Yeah, I think that’s… 
00:17:03 S1 That’s [inaudible 00:17:04].  That’s more like the easy… 
00:17:04 S2 Yeah.  
00:17:05 S1 …main part of it.  All right.  So how do you value your GP pharmacist 
role to link surgery pharmacy, hospital or like CCGS.  Do you think it 
can bridge the gap? 
00:17:19 S2 Yeah, definitely.  I think because pharmacists are now in each of 
those areas.  And they can become the bridge.   
00:17:31 S1 So they can be the link between all that.  Yeah, yeah.  And is what the 
staff over here are expecting from you as a part of your role?  
00:17:38 S2 Yeah, I think so to some degree yeah.   
00:17:42 S1 All right.  And what are your thoughts on comparing in-house 
practice from to the one employed by healthcare organisations like 
the CCG pharmacists.   
00:17:53 S2 So I think the thing is the in-house pharmacist focussed on the 




So CCG pharmacist may just be, you know, just focussing on cost 
saving, but sometimes that can create problems within the practice… 
00:18:15 S1 Okay.  
00:18:15 S2 …for GPs and you know, for example when they like stop medication, 
things like that.  Or change plans and just send a letter to the 
patients…that patients then get happy with that then come back 
and…whereas within in-house pharmacist you get to know your 
patients well.  So I know in advance sometimes.  So what they’ll do is 
they’ll send me a list of things that need changing.  And sometimes I 
know those patients are not gonna be happy with certain things.  So 
I’ll speak to them.  So patients I’ll know they’ll be okay with the 
changes so I can change it. 
00:18:43 S1 I think the more with the in-house pharmacists now where in the 
past it was like more like the organisational pharmacists.   
00:18:51 S2 Yeah, yeah. 
00:18:52 S1 Yeah, yeah.  that’s fine.  So just the last part now, Zeeshan.  It’s about 
the future of GP pharmacists.  So it depends on or based on your 
experience in your organisation.  So what future do you see as a GP 
pharmacist in the present and future general practice framework?   
00:19:13 S2 I think pharmacists will start taking more of a supervisory role as well 
now because they’re kind of establishing themselves slowly.  I think 
they’ll start to see more people coming.  So for example over here 
for the last…this is the second year now, I’ve been taking on pre reg 
pharmacists here now.  So we now for the last like two years we’ve 
had in-house pre-registration pharmacists as well full time.  So that’s 
a new role.  So it’s taking on…like supervising them.  Supervising 
physicians’ associates.  Training of the healthcare staff. 
00:19:47 S1 I think from next year onwards you can…the pharmacist can do it as 
BMD as well.   
00:19:52 S2 Yeah, yeah, yeah.  So…yeah, yeah.  
00:19:57 S1 Be intresting.  So yeah, you think there is…pharmacists will be a 
major part of the GP practice in the future yeah? 
00:20:06 S2 That’s right. 
00:20:06 S1 Based on your overall experience, what training would you like to see 




00:20:09 S2 Training.  I think hands on.  Sort of…so yeah, facilitating that hands 
on experience.  So you’re not actually seeing patients and being able 
to consult with a GP or pharmacist after that. 
00:20:32 S1 All right.  
00:20:35 S2 And that kind of training.  
00:20:35 S1 Clinical knowledge training.  
00:20:38 S2 Yeah, but I think mainly the focus should be on the clinical 
knowledge as well for a lot of pharmacists because, you know, either 
rusty or it’s not their strong point.  And a lot of the courses like  
prescribing I feel there’s a lot of emphasis on like the non-clinical 
aspects like leadership skills and you know this skill and that skill, 
constitution skills and communication skills.  Sometimes I feel there’s 
a bit too much emphasis on those and not enough emphasis on 
clinical skills, yeah.  
00:21:05 S1 It’s more on the part,  Yeah, yeah.  All right.  And how you value 
admissions feedback and perceptions about GP pharmacists? 
00:21:13 S2 So initially the patients were really like…even doing acute now like 
now I see acute clinic initially patients were like…they were not 
happy because they wanted to see a GP.  But then slowly, slowly 
because they’ve started to see what I’ve been able to do. In the 
beginning I used to get a lot, oh, I wanted to see a GP, but now 
because a lot of them know me, they’re okay.  
00:21:39 S1 Okay.  You have a good relationship with the patients that come in. 
00:21:41 S2 Yeah, definitely, yeah. 
00:21:46 S1 Okay.  And based on your experience and need of workload, do you 
see GP pharmacists as part of…or fulltime role? 
00:21:51 S2 Fulltime role.  
00:21:54 S1 Yeah, yeah.  Okay.  That’s fine.  And how will you believe practice 
pharmacists has evolved perform as a GP pharmacist in the present 
framework.  
00:22:02 S2 I think it’s evolved certainly in the face to face…there’s a lot more 
face to face clinics and things like that now compared to before.  
And…and I think taken…pharmacists taken more leadership roles 




pharmacists can start to establish themselves more within, you 
know, general practice.    
00:22:27 S1 And it is giving a bit more benefit to…at the organisational level as 
well. 
00:22:30 S2 Yeah. 
00:22:32 S1 Yeah, yeah.  That’s fine.  Brilliant.  Okay.  Considering the possible 
barriers and facilitators for current GP pharmacist role, what steps 
should be taken at an organisational level to improve GP pharmacist 
role?  Considering any barriers of facilitators, you had in the past or 
at the moment?  
00:22:51 S2 Barriers.  Do you mean within this practice or generally? 
00:22:54 S1 Generally.  I mean generally you might have or seen somewhere… 
00:23:00 S2 So I think the barriers would be to…sometimes it’s the…the admin 
side becomes a barrier because they’ll get pharmacists stuck into the 
admin stuff.  So they’re just like doing, you know, they’ll be busy 
doing med *reviews over the phone or the hospital discharges or all 
these kind of things which means it limits the pharmacist working 
within their full potential I think and expertise.  In terms of the 
solution to that I think preregistration pharmacists are certainly  a 
solution because it’s helped here where I will delegate a lot of the…a 
lot of work to pre-registration pharmacists.     
00:23:41 S1 What are your thoughts about advanced practice pharmacist? 
00:23:46 S2 So yeah, advanced practice pharmacist I think definitely is a…it’s 
allowing us to do a lot more, but then I think there’s other things like, 
you know, you’ve got physicians associates who are a lot cheaper for 
general GP’s then…then pharmacists to employ who can also do 
acute clinic and things like that and [inaudible 00:24:08].   
00:24:10 S1 That’s fine and has GP pharmacists’ role changed your overall 
perception about pharmacists? 
00:24:15 S2 Yeah. 
00:24:17 S1 The role when you doing a community pharmacist, your career 
development? 
00:24:23 S2 Yeah, definitely yeah, I think career development is…because I start 
to get bored within community so definitely from a career 




00:24:33 S1 Yeah, yeah, yeah.  Okay.  Just last few questions, any further research 
or work you want or thing that should be done on GP pharmacist at 
policy level? 
00:24:44 S2 I think yeah, research on the impact made… 
00:24:46 S1 Yeah. 
00:24:50 S2 Yeah, hard factual evidence on the impact that’s been made by 
pharmacists because I think that will allow more documentation.  
00:24:56 S1 To document how the things are working. 
00:24:58 S2 Yeah. 
00:24:58 S1 That’s fine.  All right.  Just last one.  Do you have any other 
comments to add to this topic?  Anything on your experience, 
anything, anything you want to add? 
00:25:07 S2 No, nothing else.  
00:25:07 S1 Thanks Zeeshan, that fills up our full section.  So basically this is 
about…it’s about a 20, 25-minute interview.  It will be transcribed.  If 
you want to add anything else apart from this, you can always 
contact me and I look into it.  So thanks for your time.   




(End of Audio) 
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00:00:01 S1 Hi, my name is Noshad Akhtar.  I’m doing a Masters’ research thesis 
program based on the GP pharmacist role in England and Australia.  
And today in the seminar, guys, I’m doing an interview with an 
organisational lead of Coatato in Manchester area.  I’m doing an 
interview with Ms. Naomi Miller.  I have given her the forms based 
on…for this year.  There is an interview guide based on which I will 
do the interview and I will carry on based on that interview guide.  
So, I will just quickly introduce.  It’s Ms. Naomi Miller, and an MP in 
our government organisational lead in Coatato.   Hi Naomi. 
00:00:45 S2 Hi. 
00:00:45 S1 Hi.  Can you just quickly introduce yourself?   
00:00:48 S2 Yes.  So, I’m Naomi Miller.  I’m an advanced nurse practitioner and a 
clinical lead for GTD Healthcare.  
00:00:56 S1 All right.  Naomi, you have got the…the interview that I have given 
you for the interview? 
00:01:02 S2 Yeah. 
00:01:02 S1 Yeah, yeah.  And you are not arguing with the consent to carry on 
with this interview? 
00:01:05 S2 Yeah. 
00:01:06 S1 Yeah, that’s fine.  Thank you.  So, Naomi, basically this study is based 
on the perception and expectation of key stakeholders that have 
been Australia for the GP pharmacist role.  And I want your variable 
views on the…on this perspective.  I have divided the interview in 
four basic teams, perception and challenges, working collaboration, 
pharmaceutical setting, and future of the GP pharmacist role.  So, we 
will start with the first section, which is perception and challenges.  
So…I mean, you have got the experience of working in the general 




you feel there are any gaps present in the general practice 
framework? 
00:01:48 S2 So, there’s gaps with GP’s, so GP’s are no longer coming into the 
profession.  So, we’re having to fill that with wards disciplinary team.  
I think there’s probably gaps with training.  So how we get members 
of the multi-disciplinary team trained to take on…some are 
previously…roles previously done by GP’s.   
00:02:12 S1 All right.  That’s fine.  That’s good.  And admin…you have mentioned 
about the GP board, was in a bit…in a manner that there is not many 
GP’s coming into it.  So…I mean, how do you feel the indication of GP 
pharmacist role to fill the present gaps?  How do you see the GP 
pharmacist role in this…in this perspective? 
00:02:33 S2 Yeah.  So initially, I think that I thought the pharmacist would come 
into the practice to do more of the medicines management audit 
type work.  But actually, having experience, now pharmacists are 
coming into general practice.  It’s sort of we’re realising that actually 
they are best placed because they’re used to primary care to also 
take on some clinical skills.  Take consultations because it works 
really well in conjunction to their…sort of the multiple medications 
that patients are on or tend to come with…when they come for those 
presentations.   
00:03:11 S1 That’s fine.  Because it has been a few years since the GP pharmacist 
role has started in current scheme, from your time do you feel at an 
organisational level was there any mismatch in the professional 
expectations in the standard when you took on this role? 
00:03:28 S2 Yeah.  So, I think they were used as sort of a bit of a lower level at 
work forms.  Whereas actually what we’re realising now is that 
they…they have all of those skills that actually probably placed it at 
more of an advanced level.   
00:03:42 S1 All right.  All right.  And was there any initial reservations when you 
took on the pharmacist and entered the organisational loop? 
00:03:51 S2 Yes.  So, I think initially…’cause I…’cause it was awhile ago now, I 
think I’m…I’m probably a little bit biased in the fact that I know it 
works.  So initially, yeah, there probably was reservations and, yeah, 
whether that role would be needed.  But now we know that it…it is.   




00:04:13 S2 So, I’d always see a GC pharmacist initially.  So, we…they were sent 
with a specific agenda.  Sometimes I think that’s…some we felt were 
drug company driven. 
00:04:25 S1 Okay. 
00:04:26 S2 Which was a little bit of a reservation in the beginning.  Or the 
patients weren’t gonna be treated with an…with an individual type of 
approach.  It was gonna be a…everybody’s going to stop this 
medication and it’s gonna be cheaper to put them on that 
medication.  It was almost…felt like it was a little bit money driven by 
the CCG’s.   
00:04:45 S1 And how well do you believe the pharmacist was professionally 
prepaid to take on this role?  Training-wise or knowledge-wise?  
What…they had the etiquette training with them when they took on 
this role?  
00:04:58 S2 So, I think pharmacists actually took this on really well.  So, do you 
mean did they the training? 
00:05:04 S1 I meant when did you let them in the start?  Did you feel that they 
were ready to take on this role? 
00:05:10 S2 No, I think that they probably could’ve had some more training prior 
to now. 
00:05:16 S1 That’s fine.  Yeah.  That’s…that’s the general training coming.   
00:05:18 S2 Yeah. 
00:05:18 S1 Yeah, yeah.  Okay.  And then on the organisational level, what…what 
the initial operation or challenges or hurdles you feel whilst working 
at the GP pharmacist, considering expectations and reservations you 
had?   
00:05:31 S2 Yeah.  So…so I think initially it was to do with lots of different people 
doing lots of different sections of work.  Maybe a bit I’ve perceived a 
little bit more complicated.  Patient expectations, I think, is probably 
one that we probably didn’t do very well in the beginning.  Maybe 
still not doing very well.  I don’t know whether patients understand 
who they’re seeing.  Space.  Space is always a problem.  We’ve got 
lots of…so four or five people do one job of a GP. 
00:06:05 S1 Yeah, yeah. 




00:06:10 S1 Cost factor? 
00:06:12 S2 So, cost.  So, cost effectiveness.  I think pharmacists are very cost 
effective.  Yeah.  So obviously it’s cheaper than a GP.  It’s probably 
very similar to an advanced nurse. 
00:06:26 S1 But was the cost…because in the buyers scheme there was a sheer 
burden being done by imagists.  And some of them has to come from 
the organisation.   
00:06:35 S2 Yeah. 
00:06:36 S1 So how…how it was taken from organisation.  Did the leader share 
their burden?  Was there some reservation to share their burden? 
00:06:42 S2 So, I think us as an organisation, there’s wasn’t. 
00:06:45 S1 There wasn’t. 
00:06:46 S2 Yeah, ‘cause I think we saw it as a cost-effective way as opposed to 
not. 
00:06:51 S1 That was brilliant.  Yeah.  What support was given on an 
organisational to the GP pharmacist to overcome these challenges 
and hurdles?  Was there any specific training available at this time? 
00:07:05 S2 So, no, this is alone on the job type of things.  So, I don’t think that 
anything that small…probably most organisations do really badly.  So, 
we’ve got all these different skill mixes.  And actually, I’m from a 
specific skill mix.  So hopefully I’ll have a preconceived idea of what 
other people do.  And so, think as we’ve used them that’s where 
I…our training has become more appropriate.  Yeah. 
00:07:31 S1 That’s fine.  Okay.  I think you have gone to the next answer, that…or 
did you become a scope of practice?  And…but…but just stretching 
the medical legal issues, did you remember any…any medical legal 
issue raised by any GP or nurse or anyone, where a GP pharmacist 
has crossed the boundary where you feel from clinical perspectives? 
00:07:54 S2 So, I suppose it’s the prescribing.  Plus, we’ve discussed sometimes 
as a…a difficulty in understanding the scope of practice of a 
pharmacist compared to a…a…’cause we’re all customers not 
medical prescribers.  So, I suppose it’s just…yeah, maybe just that.  
Yeah.  And then I suppose when they’re moving into clinical skills, 
have they got the relevant qualifications to back up that…you know, 




00:08:23 S1 Yeah, yeah, that’s fine.  Okay.  And on an organisational level as a 
lead, when you are including or when you’re making the multi-
disciplinary team, what should be the key performance indicator you 
believed in a GP pharmacist’s role?  So, any specific pharmacist 
indicators?  Do you think so? 
00:08:42 S2 Don’t know.  So, I suppose the indicators are a bit difficult to 
measure one…because a lot of it is about patient satisfaction, about 
whether the…the right skill mix has been used for the right 
consultation.   
00:08:55 S1 Like reviewing something like how much time is being spent for the 
GP’s or something like… 
00:09:02 S2 Yeah.  Medicine management.  Yeah, we could do that.  Or, you 
know, cost-effective nurse of…of drug regimes, that sort of thing, 
could be measured.   
00:09:09 S1 Yeah, yeah, that’s fine.  All right.  Naomi, that was…thank you.  We 
are moving to the next section.  Just looking at collaboration.  Yeah, 
it’s a bit…because it has been a game…I’m seeing, based on the 
experience of past three-four years, the policy team has been 
running as well.  So how your present working relationship with GP 
pharmacist, whether they’re members of your organisation, and has 
it changed since beginning? 
00:09:35 S2 So, yes.  So, my experience is that GP’s welcome pharmacists 
because the medicines management asset of being a GP is the bit 
that GP’s don’t want to do. 
00:09:49 S1 All right. 
00:09:49 S2 Or that’s the bit that they feel less confident to do.  So, I think that it 
was probably was welcomed.  Now, I think it’s changed because 
pharmacists are taking on other roles other than pharmacy roles.  So, 
yeah, much broader range of…of skills that they’ve got.   
00:10:07 S1 And did you feel that that working collaboration, working 
relationship, especially with the GP’s…and you said, it has improved 
since the beginning.  [Inaudible 00:10:15] coming in. 
00:10:16 S2 Yeah, ‘cause I think that…it’s probably changed because they’re more 
employed within the practice as opposed to somebody coming in 
from the CCG.  It’s just a…a person that comes in.  They’re…they’re 




00:10:28 S1 Part of the team.  Yeah, yeah.  That makes a big difference definitely.  
Yeah, yeah.  All right.  Just the next question relates to your 
profession of it as well.  So how your different shape practice 
pharmacist role be the practice nurse it is confused to be overlapping 
with each other? 
00:10:44 S2 Yeah.  So, I think we’re still working on that.  Yeah.  So…so there is an 
overlap. 
00:10:50 S1 Yeah, yeah. 
00:10:50 S2 And I think that the roles of nurses are also changing and the roles of 
pharmacists are changing.  And I think eventually they probably all 
going to be very similar. 
00:11:01 S1 Yeah, all right. 
00:11:01 S2 Yeah. 
00:11:02 S1 Yeah, yeah, yeah.  But at the moment, there is a different feeling.  A 
feeling with the… 
00:11:09 S2 Yeah.  There probably is a little bit.  I don’t know whether that’s 
because people protective as opposed trying to see that, actually, 
some people are better at doing one thing than another.  ‘Cause 
we’ve all got different skills and preferences.   
00:11:25 S1 Yeah.  It’s more like the person on the other end, how they are taking 
this slowly, especially the feedback from patients or other stuff.  
Yeah, yeah.  That’s fine.  And how is it you find GP pharmacists to 
approach and communicate? 
00:11:40 S2 Yeah.  Well, I always find them…really, it’s yeah. 
00:11:42 S1 Yeah, yeah, yeah.  That’s good. 
00:11:44 S2 Yeah. 
00:01:45 S1 Okay.  Any specific factors that come in?  You mind that they can 
infuse their working collaboration?   
00:11:51 S2 So, yeah, definitely being part of the practice team.  It’s probably 
really, really important that we do some training that involves some 
mentorship with the actual GP’s nurses that they’re working with 
helps.  So rather than just introducing a member, like a pharmacist, 
into a team as a pharmacist, I think it needs to be a proper induction 
so that they work with all the different members of the team.  And 




00:12:23 S1 I think you help them with the…the next steps as well, so, yeah, we’ll 
skip this question.  All right, let’s move to pharmacist skill set now.  
Okay.  How do you evaluate competency of pharmacists in patient-
facing role?  Like running cleanings, medication reviews, or home 
visits? 
00:12:40 S2 So, I suppose we evaluate competency by their qualifications.  So, 
mentorship.  Maybe some shadowing.   
00:12:49 S1 Okay. 
00:12:50 S2 And then obviously by consultation audit. 
00:12:53 S1 Okay, okay.  And you feel they…the present role or what they are 
coming after three-four years with the training availability, showing 
good competency to do these skills (overlapping conversation)? 
00:13:02 S2 Yeah. 
00:13:03 S1 Yeah, yeah.  That was brilliant.  And what are your thoughts 
prescribing role of pharmacists?  Any reservation you have about 
working with any of these? 
00:13:12 S2 No.  They do much better than us.  It’s… 
00:13:15 S1 Okay. 
00:13:16 S2 ‘Cause they got no…’cause they got Pharmalogical background.  
Naturally, they…the actual…the prescribing, the medication.  They 
understand the medication better.  Whereas nurses work off 
protocols more with prescribing.  They’re…they’re not prescribing 
‘cause they that medication will work better.  They’re prescribing 
because the guideline tells them to prescribe it.  So definitely 
prescribing sits well with a pharmacist. 
00:13:45 S1 That’s fine.  Any specific protocol used?  Things should be set up for 
the prescribing roll at the organisation level?  Any specific protocols?  
Anything?  Check and balance type of things? 
00:13:55 S2 Lots about that.  No, I don’t know that.  Can’t answer that one, sorry. 
00:14:01 S1 All right, that’s fine.  And what about the medicine?  I think you have 
given the answer to that now.  They had medicine management? 





00:14:15 S1 Again,  how your [inaudible 00:14:19] perferoms is what links it to 
the pharmacy, hospital, or any other health organisation, like CCG? 
00:14:22 S2 Yeah.  So…so they can obviously help with minor illnesses, being able 
to direct patients to the pharmacy.  ‘Cause obviously, we can…they 
can see it…pharmacists can see it from the other side as well.  Sort of 
costs for CCG’s and knowing what alternatives there are.  But, yeah, 
definitely the role of encouraging patients to use pharmacists more is 
easier when you understand…when you’ve worked with a 
pharmacist.   
00:14:50 S1 That’s fine.  All right.  That’s fine.  All right.  I think you have 
answered this one, but just to remember.  What are your thoughts 
on comparing the in-house practice pharmacy directly like ECG with 
one employed directly like health organisation like CCG?   
00:15:05 S2 Okay.  So, at…yeah, completely different. 
00:15:07 S1 They’re really different.  Yeah, yeah, yeah.  It’s much better to have 
the emails.   
00:15:10 S2 Yeah. 
00:15:11 S1 That’s fine. Brilliant.  All right, future GP pharmacists.  This is the last 
section, so…yeah.  And so what future do you see for GP 
pharmacists’ role in the future general practice framework?  Any 
specific activities they should be more at patient level? 
00:15:24 S2 Yes.  So, I see the role of a GP pharmacist to at the same, similar level 
as a [inaudible 00:15:31] practitioner.  So that they’re doing patient-
facing roles as well as medicine management roles.   
00:15:38 S1 Hm-hm, that’s fine.  Okay.  How are your [inaudible 00:15:45] GP 
pharmacist role?  Do you think a woman will contribute in this role?  
Have you seen 5-10 years? 
00:15:50 S2 So recently there’s been a good response, hasn’t there, from the 
NHS.  That they provided…I don’t know what they call them, where 
the pharmacists come out at pre-reg level and work within the GP 
practices and the pharmacists. 
00:16:04 S1 Okay. 
00:16:05 S2 So that’s been a new move.  I don’t know if that…I think that’s been a 
new move.  So, I think that…moving forward I think the NHS is 




00:16:15 S1 Potential.  The NHS is in the plans for the next… 
00:16:17 S2 Yeah. 
00:16:18 S1 Yeah, that’s fine.  And how do you think about the patient peak and 
perceptions?  Have you ever come across any…any patient… 
00:16:27 S2 Yeah, so I don’t think patients really care who they see.  I think that 
they just care that they…that they feel like they’ve got their 
expectations met.  So, I don’t know that describing somebody in one 
role and then another role really matters to the patients. 
00:16:46 S1 As long as they are getting the… 
00:16:47 S2 Yeah.   
00:16:48 S1 …care.  Yeah, yeah, yeah, all right.  That’s fine.  How will you 
comment on success and failure of the rule by letting impossible 
barriers and facilitators and the success of the GP ballot scheme… 
00:17:03 S2 Yeah.  So, I think that the barriers are cost ‘cause of training.  So, if 
there was some scheme where actually employers could get free 
access to training and some back film to provide that, then that 
would help.  Obviously, a success.  Failure, I suppose, is time.  So 
obviously the GP’s, I think they want pharmacists within their 
practices.  But actually, having the time to mentor and shadow them 
and provide them with the training is the most difficult bit. 
00:17:35 S1 Yeah, yeah, yeah.  That’s fine.  We’re going to go over the next 
question.  We’re gonna skip that one, yeah?  So, will you recommend 
the GP pharmacists when the GP pharmacists scheme funding is 
finished?   
00:17:45 S2 Yeah, right.  I’m sold.  I’m a GP pharmacist.   
00:17:49 S1 That’s fine. 
00:17:50 S2 Yeah.   
00:17:50 S1 Okay.  How do you feel GP pharmacists has evolved impacting on 
overall healthcare provisions?  You see that they have [inaudible 
00:18:00] much better since the beginning? 
00:18:03 S2 Yeah.  So, I think maybe in the two or three years there’s definitely 
been a change in how they avenue pap.  But that’s mainly because 
they’ve stopped coming out of that CCG role or coming out of 




00:18:18 S1 Very clear.  Yeah, yeah, that’s fine.  All right.  And what about 
departing a full-time role.  How see it about the surgeries. 
00:18:28 S2 So that will depend on the size of the practices, I suppose, yeah. 
00:18:33 S1 That’s fine.  Okay.  Based on your whole…whole experience, what 
training would you like to see for the pharmaceutical competency as 
GP for any specific expectative training you do? 
00:18:44 S2 Yeah.  It’s more the face-to-face training.  So, it’s some 
communication consultation skills, clinical skills.  Yeah, it’s mainly I 
think that…and actually advanced practice where they become 
more…do some leadership management.  You know, change…some 
change based on, you know, maybe some protocols and all sorts of 
things.  Yeah. 
00:19:12 S1 All right.  Has GP pharmacist role changed your overall perception 
about pharmacists? 
00:19:16 S2 Yes. 
00:19:17 S1 Yeah, yeah, yeah.  That’s good.  All right.  Any further research you 
want to be done on this…on this area for the GP pharmacists? 
00:19:27 S2 I don’t know.  Can say… 
00:19:32 S1 No, that’s fine.  Any other comments you want to add? 
00:19:36 S2 No.  Just that. 
00:19:37 S1 Just that? 
00:19:37 S2 Yeah.  All my experience has been positive with the pharmacists. 
00:19:43 S1 All right, thanks Naomi.  It was really nice speaking to you and 
hopefully it will be really…a regular addition to the…to my study. 




(End of Audio) 














S1 Speaker One 




Timecode Speaker Transcript 
00:00:02 S1 Hi, my name is Noshad Akhtar.  I am a GP pharmacist and at the 
moment, I am working on a research project.  The topic of the study 
is about the evaluation of expectation and perceptions about GP 
pharmacist role in England and Australia by key stakeholders.  Today, 
I am doing a qualitative interview with Dr Abdul Hadi.  Dr Abdul Hadi 
is a senior lecturer in pharmacy practise and policy in University of 
Birmingham, and he will share his views about the topic in a 
qualitative interview.  Hi, Dr Hadi.  
00:00:47 S2 Hi.  
00:00:49 S1 Hi.  Doctor, can you just briefly introduce yourself please? 
00:00:54 S2 Thank you very much, Noshad, for inviting me to your research 
study.  I’m Muhammad Abdul Hadi.  I’m a senior lecturer, currently 
working as senior lecturer in pharmacy practise and policy at 
University of Birmingham.  Previously, I’ve held academic positions in 
previous universities including an Australian university and Saudi 
university and a couple of other UK universities before joining 
University of Birmingham.  
00:01:28 S1 Thanks, Dr Hadi, for giving your time and definitely your views will be 
really valuable for my study.  So now, Dr Hadi, you have got—I have 
sent you an email with the semi-structure interview guide about the 




00:01:48 S2 Yes, I've received the participant information and the like. 
00:01:52 S1 And you're giving me the consent to do this interview? 
00:01:57 S2 Yes.  Yeah, I'm happy for you to do this interview and I'm happy for 
you to record this interview as well. 
00:02:03 S1 Thanks, Dr Hadi.  So basically, according to the semi-structure 
interview guide, it has been divided in two sections.  The first section 
is perception and challenges about this role and the second will be 
about the future of the GP pharmacists.  So I'm going to start with 
the first section and you can share your views based on whichever 
questions are there and whichever views you want to share based on 
your experience, and we’ll just add them as a part of my study.  So 
starting with the first question, Dr Hadi, what are your views about 
general practise framework and do you believe there are any gaps 
present in it? 
00:02:49 S2 Yes, I think it is some sort of a universal truth that GP workforce is 
under a lot of pressure and there is significant gaps in terms of 
human workforce not only for your GPs but nurses, physiotherapists 
and pharmacists working within GP practises.  With Brexit coming as 
well, I think this is going to seriously affect the number of nurses 
working within the NHS which will indirectly is going to affect the 
number of nurses available to work within GP practises which will 
additionally put burden on workload of GPs.  And we know from 
research that the more work pressure GPs will have, the quality of 
care will reduce and this may significantly impact the patient 
outcomes evident in primary care. 
00:03:56 S1 Right, yeah.  Definitely, yes, I mean there has been a pressure on the 
GPs from the workload and with the Brexit coming up, it can have 
also an additional impact on the general practise framework.  So just 
looking at the present scenario, where do you see the GP pharmacist 
or the pharmacist working as a general practise pharmacist in this 
scenario, and what are your perceptions about GP pharmacist role?  
00:04:34 S2 Being an academic, I think there is a strong potential that 
pharmacists can take up a lot of work that GPs do and potentially 
reduce GP workload.  For example, simple disease.  For example, 
with like gout, which only needs medicines optimisation and the 
patient outcome improve dramatically by simply titrating the dose of 
the medicines so with pharmacist being drugs experts, they should 
be able to do it easily.  And it is just one of many example, other 




shown that pharmacist in like heart failure clinics, anticoagulation 
clinics, diabetic clinics, have had a positive impact on patient 
outcomes.  And if they did like hypertension, diabetes and all the 
similar long-term conditions, that if pharmacists are able to support 
GPs in those condition ns it will dramatically reduce workload on GPs 
and they will be able to focus on more complex cases which require a 
specialists opinion.  So this is how this can happen and I can 
potentially see that pharmacist can play a very important role in not 
only reducing the GP workload but also improving patient outcomes. 
00:06:18 S1 Patient outcomes, yeah.  Yeah definitely, that’s basically the theme 
coming up that GP pharmacist has major role in the future and shape 
your views as well.  So just getting on, based on the same 
perceptions coming up, what barriers of the facilitators and 
opportunities do you see in the pharmacists adopting this role?  
From the pharmacist perspective, I mean, what can be the barriers of 
facilitators present in the general practise? 
00:06:51 S2 Again, being an academic, a lot of pharmacists who are working—
and I am the programme director for independent prescribing as well 
and I see where the pharmacist will come—20 pharmacist who want 
to do independent prescribing programme because they want to 
take up potential roles within the GP practises thinking that there is 
more—the roles are more clinical, the roles are highly paid, but they 
are reluctant as well on the same side as well to take up such 
positions, because they don't feel comfortable and especially with 
diagnosis of patients, so I think this is the most significant barrier is 
about their confidence and appropriately treat/diagnosing the 
patient and subsequently recommending appropriate medicines for 
a particular diagnosis. 
00:07:48 S1 Yeah, yeah.  So basically, you think that it’s the clinical knowledge, 
it’s the expertise in the clinical knowledge that sets (overlapping 
conversation)? 
00:07:57 S2 Yes.  I think that they will need some up-skilling there as well.  I think 
six months independent prescribing programme is not sufficient to 
prepare them to take up some role.  But I think what happens is, I 
think there should be an expectation management as well that 
pharmacists need to be aware that no one year or six months 
programme will prepare them for taking up on such a big position 
within the GP practises.  They have to adapt throughout their career 
and learn by their experience.  I think which pharmacists often find 




GP that they would expect the same quality of confidence and care 
from pharmacists as well, and then there's this lack of confidence 
which is again due to perhaps I attribute it to lack of clinical 
knowledge, their diagnosing skill is potentially impacting their 
confidence, which will ultimately affect the quality of care that they 
provide with the patients. 
00:09:15 S1 All right, yeah.  And what do you think about facilitators?  These are 
more like a barrier signs, so what do you think about the facilitators 
about this role? 
00:09:25 S2 I think because there's a lot of funding available from the NHS which 
is encouraging pharmacists, plus there is a significantly growing 
amount of research being done looking at the roles of pharmacists 
within the GP practises, I think that there are some positive news 
coming from there which is encouraging pharmacist to take up some 
role in GP practises.  And especially, there's the financial aspect to it 
as well.  Pharmacist think GP practises will pay—working in GP 
practise will be more rewarding but (overlapping background noise) 
they found it’s not.  Yeah, so I think that is one of the (overlapping 
conversation), yeah. 
00:10:09 S1 Yeah, that's fine.  That’s fine.  That’s good.  And, you know, this role 
has been—or this study has been done—or different designs have 
been implemented in different countries, UK has got might be the 
one of the biggest funding about the GP pharmacist role in NHS but 
in other countries, there are some other ways of implementing or 
integrating the pharmacist in there.  And based on your own 
research or experience, I mean, do you find or do you have any idea 
or knowledge about the GP pharmacist role in other countries?  And, 
I mean, based on that knowledge or your research or your 
experience, do you find any difference on how the role has been 
implemented in England and with the other countries like Australia 
or New Zealand or Canada or States? 
00:11:09 S2 I've not personally done any research… (audio drops) 
00:11:25 S1 Hello? 
00:11:27 S2 …because it’s partly it can be (audio breaks). 
00:11:32 S1 Sorry, Dr Hadi, I think the line did break through so if you can just 
start the answer for this question again? 
00:11:42 S2 Yes, okay.  I’ll start again, okay.  I've not personally done any 




I've read around the topic so I can share my views based on my 
reading. 
00:11:57 S1 Yeah, yeah, yeah. 
00:11:59 S2 Okay.  I think you are right, the amount of funding that's available 
right now for GP pharmacists is a lot.  No other country has invested 
so much in GP pharmacists.  There are good things and there are bad 
things associated with it.  I think having a pilot programme then 
doing evaluation of the pilot programme and then running it 
nationally would have made more sense, but because of the 
workforce pressure is so much on the NHS that they did a very small 
pilot there, I think they did some small evaluation in the UK as well 
which showed some positives.  There was some positive things that’s 
already been done I think.  Then there were some new medicine 
service.  So there've been some services that have been evaluated 
which were run by the pharmacist which gave some positive 
outcome, which encouraged the NHS to involve them more within 
the primary care.  There have been other instances as well with this 
where pharmacists have shown to improve patient outcomes.  And 
that is another factor, I think, which encourage the NHS to give 
pharmacist some additional role within the primary.  But we don't 
know yet because the pilot that they’ve done in England was very 
small and, again, depends on how well do you up-skill them and how 
confident the pharmacists are in taking up those roles and how well 
they're remunerated against those services that they provide within 
the primary care.  I think theses all factors are key and will play 
important role in future in ensuring that the patient get the best 
care, the best possible care. 
00:14:10 S1 Yeah.  So yeah, as you say, it might be not the early days but still in 
the evaluation stage and with the time, yeah, it will get a bit more 
clear idea how the things are working, so.  And when they will be at 
the stage where we can compare it with other countries, but yeah it 
might be something for the future where it can set an example for 
the other countries as well.  That’s what I have got a bit of 
impression coming up.  So, that’s fine.  Do you want to add anything 
to it or should I move to the next question?  
00:14:45 S2 Yes, please.  Move on, please. 
00:14:47 S1 All right.  Yeah, so just getting on from the same thread, why you 
believe research in this area is important?  I think it might be linking 




modulator, why you think we need to do more research and what 
aspects of more research should be done in this role? 
00:15:14 S2 I think there's no major evaluation that’s been done yet on looking at 
the roles of pharmacists within the GP practises.  I think what they 
can do is to develop subset of services and evaluate those subset of 
services using both qualitative and quantitative matters.  I think 
qualitative research is important, but what's more important is to 
have a research that shows an impact on patient outcomes.  For 
example, it can be very small research looking at number of GP visits, 
if there’s been a reduction in that, for example, medication 
adherence, hospital admissions – for elderly it can be risk of falls – 
reduction in all the pharmacy.  So these are small things that can be 
looked at.  But national evaluation is very important and will be very 
important in the long-term as well.  Because without having a 
national—because, you know, if a pharmacist is very competent, he's 
devoted, he’s dedicated, working very well in one GP practise and 
you evaluate that only that GP practise, that will never tell you the 
full picture of pharmacist working in different GP practises.  So it can 
vary; the service, the quality of service, the nature of service may 
vary depending on the competency and the confidence of the 
pharmacists.  So that is why a careful selection of pharmacists should 
be made and a comprehensive evaluation should be done before 
more money is thrown into the service. 
00:17:12 S1 I see.  Yeah, that’s fine.  Thank you, Dr Hadi.  We’ve completed the 
first section.  If you just stay online, I will be back in two minutes, just 
to get another paper and then we will start the next section.  Is it 
okay? 
00:17:23 S2 Okay.  Yeah, that’s fine.  
00:17:24 S1 Thanks.  Thanks, Doctor.  (Pause)  All right.  Dr Hadi, thank you.  
Thanks for the wait. 
00:19:41 S2 Yeah. 
00:19:43 S1 So we will move to the next section then about the future of the GP 
pharmacist role.  And I think most of the views you will already have 
given in your previous section but it will be just might be a bit more 
elaboration or explanation from the previous views in the future 
guidelines.  So starting with it, so what future do you see for the GP 
pharmacist role in general practise framework? 
00:20:12 S2 Certainly, there is a future.  The grand model of care or the model of 




community pharmacists as well, if they can integrate with the local 
GP practise and community pharmacist can deliver the same services 
as well, then the GP practises may not need to hire a lot of 
pharmacists.  So it will vary that how prepared the GP pharmacists 
are, how well they do in this year, in the next year, what are the 
results of the comprehensive national evaluation, how much 
money’s been thrown into it, and how GP see pharmacist coming as 
a partners within the GP practises and how do patients feel about 
having seen a pharmacist instead of a GP.  So there is a potential but 
the potential will depend on the work of pharmacist themselves.  So 
pharmacists need to do what they're supposed to do in a manner 
that is appropriate, that is acceptable to both GPs, their bosses, GP 
partners and for the patients. 
00:21:48 S1 Yeah, I understand.  That's more like how the pharmacists can 
present themselves in the future that will make the pathway for 
them in the future guidelines.  Absolutely right, yeah.  So how you 
evaluate NHS response to GP pharmacist role and do you think they 
will continue this role in next 5, 10 years? 
00:22:11 S2 I think given the work pressure on the NHS and within the primary 
care, with our ageing population and the requirement of our 
population, there will be investment in one way or the other.  If they 
can't recruit, the NHS has not be able to recruit the number of GPs, 
the target number of GPs that they wanted to recruit by 2020, so 
there is the potential that more money will come to GP practises to 
recruit pharmacists.  But again, whether they're able to find the right 
pharmacists with the right skill set who are able to deliver the 
patient care and achieve patient outcomes; that may vary.  And 
there is a potential role that the universities should work more 
together with the NHS to develop appropriate training programmes 
for pharmacists.  So they're up-skilled to a level that they can deliver 
better patient care, and pharmacists themselves should be prepared 
to take up those additional roles, develop confidence, build clinical 
skills not only to diagnose and to treat patient but to handle different 
complex patients as well and later on during their career working in a 
GP practise. 
00:23:34 S1 Yeah, absolutely fine.  So, I mean, mostly you have given the answer, 
but if I just want to say specifically or something.  So with the 
patients feedback and perceptions about GP pharmacists, I mean 
from the research you have done or the papers you have read, so 




00:24:02 S2 That's a very good question.  I've not read anything about patients’ 
feedback on GP practises.  But understanding what patients wants, 
what they want is someone who was able to understand their needs 
and develop a plan that fits their needs, not a genetic programme.  I 
think most of the patients do struggle with that and with GPs only 
having 10 minutes for consultation time, may not always be able to 
listen to patient stories and develop a plan with all their needs.  I 
think pharmacist with more consultation time may be able to do 
that, but again it depends how well is their working relationship with 
the patients, how confident are they.  So I think it goes down to the 
clinical skill set of pharmacist and their willingness to do well in their 
jobs is going to determine the patient satisfaction. 
00:25:15 S1 Yeah, yeah.  It's how they present themselves, how they 
communicate themselves with the patient and, yeah, it’s the 
approach, how easy they are to get on with the patients.  All right.  
And I mean, again as I said, you might have or you have mentioned 
this thing before, but if you just want to specify any specific training 
or any specific aspects of the training you think pharmacists should 
take on before or during when they have taken this role on? 
00:25:51 S2 Again, there can't be a single generic training programme that fits 
the needs of all pharmacists.  Pharmacists will be different.  The 
pharmacists working on community are different to the pharmacists 
working in hospital pharmacy.  Pharmacists having 10 years of 
experience are different than pharmacists having 2 years of 
experience.  So I don't think there can be a single training 
programme, but what needs to be done is develop small short 
courses for pharmacists as a build on their career within the GP 
practises so that they can depend and do about all those clinical 
rounds and they can pick and choose the more deals that they want 
to do.  And they should be allowed that flexibility in terms of their 
training.  And again it goes back to the GP practises as well who hire 
them to allow them a good mentor who can train them through for a 
year or a year and a half, so that they are not only competent but 
they're also confident in diagnosing and managing patients.  
00:27:05 S1 Yeah, that's fine.  Yeah, just summarising this now.  So, I mean, do 
you want to have any comments on success and failure of GP 
pharmacist role? 
00:27:19 S2 I would like it to be successful programmes because I'm a pharmacist 
myself and I would like pharmacists to be successful in whatever 




to take up these roles and there is a need for them to take up these 
roles as well.  This is an expectation from their profession to not only 
take up these roles but to deliver these roles to the best of their 
ability and to up-skill themselves that they’re better prepared to 
deliver better patient care as well. 
00:27:58 S1 And if I just—if you want to highlight any specific observations where 
you feel that, yeah, these are the observations in your mind about 
this role, any specific one you want to list on? 
00:28:11 S2 I think I've already said that a number of times now, it’s about their 
ability to diagnose patients I think, (overlapping conversation).  
They’re not being trained in their undergrad and the only training 
they receive is during their IB training.  But that is not very 
comprehensive as well because it's only six months training 
programme.  I  think really they’ll struggle with diagnosis initially but 
if they have a good mentor, they shadow a GP for six months or 
three months or they have a better referral system and they see that 
simple patients first and the complex patients later on in their 
careers, so I think it’s something can be arranged. 
00:28:56 S1 Yeah, that's fine.  And, I mean, has GP pharmacist roles change your 
overall perceptions about the pharmacists? 
00:29:06 S2 I’ve never consulted a pharmacist in a GP practise, so I don't feel 
comfortable making any comment on that. 
00:29:20 S1 That’s fine, no worries.  That’s fine.  We'll move to the next one.  I 
think you have already mentioned in previous section, but again, just 
to highlight any specific research you want to be seen to be done on 
this role? (Pause)  Hello? (Pause) Hello?  I think there's some 
problem with the connection because I can't hear Dr Hadi at the 
moment, so I'm just waiting for him to come back on. (Pause) Hello? 
00:33:12 S2 (Audio breaks).  
00:33:46 S1 Hello?   
00:33:52 S2 Hello? 
00:33:54 S1 Hello? 
00:33:56 S2 (Speaks in Foreign Language). 
00:34:03 S1 All right.  That’s fine.  No worries, Dr Hadi.  I think we’re just left with 




just ask last two questions and then we can just sum it up.  Is it okay?  
(Pause) Hello? 
00:34:27 S2 Yes.  Hello? 
00:34:29 S1 Hiya.  Can you hear me, Dr Hadi? 
00:34:34 S2 Hello? 
00:34:35 S1 Hi.  Can you hear me, Dr Hadi?  
00:34:39 S2 Oh yes, I can hear you.  I can hear you. 
00:34:41 S1 Yeah, I think you had a call in between so that’s why I think it was… 
00:34:44 S2 Yes, yeah, yeah, yeah. 
00:34:47 S1 That’s fine.  We’re still carrying on with the same call, yeah?  And I 
think we are just left with a couple of questions, so are you okay to 
carry on now? 
00:34:54 S2 Yes, I am. 
00:34:56 S1 Yeah?  So I think where we left was about your—you were 
mentioning the research that you think should be done about the GP 
pharmacist role.  So yeah, if you just want to complete your views, 
then we’ll be able to sum it up. 
00:35:15 S2 Okay.  As I mentioned earlier, in terms of research, national 
evaluation is very important.  I think the outcome or the results of 
the national evaluation will determine the future of GP pharmacists.  
If the evaluation is positive…  Because there's clearly a need.  There 
is a need.  The government has—they has not been able to recruit 
the GPs, what they should have done, there is an acute shortage of 
GPs and with growing population, there is a tremendous demands of 
primary health services.  So there is a need.  Whether pharmacists 
can fulfil the need or not, that's the question that needs to be 
answered.  And that's why I believe that the national evaluation will 
be critical, will be very, very, very critical in determining the future of 
GP pharmacist workforce. 
00:36:13 S1 Right, that’s fine.  Brilliant.  I think that we have covered all the 
section, but just I mean if you—do you want to add any other 
comments to this interview or any other aspects you want to 
mention if I have missed anything or any additional views, anything 
you want to add up? 




00:36:31 S1 Right, right.  Yeah, yeah.  That’s fine.  Dr Hadi, your views really have 
been helpful.  So thanks, Dr Hadi, for sharing your views and giving 
me your time.  Hopefully, we’ll…  I mean, this interview will be 
transcribed and so hopefully, we'll share the results with you.  And if 
ever you want to add any comments, yeah, just feel free to… 
00:37:00 S2 Okay. 
00:37:01 S1 Yeah?  Thanks, Dr Hadi. 
00:37:02 S2 Thank you very much and best of luck with your study.  Thank you. 
00:37:05 S1 Thank you, Dr Hadi.  
00:37:06 S2 Thank you.  Cheers. 
00:37:07 S1 Bye. 




[End of Audio] 
























































Interview with Nurse1/England 
S1 Interviewer - Noshad Akhtar 
S2 Respondent - Mary Mosteen 
 
 
Timecode Speaker Transcript 
00:00:00 S1 Hi.  My name is Noshad Akhtar and I'm the clinical pharmacist 
working in [inaudible 00:00:05] in Manchester.  I am doing the 
interview with Ms.  Mary Mosteen, a practitioner in one of the 
practices in Manchester.  So this is a part of my study which is about 
the evaluation of expectations and perception of key stakeholders of 
OTP pharmacist role.  Welcome, Mary.  And Mary you know about 
the bit of introduction about the study? 
00:00:37 S2 Yes, yes. 
00:00:39 S1 You've given me the consent to do this interview. 
00:00:40 S2 Yes. 
00:00:42 S1 Thanks, Mary.  So let's start then.  Basically the interview is guided is 
divided in four sections.  So, we will start with the first section that's 
called perception and challenges.  So Mary, just…I mean based on 
your experience in general practice working, what are your thoughts 
about the general practice framework at the moment and do you 
believe there is a [inaudible 00:01:07] in the present framework with 
reference of the workforce working for the general practice? 
00:01:16 S2 Yes.  There's clearly gaps because there's not enough…there's not 
enough departments for patients' needs.  The need always 
outweigh…the demand outweighs what could be given with regards 
to patients wanting to see generally doctors, and obviously that's 
being diversified now with recent kind of assistant advancements in 
practitioner and obviously paramedics are now starting to be 
involved in general practice also which is helping with particularly 
with the visits of acute patients.  And we've got like a cell pharmacist, 
we've also got a trust pharmacist.  So, we got two different 




definitely gaps but how that's gonna be filled I don't know about.  If I 
knew that, I'd be quite rich. 
00:02:13 S1 You have mentioned the right gaps.  Where do you feel the GP 
pharmacist can fill any part of this gap do you feel they can play any 
role to fill this gap? 
00:02:23 S2 Yes, often patients will come in for medication review and I think 
probably the best person, the best place is gonna be the pharmacist 
because they're always there.  Obviously pharmacists also…I know 
within pharmacists can see people for minor illnesses.  That can be a 
role that can be brought into practice or, you know, sort of, if we've 
got a pharmacist who could do that, and then was a chronic disease 
monitoring I'm sure from a point of view of a lot of that is down to 
the medication and optimising it and whereas the local guidelines 
might want to change things and everything, I'm sure, again the 
pharmacist is gonna run with the people best place to look at that.  
And if they're within the practice, patients that are quite anxious 
when you change the medication and things you got that continuity, 
sort of, advising and support them through it. 
00:03:14 S1 Like a follow-up. 
00:03:15 S2 Yeah, yeah. 
00:03:19 S1 So you have been working in a few years now with the practice firm. 
When it came into the start, when did you know that there's a 
pharmacist coming into the practice, were there any specific 
expectations you had for that role when he started?  Anything in 
your mind? 
00:03:44 S2 I think…I think as always the more people you've got with all the 
different expertise, your expectation is there's somebody else to go 
to with certain queries.  There's another person with a lot more 
knowledge on a particular subject so that's always gonna be a 
benefit.  But to be honest, I wasn't sure that the role was gonna be…I 
think it was more of an evolving role at the time.  So I don't think 
anybody really knew what the role was gonna be.  So I don't think I 
had particular expectations but just the fact that it was because it 
was good in a different discipline. 
00:04:17 S1 Was there any mismatch with what you expected and what you saw 
in the initial stages? 




00:04:29 S1 Any initial resolutions you had from the role? 
00:04:32 S2 No, not at all.  I always think the more people you've got with 
difference of experience, the better. 
00:04:41 S1 And any occupational challenges you face while working with the 
pharmacy in the initial stages?  Like any communication barrier or 
any type of hurdle or anything which you face in the initial phases? 
00:05:01 S2 Not now, I mean no, because we've got the systems on the computer 
to send messages or just face-to-face discussion, yeah. 
00:05:11 S1 That's fine.  And what do you think in your own idea, what should be 
the key performance indicators for the events to check how the 
performance is working in your own.  Because I think for the nurses, 
are there any specific key performance indicators to check on how 
they're performing? 
00:05:32 S2 I suppose with the annual appraisals, we'd look at that.  We'd look at, 
for example, this May taking, there's an audit done to make sure that 
we've not got the…we're not getting inadequate resources, et cetera 
and there's also different training that we need to undertake to 
ensure we're maintaining our skills.  So I think that's where the keys.  
So from the pharmacists, so I think probably from a practice point of 
view, it would be medication reviews up to date, are medications, 
sort of, the prescriptions and everything, are they up to date?  As in 
patients that have not had things for quite some time, is it being 
updated on the system and are patients…patients that come in 
discharged from hospitals or letters from hospitals, is that 
medication being prescribed properly and appropriately I guess. 
00:06:28 S1 Yes.  There's some key performance indicators.  That's fine.  So we 
are covered with the first section, yeah.  All right, the next section an 
important one.  The pharmacist, nurse working collaboration 
because in the initial phases, what I have seen when I have done the 
other interviews, I've been talking with my other colleagues, the 
initial factor was that it might be the overlap or it might be the 
duplication of the role, what nurses are really doing.  So just keeping 
that in mind, there are some questions we will discuss these ones.  
So how do you feel your present working relationship with the 
practice pharmacist? 
00:07:03 S2 Absolutely fine.  There's no issues.  No issues at all. 




00:07:13 S2 I'm not sure.  I don't think I can answer that properly or accurately 
because I was off for quite some time.  Once the pharmacist started 
and then I was off unwell for a number of months and then I've come 
back.  So change, I'm not sure.  I think at first, high potential reviews 
was simple impression reviews and things, that's not happening now.  
I don't think…but I think that that's being undertaken anyway and 
probably the pharmacist's other skills are better used.  So I don't 
think, no. 
00:07:44 S1 But you think that working relationship has improved. 
00:07:47 S2 Yes, absolutely as it does with any…once you get to know people and 
their roles better, yeah. 
00:07:53 S1 That's fine, that's fine.  This is a general question, yeah.  So how do 
you differentiate practice pharmacist's role with your role as a nurse 
practitioner and does it make you confused or do you get an 
impression from any other staff members?  Will they have to direct 
the work whether it is with the nurse or the pharmacist?  Any 
feedback from the practice staff? 
00:08:20 S2 From my own perspective, I don't think that's an issue because I 
think the roles are quite different.  I think at first, some of the admin 
staff were confused as to where to send the letters, some letters 
when they came in from the hospital as to whether we should go 
because it was obviously traditionally the doctor and a lot of them 
now can go through the pharmacist.  And I think maybe that was just 
an initial worry as well with the doctor that sees everything.  But I 
think that's been…it's not something that I'm directly involved in but 
certainly at practice meetings it's not coming up as an issue.  So, no I 
don't… 
00:08:57 S1 So you feel there is clear instructions.  In your own perspective you 
find a clear distinction what the pharmacist is doing and what your 
role as a nurse practitioner. 
00:09:07 S2 Yeah.  
00:09:08 S1 That's fine.  Brilliant.  Any concerns about the medical legal 
implications of the practice pharmacist with the feel that the 
pharmacist might have one or might go beyond the legal expertise. 
00:09:26 S2 I think probably down to each individual practitioner really, isn't it, 
and I think cert… 




00:09:31 S2 In my experience, I've never noticed that.  I've never…there have 
never been any issues raised or there's never been any, even 
suggestion that that's been the case so no, I don't think so at all. 
00:09:44 S1 And you find pharmacists do approach and communicate easily? 
00:09:47 S2 Yeah, very approachable, yeah. 
00:09:49 S1 That's fine.  Brilliant.  Any factors do you believe that be 
implemented to improve the growth and relationship? 
00:09:58 S2 Honestly, no.  I don't think there is because there's two-way 
communication, there is no barriers to that and the pharmacist is 
approachable.  There's messaging systems within…with our practice 
systems.  I don't…to be honest, no, I don't think so. 
00:10:15 S1 Any factors in your own mind that can use this working relationship? 
00:10:21 S2 I think it's okay.  So, I don't think…I think, you know, if I need advice 
or information, it's great to have the pharmacist there available to be 
able to ask face to face and talk through different things so yeah. 
00:10:34 S1 I think you have mentioned you got this conversation but just if you 
want to add something briefly explaining what impact the GP 
pharmacist has made on your scope of practice. 
00:10:46 S2 I say it's just having that extra diversity within the practice team.  I 
think somebody to be able to ask straight away about maybe queries 
on medication and just patients I think get better reviewed from a 
medication point of view. 
00:11:02 S1 To summarise, I mean you can say no to it as well, do you think GP 
pharmacist has made a positive impact on this scope of practice? 
00:11:11 S2 Yes, I would say so.  Definitely yeah. 
00:11:11 S1 All right.  That's all for the second section.  Now moving to the 
technical pharmacists.  Do you know the pharmacist is working as a 
prescriber as well as a patient-facing role and in a patient-facing role 
have some presentation so just facing that with those respectively?  
So how do you hear from them and how it can be from you leaks not 
within the same game as your other places or who is working at the 
moment as in other surgeries based on the people as well as if you 
were rating them.  How do you value potential performances in 
patience-facing roles like learning, cleanings and telephone 




00:11:48 S2 How do I… 
00:11:47 S1 How do you value the competency of pharmacists in patients… 
00:11:51 S2 Competency.  Well, what I see, the patients' feedback or the 
consultations and I just…it's just another face to make sure patients 
are having the right medication, another way for patients to 
understand and therefore increase…improve compliance and the 
consultations are always really quite comprehensive and the 
patients' feedback has been good as well, so yeah. 
00:12:32 S1 What about the prescribing or how would you be prescribing in 
general or how do you think the prescribing role of the pharmacist…. 
00:12:32 S2 The pharmacist. 
00:12:34 S1 Just generally. 
00:12:36 S2 I have not really had any experience with that, I'll be honest with 
you, so I don't know.  I mean, I would guess that if the patient…if 
there's letters are coming in with a descriptions, and then the 
pharmacists is the prescriber then that can improve efficiency.  But 
directly, I couldn't comment, really. 
00:12:54 S1 But do you feel if the pharmacist is playing this role, do you feel that 
it's a positive for the general in the practice? 
00:13:02 S2 Well, definitely, yeah.  If I could guess. 
00:13:05 S1 Any specific protocols you feel that should be set up at the 
organisational level for the prescribing role of the pharmacist, like 
any step wise letter and any protocols? 
00:13:23 S2 Well probably, if it's a non-medical prescribing role, isn't it.  So they 
just follow the guidelines the local guidelines that are set out for 
that.  And obviously, we've got the greater Manchester Medical 
Medicines Management which I think we all follow that that.  So I 
would say that those are the guidelines. 
00:13:41 S1 And what about the other side, like non-patient facing roles like 
medicine management, how do you feel that how competent the 
pharmacists can be or is it about the medicine management part of 
it. 
00:13:53 S2 Well, I think that's probably one of the biggest advantages of the role 
which is this faster medications and that's the area of the 
pharmacist.  So certainly I've noticed in somebody who practices 




medications haven't been used for a while are no longer dispersed it 
will be just requested and things so I think it's far safer.  More I think 
patients' medication is monitored more closely and when patients 
need new medications, if there is unusual, I think that this is far 
better with someone that really knows what he is talking about.   
00:14:32 S1 And you did mention that there are two different sets of 
pharmacists.  One is the in-practice and one is coming from the CCT 
level? 
00:14:39 S2 Yes.   
00:14:41 S1 How do you feel?  You have worked with both you have seen the 
notes there might be different treatment.  So how do you believe the 
difference between the two?  Is it better to have the…not full time, 
but might be someone who is working within the practice or 
someone coming out from the CCT like do you have a specific 
agenda? 
00:14:59 S2 I think it's always going to be better that you've got in-house for 
continuity for both staff and the patient.  But I do think as well that 
the pharmacist in the CCT when they do do it, it's effective. But I 
think if you ask a pharmacist that did both face-to-face medication 
reviews and was the practice pharmacist, I think you're going to work 
better overall.  Because it will be better for all, yeah. 
00:15:28 S1 And do you feel in how you see a pharmacist as a link between the 
practice, community pharmacy and a hospital or different 
organisation?  Do you feel that it can be the means central with a link 
for the different patient release or within three or four different 
organisations? 
00:15:46 S2 Definitely because obviously you've got sometimes issues about 
certain medications being available or not.  There's hospital only 
prescriptions that can get complicated is off for licenses and there's 
so many different uses.  I think having a pharmacist within the 
practice where you can go to and discuss that is really superior. 
00:16:06 S1 We covered the third section and law section and just a few small 
questions here.  It's about the future of keeping pharmacists over the 
line here.  What would the future do you see for the GP pharmacist 
in the future general practice being?  Basically summarizing the 
duties they should be more of the patient level, commission level or 
practice level in what next five-ten years.  How do you feel that they 




00:16:35 S2 I think probably like most roles in a general practices, it's an evolving 
role and everybody is taking on different roles so I think with a 
pharmacist it would be good to see a lot more face-to-face work 
particularly with minor illness like what they would do in the actual 
pharmacy.  So that could be a role that maybe could be evolved 
whether it be maybe a bit of a walk-in scenario or not.  But obviously 
with improved capacity for patients to be seen by a clinician that can 
diagnose and prescribe.  I think that they continue with the 
monitoring of medication and I think it's part of the pharmacy that 
has been an issue for years and years so I mean somebody that is 
specifically look at that is an obvious one, going to save an VNHS 
money, which is always a good thing but also maintain the patient 
safety and compliance hopefully as well. 
00:17:27 S2 That sounds good.  Have you did you…you haven't mention about 
the…we talked about the patient feedback so just generally 
summarize these things how you would view the patient feedback 
have you seen any or come across any patient feedback about the GP 
pharmacist role in the surgery? 
00:17:47 S2 Yes, patients who are filled what pharmacy from or if I spoke to the 
pharmacist, and quite often it will be getting more questions off 
patients are the results of that which is always going to be a good 
thing if they're questioning what they having and everything.  But 
also I think the patients do feel more aware of what they take and 
why are they taking it and yes, it's probably been the odd comment 
of, well I didn't realize that was for that, I'll make sure I take it now, 
that kind of sort of feeling. 
00:18:17 S1 What do you think might be a bit more specific with it yeah what do 
think about the part time or full time role of the GP more about and 
we can just get this it's more about the work load of the GP surgeries 
or let's just get this one out.  
00:18:32 S2 Okay. 
00:18:35 S1 In the training wise --- how you feel what training should the GP 
pharmacist have before they come in this role or during this role, 
while looking at a GP pharmacist? 
00:18:45 S2 Well, I think because obviously the required…I suppose pharmacists 
have been around for…they're everywhere aren’t they?  But I 
suppose probably if there's only going to be one pharmacist 
generally working, so there needs to be you know there needs to 




vast knowledge of chronic diseases and just life management.  So I 
think those are possibly the two things that are going to come up 
most and I think, dependent on the role as it evolves, the training, for 
example if the pharmacist is going to get involved with 
immunizations or flu season, then obviously to ensure that they're up 
to date with immunization and anaphylactic training just like 
anybody who is giving immunizations.  I think it's probably quite 
bespoke once they get into the practice depending on what the role 
the pharmacist wants to have and the practice wants to have.  Once 
that's agreed, then looking at the competencies and training that 
seems to be already had and then looking…making getting the 
training that's needed. 
00:19:47 S1 That's on the more like the medical condition and the long-term 
medical… 
00:19:48 S2 Yeah. 
00:19:57 S1 And how well do you believe the more regular pharmacists have 
evolved as GP pharmacists in affecting the overall healthcare 
provision.  Do you that it has been a positive factor has involved in a 
positive was since the beginning? 
00:20:15 S2 Yeah and I think probably as a running theme for…for us here it's 
broadens the team, it gives us another dimension so we will…just 
somebody to ask about medication, because it is such a vast area and 
it changes you know there's so many changes all the time, so it's 
absolutely a positive in practice and I think definitely improves the 
safety of prescribing them and the patient's compliance. 
00:20:45 S1 As you said it's basically the same thing coming up, the evolving one. 
So just summarizing up.  Taking into your own practice, or general 
role, the possible barriers and facilitators with the current GP 
pharmacist role, any steps you think that should be taken to facilitate 
this role within your own competency, your own working 
collaboration or within the general practice, any specific steps you 
think should be taken? 
00:21:14 S2 To improve the pharmacist's role? 
00:21:17 S1 Yes, yes. 
00:21:18 S2 It's hard to say, really because obviously I'm not directly involved in 
the employ and everything else and the decisions around what the 




00:21:33 S1 It might be good for you to personalise what elections the how do 
you improve the working collaboration or what working 
communication or these things. 
00:21:42 S2 Well I'll say I think communication is generally good and I suppose 
the only thing is partly on the practice meeting maybe the 
pharmacist attending the practice meetings. 
00:21:49 S2 Yes and that's a good kind of thing. 
00:21:52 S2 I think as far as a CCT is concerned we have the practice nurse for 
RNs or something sometimes maybe they would be good places for 
the pharmacist to turn to sometimes, because a lot of it is about 
chronic disease management we get a lot of speakers about chronic 
disease.  So the pharmacist, I mean, it's making you aware of and 
trained to know about it anyway…but updates if the guidelines 
changes and everything, but also then there'd be that 
communication there, I suppose, because with different queries.  But 
I think on the whole the communication issue is good and you know 
so … 
00:22:34 S1 That's fine, yeah, I think that's a good point.  You sending out the few 
meetings or the CCT or the CCG role especially when looking 
prescribing pharmacist.  That's a good point, yeah.  So just a few 
questions.  Quite a few research has been done.  Any specific other 
areas do you see that more research should be done on this overall 
GP pharmacist role?  Any specific thing you can put like the training 
or consultation skills or medicine management or any new specified 
area that you feel more  
00:23:09 S2 Sure, I suppose…again it's not something I'm aware of but maybe…I 
know as a practice nurse coming from working from…I know working 
in hospital coming into practices is very, very different so I would 
imagine for a pharmacist coming out of from a hospital environment 
or a community environment, into a GP practice there's going to be 
things that are a lot different and it's taken many, many years to like 
for practice nurses to get the training and everything that's probably 
appropriate and so there is now different courses that are specific to 
general practice.  So whether for pharmacists there's something like 
a bit more structured as to when they go work in general practice 
certain areas to cover and to work on being trained at before the 
entry into six-twelve months to maintain that but, again, without 




don't have an idea of what pharmacists do out in the community and 
in the hospital and, I as I say now, in a GP practice. 
00:24:11 S1 Okay. 
00:24:12 S2 But I think in hospital the pharmacist is a big part of the war team 
and is so there's no reason why the pharmacy shouldn't be part of 
the team in general practice. 
00:24:24 S1 I think it's more of defining the old description because  at the 
moment there is a confusion on how to deal or talk about it varies 
surgery to surgery, it varies organisation to organisation and so once 
that's a bit more defined, structure will come into the picture and it 
will give a bit more clear picture of all the things are we working on 
then. 
00:24:50 S2 But I think that's true in general practice really now if everybody's 
role in general practice, every practice like you could be the 
advanced nurse practitioner's their role can vary hugely from 
practice to practice and it is definitely evolving because so much is 
going into practice now, that there is just not the capacity to deal 
with it so everybody that's involved in general practice within their 
role is evolving hugely. 
00:25:17 S1 I think I've come to the end, but any additional comments you want 
to ask.  Anything you want to ask to sum it up. 
00:25:26 S2 Well, no not really.  I just I think it is a positive thing having a 
pharmacist within the practice and I do see the role will probably 
evolve quite a lot over the next few years.  And yes, I better shut it.   
00:25:41 S1 No you're fine.  Thanks Mary. 
00:25:43 S2 Okay. 
00:25:44 S1 What we will do is we will transcribe it and then I will forward you a 
copy of it if you just have a look at it and if you want to add anything 
even in the future or something, just let me know. 
00:25:52 S2 Okay.  Yes. 
00:25:54 S1 …and thanks very much for your time. Thank you. 
00:25:56 S2 You're welcome as well, yes. 
 
(00.25.58) 











Interview with Nurse2/England 
S1 Interviewer 
S2 Respondent  
 
 
00:00:00 S1 Hi, my name is Nosha Abenda , I’m a research master student at 
Huddersfield University.  And my topic is about the evaluation 
of…perception and expectation of GP pharmacist role in England and 
Australia.  Today I’m doing the interview with a practice nurse. Her 
name is Aisha and she’s working as a practice nurse at the moment in 
Moss Side Healthcare Centre.  So…and it will be just like…this 
interview of 20, 25 minutes which will cover the basic questions 
about the structure interview guide.  So I will ask Aisha to introduce 
herself and then we will carry on with the interview.  
00:00:41 S2 HI, my name is Aisha, I’m a practice nurse at Manchester Medical, 
Moss Side Health Centre.  
00:00:48 S1 Aisha, just before starting the interview, thanks for giving your time 
and this interview is basically to evaluate a GP pharmacists’ role.  You 
are giving me the consent to carry on with this interview? 
00:01:00 S2 Yes, I do, yeah. 
00:01:02 S1 So this interview will be recorded and then transcribed later.  This 
interview is divided in four sections about the perception and 
challenges, working in collaboration with GP pharmacists, 
pharmacists’ skillset in your experience and the future of GP 
pharmacists and what do you think of.  So starting with the first one, 
the perception and challenges, based on  your own experience in the 
GP practice or primary care GP practice, do you think there are any 
gaps present in the general practice framework at the moment?  
00:01:39 S2 I think there’s always a gap in any healthcare on the street to be 




needs to have them because they do cover a broad range of topics in 
the practice itself.  And they’re more of a support for every clinician.  
So I work a lot with them because as nurses we don’t deal a lot with 
medication, but as we grow in our career and become prescribers 
and things, I feel that we need clinical pharmacists more than we 
even doctors to be honest.  And GP practices, they don’t have that.  I 
feel they’re kind of losing out.  
00:02:21 S1 Yeah, yeah, that’s fine.  So you think there were gaps and that gaps 
can be covered with GP pharmacist role, yeah.  So I mean just carry 
on with the same thing, what were your initial perception about GP 
pharmacist role when it started to come and work with him.   
00:02:36 S2 I was little bit worried at the beginning because I wasn’t sure how 
they would deal with patient to patient like consultations. 
00:02:47 S1 All right.  
00:02:47 S2 Especially when the GP said oh, they’ll be doing consultations by 
themselves.  I was a little bit apprehensive about that because I 
thought oh well, I’m not so sure pharmacists are good at that kind of 
thing, but actually as we got along they ruined that because they 
worked a lot with me and then I grew more in confidence with 
medication because I worked closely with them.  So now we work as 
a team and it’s really good.  
00:03:11 S1 And just carrying with the same thing again, do you believe there was 
mismatch in any professional expectation you had from GP 
pharmacist role in the early stages? 
00:03:23 S2 Not too much, just a little bit with the patient consolations, but I 
could always see the positive side of it because there’s a lot of gaps 
with nurses and doctors and a lot of mistakes in prescribing to 
honest.  And when they came they kind of picked up on a lot of that 
and helped us.  I think we’re a little bit more confident now in 
prescribing, but also a lot more cautious in how we prescribe so 
we’re making less mistakes.   
00:03:48 S1 Okay. 
00:03:49 S2 Whereas before there was small, small mistakes that were done all 
the time and it helped to get rid of that, but I think also we did very 
high expectations of them at the beginning and we thought, as soon 
as they start, this is what they’ll do.   




00:04:03 S2 But it was a night that they did a lot of stuff that we didn’t expect, 
but they also went as we thought it would be.  So we thought, oh, as 
soon as they start that they were to just get on with it, do this, do 
that, but obviously coming from community pharmacy it’s very 
different.  So now when we have other like pharmacists coming in, 
we know exactly how to deal with it and it does help a lot.  
00:04:26 S1 So there was initial mismatch, but they have improved now.   
00:04:30 S2 Yeah.  
00:04:30 S1 Yeah, that’s fine.  Any initial reservations specific one giving the 
example like clinical knowledge, communication skill, management 
skill or course factor that [inaudible 00:04:39] discuss within this 
factors if you remember? 
00:04:42 S2 No, I don’t think that was ever an issue.  
00:04:45 S1 Okay.  Okay.  How well you believe pharmacists for professional 
prepared to perform as GP pharmacist when he started?     
00:04:53 S2 How do you mean? 
00:04:52 S1 Professional prepared like when he came up and joined the team, 
your initial…the first experience you got that how well…I mean 
clinical knowledge by his communication, by his…how well he was 
prepared to take on this role? 
00:05:12 S2 Well, when he first started I think they were more apprehensive.  So 
they were dealing with like teaching.  So he was more prepared than 
we thought he would be to be honest.   
00:05:25 S1 All right.   
00:05:26 S2 But I think it was just appropriate to be honest, everything because 
he just started and he was like, if you need any help, anything you’re 
unsure of.  But it wasn’t…there was no gaps that he needed to 
improve in or anything like that.  He just grew in…they all just grew in 
themselves to be honest.   
00:05:48 S1 Okay.  What are your personal challenges or hurdles you face by 
working with a GP pharmacist? Any operational challenges if you 
remember? 
00:05:57 S2 No, actually.  I think there was more benefits than any challenges on 




doing.  So any challenges I had before they came were helped out by 
them, so. 
00:06:14 S1 But I mean did you feel any organisational like…like availability of the 
rooms or something like on the organisational level did you feel 
any…any hurdles while working with them? 
00:06:26 S2 Not when they started because we had enough.  So a lot of the times 
before they came, if I went on annual leave, the clinics were all 
cancelled.  When they started, when I went on annual leave, they 
covered for me.  So it was more beneficial than… 
00:06:43 S1 That’s fine.  And I mean in your views what should be the key 
performance indicators for them to evaluate their impact on the 
general practice?  
00:06:52 S2 I think like everybody else really, professional development, personal 
development because that’s what keeps you going for everything to 
be honest.  Everybody…I don’t see them any differently than any 
other clinical team.  So anything that we have to deal with, they do 
because really we kind of do similar jobs.    
00:07:14 S1 Okay. 
00:07:14 S2 They’re clinicians as we are, they…they’re professional as we are.  So 
for me they’re not any different to like what a doctor would have to 
do.  They’re accountable and responsible for their actions and 
everything.  So I even think there’s anything specific just for them 
because they’re pharmacists, they’re clinicians, it’s the same. 
00:07:36 S1 All right.  That’s fine.  I think that’s…that was the first section of it, 
yeah.  And now we’re gonna move to the second which is…I think 
most important one from this question that’s the pharmacist, nurse 
working collaboration, all right.  
00:07:47 S2 Yeah.  
00:07:46 S1 So how do you value your present working collaboration with the 
pharmacist and has it changed since the beginning?  
00:07:56 S2 Yeah, it has changed, but for better really.  The work used to be 
divided nurse and pharmacist before, but now it’s just the clinical 
team.  We all do the same work together, so.   
00:08:09 S1 Okay.  It has improved.  




00:08:09 S1 Yeah, yeah.  And how do you differentiate practice pharmacists’ role 
with the role as a nurse practitioner?  Because [inaudible 00:08:16] 
might be mostly dis-confuted and overlapping job in the general 
practice.  So how do you differentiate your role from the 
pharmacists’ role? 
00:08:26 S2 I think sometimes there are times when my role comes in as nurse 
more effectively.  So when it comes to like certain consultations they 
do tend to call me in and say, can you come in and explain this to the 
patient or can you see this patient for that, but then there are other 
times when I get very confused with medication or I’m unsure what 
to give to a patient and I’ll call one of them say and can I just get your 
advice.  That’s when they really…we could see a big difference in 
them.  Otherwise most of the time it’s similar.  We sit and discuss 
everything together.  We do the work together.  If I’m unsure of 
something…so when we get a task it doesn’t get sent to the 
pharmacist or the nurse, we are one team, it comes to one work box 
and it all goes to us.  So we all deal with it the same way.  The only 
times, you know, the difference is small times when we are little bit 
unsure.  With like children.  I deal with children a lot more so I see 
them more and when they’re unsure about immunisations or 
something they’ll ask me.  Or if I’m unsure about medication, what’s 
licenced and what’s not, I go to them.  But that’s the only time really.  
Otherwise… 
00:09:35 S1 That’s fine, brilliant.  So you think they…with the time there is 
coming a bit more collaborating between your role and the 
pharmacist role?  Yeah, yeah.  And it’s more coming towards like a 
clinical thing, yeah.  
00:09:44 S2 Yeah 
00:09:47 S1 Yeah.  So how…have you got any concerns related to medical, legal 
implications in the scope of pharmacists where you think sometime it 
might be a pharmacist has gone beyond his expertise?  
00:09:58 S2 No, because especially now we have some pharmacists who are 
doing acute clinics where the good thing is every acute clinic they do, 
the speak to do a doctor and say, is this what you would 
recommend?  So I think they tend to be more cautious than doctors 
even.  And I guess that’s because of the legal implications, they tend 
to understand where they can’t overstep a little bit more than I 
guess, maybe other clinicians.  I think even we tend to take more 
risks than they do because we think oh, like for nurses the indemnity 




more cautious because they feel like they’re responsible for their 
own indemnity, so. 
00:10:44 S1 That’s fine, that’s fine.  Okay.  How do you find pharmacists to 
approach and communicate? 
00:10:48 S2 I think they’ve improved a lot.  Now when I go to a pharmacy I know 
the difference straight away.  I can see clinical pharmacist and  a 
pharmacy that I see over the counter. 
00:11:02 S1 Yeah, yeah.  So you find it easy to communicate with the pharmacist 
in general practice now? 
00:11:07 S2 Definitely.  
00:11:07 S1 That’s fine.  And what factor you believe influence this working 
collaboration in the practice? 
00:11:15 S2 I think it’s because of the increase of…because they deal with a lot 
more patients so they’re confidence has improved a lot more that 
way.  And they tend to know the work effectively actually more 
than…because in the community they deal with just medication and 
it’s just a quick five minutes one-to-one whereas here they can 
sometimes be with a patient for like 15 minutes, 20 minutes dealing 
with everything.  And that’s improved them in their communication.  
Even with nurses I think at the beginning it was a little bit different.  
00:11:46 S1 Okay.  Okay.  Any steps you think that can improve this working 
collaboration between you and the pharmacist? 
00:11:54 S2 I think it’s a work in progress, but I don’t think…but I guess you can 
say like it’s an individual thing as well.  So different nurses and 
different pharmacists, you know.  Because I know some nurses who 
will say, oh no, pharmacists, I couldn’t work with them like that, but I 
guess that’s where they’re losing out because they’re quite an asset 
to the practice.  
00:12:15 S1 All right, yeah.  That’s fine.  Okay.  And I mean just…sort of if you 
want to add something like has…or what impact a GP pharmacist put 
on…on your scope of practice where I mean, where you were 
working before and now.  Has it changed your scope of practice as 
well? 
00:12:32 S2 Yeah, quite a lot actually.  Even with the prescribing when I first 
started, I was very cautious and didn’t want to aggressively treat 
anybody.  But having them there, knowing I can quickly ask them oh, 




or thing, knowing that there’s staff support, it’s easier for me to 
make those decisions quickly than to say to the patient, actually, let 
me discuss it with a doctor and I’ll call you in a weeks’ time.  It’s a lot 
easier to just message one of the pharmacists and say, do you think 
this is the right thing?  And they can easily say yes, that’s what to 
give next.     
00:13:10 S1 That’s fine, brilliant.  Talking about the second section, I will just 
quickly go to the…mostly you have given the answer of some of 
these questions, but I will repeat the question if you want to add 
something.  Yeah.  It’s about the pharmacist skillset.  So how you are 
working with the pharmacist and what skills you feel pharmacists has 
gone.  So how you value competency of pharmacy in patient facing 
roles like running clinics, doing medication reviews and home visits?  
It’s more like a clinical, like patient facing roles, yeah.  
00:13:37 S2 The thing is its different though because like they’re very good at 
medication use.  With patient consultations they need to do a lot of 
them to get used to it because I think at uni they don’t tend to do a 
lot of that.  Whereas with us, at uni, that’s most…90 percent of our 
teaching, that’s how it is.  We do face to face.  So I think medication 
reviews and all the other reviews, home visits where it’s a few 
minutes, they’re really good at that right at the beginning.  But face 
to face it needed time to build up.  So I think what they will benefit 
from like other pharmacists is maybe to sit in with the nurse a little 
bit because at the beginning when they started I wasn’t here as 
much and…and then when I came back I saw the difference.  So they 
sat in with me quite a lot and saw how I dealt with the consultations 
and it really improved how they dealt with their consultations.  
00:14:27 S1 Brilliant.   
00:14:27 S2 Because they can be a bit apprehensive and it’s a bit like no, 
just…just do what you think is right, you know.  And that helped after 
a while. 
00:14:36 S1 Brilliant.  Yeah, yeah.  That’s my own experience as well.  Sorry, just 
getting up here.  About the prescribing role, so what are your 
thoughts about prescribing role of pharmacists?  Highlighting any 
reservations, you might have about pharmacists working as a 
prescriber?   
00:15:05 S2 No.   




00:15:06 S2 Because they’re the ones who pick up all the mistakes the doctors 
make, so I think they’re probably better off than any one of us.  
00:15:11 S1 All right, all right.  I understand.  So you’re confident about them 
playing as a prescriber role, yeah?  
00:15:18 S2 Because I’ve dealt with different pharmacists.  So I’ve dealt with 
pharmacists at the hospital.  They’re the ones who pick up all the 
mistakes we make.  We’ve dealt with pharmacists in the community.  
They’re the ones who return all the prescriptions and say that’s not 
the right dose you’ve prescribed or you know, can you check it again.  
And in clinical it’s the same.  They’ll see a prescription and they’ll say 
actually, I don’t think this is the right thing, you know, it should be 
prescribed like this.  Or this is not licenced anymore or you know, 
they know the up to date information.  So no, I have absolutely no 
reservations.  
00:15:50 S1 That’s good.  In your views, what protocol should be set up at an 
organisational level or practice level for prescribing pharmacists?  Do 
you think there should be any protocols?   
00:16:01 S2 I think at the beginning its exactly the same as when nurses 
prescribe.  The only difference is because we…the diagnosing time, 
we’re not as great as doctors obviously because of their training.  So 
there it’s all to do with training.  Doctors are really good at seeing 
something and saying, okay, let me look at it as a whole and do 
everything else and then give the right thing.  We’re good at, okay, 
this is what you’ve diagnosed, Okay, this is the medication for it, but 
when it comes to like acute things, oh, I’ve got to rush, let me have a 
look, this is where we’re a little bit cautious in saying, oh, I think this 
is this.  That’s where we kinda lack and I think with the pharmacist 
it’s the same as well.  We can be quite apprehensive even though a 
lot of the times they write what they’re saying, but I think it’s more 
to do with legal as well because they can be a bit more cautious and 
say actually, let me get a second opinion before I prescribe you 
something.   
00:16:57 S1 It’s more like a link with the GPs here.  
00:17:02 S2 Yeah, maybe if they had more training for like acute stuff for the…for 
the pharmacist.  
00:17:03 S1 For minor types yeah, yeah.  Okay.  What is your thoughts about 
pharmacists working for the medicine management skills 




00:17:15 S2 Yeah, they are quite…and especially when they’ve done clinical 
knowledge as well.  It works out really well.   
00:17:21 S1 All right.  That’s fine, that’s fine.  How do you value your GP 
pharmacists to link surgery with community pharmacy in hospital or 
other healthcare organisations like a CCG?  
00:17:29 S2 I’ve had not much experience with that to be honest.  So I don’t 
really know.  
00:17:35 S1 All right.  But do you think that it can be link person between these 
different organisations?   
00:17:41 S2 Yeah, because sometimes when for example…I’ll give you an 
example, with the vitamin D protocol, we’re always unsure.  But then 
the clinical pharmacists are always the ones who are saying actually, 
we’ve received something from medicine management this is what it 
says.  And it’s like oh, okay then.  We need it somewhere written 
down, you know.  So yeah, actually a link, but… 
00:18:01 S1 So it’s the link of the…between the different organisations has been 
a part of the role here.  All right.  And this last question, so what are 
your thoughts on comparing in-house practice pharmacists?  
Employed directly by Sergy and the one which comes from different 
organisations like CCG pharmacists?    
00:18:21 S2 I’ve mainly dealt with in-house pharmacists.  
00:18:23 S1 All right then.  
00:18:24 S2 So I don’t…I don’t know to be honest and I’ve not…I don’t really work 
anywhere else, but the pharmacists that I’ve met outside like you say 
they’ve done different work and sometimes it’s nicer when they are 
in-house because they know the running’s.  Just like if you were 
working as nurse somewhere else and you don’t know the ins and 
outs, you know, as efficient as you are in your own practice.  But I 
think it helps when you do go other places.  It helps to see what 
works somewhere else and what doesn’t and you can put it in your 
own practice, yeah.  
00:19:01 S1 That’s fine. All right.  That covers our third section.  Now, the last one 
is more about the future of GP pharmacist role, yeah.  So what future 
do you see about a GP pharmacist role in future general practice 
framework?  Any specific level that you think should be involved at 
patient level, clinician level or practice level?  How you see the future 




00:19:23 S2 I think  there should be a lot more funding to do stuff to be honest 
because they do…we do benefit.  So like the nurses get a lot of 
funding to do a lot of things.  But the pharmacists don’t get as much.  
However, I can see that they’ve got a bit benefit to the kind of 
training that we have and you know, more.  So sometimes what 
stops them against…can be the funding to do stuff and the GP 
practices as well because they’re thinking oh, will the funding be 
coming out of our pocket.  That makes them a little bit apprehensive 
as well.  I think on that level if that could’ve been improved, it’d be 
better.   
00:20:02 S1 Yeah, yeah, that’s fine.  But do you feel that GP pharmacists is in the 
plan of the…or should be in the plan of [inaudible 00:20:10]? 
00:20:13 S2 Yeah, I think there’ll probably be…now, when you think of a GP 
practice, I don’t think it will be a GP nurse healthcare assistant.  I 
think now it will probably be like GP clinical pharmacists, nurse, all 
the other stuff.  It will be like in the future.  That’s how people see it. 
00:20:29 S1 How do you value patients’ feedback about GP pharmacists?  Have 
you got any experience?  
00:20:33 S2 Yeah, do have a lot of patient feedback now.  We actually have 
patients who will say, can I please see this person?  Can I please see 
this person?  Because they know they’ve been able to manage their 
symptoms a lot better.   
00:20:44 S1 All right.  Yeah.  So it’s all positive feedback coming up?  All right.  
That’s fine.  And based on your own experience and need of 
workload, do you see the GP pharmacist as a part time or fulltime in 
this organization? 
00:20:57 S2 Fulltime. 
00:20:58 S1 Fulltime.  
00:20:58 S2 Yeah. 
00:21:01 S1 Okay.  Again, based on your overall experience, what training do you 
see that should be given to the pharmacist to improve the 
competency as GP pharmacist? Any specific respect of training 
specifically?   
00:21:11 S2 I think at the beginning it’s patient facing consultations.  That kind of 




good at it, just because they don’t have the confidence I think.  It’s 
just the confidence building really.   
00:21:29 S1 And how well you believe practice pharmacists has evolved or 
perform as a GP pharmacist impacting all over healthcare of 
provision?  Any patient care highlighting any practice level benefits.  
So have they evolved from the initial phase up till now.  Do you think 
they have evolved?  
00:21:48 S2 Yeah, quite a lot and we’ve seen quite a lot of benefits actually 
because the doctors used to spend a lot of their times doing 
medication reviews.  And telephone consultation regarding 
medicine.  That medication reviews and telephone consultation 
regarding medicine.  That medicine.  This needs to be changed, that 
needs to be changed, what can we give now?  And it used to take a 
lot of time because they’d have to call an outside pharmacist to ask 
oh, if this is no longer available, what is?  And it used to take a lot of 
time whereas now the pharmacists just deal with that.  And 
sometimes I deal with that as well, but it helps because they’ve got 
more time to do other things.  
00:22:19 S1 All right.  That’s fine, brilliant, yeah.  And how has GP pharmacists 
changed your role or perception about pharmacists in general, 
pharmacists as a professional, has it changed your perception?  
00:22:32 S2 Yeah, quite a lot because I didn’t used to think of them as clincians 
whereas now they are just…yeah. 
00:22:39 S1 All right.  Considering the possible barriers and facilitators for current 
GP pharmacist role, what steps should be taken to improve GP 
pharmacist role at an organizational level.  Any steps you think that 
can improve this role?  
00:22:53 S2 I don’t think because it’s a work in progress I think and we’ve taken 
action for every little thing that can…you know, as we got along, but 
it’s just like nurses, if  they get the training then everything’s fine.  I 
think they definitely need training before they come to do anything 
like…it shouldn’t been good for them to just be sent in the deep end.  
That…I think that would be disaster, but other than that when they 
have training, then they’re absolutely fine.  They’re even better than 
some of the nurses I can think of. 
00:23:28 S1 All right, that’s good.  And briefly describe any [inaudible 00:23:32] 




or nurses and different provision of the…so do you think any specific 
research should be done on the GP pharmacist role?  
00:23:41 S2 Yeah, I think to be honest, they don’t get a lot of recognition for the 
work they do.  So clinical…like GP pharmacist, they can be really good 
at consultations and dealing with…just with the patients overall, but 
it’s not recognized.  People think oh, nurses as advocates, as 
advocates, they’re really good, but working with the GP pharmacist, I 
can see that actually they’re really good as advocates as well.  They 
can say this is not…this isn’t beneficial for this patient, I’m sorry, can 
we try that, can we try this and they’re really good at that, but 
when…I never thought actually, that is their role, that is what they 
do.  This…you know, they’ll tell the doctor this patient, 75 don’t give 
him this or reduce the dose.  We never thought of them as 
advocates, but that is what they are.  I think research into that and 
actually giving them at recognition would be really good for them. 
00:24:40 S1 Yeah, that’s fine.  And I mean it goes over most of the section.  So 
just the last question, do you have any other comments to add? 
00:24:45 S2 Not really. 
00:24:46 S1 Not really yeah? 
00:24:48 S2 I think I spoke a lot. 
00:24:50 S1 No, it’s been really beneficial because it values the experience with 
the data we have.  So thanks Aisha it’s been really helpful and I hope 
I to speak to you again sometime with other things I’m working.  




(End of Audio) 




















Interview with GPP1/Australia 
S1 Noshad Akhtar 
S2 Amy Page  
 
Timecode Speaker Transcript 
00:00:03 S1 Hi.  My name's Noshad Akhtar and I'm a GP pharmacist [inaudible 
00:00:07].  And also, I’m doing a research study on the topic of 
evaluation of expectation and perceptions of GP pharmacist role in 
England and Australia.  And today, I’m doing an interview with Ms 
Amy Page who is a GP pharmacist in Australia and this is a qualitative 
interview.  Hi, Amy. 
00:00:30 S2 Hi. 
00:00:31 S1 Hi.  Can you just briefly introduce yourself, please? 
00:00:35 S2 I'm Amy Page.  I have been a GP practise pharmacist for four years in 
Melbourne, Australia.  It's a fairly new role in Australia, so I’m one of 
the earlier pharmacists to be working in GP practises.  I had a 
background in clinical pharmacy and education and was undertaking 
my PhD already when I started working as a GP practise pharmacist. 
00:01:08 S1 Thanks, Amy.  Amy, you have given me the consent to carry on with 
this interview?   




00:01:15 S1 Yeah.  And you have the information, the initial information about 
the study, yeah?   
00:01:20 S2 Yes.  
00:01:21  So you want me to start, yeah?   
00:01:23 S2 Yes.   
00:01:23 S1 Yeah.  Excellent.  Amy, as you know, this is about the comparative 
study of the GP pharmacist role in England and Australia.  The 
[inaudible 00:01:31] interview guide and has got four sections which 
have been divided into perception and challenges, GP pharmacists 
working collaboration, pharmacist skillset, and the future of GP 
pharmacists.  So, I will start with the first topic.  If any question you 
don't want to answer or skip, let me know and I'm recording this 
interview and at the end of the interview, it will be transcribed and if 
you want, I can give you a copy of the transcription.  If you want to 
add or delete anything, let me know in the transcription.  So, I will 
start with the first topic, the first section of it, that’s perception and 
challenges.  So, based on your own experience on the role about the 
pharmacists in Australia or general practise framework in Australia, 
do you believe there are any gaps present in general practise 
framework in Australia at the moment?  
00:02:31 S2 For pharmacists working in that environment, you mean?   
00:02:34 S1 Just generally you know, how things are working in about the general 
practise if there are any gaps about the lack of GPs, or lack of nurses, 
or any gaps present where there is an excessive workload on GPs or 
nurses or other healthcare professionals? 
00:02:55 S2 Yes, I'm working in an area on the edge of the city so it's often 
challenging to recruit health professionals there.  We've been down 
a GP for a while now.  There's also challenges in the structure 
financially rewarding doctors to do the work rather than other health 
professionals unlike in England, I believe.  Which means that the 
delegation of jobs is limited or willingness to delegate jobs can be 
really limited.  But we have a strong ethos at the practise where I am 
of having the most appropriate person for the job doing that role and 
we try to be into [00:03:50] professional.   
00:03:51 S1 All right, fine.  That’s fine.  And you know the gaps which you have 
specified within you practise or where you're working.  Is it 
something that has been discussed within the Australian system that 




00:04:10 S2 Not particularly.   
00:04:12 S1 Not particularly.  All right, fine.  So, I mean, what was your initial 
perception about GP pharmacist role integrated to fill this gap?  Is 
there something that has been taken on specifically in your practise 
as an option to fill that gap in? 
00:04:29 S2 No, not at all.  The reason for me being at the practise was that we'd 
identified—the practise had identified that they had a significant 
proportion of their older patient, of their patients generally, who 
were taking eight or more medicines.  And we wanted to be able to 
reduce that proportion of people who were taking eight or more 
medicines because they wanted to improve the quality of care that 
they would be able to deliver to their patients. 
00:04:59 S1 Okay, okay.  Is it more like dealing with polypharmacy, just 
specifically dealing with polypharmacy?   
00:05:06 S2 Yeah.   
00:05:07 S1 All right.  Okay.  That’s fine.  Okay.  So, what were your thoughts 
about initial expectations or again, initial expectations, other 
healthcare professionals had from GP pharmacist role when you 
started?  Have you been working there for three full years, you're 
saying, yeah? 
00:05:29 S2 Four years now, yeah, four and a half years. 
00:05:32 S1 Okay, right, yeah.  So, I mean, what were your thoughts about their 
initial expectations from yourself?  Was there any mismatch 
between the expectations or what you can do initially as a GP 
pharmacist?   
00:05:45 S2 No, the expectations were fairly well matched.  They wanted 
someone who could champion the prescribing and that was the area 
of my PhD.  So, it was fairly well matched and the principal GP and I 
had fairly similar interests and skills, so we were able to work at 
programmes together which were then discussed with the broader 
team.  
00:06:12 S1 All right.  That’s fine, that’s fine.  And were there any initial 
reservations about your role?  Factors like clinical knowledge, 
communication skills, management skills or [inaudible 00:06:22] 
factor? 
00:06:25 S2 No, it was more that we started off with doing what's called home 




information, and then it's evolved over time and changed over time, 
so I think it was fairly well accepted roles for a pharmacist and they 
were grateful to have a pharmacist available. 
00:06:45 S1 And I mean, were there any initial reservations during like you were 
yourself, you thought that you were ready to take on this role from 
your own clinical knowledge perspective or you had the 
communication skills, everything, those type of things where you 
told yourself that you're okay to do this role initially? 
00:07:06 S2 Yeah, I was actually because the role evolved over time.  So, the role 
started off with what I was comfortable with doing and providing 
and then it grew and changed over time.  And as I said, I came into it, 
I'd already had a master at clinical pharmacy.  I was undertaking my 
PhD at the time, I had already had a graduate certificate in health 
professional education.  So as far as skill base, I was well prepared 
for starting that role. 
00:07:39 S1 All right, that’s good, that’s good.  All right.  Were there any initial 
operational challenges or hurdles you faced while working as a GP 
pharmacist? 
00:07:49 S2 The main one is financial reimbursement to be able to do some of 
the roles or some of the ideas that we've got that’s just not the 
financial structure. 
00:08:04 S1 Okay, okay.  That was the initial or has it improved now? 
00:08:08 S2 No, ongoing.  Initial and ongoing. 
00:08:11 S1 All right, that’s fine.  That’s good.  And most probably you have 
answered this, but I just want to quote this one.  What are your 
views on emotional challenges especially in the initial phase such as 
perceived professional inadequacy or developing clinical aptitude for 
patient-facing clinical skills?  Although you already had the master’s 
so most probably you will be comfortable in [inaudible 00:08:38].   
00:08:39 S2 Yeah, no, that’s fine. 
00:08:39 S1 Was there any other emotional change?  Was there any barrier while 
working with the GP? 
00:08:50 S2 No, not really because I'd already been working in an 
interprofessional setting for several years before I started working in 




professionals.  I think perhaps if I’d never worked in an 
interprofessional environment before, it might have been. 
00:09:10 S1 Might have been, yeah.  Like someone who haven't got that 
background, do you think like if a fresh graduate or if someone hasn't 
got that clinical background, it will be difficult for them to go and do 
the role what you have done, isn't it? 
00:09:26 S2 Yes.  Yes, I think it would be. 
00:09:30 S1 And what support did you receive at the organisational level to 
overcome any challenges you had? 
00:09:41 S2 No, I wouldn’t say so much challenges, as you know, as in a barrier 
challenge.  It was more that we were looking to be innovative and 
develop new programmes that hadn't been done before.  And when 
there was no funding available for them, so it was more the 
challenges of working out new roles. 
00:10:02 S1 All right.  So was there any support there financial-wise from the 
organisation to help you out, or was it like any specific funding 
coming from the government for this role? 
00:10:17 S2 A little bit the funding from the government for a specific 
programme which was the home medication reviews and then the 
principal GP and I put in a lot of our own time to developing it. 
00:10:29 S1 Okay.  Okay.  I think you have answered this, how will you believe 
you are professionally prepared to perform as a GP pharmacist with 
your clinical background? I mean, in your own views now you have 
got the experience of three, four years.  What do you think that 
there should be any specific key performance indicators in any 
government or any organisation to evaluate the role of the GP 
pharmacist? 
00:10:59 S2 No, I don't think so.  Mainly because I think that the different roles of 
the GP practise pharmacists are quite different.  So, if you're only 
undertaking patient-facing roles, that's going to be very different to if 
you're doing governance roles.  So, if you were if you were to put in 
generic KPIs, you would limit the role to one particular function and 
each GP practise probably, and the population in each area is going 
to have different needs. 
00:11:39 S1 Yeah, so it's difficult you think to pinpoint any specific key 




00:11:45 S2 Yes, because the needs of the patient population and the needs of 
the GPs change so much. 
00:11:55 S1 Yeah, it's very surgery to surgery which what role they want you to 
play, isn’t it? 
00:12:00 S2 Yeah. 
00:12:02 S1 The same over here, because in some of the practises, they want you 
to do a more clinical role, and some of them, they want you to do 
the meds management role, so... 
00:12:12 S2 Yeah, and do they want you to be teaching the GPs and the nurses 
about education or do they want you to be putting in protocols and 
policies and that sort of thing, or do they want you to be facing a 
patient, you know, patient-facing roles, they’re so different. 
00:12:30 S1 It’s different, exactly.  That’s fine.  Amy, that covers our first section, 
so thank you for that.  And the next one is about the working in 
collaboration with the other healthcare professionals.  So, I mean, 
how will you evaluate your present working collaboration?  I know 
you have got an experience of three, four years and you were 
working as a healthcare professional before as well.  But just 
specifically as a GP pharmacist, how will you evaluate your working 
collaboration now with the healthcare profession especially GPs and 
nurses?  I don't know how the nurses’ system work in Australia, but 
has it changed since the beginning?  Has it's got stronger since the 
beginning? 
00:13:13 S2 Ah, it's definitely stronger as they’re used to having me there, but I 
don't think—I think that's just the way….  I think that's because they 
trust me.  I don't think that's necessarily because it's a pharmacist 
role that they’re used to, I don't know if another pharmacist could 
walk into this.  In fact, I've suggested another pharmacist comes and 
works at the same clinic and they’re like, “No.” 
00:13:41 S1 Okay, okay.  Is it because, I mean, just adding the question, is it 
because they feel that there is no need for the pharmacist or is it 
because they feel that the other pharmacist won't be able to do the 
quality of the work what you're doing? 
00:13:59 S2 Exactly.  They think that—they know that they like and trust my work 
and that I work to a high level and they don't trust that another 
pharmacist would do the same.  I’ve offered to mentor and support 




00:14:18 S1 All right, all right.  But do they feel that there is a need for the 
pharmacist? 
00:14:25 S2 Yes.  Yes, they want more time than I'm able to give, but they don't 
want somebody else. 
00:14:33 S1 I see that.  So, it's more like a personal relationship you have with the 
team out there.   
00:14:38 S2 Yes.   
00:14:39 S1 All right.  That’s fine.  And do you think that—I mean, it has got 
something to do with your clinical knowledge or is it something to do 
just overall from your academia background? 
00:14:56 S2 I think it's both.  I think it's my academic background and my clinical 
background and how I interact with the team. 
00:15:04 S1 Okay.  Okay.  That’s fine, that’s fine.  All right.  Brilliant.  Okay.  Over 
here, it might not be the, I mean, the relevant question in Australia, 
because I think Australia nurses are working in a different way.  But 
over here, nurses are very much a part of general practise over here.  
But I mean, I don't know how it works out there, but how do you 
differentiate your role from the practise nurse because it’s often, 
sometimes it is confused to be overlapping with each other?  Is it 
same over in Australia as well, or…? 
00:15:41 S2 It's the same, but I've been very, very specific that I only look at the 
medications, I don't do any of the activities that the nurses do. 
00:15:52 S1 Okay, okay.  Can you just (overlapping conversation)? 
00:15:55 S2 Because any patient-facing roles are purely using the home 
medication review model which is a role that only a pharmacist can 
do, and any roles, any other roles I do are all purely medication-
focused.  I am very specific that I don't want to do any roles that are 
already being filled by the practise nurse.  So, we've got that 
differentiation, that's not been an issue because I'm very aware of it. 
00:16:25 S1 Okay, so there is no overlapping going on in your practise.   
00:16:27 S2 No. 
00:16:28 S1 That’s fine.  All right. 
00:16:29 S2 No, but that's something that I've been very personally cognisant of 
because I don't want to replicate or duplicate work that can be done 




00:16:40 S1 Okay.  But in your own experience, it might be from your other 
colleagues, it there something that is going on in any other practises, 
it might be another GP pharmacist working, do you think so, any 
[inaudible 00:16:52]? 
00:16:55 S2 I think there's some people who are really keen to work in GP 
practises who will say that they are capable of doing X, Y, Z activity 
that is currently done by a nurse.  But I don't know if any of that's 
happening at the moment because there's funding for a nurse to do 
those roles and there's not funding for a pharmacist to do those 
roles. 
00:17:16 S1 All right.  Yeah, I understand.  That’s fine.  So, have you got any 
concerns related to medicolegal implications or scope of your role as 
a GP pharmacist, situations where concerns raised about 
pharmacists has gone beyond their area of expertise? 
00:17:36 S2 I haven't come across that yet, but it's still very small numbers of 
highly skilled pharmacists who are working in GP practises in 
Australia still. 
00:17:51 S1 All right.   So, there is…yeah, I mean, because you have got [inaudible 
00:17:58] strong background so you won’t have come across these 
types of things?  That’s fine, yeah, I understand.  Okay.  And how is it 
you find GP or nurses or other healthcare professionals to approach 
and communicate within your GP practise? 
00:18:16 S2 The owner, did you say? 
00:18:18 S1 I mean, all the GPs, how easy for you to communicate with them or 
approach them for any task or any delegation, anything?  Is it easy to 
approach them? 
00:18:30 S2 It's really easy.  I don't have a problem. I mean in particular, the 
principal GP, so that's what we call the GP owner, he and I are very 
close, so we’ll regularly email or phone each other.  So, yeah, we 
work very closely.  And that sort of, I guess, facilitated the 
relationship with everybody else.  It's just been—it’s a really pleasant 
workplace where I am. 
00:19:10 S1 All right.  That’s good.  It's all about the experience, isn’t it, with the 
time it gets stronger and stronger. 
00:19:20 S2 Yeah.  Yeah, everybody’s used to me there so when a new—like 
when a registrar comes on, a new registrar because we get a new 




fantastic.  We've got a practise pharmacist.  I've never had that 
before.”  And everybody else accepts me, so they say “Yeah, that’s 
just good.”  Know there's no, you know, I'm just another member of 
the team. 
00:19:48 S1 All right.  [inaudible 00:19:48] . That’s fine, that’s good.  In general, I 
mean, if you have to give advice to any other organisation or even in 
yours, your own practise, is there any factors or do you think any 
steps can be taken to improve this working collaboration? 
00:20:11 S2 Better funding models would help.  That would enable us to do more 
if we were better funded.  I mean, that's probably the main thing. 
00:20:26 S1 Can you just highlight, because I'm not aware about the funding, I’ve 
got different feedback about the funding in Australia.  So how is 
funding working at the moment [inaudible 00:20:36] GP pharmacist? 
00:20:39 S2 At the moment, there's no direct funding, so there’s what we call the 
home medication review model which can cross subsidise the role.  
Or you can use MBS item numbers to do shared consultation.  So 
basically, the doctor is the one doing the consultation, but you get a 
proportion of the fee if they poke their head in the door. 
00:21:03 S1 Okay.  Okay.  I have heard about this home medication review that 
GPs refer you the patients to do the home medication reviews, isn't 
it?   
00:21:12 S2 Yes, that’s correct. 
00:21:14 S1 And you’ve described.  And do you need to be a GP pharmacist for 
this or take on (overlapping conversation)?  No, they can 
(overlapping conversation)? 
00:21:21 S2 No, you need to be a — any pharmacist can go through the 
accreditation process to be able to do it.  And once you’ve done the 
accreditation process, you can do it.  You can do it so community 
pharmacies directly through a GP practise are embedded in a GP 
practise. 
00:21:40 S1 All right.  But the community pharmacists who is doing this role, they 
won't be considered as a GP pharmacist, isn’t it? 
00:21:46 S2 That's correct. 
00:21:47 S1 Yeah, because GP pharmacists is a different role, it’s more like when 




00:21:53 S2 Yeah, that's correct.  So, it’s basically just using it as a funding 
mechanism to make it happen. 
00:22:00 S1 All right.  But is there no funding available, like to have a specific GP 
pharmacist role in Australia at the moment?  
00:22:08 S2 No, not at the moment.  There'll be a payment that’ll be eligible 
starting mid next year, but not now. 
00:22:17 S1 Okay.  That funding is specifically for the GP pharmacist? 
00:22:21 S2 No, currently there's a funding for a practise nurse, and next year, 
mid next year, that will be extended that they can choose to pay for 
a practise nurse or a practise pharmacist or any other allied health 
professional. 
00:22:38 S1 All right.  So (overlapping conversation). 
00:22:39 S2 So, most practises will probably just continue to employ their nurse 
the way they always have. 
00:22:46 S1 Okay.  And that decision has to be taken by the lead GP or the main 
GP? 
00:22:51 S2 Yeah.   
00:22:53 S1 Okay, okay.  That's fine.  That's fine.  All right.  That covers our 
second section.  Thank you for that.  And the third one is about the 
pharmacist skillset that depends, I mean, more about how the 
pharmacist is equipped with the knowledge.  So, I mean, how you 
valued competency of pharmacists in patient-facing role like running 
clinics, doing home medication reviews, or home visits?  So, you 
think is it competency-wise you’re enough competent to do this 
role? 
00:23:33 S2 I think so, but it's a steep learning curve doing appropriate 
documentation and someone like, I don't think pharmacists are 
usually doing sufficient documentation.  And a lot of it's about—I 
mean, it depends what sort of background you come from, so I think 
a lot of community pharmacists are very used to developing rapport 
with people very quickly.  It's about how quickly you can develop 
that rapport and talk to people. 
00:24:07 S1 Yeah, because there’s the challenge to have a patient-facing role, 
you need to be equipped with your mainly clinical knowledge, 




00:24:20 S2 Yeah, it's not just the clinical knowledge, though, it's also that ability 
to build that rapport and get that information and how do you 
synthesise that information. 
00:24:32 S1 But, you know, in…sorry, go ahead. 
00:24:34 S2 Yeah, you go. 
00:24:36 S1 In your work, I mean, once you finish your degree as a pharmacist, 
do you get any specific time for the training like to work before you 
actually start working as an independent pharmacist?  Like over here, 
they have a pre-reg year, so is there something that's in Australia as 
well? 
00:24:55 S2 Exactly the same.  So, we've got a four-year degree and then a 
one-year preregistration year. 
00:25:02 S1 All right.  And that pre-reg year, is there anything with any specific 
time or any specific link to work as a GP pharmacist? 
00:25:15 S2 No, none. 
00:25:16 S1 No.  All right.  So, it's more like community and hospital, isn't it?   
00:25:20 S2 Yes. 
00:25:21 S1 All right, yeah, that’s fine.  All right.  I don't know whether this 
question is relevant or not, but what about the prescribing role for 
the pharmacist, how [inaudible 00:25:31] how is the situation about 
the prescribing role for the pharmacist at the moment? 
00:25:36 S2 No, there's none.  Pharmacists don’t have prescribing rights in 
Australia. 
00:25:41 S1 Okay, okay.  Is it something that's being considered? 
00:25:44 S2 It's being considered, but it's not current. 
00:25:48 S1 It's not going to do, okay.  That’s fine.  Have you ever discussed it 
with your GP, lead GP or any GP, any reservations they would have 
said that “These are my reservations” or might be their reservations 
about prescribing role for the pharmacists? 
00:26:07 S2 They would not be supportive at all. 
00:26:10 S1 They won’t support it.  All right.   




00:26:13 S1 Okay.  Is it more because they don't trust the…? 
00:26:19 S2 No, they just think it's a GP role, they wouldn’t support it. 
00:26:22 S1 They won’t support it, all right.  That’s fine.   Okay.  What are your 
thoughts about the medicine management skills of the pharmacist? 
00:26:34 S2 I think that's essential and I don't think it's just the clinical 
knowledge, I think it's also being able to see what patients are doing 
and support patients to manage their medications. 
00:26:44 S1 Yeah.  So, is it more like the stronger side of the pharmacist to have 
the medicine management role in the GP [inaudible 00:26:53]?   
00:26:53 S2 Yeah. 
00:26:54 S1 That’s fine, all right.  And how will you evaluate your role as a GP 
pharmacist to link with the other organisations like Community 
Pharmacy, with the hospital or any other healthcare related 
organisations? 
00:27:09 S2 Not with the hospital, but very important with the Community 
Pharmacy.  I liaise with them a fair bit. 
00:27:17 S1 Okay, okay.  That’s fine.  And I don't think the next one will be 
related to you because over here there is in-house practise 
pharmacists and then there are some pharmacists who are coming 
from the Clinical Commissioning Group in England.  I don't think this 
is working in Australia as well, let’s skip this question.  That’s fine.  
The last section is the future of the GP pharmacist.  So, based on 
your own experience or your present situation or present position in 
the academia or healthcare organisation, where do you see the GP 
pharmacist role in Australia in the next couple of years? 
00:28:00 S2 I don't think it's going to change substantially in the next couple of 
years, but where I'd like to see it is if there was a funding stream 
pharmacists could access the same sort of funding that doctors do, 
which is called our MBS, our Medicare Benefits Scheme, so that we 
could actually bill for the services that we provide. 
00:28:21 S1 Okay, Okay.  Okay.  So, you think that there should be some type of 
funding model that comes up specifically for the GP pharmacist? 
00:28:32 S2 Yeah, without being able to fund it more, it's limited. 
00:28:38 S1 It’s limited, all right. 




00:28:43 S1 All right, yeah.  Is there any discussion or any support for this role as 
being provided by the pharmacist main organisation, regulatory 
organisation in Australia? 
00:28:54 S2 A little bit, but it's more lip service. 
00:28:57 S1 Okay.  That’s fine.  Okay.  And based on your own overall experience, 
what training you would like to see to improve this competency as a 
GP pharmacist, anyone who is coming in this role?  Do you think 
there should be any specific training that should be given to them 
before they join this role? 
00:29:21 S2 Not specific training, because it depends on what sort of role that 
and practise role functions that they're going to have and what sort 
of practise specific needs there are and patient specific needs at that 
particular practise.  But I do think it needs to be a highly skilled 
pharmacists going into the role.  I don't think it's an entry-level 
position. 
00:29:45 S1 Yeah.  So, you don't think that any community pharmacists can take 
on this role straight from community to general practise? 
00:29:54 S2 Oh, I don't see any reason why it couldn't be done by a community 
pharmacist, but it would have to be, it couldn’t be somebody without 
further well-developed clinical skills, well developed patient skills, 
well developed interprofessional skills.  It couldn't be somebody a 
year or two out of having readjusted. 
00:30:21 S1 Yeah, so there should be training that should be given to them with 
the experience of one to two years and then they can take this role 
(overlapping conversation)? 
00:30:30 S2 No, more than, more than that. 
00:30:32 S1 More than that.  All right. 
00:30:34 S2 They need to be experienced. 
00:30:36 S1 They need to be experienced, yeah.  That’s fine, yeah.  How you 
valued any patient feedback, have you received any patient feedback 
when you're working with the GP in the GP area and how you're 
getting the feedback from the patients [inaudible 00:30:53]? 
00:30:55 S2 Most of the feedback from the patients is via the GPs or via patients 
contacting me again.   




00:31:04 S2 And it's been overwhelmingly positive. 
00:31:07 S1 All right.  So, they do take you as an important member of the clinical 
team in the practise?   
00:31:14 S2 Yeah. 
00:31:14 S1 Yeah, all right.  That’s good.  I don’t know whether this question is 
relevant or not, but based on your experience in need of workload, 
do you see GP pharmacists as a part-time or full-time role? 
00:31:33 S2 It could easily be full-time if there was funding available for it to be 
full-time.   
00:31:39 S1 All right.  So, you think they can—there is work available or there is 
the need where a full-time pharmacist can be employed if funding is 
(overlapping conversation)? 
00:31:49 S2 Yeah. 
00:31:50 S1 All right.  Okay.  And how do you believe as a practise pharmacist you 
have evolved since you have beginning, how it has changed your 
scope of practise since you have beginning working as a GP 
pharmacist? 
00:32:06 S2 It’s changed a lot.  It's continuing to evolve as we look for new 
programmes to initiate and develop over time. 
00:32:15 S1 All right, fine, yeah.  Is it something within just your practise or is it 
something overall going on in Australia? 
00:32:23 S2 No, just within our practise. 
00:32:25 S1 Just your practise, all right.  That’s fine.  And considering the possible 
barriers and facilitators for current GP pharmacist role, what steps 
should be taken at organisational level to improve GP pharmacist 
roles?  It might be you have answered this one before, but…. 
00:32:39 S2 Yeah, I think I've already answered that one. 
00:32:41 S1 And there’s more like a funding one, yeah.  That’s fine, yeah.  You 
have answered the next one as well, so...  Okay, just last few 
questions.  You have got the academia background as well and 
you're doing research as well, so in Australia or overall 
internationally, would any specific research you want to be done on 
the GP pharmacist role? 
00:33:05 S2 I think it would be really valuable to have a lot more research on the 




useful to see how it changes the appropriateness of medication 
therapy.  The only reason we haven't done that is because we're 
limited to one practise and choosing outcomes is challenging.  But I 
really think we need a lot of that research and particularly if we’re 
able to aggregate that over multiple practises or large areas to show 
health outcomes ideally. 
00:33:37 S1 Yeah, yeah.  So, in your own knowledge, is there any research been 
going on at the moment about this role in Australia? 
00:33:48 S2 Only small-scale evaluations. 
00:33:50 S1 Only evaluations type of thing.  All right.  So, you think the 
international type of like my topic, is it something that’s going to be a 
valuable thing to add on in the research area for Australia? 
00:34:06 S2 Yeah.  
00:34:09 S1 Because in England, it's quite a strong system of the GP pharmacist 
role with the funding that has been going on and even now, the 
funding here has come to end but many practises, they have 
employed GP pharmacists now. 
00:34:23 S2 Yeah, you’re lucky. 
00:34:26 S1 Yeah, yeah, it has changed quite a lot in the past four or five years 
and [inaudible 00:34:33].  And I’m myself working with [inaudible 
00:34:35] a big organisation, so they have really taken it on.  So, 
yeah, it has got really well on this end.  That’s fine, Amy.  That's 
good.  Any other comments you want to add about this topic, about 
this research, anything to add on? 
00:34:54 S2 No, I think that's been really comprehensive and I think that your 
research will be really valuable.  I'm really looking forward to seeing 
the results. 
00:35:02 S1 The results, yeah.  Thanks, Amy.  It was really nice speaking to you.  
And what I will do, I will—once transcribed, I will pass the copy to 
you, and if you want to add…. 
00:35:14 S2 Oh, I don't need to see the transcription, but I would like to see the 
finished paper, it’d be a pleasure. 
00:35:21 S1 Yeah, definitely.  Definitely, I will pass it on to you.  So, I will finish 
this recording now.  Thank you. 




00:35:30 S1 Thank you.  Thanks, Amy. 




[End of Audio] 
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Evaluate expectations and perceptions of GP pharmacist role in England and Australia by 
key stakeholders – Karen Starling GP Pharmacist 
Because it is a new role in Australia, I feel the particulars of the role of pharmacists in GP 
practice is still to be determined.  At the moment the role is based on specific clinic needs.  It 
is also greatly affected by lack of funding available for pharmacist professional services and 
understanding of the role.  I was employed in the role through funding provided by the 
Eastern Melbourne Primary Health Network (EMPHN).  The job description was to fulfil clinic-
specific requirements so it was difficult to know exactly what the job would entail.  A lot of 
the services I thought may involve a pharmacist were already well covered.  The clinic I work 
at is well organised with nurse-led cardiovascular, diabetes and respiratory clinics already in 
place. 
Because this is a completely new role, I think many GPs are still trying to figure out how they 
can use the services of a GP Pharmacist.  Many of the GPs expressed a willingness to work 
with a pharmacist but were unsure how this would work with the current model of practice.   
Initially I was concerned about being able to respond to queries in a timely fashion and also 
access to drug-specific references.  I have not found the time factor to be an issue and have 
been able to recommend some references to the clinic that have been accepted.   
Some of the challenges faced: 
-Identifying needs of clinic and working out how to address them specifically.   
-Takes time to establish rapport and relationships with the staff at the clinic and understand 
how the systems work in order to utilise resources effectively.   
-Lack of specific training and resources for GP pharmacists 
-Lack of understanding from GPs, nurses, staff and patients about the role of a GP pharmacist.   
 
Current pharmacist training in Australia does not fully prepare you for this role though there 




to address this.  Being an experienced pharmacist working in both hospital, retail, 
manufacturing and Home Medicines Reviews gave me a good foundation for the role of GP 
pharmacist.  If this role is to continue and grow, more specific training would be an advantage.  
The PSA has recently started a foundation course for GP pharmacists and there are guidelines 
for general practice pharmacists and practice support tools. 
 
I have had the support of the ‘GP-champion’, the project manager and many of the other staff 
including nurses and administration to overcome some of these challenges.  Many of the 
challenges are ongoing and I am finding the support is growing as there is more understanding 
of my role and increased rapport built with both staff and patients 
 
I am employed at the clinic as part of a primary health network funded project.  The objective 
of the project is: To improve the quality of prescribing by the 20 GPs, to reduce drug related 
problems (particularly for older patients) and to establish a culture where medication reviews 
are performed in every appropriate circumstance.  To improve the capacity of the general 
practice to implement a Health Care Home model in the future, by demonstrating the benefits 
of inter-professional collaborative care.   
The target outcomes include: 
-Improved medication management for elderly patients, particularly for those with multiple 
chronic conditions, polypharmacy, or taking medications with narrow therapeutic windows 
or dangerous side effects.   
-Improved medication management includes reduction in adverse drug reactions, improved 
medical adherence, reduction in non-indicated prescribing, reduction in over dosage of 
medication, reduction of sub-therapeutic dosages, reduction in untreated patient indications, 
and increase in appropriate medication selection.   
Measuring the success includes many factors including: 
-number of patients engaged by the project 
-number of referrals to pharmacist from GPs and others 
-number of consultations with pharmacist 
-number of HMRs/RMMRs 
-measure GPs self-assessed acceptance of Pharmacist’s recommendations, competence with 
poly-pharmacy, knowledge of drug interactions/side effects, feelings of support when 
managing polypharmacy 
-GP acceptance of pharmacist recommendations 
-measuring patient outcomes using ICHOM measures  
 
Factors affecting collaboration: 
The majority of the GPs and Nurses at the clinic I am currently working in are supportive of 
the role.  GP acceptance, trust and understanding of the capabilities of pharmacist in GP role 
plays a big part in how this collaboration works.  People with experience working in team 
environments are better able to adapt to the collaborative approach.   
Steps to improve collaboration: 
Continued support of GPs, particularly in patients with chronic conditions and multiple co-
morbidities. Improved understanding of the role a pharmacist can play in improving patient 
outcomes.   
 




We have a GP feedback form for each home medication review which is used to evaluate 
pharmacist’s input and gives GPs the opportunity to provide feedback.  I have spoken to GPs 
about the ‘usefulness’ of HMRs and encourage feedback and information to guide the 
reviews.  For example, the GPs often include specific reasons for referral which really helps 
me provide patient specific support.  Working at the clinic gives me the opportunity to liaise 
directly with GPs with the results of HMRs or any specific concerns.  A future focus of the HMR 
process would be for the pharmacist to be involved in a case conference situation with the 
GP, patient and/or carer and pharmacist discussing the results of the HMR.   
Pharmacist prescribing: 
Although this has been talked about in Australia, it is not yet a reality.  My reservations would 
include patients wanting to bypass the GP and ‘just get a script’.  There would need to be 






Interview with Organizational Lead/Australia 
 
S1 Speaker One 




Timecode Speaker Transcript 
00:00:01 S1  
00:01:02 S2 Okay.  My name is Christine, I am a pharmacist for the crown I am- I 
work for a primary health network which is a government funded 
agency that I use to work in the primary care space to create a more 
integrated system, and I specifically work as a quality use of 
medicines lead in that organisation which is why I have been 
involved in a couple of pilot projects to explore the workforce role of 
the pharmacist in general practice, and so I guess I have come from 
an agency that has commissioned and provided funding for that 
happening to two other practices in our catchment. 
00:02:03 S1  




00:02:22 S1  
00:02:28 S2  
00:02:29 S1  
00:02:46 S2  
00:02:47 S1  
00:03:27 S2  
00:03:27 S1 So Christine, what are your views about the grand general practice 
framework and how the general practices working in Australia at the 
moment and do you feel there are any gaps present in the way a GP 
pharmacist can come and play a role in? 
00:03:47 S2 Well yeah, I do, I do have a pharmacist perspective I guess as well, 
but I think general practice I guess from Australia, what we find is 
that the most frequent interview in a general practice is the writing 
of a prescription, that’s an activity that’s done more than anything 
else, and that the pharmacist has a particular expertise around 
medicines which we frame in a framework called quality use of 
medicines which cover some several different domains, but there is I 
guess, within that episodic care that the GPs provide probations, 
there’s a gap in a more overarching expertise into decisions about 
medications and monitoring that would be- could fulfill by having a 
resource of a clinical pharma system in the practice. 
00:04:59 S1 All right, all right.  That’s fine, brilliant, thank you.  And what was 
your initial perception about GP pharmacist when you take- when 
you took over this pilot scheme, what were your initial perception 
about this role to fill in the gap which was present or is present 
within general practice and hasn’t been changed since then? 
00:05:25 S2 Well so I guess- so it’s not me that’s working in the practice just so 
that you understand, the way that we went about this was really to 
have the general practice lead the role, so they needed to sort of be 
a bit invested in what they wanted to get out of having a clinical 
pharmacist as part of the team, and the organisation I work for was 
just funding that role so that it would be explored, so I think it’s quite 
difficult for a pharmacist to sort of be dropped into a general 
practice where all the day to day processes are happening whether 
they’re there or not, and to find their niche, their place, where they 
can feel that they are making a difference, and there was also- 




week, so the pharmacist can’t be there all the time, so for them to 
find what are the things they can do in that time that make a 
difference to the patience and to the practice. 
00:06:56 S1 All right, yeah.  So it’s a bit of time issue as welcoming people, it’s 
not like a full time role at the moment. 
00:07:03 S2 Not at the moment, no. 
00:07:04 S1 Not at the moment, all right, yeah, yeah, that’s fine.  And you will 
have also contacted with the other clinical team members like GPs or 
nurses who have been in touch with the GP pharmacist in practice as 
well, so do you believe there was or anyone of them has shown any 
mismatch of expectations of what has happened since the- and since 
this pilot scheme has started? 
00:07:35 S2 Well certainly some GPs are more adjourned to what they- they can 
work with the pharmacist than others, but it is a role that needs time 
for that sort of relationship and trust to be built, I think- so some GPs 
are much faster or more trusting, other GPs are slower to sort of see 
how they can relate to the pharmacist, what sort of tasks that they 
expect or expertise they can expect, so it’s certainly not even across 
the board, and the we- in our general practices, we have practice 
nurses, they’re called practice nurses rather than a trained nurses, 
who have patient facing roles, some of which would overlap with 
what the pharmacist could also be offering, so- and I think when a 
new position comes into place, people might be a little bit concerned 
about role encouragement and that might have been more of that 
with the nurses than other staff and other- than the GPs themselves, 
but nothing serious, so I think it’s something that the pharmacist 
have been mindful for, for example, nurses working with patients 
who have respiratory conditions or type two diabetes, there’s a lot of 
overlap in showing people how to use devices and how to manage 
the medicines in that setting which the nurses probably have been 
doing all along and may not want to really increase some of their sort 
of activity.   
00:09:42 S1 All right.  So yeah, it’s a bit of what you can say- over here, it was the 
same thing as well even when I started, it was always like well, I think 
the role rather than bleaching the cat, it was more like there was a 
bit of concern that we have come to take over what nurses was 
already doing in the practice, so yeah, there was a bit of a mismatch 
of the expectations, all the role specifications, same scenario with it 




00:10:17 S2 Yes. 
00:10:19 S1  
00:10:45 S2  
00:10:50 S1 All right, sorry, sorry, Christine.  What I mean was I mean looking at 
the present scenario now or whichever role specifications have come 
now for the GP pharmacist here, do you believe or do you think that 
how well the pharmacist was professionally prepared or trained to 
take on this role? 
00:11:14 S2 I don’t, but I think that because it’s a new role and despite that 
there’s been quite- there is quite a lot of activity on that front, 
people have independently started working with general practice, so 
not many but a few, and so they’re sort of the ground breaking 
people that are feeding back to our industry ways to go about this, 
professional society as a pharmaceutical society of Australia is 
currently using that sort of information to create a training package 
to prepare pharmacist for working in that role, so they’ve come 
behind the trend setters, the people who have broken the ice, but I 
think it’s very hard to actually sit very specifications for the roles, 
because each focus is very different. 
00:12:18 S1 Has its own demands, yeah, yeah. 
00:12:20 S2 And I think the way our pilot was triggered was really a identified 
area of concern for older people on polypharmacy, so polypharmacy 
is a sort of the first word of the year and people somehow think that 
you can you know, accept with a click of a fingers, and so one of the 
solutions that we come up with was to have a pharmacist as part of 
the GP team so that they could perhaps focus on older patients in 
the practice who were on a lot of medications and review their 
medication management and work with the GP on a you know, 
carefully and considered and monitor the prescribing way that was 
deemed appropriate… 
00:13:21 S1 So you think- so if I’m getting it right, so basically the training 
modules or the training sector is being renewed or I mean they are 
designing the training based on whatever experience or whatever- I 
mean the things have happened in recent years, based on them, 
there are new training modules or structure is being done by 
different organisations in Australia if it… 
00:13:50 S2 Really being done by the pharmacy legal society of Australia, and 




our system is quite different, so our general practices work on a free 
for service model and I think in UK it’s more a cavitation model, so 
that- the system starts in our model where doctors are rewarded for 
[inaudible 00:14:29] it is really quite hard to put in- implement 
activities on there about quality improvement necessarily, but the 
report has to be preserved so that means that spacing the general 
practice is a priority for a prescriber rather than somebody who is 
actually not generating income. 
00:15:03 S1  what the initial operational challenges or hurdles you face while 
working with the GP pharmacist as an organisational lead 
considering expectations and reservations you had, expect like, job 
description, management skills, communication skills, initial training, 
cost factor, any specific barrier you face? 
00:15:44 S2 I think I was concerned about the challenges of the pharmacist being 
fairly isolated within the practice, so we attempted to put in 
conditions I guess to help mitigate that in that there needed to be a 
champion GP and a demonstration by the practice that- of how they 
wouldn’t utilise that role, and so to make sure that the pharmacist 
had you know, a visible presence and a name on the door, an email 
address, a space to work, was part of the clinical team, invited to 
clinical meetings, et cetera, so I think because we insisted that spend 
a couple of months of trying and getting all those things in place 
before the pharmacist commenced, I think we were able to mitigate 
that risk, and compared to now as a trial sort of being underway 
where the pharmacist spend six months trying to demonstrate that 
they were useful process. 
00:17:00 S1  
00:17:03 S2  
00:17:04 S1 Yeah, yeah, definitely.  I think it was an almost similar over here as 
well, availability of the rooms, integration into the team, initial 
concerns, how the- what task they have been given out, cost factor, 
all these were here as well, a bit of different structure but yeah, I 
think the initial reservations they was saying they’re the same, so 
this one. 
00:17:29 S2 Yes, and one other concern that was- has been raised, not 
specifically me, but something that is in the background that is of 
concern is the relationship with the community pharmacist that they 
don’t feel that the role or they’ve been bypassed, because they also 




so that the role of the GP- pharmacist in general practice was more 
to coordinate and connect and refer patients back to their 
community pharmacy for services that they can provide like you 
know, I guess words to text, but other forms of medication checks 
that the pharmacies can provide and that they area also 
remunerated for. 
00:18:34 S1 Right.  Just getting to another question from the same discussion, 
how did you choose the GP pharmacist for the pilot scheme?  
Because I mean sometimes it’s the community pharmacist who have 
got a bit of training and they can upgrade themselves for the role or 
was there any specific other criteria to apply for this role? 
00:18:57 S2 What we have in Australia is an intervention called a medication 
management review that is done in the home, to undertake that 
work pharmacist had to undergo an accreditation process with some 
up skilling that gives them a bit more expertise in working with- 
making reports for doctors, making sense of pathology reports as it 
relates to medications and targets and goals and things like that, so 
we have a workforce that is highly skilled and they often are not 
working fulltime in community pharmacies, they may be doing all of 
that sort of medication review work or part time in a pharmacy and 
part time doing reviews, so- and because the home medicine review 
is an intervention that’s done jointly between a GP and a pharmacist, 
an accredited pharmacist, the GP is also remunerated for that 
intervention for their party net, and the pharmacist is remunerated, 
so the- and most general practices want to have more of that activity 
from the pharmacist that works there, either- so coordinating that 
sort of work or identifying patients that would benefit from that, et 
cetera, so the practices actually had to employ the pharmacist, so 
our agency didn’t employ the pharmacist, we provided the practice 
with funding and they advertised and interviewed and employed the 
pharmacist themselves. 
00:20:51 S1  
00:20:53 S2 And mostly they were looking for an accredited pharmacist so- and 
someone who had a bit more maturity and experience. 
00:21:01 S1 Okay, all right.  That’s fine, brilliant, and all right, that’s fine.  Just 
moving on then Christine, I think you have answered this one but I 
will just repeat the question if you want to add something, what 




organisation to GP pharmacist to work in this challenges and 
hurdles? 
00:21:27 S2 Is that a question that’s on my sheet? 
00:21:30 S1 Yeah.  I think it’s question number seven, but most probably you 
have already answered it, yeah. 
00:21:39 S2 Yeah.  So I guess with that- that’s we’re insisted that they prepare for 
the pharmacist role and so they had a three month lead up time 
before they needed to employ a pharmacist, they could employ 
them sooner than that, but it was expected that they would help 
develop the plan of the work and what they would be doing and 
basically prepare their practitioners in their space and their team on 
the role. 
00:22:10 S1  
00:22:13 S2 But yeah, for the actual talking with the pharmacist, yes, we had 
close contact with the pharmacist once they were selected and 
employed, we connect them with a GP pharmacist who was working 
in another state who had been joined there for 10 years who had a 
lot of insights, so we had a Skype call resume meeting or something, 
where they connected with that person, also there is like a chat 
room for pharmacist working in general practice that- who can you 
know, they- it’s like a projected check room where they can just 
share experience, so we made sure that they had access to those 
peer to peer type supports. 
00:23:09 S1  I understand and I think there’s the basic support, I mean from my 
own experience, I think that’s the basic or the best support you can 
give just to give a bit of feedback and a bit of support from the back 
that yeah, you are here for your specific role and we have training 
support or all this support yeah, definitely helps out, so that’s fine. 
00:23:34 S2 Yes. 
00:23:35 S1 Okay.  Let’s moving on to number eight, just what are your views on 
GP pharmacist scope of practice, has there ever been any medical 
legal issues where concerns were raised by yourself or any other 
helping professional about GP pharmacist area of expertise 
(Background Noises) 
00:23:56 S2 I don’t believe it has, and I think that’s what the pharmaceutical 
society in their developing the training package, I mean in Australia 




pharmacists, so we have- we always have in Australia, we possible do 
there as well a bit of a turf was between doctors and pharmacist, 
doctors always feeling pharmacist are trying to take over the world, 
so I think that there is definitely a need to be quite clear about the 
scope of practice and the pharmacist is obliged to conform with the 
pharmacist sort of guidelines and ethical obligations and not to be 
doing things outside their expertise, so that means that they’re not 
doing some of the- a lot of the things that the nurses can do in terms 
of more patient focused health checks and things like that, although 
it’s not out of a pharmacist scope to take blood pressure for 
instance, but it might be out of their scope to start you know, looking 
in ears and down throats and things when there’s no nurses here to 
do that. 
00:25:31 S1 But I mean by now or by today, there has been no medical legal issue 
that has been in your knowledge about pharmacist crossing their 
boundary or something where the issue has been raised up by any 
clinical person that pharmacy should have not done this. 
00:25:52 S2 Not that I’m aware of. 
00:25:53 S1 Not aware, brilliant.  That’s fine, brilliant, okay.  This last question for 
this one, what should be the key performance indicator you think 
for- to assess or to gauge up the pharmacist role in GP practice, any 
specific key, KPIs you think should be there for the pharmacist? 
00:26:13 S2 Well that’s been a really difficult area to decide how do you evaluate 
an outcome, so we have the convenience of being able to I guess, 
see an increase in home medicine reviews conducted in the practice, 
so it’s a bit underutilised intervention, because it’s quite 
complicated, the doctor- the GP has to identify the patient, discuss 
whether they would be happy to have a pharmacist come to their 
home, then make a referral on the pharmacist to send to, then the 
pharmacist has to bring the patient and make an appointment at a 
convenient time to go their home, and go through all their medicines 
and their issues, and the pharmacist has to write a report and 
provide that back to the GP who made the referral who then has to 
recall the patient to the practice for a consultation to devise an on-
going medication management plan and if all that work with the 
patient, so it’s quite a… 
00:27:25 S1 It’s a difficult one to, yeah, yeah… 




Notes abt positive impact of Home mediscine reiew service. 
 
Yeah, it’s a clumsy thing, so many GPs, if they weren’t happy with the 
first attempts that pharmacist writing reports on that, they often 
didn’t pursue that or forget about it like, don’t remember it exists, et 
cetera, so it’s easy to increase that by having a pharmacist there to 
identify patients and do a lot of that preliminary work and to 
coordinate that whole medication review stuff, so we had differ in 
measuring that because it is a medicine supportive intervention that 
the government has been prepared to pay for and you know, there’s 
been researches, it’s an evidence based intervention that helps 
things like HbA1c and cholesterol levels a ND number of medicines, 
et cetera, so we’re counting that, and then any other- we’re counting 
direct patient encounters that the pharmacist has with patients in 
there, so they might have direct face to face consultations with 
patients about medicines here, and we also count the number of 
contact with GPs around questions or clinical meetings like, 
sometimes a pharmacist are presenting on a clinical topic, so how 
many clinical meetings, et cetera, and also, we’re also measuring 
patient’s sort of satisfaction and a measure of GP satisfaction… 
00:29:16 S1 That’s really nice Christine, because I think when I ask this question 
over here, I mean we have got a bit more experience, but to be 
honest to you, your answer is much more in detail and it has given 
some good ideas to be honest, so yeah, thank you, that’s good.   
00:29:34 S2 Okay. 
00:29:34 S1  
00:29:41 S2 I think we can move onto the next one. 
00:29:43 S1 Next one, all right, brilliant.  All right, thank you.  All right.  The 
second one is about the working collaboration, most probably you 
have answered quite a few things already in your previous answers 
but I will just repeat the question if you want to add something to it, 
it’s about the GP pharmacists, nurse, organisational lead and other 
staff members in the practice working collaboration, all right.  So I 
mean how you evaluate the working relationship of GP pharmacist 
with other team members of your organisation, and do you think it 
has been improved since beginning? 
00:30:22 S2 I guess because we have had maybe monthly- two monthly meetings 




generally the practice manager and the pharmacist, and I think- the 
working relationships appear to be very really good, although we’ve 
got two practices, one where the pharmacist is much more 
micromanaged by the practice manager, and the other one where 
the pharmacist has sort of more created their own- have got what 
they do, they’re not sort of like having to- these are micromanaged, 
and that’s just a personality of the practice managers in each 
instance.  (importance of practice manager in defining role) 
00:31:19 S1 So I mean what do you think which one is…? 
00:31:20 S2 But overall- sorry? 
00:31:23 S1 So I mean just comparing both practices, what do you think in your 
own personal opinion, which one is working better? 
00:31:37 S2 It depends what you’re looking at from, it appears if you’re just going 
on numbers, and I mean they’re very- they’re totally different 
practices, but it seems like the one that’s got the free scope seems to 
be able to be really increasing the amount of reviews, but then it’s a 
much bigger practice that they’ve got two other several practices, so 
he has actually got a lot more people to work with, the other one 
that is micromanaged is I think that pharmacist who’s a very, very 
experienced pharmacist, and also she must be a whole lot more 
cautious I think about territorial boundaries and things, she’s doing 
very well, but I think it’s a little bit hard going for her. (for discussion) 
00:32:37 S1  
00:32:40 S2 But they’re both happy, they’re both happy, it’s you know, and I have 
had contact with pharmacists doing this in other settings and other 
PHNs, other primary health clinic networks, who had said that that 
was awful and they didn’t work because the GPs didn’t have any 
idea what they were there for, they had been assigned a document 
by some business corporation lead who didn’t even tell the GPs, I 
have no idea what the pharmacist was there, and they couldn’t 
really get much leeway, so they actually folded. 
00:33:19 S1  
 S2  
00:33:26 S1 A lot better than that, all right, that’s good, that’s good.  Okay, 
brilliant.  Okay.  okay, the next one, how do you differentiate 
practice pharmacist role with another practice nurse, I mean as 




we have discussed before, but I mean just specifically where you 
think is the top of still there with the nurse as well? 
00:34:00 S2 I think the pharmacist are very aware of that, that that’s going to be 
a problem solving, they’re just very careful and offer- they offered to 
help separately but don’t try to takeover, but it does- I think the 
pharmacist feel that they would do actually a better job of some of 
those things, but that’s not- that’s just based on their biased, so it is 
a difficult area that has to be sorted, because in the end you really 
want each person working to their full scope, so not feeling 
aggrieved by that but finding where is the place that the pharmacist 
can make the most difference to the patients, and maybe in time, 
the practice can say, “Well, we can actually relieve the nurse of a 
whole section of what she’s doing with diabetes patient, and she can 
then see more patients and the pharmacist just is signing off on the 
medication part of that.” I think that takes time and I think that will 
happen eventually. 
00:35:18 S1 It will happen, yeah.  I think it just need a bit of time, acceptance of 
the role and just to be a part of the team, to be honest just sharing 
my opinion- my reviews and my experience, it was same in this hand, 
you can see a bit of tension in the air, but now, I mean I have been 
working like two, three years now, and it has been so much easy now 
what I need to be passed on or what task I need to do, where are my 
boundaries or what I need to be doing, so yeah, that is- it’s just a bit 
of time, acceptance of the role and it does work out, it does work 
out.  All right, brilliant.  So just moving onto the next one, I will just 
combine them altogether, how easy you find GP pharmacist to 
approach and communicate?  I mean this was- it was a question 
which I just made out for the organisation lead in England when I 
was working because she was not a pharmacist, she was- I mean we 
had an organisation here so if you want to answer this one or 
whichever way, shall we move on because you are in contact with 
them, I think you have answered this question, okay, if you want to 
add something there? 
00:36:50 S2 Sorry, I lost you just towards the end of that.  Did you want me to 
comment on that? 
00:36:55 S1 I mean yeah, I mean if you want to add, because you already have 
answered this one, but if you want to add something to it, number 
12. 
00:37:02 S2 Yes, so yes, so I guess it’s my peculiar- because I am a pharmacist and 




do with them, so I just think there is an understanding you know, you 
live and breathe the same issues, so I love communicating with other 
pharmacists and… 
00:37:31 S1 And they are… 
00:37:32 S2 And yeah on how that’s going. 
00:37:34 S1 And they are easy to get the messages from you or from the other 
side of the team and they are communicating well with you and they 
have got it, yeah, yeah, just giving the right feedback about the pilot 
scheme, everything has been working well, yeah. 
00:37:51 S2  
00:37:54 S1  
00:37:56   
00:37:57 S1  
00:38:02 S2  
00:38:03 S1 What factor you believe influence this working collaboration and 
what steps you think should be taken or can be taken to improve this 
working collaboration? 
00:38:17 S2 So do you mean just the general working collaboration within the 
practice for those people or for me as a lead involved? 
00:38:24 S1 Just generally, anyone I mean you think so, for yourself or with the 
team as well, even if- you know the clerical staff as well who is 
dealing with the prescriptions or dealing with the queries over the 
counter, over the reception, all those type of people. 
00:38:43 S2 I think with- as organisation funding, we have sort of looked for early 
signs of maybe acceptance of the role and getting to know them 
from the receptionist you know, right through to you know, the 
senior principal GP, and I think that that all worked very well but that 
has been because of the engagement and investment of the practice 
manager, because they’re sort of the- I guess they’re looking for the 
next cheque from us, the next payment, and they want it to work, so 
if it all falls apart, the money stops. 
00:39:35 S1 All right, all right, yeah. 
00:39:36 S2 So I think it’s been- it’s worked very smoothly, I think we’re really 
happy, and my colleague who is actually the contract manager for 




that he has now got represented like a dashboard with sort of 
growths and refs and things and it looks very- and it’s very 
encouraging for them I think to see that things are actually moving, 
and you know, they’ve got it all there in front of them, so I think 
that’s been encouraging. 
00:40:19 S1 You think, all right, that’s fine.  And how you feel, I mean you did 
mention a few- something about the working collaboration of 
pharmacist and practice with the community pharmacist, where do 
you think that stands now at the moment? 
00:40:37 S2 Okay.  One of the two pilot areas we had to do a little bit of 
(Background Noises) on that area, because it was- the pharmacist 
and general practice made the mistake of thinking that they should 
be doing all the home medicine reviews himself, and so previously 
the work had been done via the community pharmacy who- they 
own accredited pharmacist society with their business who provided 
the home medicine reviews, then- so some- and they weren’t 
impressed, so that feedback was received and the pharmacist, once 
he understood that we were- because the number of home medicine 
reviews that can be remunerated for any particular pharmacist is 
kept, they can’t do more than 20 in a month, and so we said you 
know, we didn’t want you to do them, you can do some outside the 
20 hours because remunerated by the government, but we wanted 
you to identify the patients that would benefit the most and 
coordinate them, help the doctors to you know, get the referral 
down and get out there, and to work with our community providers 
to build up a network, so that was remedied, but yeah, that was 
something that we didn’t expect to happen. 
00:42:13 S1  
00:42:17 S2  
00:42:19 S1  
00:42:23 S2 Yeah.  No, I just think it’s important to be to make sure that the 
community pharmacies role is not undervalued or bypassed and that 
they are still made aware of the paramount of what is supporting 
patients, because they’re the first one- they see them every month 
to get their prescriptions and walk- they can just walk in without an 
appointment, and the community pharmacist do a great supporting 
role, so I definitely want to manage that relationship. 




00:43:03 S2 Yeah, that particular problem is now solved. 
00:43:06 S1  
00:43:13 S2 Yes, sure. 
00:43:13 S1 It’s about the pharmacist skillset again, So it’s more I mean about the 
patient facing role about- for the GP pharmacist, I don’t know 
whether they are doing at the moment in the practices out there or 
not, but how you feel are they really do have a bit more like a patient 
facing role now in the GP practices like, running clinics or any 
vaccinations or- I mean doing the long term reviews, something like 
this? 
00:43:53 S2 I think that won’t take long to evolve, there’s certainly pharmacist 
that have sufficient expertise and perhaps are doing these things in 
other settings, I think it is an evolving thing in general practice 
because I guess most of like the clinics would be a nurses- nurse led, 
and that would be- so I guess it really come to understand the 
expertise and the scope of practice of the practice pharmacist to get 
the most out of what can be offered I think. 
00:44:43 S1 But in your- these two pharmacist, are they doing any patient facing 
role other than the reviews at the moment? 
00:44:53 S2 Yes, they do patient facing roles and- so sometimes a doctor will 
send a patient in directly to the pharmacist to- as for a consultation 
around their medications, maybe it’s around demonstrating device 
technique or ask for medications or reinforcing complex instructions, 
just making sure that they’ve got all that because then the doctor 
doesn’t have to spend that time I guess, if the pharmacist is there, 
they could be seeing another patient and know that the pharmacist 
will look at what those medications are and ensure that the patient 
has sufficient information, resources, printouts, et cetera, to make 
sure that they can make those medications, so that exists now, yes. 
00:45:44 S1 Yeah, definitely.  All right, that’s fine.  And what are your thoughts 
about the prescribing role of the pharmacist, any reservations you 
have with yourself or you have any reservations from the GPs or 
nurses or any other organisation? 
00:46:03 S2 It hasn’t been actually part of the role as we see it now, I think there 
is a current- a lot of talk currently about pharmacist about 
prescribing, and that the society- the pharmaceutical society 
supports a- like a supervised non-autonomous prescribing, so I guess 




could write the next repeat prescription sort of level, but not a part 
of prescribing, so our workforces are ready to take that on by yeah, if 
there was any more autonomous prescribing it would be specialised 
and section would probably be only in specialised settings, so I 
guess- I think it would fit quite well but it’s- we’re not mature 
enough in that area yet to actually have sensible discussions with 
practices about that yet, that’s not possible yet. 
00:47:21 S1  
00:47:24 S2 It’s not possible yet.  We do look with envy over UK because we 
know that you have pharmacist prescribing and it’s- but we have a 
very bristly at times relationship at higher levels between the GP- the 
paid body and our own pharmacy paid body that plays out in the 
media on the ground and get along quite reasonably, and there’s no 
pharmacist pretending that they’re writing prescriptions, yeah, so 
that’s the conversation that plays out in the media really, but it is an 
aspiration to have more scope in selected prescribing roles. 
00:48:16 S1 I think we have answered the- something about this model about the 
protocols you said about organisational level so it is more like set of 
the standards or specific field where the pharmacist can prescribe, 
but I think it’s in a very initial phase, even the discussion is in a very 
initial phase at the moment in Australia, am I right? 
00:48:41 S2 Yes, yes, and it would require policies and training and credential and 
regulatory changes, et cetera, so at a lower level, there doesn’t need 
to be perhaps regulatory changes, but there needs to be 
credentialing because yeah, everyone might want to do this and so it 
will be quite- it will evolve in little bits I think, so they might- but I 
think mean they’ve sort of changed scheduling to allow pharmacist 
to supply and that’s almost like prescribing so like for morning after 
pill and things like that, and limited to things for treating migraine, 
but there’s sort of limits around what you can supply that for and 
recording it, so it’s semi there in small areas, and whether it just 
grows a little from there. 
00:49:52 S1 Definitely.  Because in UK… 
00:49:54 S2 Which would mean that would it necessarily help to change the 
schedule from prescription only if pharmacist could prescribe certain 
prescription only. 
00:50:05 S1 All right, yeah.  And in UK it started with the supplementary 
prescribing where there was an agreed document type of thing like 




between pharmacist, patient, and the GP, the GP has done the 
diagnosis, they have put the patient on some prescription most 
probably, and then whenever the patient needs the next load of the 
pill, rather than going to the surgery that yes, she use to go to the 
pharmacist and they were allowed to issue the prescription based on 
nothing has changed, so yeah, that was more like a supplementary 
prescription, yeah, yeah. 
00:50:46 S2 That will be exactly how it happened, so limitations, yeah, the doctor 
has to be involved in the beginning and it has to be like you say, no 
changes, no red flags, it’s really just a repeat and things going well, 
and I think that we’re all moving to that, but it would probably take 
50 years but… (Laughter) 
00:51:11 S1 You’re right in that one.  Okay, that’s good.  All right.  Because in UK, 
it has progressed very quickly to be honest and I think it was a good 
push from our society and which was supported by the GP federation 
as well, I think they do realise now that how much workload even 
just the prescription, the workload that has been taken by the 
pharmacist in UK now, and they do appreciate it now, they do 
appreciate it now, yeah.  So that’s good.   
00:51:46 S2 Yeah.  That’s a nice point to get to. 
00:51:49 S1 Yeah, yeah.  It was, but I mean the other concern that they 
understand was in the med insurance because they were a bit 
concern about the insurance, but now all of the surgeries, they do 
take the pharmacist, even with the prescribing role in their own 
insurance because they have got a bit more trust on the system now 
and which is a really good point- which is a really good positive thing 
for the pharmacist, but otherwise in terms of insurance for the 
pharmacist, for the prescribing role was very high for the pharmacist 
on its own which was a big barrier, but now it has changed so which 
is a good thing to have. 
00:52:31 S2 Okay. 
00:52:33 S1 All right.  The number 18th one, what are your thoughts about the 
medicine manage skills of the pharmacist, I think that’s the main 
role which is being done at the moment in Australia, so… 
00:52:46 S2 Yeah, yeah.  These and they’re already credentialed and I guess 
when the doctors- they’re interviewed for the role by the practice, 
they judge a person on maturity and experience and patient you 
know, how they approach patients, how they write reports for 




that do that sort of well and doctors you know, get offended by the 
report instead of feeling supportive. 
00:53:25 S1 All right, yeah, yeah, yeah. 
00:53:29 S2 I think there’s room for improvement around that stream like that 
because it’s- when we did research or surveys to try to discover how 
the GPs prefer to receive the report as in how much it contain, what 
types of things and how it sit out, blah, blah, there was so many 
different answers you know, that goes just all over the shop, so it 
didn’t really get changed. 
00:53:58 S1 Okay, all right, all right.  That’s fine. 
00:54:02 S2 Sorry, yeah.  What one GP likes, the other GP doesn’t. 
00:54:06 S1 Yes, a big different, all right.  That’s fine.  Okay.  Number 19th one, 
how well your GP pharmacist role to link surgery with community 
pharmacy hospital in any other health related organisations and do 
you think the pharmacist can be in the centre of this 
communication? 
00:54:29 S2 I think that would be really good- it would rely on the pharmacist 
being full time which our pilots are not, I think that coordinating role 
where decision are being made about medicines is just- it’s 
underestimated how much improvement could be made if that role 
is done and done well, so I mean probably the same in the UK but 
discharge from hospital is such a big gap for things going wrong, the 
discharge information often doesn’t get to the GP before the patient 
comes back, they often don’t even know their patients in hospital, 
the pharmacies packed three- we use the packs ahead of time and 
doesn’t know that everything’s changed and so it would be an ideal 
area for a pharmacist to communicate, coordinate all the players 
that the GP has the information, the community pharmacy has the 
information, the family and the patient have some opportunity to be 
probably informed and understand any new medicines and changes 
and they will have to take things and how to manage the discharge 
clutter of OP wards and things like that. 
00:56:06 S1  
00:56:08 S2 Do you have that in UK, everyone comes out of hospital with a 
packet of oxycodone here. 
00:56:13 S1 Is it?  All right.  Okay.  We have got I think in the last few months we 




initiating any opioid like oxycodone or morphine, it’s just for a couple 
of weeks and then we have to review it and most probably yeah, 
unless it is something essential, otherwise we’re not going to 
continue it, so- unless there’s more like a pharmacist role to start 
with in reviewing the pain management and getting something, it 
needs to be continued and we just keep it like an acute item, and 
then we don’t put them all with it so that every time when they 
order something, we have to review how the things happen in past 
month, so… 
00:57:09 S2 Yes, yeah.  I think that’s important, they’re starting to move on what 
we’re calling opioid stewardship in hospitals, but also so that it’s 
alright for us making decisions about this and that but the patient 
often doesn’t have the clue, because they you know, so involving the 
patient in understanding the pain, recovery trajectory, what they can 
expect and what they- how long the tablets are meant for and how 
they take care and keep and touch and all that sort of stuff, I think 
that’s sort of something that pharmacist could really take on, yeah. 
00:57:47 S1 Yeah.  I think there’s something with pharmacist can differentiate or 
stand up separately about the nurses, because the nurses, yeah, they 
have got clinical knowledge that it might be because of their 
experience, but pharmacist, they have got much more better 
knowledge medication-wise, so yeah, that’s where they can stand up 
into- in taking this role, yeah. 
00:58:13 S2 I think sometimes- so we have new senior roles here, you probably 
have that too, sometimes the nurses are called in to that to provide 
what they describe as medication management which is really 
medication administration, and then just make sure it’s put in their 
head or whatever, but they’re not across hey hang on you know, 
what do you do with these, why are they so bruised for their you 
know, it’s just- they just want to sign chart and give it whereas the 
pharmacist are like, “Oh, we think of all these other things.” and 
that’s different, so when I think managing the administration of a 
child medicines compared to medication and management.  
00:59:05 S1  
00:59:59 S2  
01:00:00 S1  
01:00:02 S2 But it’s only funded- the only funding that the pharmacist and 
general practice can get is by doing or coordinating, generating 




government doesn’t pay pharmacist to be there yet, so that’s a 
struggle because there’s no way to get them remunerated, so 
organisations like us getting often paid, give the practice the money 
to pay the pharmacist, but when we step away, if they can’t see that 
there’s enough value to continue that themselves with perhaps what 
they can generate from home medicine reviews, it’s likely to 
diminish, it’s likely to be an eight hour awake role. 
01:00:51 S1 Okay.  But the funding of the money you are paying is separate to 
that home medications reviews, isn’t it? 
01:00:59 S2 It is, it is.  So we’re paying like, so that they can pay the pharmacist to 
salary, the pharmacist has another 20 hours of their work where they 
can draw home medicine reviews if they choose, but one of the 
pharmacist work in a community pharmacy so she hasn’t got time to 
do them, the other pharmacy doesn’t and he does a lot of additional 
home medicine reviews in his own time. 
01:01:25 S1 
01:01:38 S2 
01:01:39 S1 Yeah, all right, this one.  So these questions are based from the 
previous discussion that we have and see how the things are moving 
out for the future, so- I mean would you think now is the future of 
the GP pharmacist role in the next one, two years, where you see the 
things are moving up now? 
01:02:00 S2 I think they’re moving very rapidly, there’s more PH and so there’s 31 
PHN across Australia, and several of them, probably- there’s 
probably about 20 that now involve in piloting- this is a workforce 
model to get learnings from it, to find out how does it work, what are 
the barriers, what are the enablers, et cetera, the society is creating 
a package they’re talking about you know, from the beginning as a 
career path, so I think over the next- I’d say over the next five years, I 
think a critical thing would be how is it going to be remunerated if 
the government can see that this would save them money, they may 
provide some sort of incentive funding to practices to have practice 
sessions there has been a sort of a cost benefit analysis done for to 
try and influence government on this, so we worked out that every 
dollar invested in the role of the GP pharmacist would transfer to a 
saving of a $1.56 costs to the health system. 
01:03:30 S1 To the health system, all right.  I think I will just move to number 25th 
question I have, based on this discussion, one aspect is the woman 




with the GPs or any GP lead or practice where they can take 
pharmacist on their own practice budget and see if they want to 
employ without any funding support? 
01:03:58 S2 I think that would be- it has happened, it has happened, and I mean I 
know of one and there’s probably more, and we get GP to say I 
wanted to start up a practice and they said these are the people I 
needed on my team, a receptionist, a nurse, a pharmacist and 
someone to do the accounts, et cetera, so some do things like that, 
but I think that getting incentive payments is what our practice has 
just learned to expect and that’s probably would be the thing that 
makes a bigger difference.   
01:04:39 S1 All right, brilliant, that’s fine.  Brilliant, okay.  All right.  I think we 
have answered the number 22 because you have said that in the 
next five to 10 years, the things will change over a period, but if you 
want to add something to that or should we move onto the number 
23rd? 
01:04:58 S2 Mm-hmm. 
01:04:59 S1 Okay.  And any feedback from the patient about the GP pharmacist 
role where you see how the patient has been giving the feedback 
about the pharmacist working in the GP practice? 
01:05:11 S2 Yeah.  They use like just a very simple patient satisfaction survey like 
a little- like at a scale of one to five to measure level of satisfaction or 
relevance or something, and so it’s quite basic but they give them 
the form and they just put it in a box in the reception on their way 
out, and that- so their score is really high, it’s like, 4.9 out of five on 
average or something like that at the last- on the last survey, so they 
said there has been- I mean possibly people who feel lows you know, 
people who are satisfied and the ones who are not- don’t bother, so 
it’s not terribly rigorous, that’s an indicator, and I guess there’s other 
ways that they could give feedback to the practice if they were 
unhappy and that hasn’t happened. 
01:06:10 S1 It hasn’t happened, all right, that’s good, that’s good.  All right.  
Okay.  (Pause) Number 25th we have done, so we will just move onto 
the- I think number 26th again is something related to the employing 
of the GP pharmacist so we have these question again, I mean if I’m 
skipping any questions which you want to answer, just let me know, 
yeah, because I think we have those two questions, yeah, yeah. 




01:06:42 S1 Yeah, all right.  How well do you believe GP pharmacies has evolved 
impacting on overall healthcare provisions, I mean do you believe 
the initial mentor or training, all the mental strength of the 
pharmacist when they started this role and with this thing now, have 
they strengthen themselves up? 
01:07:09 S2 So they’ve been going only a little bit over 12 months, so it’s a bit 
hard to judge on overall health care provisions, I think it’s a bit- it’s 
hard to measure with a small- two pharmacist in two separate 
practices. 
01:07:38 S1 But do you feel that pharmacist on the round, they are feeling more 
comfortable now working and going there in the practices? 
01:07:46 S2 Of course, yes. 
01:07:47 S1 Yeah, yeah, yeah.  Definitely more comfortable, yeah, that’s good, all 
right.  And what do you think, I mean do you think that on the round, 
how the feedback is coming or the workload, do you feel that it 
should be still carry on with the full time or should be still as a part 
time or full time role? 
01:08:06 S2 Okay.  Well it’s being funded as a part time, so I mean point 5 EFTS 
we call it or 20 hours instead of 40, and I think that once the role 
evolves and moves into things like coordination and other systems 
help that, so some of the things- systems things need to be changed 
to enable full benefit of the role, and then I think it would need to be 
a full time role where every day you know that there was a time that 
a patient could see a pharmacist or that a doctor could ask a 
pharmacist to stay for advice about a clinical medication decisions or 
follow up discharge or create you know, a presentation to deal with 
clinical conundrum or whatever, I think it needs to be a full 
important full time role. 
01:09:16 S1 Full time role, yeah, yeah.  No, that’s brilliant, that’s fine.  Okay.  And 
I mean based on your own overall experience of any specific aspects 
of training, would you like to see for the pharmacist to improve their 
competency as GP pharmacist? 
01:09:34 S2 Yeah.  I think- this is a hard one, I think I’ve looked at my couple of 
training practices that have been devised by the pharmaceutical 
society, and I think you can do that sort of training but nothing will 
substitute actually working in a GP practice, because you just really 
needed experience, so I think it is something that the training is part 
of it but I think it really needs opportunity for clinical placement of 




whole lot of training about general practice, and then in reality 
they’re all different, they all go about things slightly differently, and 
they are private businesses here and there so they’ve got a bottom 
line, they’ve had expectations, I think the opportunity to experience 
working in a general practice alongside the theory training will be a 
very important- being and that’s probably had put in place into, 
you’ve got more experienced pharmacist or any in places to be 
mentors. 
01:10:59 S1 Okay, all right, all right.  That’s fine, that’s fine.  All right.  Where we 
are now?  Okay, I will just move onto the- I think we are just 
finalising, we are just summarising it at now, so last few questions, so 
how are you going to comment on the GP pharmacist role from the 
success or the failure of this role just summarising any barrier and 
facilitators in your own opinion, just summarising the whole 
discussion? 
01:11:37 S2 Sorry, I don’t quite understand what you’re saying, I’m not sure… 
01:11:40 S1 Sorry, sorry.  I mean just summarising the whole discussion Christine, 
if you just want to highlight a few bullet point I put in just to say- I 
mean what should I say, comment on the success and the failure or 
any bullet points how the role can be successful and I mean any 
specific barriers or facilitators for this role, any bullet points, either 
like a cost factor. 
01:12:17 S2 The cost factor is critical I think, that’s a barrier, that’s the biggest 
barrier in Australia for a pharmacist working in general practice 
because there is no pathway for remuneration on the role per se, it’s 
only the home medicine home review that can attract some 
remuneration from the government for that, but you don’t want to 
just make that just about that, there’s so many other things that’s 
just… 
01:12:48 S1 So if I just say that this is the biggest barrier at the moment, yeah? 
01:12:53 S2 Yeah.  It is, there’s no formal remuneration pathway. 
01:12:57 S1 And what would you think is the biggest facilitator at the moment 
like supporting…? 
01:13:02 S2 The biggest facilitator at the moment is I think the experience of the 
medication expertise that the pharmacist brings to the team. 




01:13:21 S2 And I think on the barrier side is that it’s generally quite a lack of 
knowledge by other health professionals of what a pharmacist does, 
especially conceptualising and non-dispensing role for pharmacist, so 
a lot of nurses, they’re all- even doctors just can’t quite get their 
head around it, this isn’t a dispensing role and then- so they just 
think, “Oh, what do you do then?” 
01:13:54 S1  
01:13:55 S2 So I think that’s a barrier that the role is not well understood what a 
pharmacist, so we just know what we do and what we can do, so 
we’re a bit stunned when people also don’t know, that’s silly of us.   
01:14:14 S1 Yeah, yeah, yeah.  I think with the time runs, we have got a bit more 
clarification on the role specifications based on what surgery needs 
and yeah, you can highlight this thing a bit more openly that this is 
my role and this is how I can integrate into the scheme, but yeah, it 
will take some time to… 
01:14:34 S2 Yes, and I think that will be important going forward and then how- 
when individuals bring within that specified role is you know, more 
or less of a benefit for each practice in individuals but to understand 
the role and why you want it is paramount. 
01:14:56 S1 Yeah, brilliant, all right.  That’s fine.  Christine, just a last thing, based 
on the research, I mean quite a few research articles have been 
published in UK and I think there are quite a few coming up in 
Australia as well about this role, any specific aspect you feel that in 
any further research that should be done on this- on GP pharmacist 
role, any specific aspect of the research? 
01:15:29 S2 Well I guess trying to demonstrate the benefit to patients really, it 
would be good if we could do that and it’s quite difficult because a 
lot of the funding, all that doesn’t long enough to see how it makes a 
difference over time once relationships are established, and even 
when you’re looking at reducing polypharmacy, you need quite a 
length of time for any general practice setting, I think it’s easier in an 
aged care facility, but in general practice is all comers, the 
pharmacist who need to deal with what presents and so it’s you 
know, it’s a lot of work, so in our funding, there’s just not sufficient 
money to get a whole heap of that and analyse it, it’s hasn’t been 
funded by that, so you’re trying to use these sort of surrogate like as 
a measure of things that don’t fit the government need for how 




01:16:40 S1 All right, yeah, yeah, yeah.  I think one of the other thing which I 
have found based on Australia is the- getting the views from the GPs 
about this role, and I’m having a bit of difficulty because I am away, 
so it’s a bit difficult to get engaged with the GPs out there, but even 
in the articles where we need a bit more input from the GPs how the 
things have been working in Australia about this role, this is my 
personal opinion, yeah, but yeah, I think the more feedback we get 
from the GPs about this role, the better research can be done and 
that can (Overlapping Conversation) the pharmacist, yeah, yeah. 
01:17:26 S2 So did you get any response from our GPs? 
01:17:29 S1 To be honest not yet directly, I think one of your pharmacist say she 
has a Saturday, the practice will give me the written response so I 
think they are having an inspection soon, some type of inspection, 
so… 
01:17:43 S2 Okay, yeah.  Looks like having their practice accreditation, everything 
stops doing practices to get their accreditation (Overlapping 
Conversation) they can’t get anything in.  Okay.  So that would be 
Karen, and does Karen have an interview with you? 
01:18:01 S1 I think I said that either we can do the interview, but if the whole 
practice has given me the written response, I said to Karen that if you 
can give me the written response as well then I can just keep it on 
the same- the way the methodology will remain the same, yeah, 
yeah, so I can integrate them (Overlapping Conversation) yeah, yeah, 
but… 
01:18:22 S2 That’s good.  All right Noshad, I do wish you well with putting all this 
together, I don’t envy you dealing with all these interview data. 
01:18:32 S1 Yeah, yeah.  That’s fine, thanks Christine and it has been really 
helpful, if you want to add anything else later, just let me know and I 
can have another sessions, but I think we have done quite a good 
covering and I’m really grateful for your time, it’s a big help. 
01:18:48 S2 Okay.  When you’re in Australia drop me an email just in case there is 
an opportunity just to catch up for a coffee or something. 
01:18:57 S1 Yeah, yeah, definitely.  I’m not sure where I’m going, but it’s 
somewhere in Melbourne, but yeah, I will give you an email and if if 
able we can have a sit down definitely, it will be really useful, yeah, 
yeah. 




01:19:11 S1 Thanks Christine, thanks for your time. 
01:19:13 S2 Okay, thank you. 
01:19:14 S1 Thanks a lot, take care. 
01:19:15 S2 Bye-bye. 
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00:01:13 S1 So I'm Lautitia Hetting.  I'm a pharmacist in Australia.  I’ve worked in 
quite a number of settings in Australia as well as originally in South 
Africa before coming to Australia but I’ve been here now for about 
21 years.  So I’ve worked in various clinical settings as well as more 
policy settings as well.  And before I joined Galtas Health, I worked as 
an academic.  So I've got a bit of academic background as well.  And 
when I was in academic, we also did some research with one of our 
students to the role of GP pharmacist in Australia and I think that’s 
how you kind of about our paper.  Currently, I'm working as a clinical 
researcher for Queens and Health at Goldcoasts. 
00:02:12 S2  The first one we started is about the perception and challenges 
about the GP pharmacist role from your research or from your 
experience, how you can see it.  So what are your views about 
general practice framework in Australia?  And do you believe there is 
any specific gaps that can be seen in Australia? 
00:03:57 S1 I mean working in a hospital setting here, certainly we identify that 
many patients come to hospital when they could actually go to their 
GP.  And for some GP practices, it’s quite challenging to get an 
appointment in Australia and they’re just quit busy and patients 
often when they need to see a doctor urgently, they’d rather just 
come to the emergency department with actually an issue that could 
have been dealt with by one of the primary healthcare so specifically 
in Australia, the model is quite challenging in that.  I mean obviously 
it’s funded by the government because most, or some of the GP’s 
practices they are pretty full.  Some of the GP practices, they do 
private funding so on top of the government funding that they 
charge an additional feel even though these practices are sometimes 
pretty difficult to get into.  So certainly  I think in terms of gaps, one 
of the main gaps or one of the main challenges is the fact that it can 
be quite difficult to get into a good GP.  And yeah, that then flows on 
to the public hospitals being flooded and we have issues sometimes 
with availability of this because people come to emergency 
department when they could really be looked after by someone else.  
00:05:39 S2 And then can you see realistic GP appointment it’s the same over 
here in England as well. And that's where the role of the GP comes.  
Do you feel the same thing? Or do you feel that gap the GP 
pharmacist can be integrated into the system? 
00:06:06 S1 Definitely, I think if I mean there’s already nurses integrated into 
marginal practices. And they do have some other and like health 




number of things and I suppose some of the lighter bits specifically if 
I look at what pharmacists do in our emergency department setting 
when patients come in, they can do that original medication reviews, 
when they come and reconciliation and so you know just as a start 
that's already some work that they can take from the GP’s.  And it 
certainly can get involved with helping patients with chronic 
conditions as well in terms of their medication and management so 
certainly I think it can take a load of GP’s to make them available to 
focus on other aspects and then also provide better and more 
accurate information about patients medication and also work on 
preventing medication related problem because that's what we do as 
pharmacists.  We are the experts in medication and so it’s our role to 
look at medication related issues.  
00:07:32 S2 It’s fine.  The initial time we give to the patient to report to the 
hospital the GP pharmacist can do the medication or the initial check 
up just to avoid patient going to the hospital.  Yes, that's fine.  So 
what barriers to facilitate, what opportunities do you think 
pharmacist, what do pharmacists adapting to slowly?  What will be 
the barriers anticipated for the role?  
00:08:06 S1 Yes so our project sort of focused on that quite a lot.  So as their 
man, let’s focus on facilitators first.  I think facilitators, one of the 
aspects is that our professional organisation, the pharmaceutical 
society supports the role of GP pharmacist and has developed a 
framework around that as well.  So that's definitely a facilitator.  And 
one of the other facilitator is that we in Australia have home 
medicine reviews. And so the government aids the pharmacists to do 
medication reviews at the patient’s home.  And so most of the GP 
pharmacists also do a medicine review so that gives them that 
funding opportunity to get funding from the government to go to 
patient’s homes to do this.  But then in the same sense, the main 
barrier of it here is that there is a specific funding for pharmacists to 
be GP pharmacists and that's why most of them use the HMR model 
for their funding and very few GP practices actually pay the 
pharmacists. They give funding from other sources to sponsor the GP 
pharmacists except for there are a few trials where they got specific 
money to pay the pharmacist to be in the GP practices so that 
certainly a barrier the fact that there’s no government funding for 
that.  And at the moment, there’s also, and our ability for 
pharmacists to claim from the government so in Australia the 
doctors can claim through Medicare for their items.  Pharmacies 




doing work that's not related to a community pharmacy is if they do 
a medication review and like I said a lot of GP pharmacists use that 
model to find and to work in GP practices.  So certainly the barrier is 
the fact that there is no government funding for that sort of role, 
directive government funding and whereas the other barrier is the 
fact that our main pharmacy ownership organisation which is the 
pharmacy guild, they do not really support GP pharmacists so they 
would rather let the community pharmacists sort of work closely 
with GP practices.  And in their opinion, if you are going to have a 
pharmacist working in a GP practice, that should be the community 
pharmacist so because they’re basically just looking after their own 
but that means that you're not giving other pharmacists the 
opportunity to take on this speciality role.    
00:11:10 S2 Just a little key points from this.  So basically at the moment, the GP’s 
are working for patients for home medication reviews to the GP 
pharmacists or community pharmacist? 
00:11:24 S1 Neither.  It’s unaccredited pharmacist so you need to have an 
additional qualification to do medication reviews.  And so you can be 
a community pharmacist or you can be, you don’t have to be a 
community pharmacist to do those medication reviews but you must 
have the additional credentialing to do this.  So what I tend to do is 
get pharmacist who do have this additional credentialing to work as 
the GP pharmacist because that means that they can use the home 
medicine review funding mechanism to pay them. 
00:12:05 S2 And this funding is for the practice? 
00:12:12 S1 No, the funding, yeah, some of the funding goes to the practice and 
some goes to the pharmacist so some of the funding so if the GP 
refer someone, they give money.  And then when the pharmacist do 
get money for to go and do the report and all of that so the 
government post both of them separately so that's why they use this 
model to fund GP pharmacists.    
00:12:41 S2 GP pharmacists but.... 
00:12:41 S1 That is actually a model intended for something else. 
00:12:46 S2 But to play this role and you performed this and especially you don’t 
need to be a GP pharmacist if I am right. 




00:12:56 S2 If I'm right, to perform this role or to do the medication review, you 
don’t need to be specifically a GP pharmacist. 
00:13:05 S1 Yes.  No, you don’t.  You can be an independent accredited 
pharmacist.  You can be, as long as you got this credential, you can 
go out and you’ve got to refer or you don’t have to be a GP 
pharmacist. 
00:13:17 S2 That's fine.  And there’s the open addition Pharmacy Guild so 
basically they are backing more like community pharmacists to go 
and perform this role. 
00:13:30 S1 Yes, yes.  So they’re not supporting GP pharmacists because in their 
opinion the community pharmacist is already fulfilling that role.  And 
in their opinion they say if there is scope to have a pharmacist in a 
GP practice then that pharmacist should be the same as the 
community pharmacist.  So maybe the community farmer just works 
in the community pharmacy three days a week and go and work in 
the GP practice two days a week.  So they don’t acknowledge the 
fact that maybe you need the independent pharmacist that can 
working in that practice, that can work with a lot of community 
pharmacist not only one you know.  So I think that's the main barrier 
for implementation in Australia is the fact that the guild is, because 
the reason they’re not supporting that model is because they don’t 
want the government to pay money for other pharmacist.  And they 
want all the money to go through to community pharmacies.  
00:14:27 S2 Community pharmacies, okay.  But in addition with the medication 
reviews with GP pharmacist can play the role as well like when... 
00:14:38 S1 Exactly. 
00:14:38 S2 …when running. 
00:14:48 S1 Yeah so a pharmacist working in a GP practice like you said they 
should have a lot of roles not only bring medication reviews which 
they actually need to go to the patients home to get the money from 
the government.  They can do lots of other things like developing 
protocols, doing some audits, a lot of other things but there is a 
government, the government pays for them to do it. 
00:15:15 S2 Is there any organisation or any settings who is supporting this role 
in Australia?  
00:15:21 S1 Yeah so like I said before we’ve got a number of professional 




pharmacist, the Pharmaceutical Society of Australia.  They support 
the role.  The Pharmacy Guild which basically looks just after the 
community pharmacy owners.  They’re not really support the role 
but PSA’s and I think our hospital pharmacy association is also in 
support of the role.     
00:15:52 S2 Alright.  That's fine.  Based on your research and work on this role, is 
there any competitive, have you got any comparison, how you 
compare this healthcare system with the other countries like Canada, 
New Zealand or England as well where this role is a bit more 
established than Australia?  
00:16:15 S1 We looked into some of the literature.  We didn’t directly compare 
but I mean certainly we are aware of the fact that there’s a much 
better model already in existence in England.  So Australia is sort of 
like I think piggy bagging on that model to try and get our model 
established.  So we certainly looked into what’s happening 
internationally and we’re aware that Australia is lagging behind.    
00:16:45 S2 That's fine.  And do you believe there is need of more research in 
this, and why do you think this is more important to have more 
regarding this role in Australia? 
00:16:58 S1 I think definitely.  I think there’s more research needed in terms of 
looking at not only the barriers and facilitators and all of that but 
then also specifically looking at what GP pharmacists are doing so 
our research looked at that a little bit so what tasks are they actually 
doing in the practice.  So there’s more research needed because that 
can help inform whether there are special training required for 
pharmacist working in GP practices and also they could have been 
informed potential future funding models so certainly I think there’s 
a lot of research needed, yeah. 
00:17:41 S2 Alright. That's fine. That’s the first section, I mean based on your 
experience of how thing are working in Australia, how there will be 
few questions about the future of GP pharmacists in Australia. So 
how you see the future, how you see the present system and will you 
see the future of the GP pharmacist role in the next 5 to 10 years 
while the things are developing out there.   
00:18:08 S1 I think it;s really an important role in Australia and I think all of the 
things that I've talked about before the professional organisations 
need to keep pushing for that.  And specifically also to provide 
another career option for pharmacist especially some of the younger 




out of university are quite frustrated with working in community 
pharmacies.  Not everybody likes that sort of business model and so 
certainly that would give them another option.  And so I think it’s a 
nice, it could be a nice career path and definitely yeah, probably 
need to be a bigger push to get it up and running and Australia.    
00:18:59 S2 And do you see government organisations they are backing this role 
any positive feedback from the government organisation about this? 
00:19:10 S1 Government I'm not so sure.  But some of the general practitioner 
organisations are very positive about it. 
00:19:20 S2 Have you contacted any GP or any division in the who has been 
working with the GP pharmacists and any feedback from them about 
this role? 
00:19:30 S1 I certainly in our previous research we talked to a lot of them and I 
know a few pharmacists who work in GP practices and they are very, 
I mean on for them it’s a  learning curve as well and they have 
different experiences depending on which practice they’re working 
on but generally it’s very professionally rewarding for them because I 
mean obviously they do have access to a lot more information about 
patients then they would otherwise not have access.  And the 
feedback that I got from them is a lot of them said that once I started 
to work at the practice not only the GP’s but also some of the other 
health professionals at the practice like the nurses really appreciate  
the value of pharmacists whereas previously they didn’t really quite 
realise what clinical pharmacists do have and you know how we can 
help with a range of aspects in a practice not clinical as well as 
protocol development and other areas as well.   
00:20:38 S2 And what about the GP’s feedback about, have you received any 
GP’s feedback?  
00:20:45 S1 Well I've been to conferences where they talked and very positive 
about it. I mean obviously the GP’s are the ones that actually are 
quite proactive and they’re the champions because the other ones 
don’t really have a pharmacist working in the practice so they love it. 
00:21:03 S2 Positive coming feedback from this side.  That's good.  And I mean in 
your research or in your experience,  how the patient sees, how they 
take this role I mean dealing with the GP pharmacist and the general 
practice.  Any experience about the patient feedback?   
00:21:24 S1 No, we didn’t talk to patients at all.   Some of the other pharmacists 




hurdle of explaining to the patients their role, the patients really do 
evaluate especially the ones that are looking after chronic patients 
and they say once they’ve sort of established, their practice tend to 
come to them first before they, because they realise seeing the 
pharmacist first will then help the GP to make better informed 
decisions.  So yeah, once I think they got past that initial questioning 
about what’s the pharmacist going to do and patients who 
understand the value.  
00:22:20 S2 Yah, the initial hurdle.  I understand.  That's my own personal 
experience as well because I have been working now for about four 
years now so yeah the initial [inaudible 00:22:30] then they were 
expecting GP’s or nurses to come across but now they really see 
many any issues and then follow up with the GP so yeah.  That's 
going to be a work flow. 
00:22:49 S1 Yes that workflow also for the other practice staff to understand how 
the workflow needs to be. 
00:22:58 S2 Yeah, definitely.  And just summarising all the questions now so it 
might be you have already answered this question but just to 
summarise it up.  So do you want to comment now how would you 
comment on the success and failure of the GP pharmacist role in 
Australia?   
00:23:20 S1 I mean it’s hard because like I say they’re currently doing some trials 
and certainly there are some research coming out to show it’s quite 
positive so it’s all sort of like pointing in the right direction.  The main 
hurdle is really to sort of try and get some sort of funding mechanism 
because we really need to make sure these dedicated funding for 
pharmacists to provide that service.  Some of the GP practices at the 
moment funded from the practice but my understanding is most of 
them actually use some medicine review money to support that role 
so they really need to look at how to sponsor pharmacist being in 
practices and sort of work on a model where depending on the size 
of the practice that would determine the allocation of the money. 
00:24:20 S2 One point was out here but you know the prescribing role of the 
pharmacist working as a presciber. What’s your views on the 
prescribing role of the pharmacist?   
00:24:32 S1 I think in collaboration with other health professionals like with the 
GP I think there can be some protocols around that.  But personally 
I'm a bit hesitant to give community pharmacists prescribing rights 




always say you need to separate dispensing from prescribing.  And 
moving that into that area we’ll start to cross the boundaries.  So I 
think certainly certain settings like for example in the emergency 
department where there are some models with pharmacists 
prescribing specific medication within protocols and within a medical 
team.  Yeah so to me that's, those sorts of models what they really 
should be looking at.  I'm not very, I'm a little bit hesitant to support 
pharmacists and community pharmacists starting to prescribe 
antibiotics and other medication because we’re not trained to be, to 
do diagnosis.     
00:26:01 S2 In England, because loads of pharmacists are working to prescribe 
[inaudible 00:26:08] but still you need the different doctors once the 
protocol Is set up then it can be followed by the GP pharmacists. 
00:26:22 S1 Yes and I think you know that that's a model that can work because 
I'm working with the healthcare team.  And even with continuing 
patients’ medication to chronic medication they’re still as a GP 
pharmacists you're still working within that team.  But compared to a 
community pharmacists that would work in isolation.   
00:26:43 S2 Isolation, yeah.  As the GP pharmacists it needs more sense to have 
the medication.  That's fine.  So just coming to the training, based on 
your role and experience, what training would you like to see for the 
pharmacists and through competency as a GP pharmacist...? 
00:27:08 S1 I think, yeah I mean obviously I’m not, I'm probably not informed 
enough to make some decisions around that.  But in Australia I think 
the model that we already have to train pharmacists to become, to 
do medication reviews so that whole credentialing process is quite 
robust and that would be adapted or training of GP pharmacists.  I 
don’t think any new graduate might have, they might have the 
clinical skills but they may not have the communication and the 
system skills to moving to that role.  So I do think it needs additional 
credentialing.    
00:27:55 S2 It’s more like that the overall training but there should be training 
that should be present out there in addition to the home medication 
review.   
00:28:07 S1 Yeah so it could be fairly similar to that but I certainly think it needs 




00:28:21 S2 Alright just last question, you have probably answered this one but 
any specific thing in Australia or international, any specific research 
expect on the GP pharmacist role? 
00:28:43 S1 I think I sort of already covered so I think there’s quite a number of 
aspects that could be looked at in terms of setting up to various 
facilitators and all of that but then also looking at the potential value 
of the pharmacy services.   
00:29:04 S2 That's fine.  Any other comments, any other addition you might have 
in this questionnaire but from your own experience if you want to 
add any other comments about this study or about this role or 
comparison between England and Australia? 
00:29:19 S1 No, I don’t have any other comments.  I think we’ve covered 
everything. 
00:29:24 S2 That's fine.  Thanks.  It has been really helpful.  I'm sure comparing it 
would be debatable from England it would be really helpful so thank 
you for your time.  I will transcribe this interview and if you want a 
copy, I can send you a copy of this interview if you want to add 
something to it or if you want to recommend, you can always let me 
know.  And I can change it and adjust it. 
00:30:02 S1 I don’t think I need to look at the transcript but what I would 
appreciate if once you sort of write it all up and you submit for 
publication if you can just keep me informed once you've got a 
paper. 
00:30:19 S2 Yeah, definitely. 
00:30:19 S1 I would like to get that. 
00:30:23 S2 I will definitely let you know once I have the completed this before 
submitting or before finalising, I will let you know and you can have a 
look into it with your views and if anything, needs changing.  
00:30:40 S1 Okay. 
00:30:41 S2 Okay.  Thanks Dr, Laetitita.  I'm really grateful for your time and lets 
hope for the best.  
00:30:48 S1 Okay. All the best with your research. 
00:30:53 S2 Thank you.  Yeah.  




00:30:55 S2 I'm in the, almost on the later stage and just finishing the final data 
and that will be used from Australia and just writing the analysis 
now. 
00:31:09 S1 Sounds good. 
00:31:11 S2 Thank you.  Thank you, Dr. Letititia. 





[End of Audio] 
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Timecode Speaker Transcript 
00:00:04 S1  




00:00:47 S1  
00:00:51 S2  
00:01:31 S1  
00:01:40 S2  
00:01:43 S1  
00:01:50   
00:01:51 S1  
00:02:00 S2  
00:02:04 S1 If you feel, there are two portions or two sections on the 
questionnaire.  One is about protection and challenges and the road 
of GP pharmacist.  We would start with the first section that’s 
protection and challenges.  And it’s more about how the perceptions 
or you know still about the GP pharmacist role and challenging case 
about this newly developed role, coming up in the family care health 
program so just starting with the first question.  So what is your view 
about the general practice structure in Australia?  Are there any gaps 
presented in that structure and the composed…? 
00:02:47 S2 Oops.  Just be careful.  I think we’re losing the connection? 
00:02:50 S1 Is it?  Can you hear me properly now? 
00:02:57 S2 Okay. If there's a problem, I’ll put my hand up and you're back now.  
So let’s talk before we lose the connection.  So I was fortunate to be 
working in Queensland when the first person, the first pharmacist 
was doing his PhD and investigating pharmacists in GP practice and 
that was Doctor Chris Freeman.  So that was around about 2012, 
2013.  And it was very exciting to hear from Chris about what he did 
and how he managed to really revolutionise practice in Australia.  He 
was I think the first GP pharmacist.  So from their point of view, that 
was very positive.  He seem to have, he seemed to play an extremely 
relevant role and help the doctors in many ways and also help the 
patients about a month or six weeks ago, I was invited to be an 
examiner on a panel for a nurse practitioner who was about to 
qualify, well a candidate who was about to qualify as a nurse 
practitioner specifically in a pain clinic that was focusing on people 
who had, I think it was an orthopaedic clinic.  So she was working 
under a specialist who did a lot of operations, back operations and 




coming into a role in general practice.  And interestingly, they didn’t 
have a pharmacist in that particular practice and that was one of the 
discussion points that came up as how valuable a pharmacist, even a 
part time pharmacist would be to give the nurse practitioner some 
guidance on some of the medicines so that’s just a short, my 
perception of, to answer that question. 
 
No clear answer about gaps but general statement that it will be 
useful 
00:05:00 S1 Alright, that’s fine.  That’s good.  So it was around about 2012 when 
the first GP pharmacist came.  It was this year so it was only about 
2012 when the first GP pharmacist came about.  
00:05:17 S2 Roughly about that.  I don’t know exactly but that when I was 
working at Queensland and I know he was busy doing his PhD around 
about that time. 
00:05:27 S1 Alright.  Fine, that’s good.  So I think you answered the second 
question as well.  It was about the perception of GP pharmacist role 
and how the GP pharmacist role can be bridging the gap in the 
healthcare system.  I mean based on your own experience from 
education, education wide, do you feel the importance of, this role 
can be important in the demographic…?  
 
Importance / expectations of GP pharmacist role / role specifications 
00:05:53 S2 I think there's a very valuable role.  It sort of has two sides to it.  One 
of it is assisting the GP’s with their continuing professional 
development and they continue education.  The other role is directly 
associated with the patients so I suppose you could say that even a 
third role is by taking on some of the things that doctors and nurses 
currently do, pharmacists can free up those other health 
professionals to specialise more in the things they do specifically and 
pharmacists can start working more and more with medications and 
optimising the use of medications.   
00:06:40 S1 That’s fine.  I mean what barriers facilitated or opportunities that GP 
pharmacists adapt in this role.  
00:06:50 S2 Well there are quite a lot of barriers and unfortunately there is 
sometimes a perception, can I call it a turf?  Would that make sense 
where the professions all seem to wanting to protect their own turf if 




kind of break down those barriers to actually show the benefits of 
pharmacists being able to expand their roles.  And one of the phrases 
that they use in Australia at the moment is, it’s not so much about 
expanding the role of the pharmacists because working with 
medicine is something we always have done but it’s about 
pharmacists practicing to their full scope of practice.  That’s the 
phrase that they're using. 
00:07:48 S1 So when they say to set up, is it more with the GP or any other 
healthcare property? 
00:07:57 S2 I think putting pharmacists into GP practice has a lot of benefits 
because then patients experience a holistic care especially if you got 
pharmacists, nurse and GP.  The turf war often happens when 
pharmacists are not incorporated into GP practice because then they 
start doing other services like vaccination, weight management, et 
cetera, et cetera.  They do that within community pharmacy and 
sometimes that is then seen as direct competition to services that 
GP’s also provide. 
00:08:40 S1 How do you feel the financial side as a barrier in Australia? 
00:08:47 S2 I'm not, actually I can’t comment on how pharmacists get paid so 
yeah, probably wouldn’t help if I were to comment on it because I 
don’t actually understand how the GP’s, how the pharmacists and 
GP’s get paid.  I do want to mention though just in case you're not 
aware of it, there is another system in place in Australia called home 
medication reviews. 
00:09:18 S1 Yeah, I've heard of them. 
00:09:19 S2 Okay so sometimes they had done inpatient’s homes and sometimes 
these medication reviews are done in what we call residential age 
care facilities.  And both of them have to be authorised by a doctor 
but both of them are actually paid for by the government.  So that’s 
another way where if a pharmacist is in a GP practice that’s another 
role that they can be playing and a service that they can be providing 
through the GP practice.  However the pharmacy profession also 
wants to enhance the roles of pharmacists so although there's a lot 
of support for GP’s, for pharmacists in GP practice, community 
pharmacists are also conscious that they need to be viable and 
sustainable.  They also need to provide these services directly from 
community pharmacies. 
00:10:30 S1 That’s fine.  That’s good.  Thanks.  Based on your own experience 




healthcare system of other countries?  How do you compare it with 
Australia from England or Canada or New Zealand?  And did it feel 
there is difference in the role of how the GP pharmacists are working 
in these countries?  If you have an experience on that.   
00:11:06 S2 Well the only experience I have as a I say is at conferences in 
Australia where we, and reading published papers and knowing 
some of the to work, pharmacist in GP practice so although I lived 
pharmacist in New Zealand, when I was living there, there was no 
pharmacist in a GP practice and I'm afraid I don’t know whether they 
have them yet or not.  It does seem to be picking up quite a lot in 
certain areas in Australia and in certain types of practices.  Often it’s 
on a part-time basis.  And I also see that quite a few of the practices 
will be having nurse practitioners doing, well in some ways, they do 
similar sort of roles but they focus more on patient care as a nurse 
would.  Whereas the GP’s will be looking specifically at drug 
interactions, optimising medications. (FUTURE) 
00:12:22 S1 That’s fine.  That’s good.  And why do you believe that certain area is 
important at the moment?  
00:12:30 S2 Well anything that is new needs to be monitored so there's definitely 
evaluation has to happen.  And when something is found to be good, 
it also provides opportunities to research how it can be modified and 
actually expanded into other areas.  (Research) 
00:12:52 S1 Yeah, I mean beginning, we see in England it is a very promising role 
at the moment because of the NHS policy, the thing about political 
and loads of [inaudible 00:13:07]. 
00:13:14 S2 I would imagine that in a system like England where you have the 
NHS because that’s very different to Australia where a lot of it is 
private.  I could see it working very well.  And it’s not that it doesn’t 
work well here.  It’s just the different financial model.  It’s a different 
economic model.   
00:13:36 S1 Thanks.  So that’s the first section.  And second section is more about 
the future of the GP pharmacist.  I mean based on your experience 
on papers or when you have shared the view or somebody had 
shared the views what the GP pharmacists, what do you see GP 
pharmacist’s role in Australia and if you want to just elaborate again 
about something for the people. 
00:14:06 S2 Sure.  I think that this is one of those things that might be specific for 
certain individuals.  It’s definitely an area of specialisation.  I don’t 




GP pharmacists because I think it’s something that certain people are 
very well suited to and can actually really build their own strength 
and develop very good knowledge in specific areas such as 
pathology, results and patient counselling so yeah.  I would see the 
sort of individualised potential.  
00:14:52 S1 Alright, yeah.  Can you hear me now? 
00:15:00 S2 Just, yeah you came back. 
00:15:04 S1 Are you finding developments for the role in this structure at the 
moment in Australia? (Government role) 
00:15:12 S2 In Australia, I haven’t heard so much about the government’s role 
because that all depends on, it depends very much on the 
spokespeople so basically the organisations, the group as in 
pharmacists and the organisation that represents medical doctors.  
And they will argue for whoever should be remunerated for the roles 
that they're doing so that’s how the government seems to get 
involved because there's only a certain amount of money and the 
government has to use that as best, for the best of the country. And 
as I understand at the moment, the pharmacists in GP practice 
seems to be more of a private arrangement. 
00:16:11 S1 That is more from on the structure of the general practice rather 
than in the support from the government at the moment. 
00:16:22 S2 That’s my understanding, yes, yup. 
00:16:26 S1 Alright, that’s good.  And I mean from the patient perspective, how 
do you see the role of GP pharmacist in the practice from a patient 
perspective? 
00:16:39 S2 From a patient’s perspective, am I looking at question eight? 
00:16:46 S1 Yes. 
00:16:48 S2 So that’s the patient’s feedback.  So if you look into collect feedback, 
I suppose it would just be in the usual way when you do surveys or 
questionnaires or interviews and at times just talking to people 
without formal evaluation is a good way to go.  And then there's the 
adult thing when something is working well, patients will come back 
and they will give positive feedback.  (No data) 
00:17:18 S1 That’s good.  Alright.  This might be a bit repeating the questions but 





00:17:32 S2 Well, I'm only going to draw on one example or two examples here 
that I've mentioned before so I know that because Dr. Chris Freeman 
is getting very busy with other things that he's involved in.  He's 
actually being able to expand his role, or maybe I shouldn’t say 
expand his role but he’s actually employed all the practices 
employed another pharmacist who can help him as he is very busy as 
he's currently the president of the Pharmaceutical Society.  So that’s 
a very good sign that other pharmacists are able to step into that 
role and similarly, I saw how well the nurse practitioner was 
prepared and had specialised in the area that she worked in, in the 
practice was the orthopaedic surgeon.  She had a very good 
knowledge of the patient’s, their problem, their nursing and their 
medications. 
00:18:39 S1 And based on your role or experience, what training what you like to 
see for the pharmacist or competency as GP pharmacist? 
00:18:48 S2 Well I think our undergraduate training gives them a fairly good basic 
training including looking at pathology and counselling and what we 
call quality use of medicine or optimising medicines.  Much of that 
experience actually occurs in practice so we can only provide to a 
certain level but it’s only once they get out in practice and actually 
get challenged in the workplace to see what they can do.  And also to 
see whether their knowledge is up to standard when compared to 
the knowledge of the other people practicing in a GP practice 
including the doctors and the nurses who are there. 
00:19:48 S1 In the in my knowledge from England let’s take a couple of training 
modules of the new structure made for the GP pharmacist role by 
opinion.  Have you seen some type of expert training module, the 
structure of the GP pharmacist in Australia? 
00:20:13 S2 Well, whether they're specifically for GP pharmacists I'm not sure but 
I know that the Pharmaceutical Society of Australia as well as two 
other organisations that specifically focus on professional 
development so including The Pharmacy Guild and one other 
organisation, there is a lot of very high standard training sort of self-
learning if I can use that word and modules that pharmacist can 
complete.  Also to become what we call an accredited pharmacist so 
that’s a person who does home medication reviews and also there's 
medication reviews in aged care facilities, you have to go through 
quite a rigorous extra training program where you submit a lot of 





00:21:27 S1 Just a couple of questions more.  So based on your own experience 
how GP pharmacist role change the overall perception about 
pharmacist in Australia at the moment it’s a new one for me? 
00:21:40 S2 I think definitely.  I think whenever there are new innovations in the 
profession, its members get very excited about new possibilities and 
other places where they could practice and people seem very keen 
to develop interprofessional and multidisciplinary approaches to 
working with patients so yes, I think it’s very positive. 
00:22:08 S1 And another repetitive question but can you briefly describe any 
potential you would like to see in GP pharmacists and how it will 
impact to improve the quality of the structure of the GP pharmacist 
role?  Any specific area where you want the research to be carried on 
for the GP pharmacist role? 
00:22:29 S2 I would like to see how positive results or the sharing of positive 
results and experiences can actually impact and encourage people to 
explore more interprofessional work because there is much good 
that could be done for the benefit of patients when GP’s and 
pharmacists work together.   
00:22:58 S1 Because I see from my own experience at the moment for GP nurses 
and pharmacist because what’s going on England at the moment, 
there was a bit of scary thing that came at the start from the role of 
the nurses.  But now there is much differentiation that has been 
done from the nurse.  Everything seems to be working in available 
scheme at the moment in England so yeah technically….   
00:23:35 S2 So maybe just to add to that would be what you’ve just mentioned, 
the differentiations so that one is quite clear what are the roles so 
that that expertise is built up and yeah becomes a speciality of that 
particular profession. 
00:23:55 S1 That’s good.  And just summarising now, any other comments you 
want to add, anything which might have been missed out from the 
questionnaire?  Is there anything you want to add on? 
00:24:06 S2 I think you’ve been very, I think you’ve covered a lot of things.  It 
would just be to reiterate that there would be certain limitations to 
what I’m able to provide but I've been happy to share my 
perceptions and there was definitely quite a lot of excitement when 
GP practice, pharmacists in GP practice first came about.  And it has 
also, I think there's a lot more focus now on all sorts of other roles 




actually encouraged people to start thinking what they can do in 
pharmacy practice so yeah. 
00:24:55 S1 It’s great I started only as a community pharmacist but even with the 
community pharmacist those roles can be found.  
00:25:05 S2 Lots of roles.  Alright. 
00:25:09 S1 Thanks for participating.  It was really knowledgeable.  It was really 
helpful to have you and hopefully once I will show you my data 
definitely I will share my study with you and at any moment if you 
want to change anything then let me know. 
00:25:29 S2 I will do that.  Thank you, Noshad.  It was a pleasure and best of luck 
with the work.  
00:25:36 S1 Thanks.  Thanks so much. 





[End of Audio] 
Duration 25 minutes and 40 seconds 
Appendix 20 
Written Statement by Nurse/Australia 
 
Evaluate expectations and perceptions of GP pharmacist role in England and Australia by 
key stakeholders – Maree Pulcinski Registered nurse Div. 1 
My initial views when a GP pharmacist was introduced to Blackburn Clinic was that it will be 
a great service as an educational resource and risk management for patients and Doctors.   
I did not have any initial reservations about the introduction of a pharmacist as I am very used 
to working within a team environment.    
I did not have any expectations about the professional skills or role of the pharmacist as it is 
not a role I have come across before.  Some challenges for nurses working in private GP clinic 
integrating a GP pharmacist into the team include: time constraints, workload and 
remembering to refer patients/pharmacist-related queries as I am used to dealing with these 
in my role as a clinic nurse.  It also takes time for relationships to develop and for 
understanding of each others skills and abilities to become apparent.  Delegation of roles in 




Development of this relationship is aided by willingness of both sides to communicate, 
collaborate, exchange ideas and direct workload to the person with most appropriate skill set.   
The key performance indicators to analyse GP pharmacist role should include: patient 
outcomes, clarity of medications, GP-pharmacist care plans, healthy at home- keeping 
patients at home and minimising risks for patients 
Some challenges include the lack of support for autonomy for health professionals other than 
doctors by the Australian health system.   For collaboration to work a lot more support needs 
to be built in to the system and there are differences between Private vs public infrastructure 
and resources.   
Factors influencing the success of integration of a pharmacist into GP practice include 
proximity, openness of the pharmacist to work with others and adapt to the way the clinic 
runs.  I have found the pharmacist approachable and easy to communicate with.  Because we 
have never had a pharmacist as part of the team it will take time to adapt and understand 
their scope of practice.    
The future role of GP pharmacists may include education, risk reduction, medication safety, 
training, quality activities and liaison with other health professionals.   
I feel we are still in the early stages of seeing how the role can evolve and an important part 
of this is improving the understanding about what services the pharmacist can provide.  
My perceptions about pharmacists have changed since seeing a pharmacist in a different and 
expanded role and having a better understanding of their skill set.  This improved 
understanding will lead to improvements in patient care as pharmacists contribute to the 
team management of patients.   
I think having a pharmacist as part of the team at a medical clinic is important as improved 









































Written Statement by GP/Australia 
 
Re: The Uk research project comparing GP pharmacist role in UK and Australia 
 
My experience as one of practice principals and directly involved in the GP Pharmacist role 
has been overwhelmingly positive. 
The GP pharmacist has filled a relevant and important role within our practice. We have been 
able to take advantage of the pharmacists’ experience and expertise to improve our own 
prescribing, enhance medication safety, educate our patients and staff and prevent negative 
outcomes through safer medication taking and reducing polypharmacy. 
These goals have been achieved through direct direct advice from pharmacist to GP, patient 
interviews with the pharmacist, home medication reviews and having the GP pharmacist 
presenting at our monthly clinical meetings. 
My only reservation of this role and its future ishow it will be funded beyond its current pilot 
program. The only current funding benefit that I can see is through promotion of home 
medication reviews. The lack of medicare funded consultation with the GP pharmacist makes 
the provision of a consulting room difficult to justify compared with the ability to lease the 




My conclusion however is that having a pharmacist working within a General practice is 
professionally stimulating and rewarding for both professions and of immense benefits to our 
patient. 
 
